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ZUSAMMENFASSUNG 
Mehrfach ungesättigte Fettsäuren (PUFAs), insbesondere die Omega-3-PUFAs 
Eicosapentaensäure (EPA) und Docosahexaensäure (DHA), zeigen vielfältige 
gesundheitsfördernde Wirkungen. Da eine hohe Nachfrage nach diesen PUFAs besteht, 
müssen nachhaltige Quellen für die Produktion im Industriemaßstab, wie z. B. die mikrobielle 
Fermentation, als Alternative zu Fischöl etabliert werden. Im Rahmen der vorliegenden Arbeit 
wurde die Fähigkeit von terrestrischen Myxobakterien, PUFAs mit Polyketidsynthasen 
verwandten PUFA-Synthasen de novo zu produzieren, intensiv studiert. Es wurden 
verschiedene Typen von PUFA-Biosynthesegenclustern identifiziert und ihre Produktspektren 
im Detail analysiert. Da die nativen Produzentenstämme biotechnologisch und genetisch 
schwer zugänglich sind, wurden Methoden der Synthetischen Biotechnologie zur 
erfolgreichen Übertragung und Expression der myxobakteriellen PUFA-Biosynthesewege in 
geeigneten Wirtsstämmen entwickelt. Neben dem myxobakteriellen Modellstamm 
Myxococcus xanthus haben sich Pseudomonas putida und die Fetthefe Yarrowia lipolytica als 
vielversprechende Wirtsstämme erwiesen. Um Einschränkungen bei der Effizienz der 
heterologen Expression von nativen Biosynthesewegen zu beheben, wurden erstmals auf 
künstlicher DNA basierte PUFA-Gencluster für die PUFA-Produktion in den rekombinanten 
Stämmen eingesetzt. Die heterologe Expression mutierter oder hybrider PUFA-Gencluster 
lieferte tiefere Einblicke in den Synthesemechanismus der PUFA-Synthasen. 
 
ABSTRACT 
2 
 
ABSTRACT 
Polyunsaturated fatty acids (PUFAs), in particular the omega-3 PUFAs eicosapentaenoic acid 
(EPA) and docosahexaenoic acid (DHA), are associated with several beneficial health effects. 
As there is a high demand for these PUFAs, sustainable sources for industrial-scale 
production, e. g. microbial fermentation, have to be established as an alternative to fish oil. In 
the present work, the capability of terrestrial myxobacteria to produce PUFAs de novo via 
polyketide synthase-like enzymes known as PUFA synthases was intensively studied. 
Different types of PUFA biosynthetic gene clusters were identified and the corresponding 
product spectra were analyzed in detail. Due to restricted biotechnological and genetic 
amenability of the native producer strains, Synthetic Biotechnology approaches have been 
developed to successfully transfer and express myxobacterial PUFA biosynthetic pathways 
into suitable host strains. In addition to the myxobacterial model strain Myxococcus xanthus, 
Pseudomonas putida and the oleaginous yeast Yarrowia lipolytica turned out as promising 
host strains. Limitations related to the efficacy of the heterologous expression of the native 
biosynthetic pathways were addressed for the first time by the usage of PUFA gene clusters 
based on artificial DNA for PUFA production in the recombinant strains. Heterologous 
expression of mutated or hybrid PUFA gene clusters provided deeper insights into the 
synthetic mechanism of PUFA synthases. 
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INTRODUCTION 
 
Polyunsaturated fatty acids (PUFAs) – Fatty acids with health benefits whose increasing 
demand requires sustainable sources 
Lipids are naturally occurring hydrophobic or amphiphilic small molecules that serve as 
energy storage, structural components of membranes, or signalling molecules [1]. Essential 
constituents of lipids represent the fatty acids, which are commonly aliphatic, straight-chain 
monocarboxylic acids with an even carbon number. However, there are some exceptions, such 
as ring containing fatty acids, branched-chain fatty acids with an iso-structure (methyl group 
at the penultimate carbon atom) or an anteiso-structure (methyl group on the third carbon 
from the end), odd-numbered fatty acids, hydroxy or epoxy fatty acids, to name but a few 
[2;3]. Fatty acids are termed saturated (SFAs) if they contain only carbon-carbon single 
bonds. In contrast, monounsaturated fatty acids (MUFAs) comprise an additional double 
bond, whereas polyunsaturated fatty acids (PUFAs) contain multiple double bonds. In the 
most abundant PUFAs, double bonds are in cis configuration and not conjugated, as they are 
separated by a methylene group. A simplified nomenclature specifies the chain length and 
number plus position of double bonds (Figure 1). Positions of double bonds are determined by 
the number of the first carbon atom that forms the double bond, indicated by “Δ”, counting 
from the carboxyl group carbon as number one. Since the double bonds are usually present at 
three carbons intervals, PUFAs alternatively can be described simply by indicating the 
number of double bonds and the position of the double bond closest to the terminal ω-carbon, 
indicated by “n”. The remainder of the double bond positions can then be inferred. 
 
 
Figure 1. Structures of selected long-chain polyunsaturated fatty acids (LC-PUFAs). 
Linoleic acid (LA)
(18:2Δ9,12; 18:2n-6)
γ-Linolenic acid (GLA)
(18:3Δ6,9,12; 18:3n-6)
Arachidonic acid (AA)
(20:4Δ5,8,11,14; 20:4n-6)
Eicosapentaenoic acid (EPA)
(20:5Δ5,8,11,14,17; 20:5n-3)
Docosahexaenoic acid (DHA)
(22:6Δ4,7,10,13,16,19; 22:6n-3)
α-Linolenic acid (ALA) 
(18:3Δ9,12,15; 18:3n-3)
Dihomo-γ-linolenic acid (DHGLA)
(20:3Δ8,11,14; 20:3n-6)
Figure 1. Structures of selected polyunsaturated fatty acids (PUFAs).
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The role of long-chain PUFAs (LC-PUFAs) in health is one of the most studied areas of 
nutrition science. The first observations were made in the 1960s when epidemiologists 
noticed that Greenland Eskimos had a low incidence of coronary heart disease. Compared to 
Danes, Greenland Eskimos had similar blood levels of total lipids but considerably higher 
blood levels of eicosapentaenoic acid (EPA, 20:5, n-3) and docosahexaenoic acid (DHA, 
22:6, n-3) as well as lower blood levels of linoleic acid (LA, 18:2, n-6) and arachidonic acid 
(AA, 20:4, n-6) [4]. Based on these findings, along with observations in other populations, 
such as in Japan, associations between intake of n-3 LC-PUFAs and cardiovascular diseases 
have been noted [5]. Numerous studies emphasize the prominent physiological roles of n-3 
and n-6 LC-PUFAs in different organs. For instance, the high content of AA, 
docosatetraenoic acid (DTA, 22:4, n-6), and DHA in the neuronal tissue implicates these fatty 
acids as critical for normal development and functioning of the brain [6;7]. DHA is the 
predominant LC-PUFA in the glycerophospholipids of the grey matter, whereas in white 
matter, there is a higher proportion of n-6 than of n-3 LC-PUFAs [6]. An essential biological 
function of LC-PUFAs is the formation of eicosanoids derived from n-6 and n-3 C20 PUFAs 
and of docosanoids derived from C22 PUFAs [8-15] (Figure 2).  
 
 
Figure 2. Formation of eicosanoids from dihomo-γ-linolenic acid (DHGLA), arachidonic acid (AA), and 
eicosapentaenoic acid (EPA) and docosanoids from docosahexaenoic acid (DHA) via cyclooxygenase 
(COX) and lipoxygenase (LOX) pathways.  
 
 
cell membrane phospholipids
DHGLA AA EPA DHA
phospholipase A2
1-series 
prostanoids
3-series 
leukotrienes
2-series 
prostanoids
4-series 
leukotrienes
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prostanoids
D-series 
resolvins & 
protectinslipoxins
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resolvins
COX LOX
anti-inflammatory
anti-inflammatory & pro-resolving
Figure 2. Formation of eicosanoids from dihomo-γ-linolenic acid (DHGLA), arachidonic acid (AA), and
eicosapentaenoic acid (EPA) and docosanoids from docosahexaenoic acid (DHA) via cyclooxygenase
(COX) and lipoxygenase (LOX) pathways.
anti-inflammatory
COX LOX COX LOX
LOX & aspirin-acetylated 
COX-2
LOX
5-series 
leukotrienes
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Low-grade inflammation induced by pro-inflammatory mediators, such as cytokines, has 
been identified as a key factor in the development of metabolic syndrome. This disorder is 
characterized by abdominal obesity, hypertension, dyslipidemia, and elevated fasting plasma 
glucose or insulin resistance and increases the risk of developing cardiovascular disease, 
particularly heart failure, as well as diabetes mellitus type 2 [16]. It may be possible that these 
chronic diseases can be prevented or treated by modulating the ratio of pro- and anti-
inflammatory eicosanoids [13]. In the formation of the eicosanoids and docosanoids, AA, 
EPA, and DHA compete for the same enzymes, COX and LOX [9] (Figure 2). As plasma 
lipids and cell membranes typically contain a higher proportion of AA than of EPA plus DHA 
[17], AA is the predominant substrate for these enzymes. However, it can be speculated that a 
higher concentration of EPA plus DHA could either antagonize AA metabolism or simply 
dilute out the concentration of AA and subsequently decrease the formation of the potent 
inflammatory and pro-aggregatory eicosanoids [18]. As the fatty composition in tissues 
reflects the fatty acid composition of the diet [19], it may be possible that the risk of chronic 
diseases can be reduced by a higher dietary intake of n-3 LC-PUFAs [9;13]. Based on these 
indications, it is hardly surprising that these fatty acids have gained increasing interest in 
nutritional research over the past decades. 
Due to the potential beneficial effects of n-3 LC-PUFAs on human health, several 
worldwide government and health organizations have made some recommendations for 
dietary intake of n-3 LC-PUFAs. The Food and Agriculture Organization of the United 
Nations (FAO) recommends intake of 250 mg to 2 g EPA and DHA per day [20]. The intake 
recommendation of the European Food Safety Authority (EFSA) as well as of the German 
Nutrition Society (DGE) corresponds to approximately 250 mg EPA and DHA per day 
[21;22]. Indeed, the real daily intake of these n-3 LC-PUFAs among Western populations is 
below these recommendations: According to the National Health and Nutrition Examination 
Survey 2009-2010, the mean daily intake of EPA and DHA was 90 mg among US-American 
women and 120 mg among US-American men [23]. Using data from the German Nutrition 
Survey 1998, the determined mean intake of EPA and DHA was 186 mg per day for German 
women and 255 mg for German men [24]. Dietary sources of LC-PUFAs are ubiquitous and 
vary widely among the different types of fatty acids. LA occurs in almost all dietary fats and 
represents a main component of most plant oils. α-linolenic acid (ALA, 18:3, n-3) is primarily 
present in vegetable oils, such as flaxseed oil, canola oil, and soybean oil, although its 
presence is usually much lower than that of LA [25]. AA is predominantly present in meat, 
poultry, and eggs [26]. The major sources of EPA and DHA are marine fish, especially oily 
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fish, such as cod, herring, mackerel, salmon, as well as sardine, and the corresponding fish 
oils [27].  
There has been a steady increase in fish production since 1950. In 2010, the total world 
production of fish and other seafood was 148.5 million tons (88.6 million tons from capture 
and 59.9 million tons from aquaculture), and of this, 86% were available for human 
consumption. The remaining 14% were destined for non-food products, mainly for the 
manufacture of fish meal and fish oil [28]. The total production of fish oils is approximately  
1 million tons per year. In 2007, 81.3% of all fish oil was used by the aquaculture industry to 
produce feed, and salmon farming alone used about 37% of all fish oil produced in 2008. The 
remaining 18.7% were processed into products for human consumption, mainly as fish oil 
capsules [20;29]. The principal problem in aquaculture is the unfavourable “fish in/fish out” 
ratio. For salmon farming, it is around 4:1. This means it takes about four kilograms of wild-
caught feeder fish to provide the fish meal or fish oil needed to raise one kilogram of salmon 
[30]. Intensive fishery activities, in order to supply fish for human consumption as well as to 
deliver feed for industrial fish farms and fish oil supplements, result in alarming effects on 
fish levels and on marine ecosystems [31]. Hence, neither wild nor farmed fish constitute a 
sustainable source of n-3 LC-PUFAs, and it seems improbable that this source can satisfy the 
keen and increasing demand for omega-3 products. These inferences are evidenced by actual 
market research: In 2013, global production of omega-3 products was estimated at 
2.49 million tons, worth US$ 4.5 billion and is forecasted to grow substantially in the next 
few years [32]. Moreover, fish oil shows substantial variability in composition and quality. In 
contrast to vegetable oils, it is susceptible to contamination with heavy metals, such as 
mercury and cadmium, and lipophilic organic chemicals, such as polychlorinated biphenyls 
(PCBs), organochlorine pesticides (OCPs), and polybrominated diphenyl ethers (PBDEs). 
These contaminants are typically bioaccumulated in the marine food network and lead to a 
biomagnification in the lipid fraction [33;34]. Furthermore, the usage of fish oil has become 
unpopular due to unpleasant odour and flavour, unsuitability for vegetarians, and expensive 
purification [35].  
In quest of alternative, sustainable sources of n-3 LC-PUFAs, vegetable oils produced by 
the reconstitution of n-3 LC-PUFA biosynthetic pathways in transgenic plants, are currently 
being developed [36]. Besides, microbial oils, also termed single cell oils, are of great 
commercial interest. Mainly, the primary n-3 LC-PUFA producers in the marine biota, 
microalgae, serve as uncontaminated source for the constant production of high-quality n-3 
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LC-PUFA-containing oils. An extensive number of microalgal species is capable of 
accumulating large amounts of n-3 LC-PUFAs. The heterotrophic thraustochytrids 
Schizochytrium sp., Thraustochytrium sp., and Ulkenia sp. as well as the heterotrophic 
dinoflagellate Crypthecodinium cohnii exhibit production of up to 52%, 37%, 38%, or 44% 
DHA of total fatty acids (TFAs), respectively, under improved cultivation conditions [37-40]. 
Photoautotrophic microalgae, such as the eustigmatophyte Nannochloropsis sp. and the 
diatom Phaeodactylum tricornutum, produce up to 30% or 36% EPA of TFAs, respectively, 
under improved cultivation conditions [41;42]. The commercial production of algal oil started 
with the large-scale fermentation of a Schizochytrium sp. strain by OmegaTech (USA) in the 
early 1990s. Since then, algae biotechnology has grown steadily with increasing numbers of 
companies attempting to develop production processes for a wide array of applications. 
Nowadays, DSM (The Netherlands) is probably the most prominent commercial producer of 
DHA-rich oil using both a Schizochytrium sp. strain and a Crypthecodinium cohnii strain. 
Similar DHA-rich oils are produced by Lonza (Switzerland) using an Ulkenia sp. strain, 
whereas Qualitas Health (Israel) uses a Nannochloropsis oculata strain to produce an EPA-
rich oil, to name but a few [43]. At present, achieving economically viable production of n-3 
LC-PUFAs by microalgae is still a major challenge and requires additional developments, 
especially in terms of improved large-scale fermentation processes ensuring optimal growth 
conditions for enhanced lipid biosynthesis [44]. Hence, as the ideal microorganism for 
industrial-scale production of single cell oils has obviously not yet been identified, further 
exploitation of the microbial biodiversity and screening for PUFA-producing microbes seems 
to be a reasonable approach.  
 
 
PUFA biosynthesis – Biosynthetic diversity by aerobic and anaerobic routes 
PUFAs can be biosynthesized via two principal pathways, the anaerobic route for de novo 
PUFA biosynthesis and the more common aerobic PUFA biosynthetic pathway. The latter 
operates in a wide range of organisms and utilises saturated fatty acids (SFAs) as biosynthetic 
precursors. Initially, synthesis of the SFAs is catalysed by fatty acid synthase (FAS;  
EC 2.3.1.85), which is found ubiquitously across all groups of organisms. The biosynthetic 
mechanism is strongly conserved between bacteria and eukaryotes, albeit the arrangement of 
the catalytic entities within the proteins differs [45]. There are two principal classes of FASs. 
Fungi and animals possess a type I FAS system, which consists of large, multifunctional 
polypeptides forming oligomers [46]. Type II FAS system is found in archaea, bacteria, and 
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plants and is characterized by the use of discrete, monofunctional enzymes [47]. The 
substrates of FAS are derived from the acetyl-coenzyme A (acetyl-CoA) pool. Typically, 
acetyl-CoA serves as starter molecule, whereas malonyl-CoA is required for all the elongation 
steps. Malonyl-CoA is formed by carboxylation of acetyl-CoA using acetyl-CoA carboxylase 
(EC 6.4.1.2) [48]. As a key feature of the fatty acid biosynthetic pathway, the starter molecule 
and the intermediates are covalently bound to a small, acidic protein called acyl carrier protein 
(ACP) [49]. Thereby, the carboxyl groups of the fatty acyl starter molecules or intermediates 
form a thioester linkage to the sulfhydryl group of the 4'-phosphopanthetheine (4'-PP) 
prosthetic group which in turn is linked to the active site serine of ACP through a 
phosphodiester bond. Thus, the apo-form of ACP has to be posttranslationally activated to the 
holo-form by transfer of the 4'-PP moiety from CoA to an invariant serine residue. This 
reaction is catalysed by a 4'-phosphopantetheinyl transferase (PPTase) [50] (Figure 3).  
 
 
Figure 3. Posttranslational modification of an acyl carrier protein (ACP) by a 4'-phosphopantetheinyl 
transferase (PPTase).  
The 4'-phosphopantetheine of coenzyme A (CoA) is transferred to a conserved serine of the inactive apo-ACP 
generating the active holo-ACP and adenosine 3',5'-bisphosphate (3',5'-ADP). 
 
 
The pathway proceeds in two stages, initiation and cyclic elongation (Figure 4). At the 
outset, acetyl transferase/malonyl transferase transfers the acetyl/malonyl group of acetyl-
CoA/malonyl-CoA to ACP. The first reaction in the elongation cycle is the decarboxylative 
Claisen condensation of malonyl-ACP with the acetyl group or the growing acyl chain at the 
active site cysteine of the β-ketoacyl-ACP synthase. This is the only irreversible step in the 
elongation cycle. The β-keto group is then reduced by sequential action of the NADPH (the 
reduced form of nicotinamide adenine dinucleotide phosphate)-dependent β-ketoacyl-ACP 
reductase, the β-hydroxyacyl-ACP dehydratase, and the NAD(P)H-dependent enoyl-ACP 
reductase to yield a saturated acyl product. This intermediate functions as a starter substrate 
for the next round of elongation with malonyl-ACP until the growing fatty acid chain reaches 
ACP
CoA     3',5'-ADP  
ACP
apo-ACP holo-ACP
Figure x. Posttranslational modification of an acyl carrier protein (ACP) by a 4'-phosphopantetheinyl
transferase (PPTase).
The 4'-phosphopantetheine of coenzyme A (CoA) is transferred to a conserved serine of the inactive apo-ACP
generating the active holo-ACP and adenosine 3',5'-bisphosphate (3',5'-ADP).
PPTase
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a length of 16 to 18 carbon atoms [51;52]. The product is either released from ACP as free 
fatty acid by a thioesterase [46] or the acyl chain is directly transferred from ACP into 
glycerophospholipids by various acyltransferase systems [53].  
 
 
Figure 4. Biosynthesis of saturated fatty acids (SFAs) by fatty acid synthase (FAS).  
The primer molecule (in the form of acetyl-CoA) undergoes several rounds of decarboxylative Claisen 
condensation reactions, resulting in the elongation of the fatty acyl chain by two carbons (derived from malonyl-
CoA) per cycle until the growing fatty acid chain reaches its final length. Following each round of elongation the 
β-keto group is fully reduced. 
 
 
Double bonds can be inserted into SFAs via the aerobic pathways by employing position-
specific desaturases and elongases, which allow for the introduction of more than one double 
bond per fatty acid. Fatty acid desaturases (EC 1.14.19.-) are usually membrane-bound, non-
heme iron-containing enzymes that introduce a double bond at a specific position in long-
chain fatty acids. This reaction requires molecular oxygen, NAD(P)H, as well as an electron 
transport system (cytochrome b5 reductase (EC 1.6.2.2) plus cytochrome b5 or ferredoxin-
NADP
+
 reductase (EC 1.18.1.2) plus ferredoxin). The action of the desaturases alternates with 
the activity of fatty acid elongases. Fatty acid elongases are very-long-chain β-ketoacyl-CoA 
synthases (EC 2.3.1.199) and catalyse the decarboxylative Claisen condensation of malonyl-
CoA with a LC-PUF acyl-CoA. The β-keto group is then reduced by sequential action of the 
distinct enzymes very-long-chain β-ketoacyl-CoA reductase (EC 1.1.1.330), very-long-chain 
β-hydroxyacyl-CoA dehydratase (EC 4.2.1.134), and very-long-chain enoyl-ACP reductase 
(EC 1.3.1.93) in a NADPH-dependent manner. Fatty acid desaturases and elongases are 
classified according to their regiospecificity: Δ-desaturases insert the double bond at a fixed 
position counted from the carboxyl group carbon, whereas Δ-elongases insert ethyl groups at 
a fixed position counted from the double bond closest to the carboxyl group carbon [54-56]. 
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Figure x. Biosynthesis of saturated fatty acids (SFAs) by fatty acid synthases (FASs).
The primer molecule (in the form of acetyl-CoA) undergoes several rounds of decarboxylative Claisen
condensation reactions, resulting in the elongation of the fatty acyl chain by two carbons (derived from malonyl-
CoA) per cycle until the growing fatty acid chain reaches its final length. Following each round of elongation the
β-keto group is fully reduced.
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Several aerobic LC-PUFA biosynthetic pathways, utilising diverse desaturases and 
elongases, have been identified in eukaryotes (Figure 5). After synthesis of stearic acid (SA, 
18:0) by FAS, vertebrates can readily introduce a double bond at the Δ9 position using Δ9 
desaturase to generate oleic acid (OA, 18:1, n-9). However, they cannot introduce additional 
double bonds between position Δ10 and the methyl terminal end. Thus, LA (18:2, n-6) and 
ALA (18:3, n-3) are essential fatty acids for vertebrates. They must be obtained from the 
consumption of plants, which can introduce double bonds at positions Δ12 and Δ15 using Δ12 
and Δ15 desaturases [55;56]. Once LA and ALA are absorbed from the diet, they can be 
further processed. Thereby, the Δ6 pathways are the conventional pathways, widely present in 
most eukaryotic organisms except for higher plants. These pathways need only Δ6 and Δ5 
desaturases and Δ6 elongase for the conversion of LA into γ-linolenic acid (GLA, 18:3, n-6), 
DHGLA (20:3, n-6), and finally AA (20:4, n-6) in the n-6 series or for the conversion of ALA 
into stearidonic acid (SDA, 18:4, n-3), eicosatetraenoic acid (ETA, 20:4, n-3), and finally 
EPA (20:5, n-3) [54] in the n-3 series. The two pathways are independent of each other, but 
there is competition for the conversions, since both pathways use the same enzymes. The 
predominant route for DHA biosynthesis in mammals represents the Sprecher pathway [57]. 
First, EPA is elongated to docosapentaenoic acid (DPA, 22:5, n-3) by Δ5 elongase, and then 
DPA is elongated to tetracosapentaenoic acid (TPA, 24:5, n-3) [57-59]. TPA is desaturated to 
yield tetracosahexaenoic acid (THA, 24:6, n-3) by the Δ6 desaturase which most likely also 
desaturates LA and ALA [60;61]. Finally, DHA is formed through shortening of THA by two 
carbon units during β-oxidation in the peroxisomes [58]. Alternative pathways for the aerobic 
biosynthesis of AA, EPA, and DHA (Figure 5) have been discovered and biochemically 
characterized in marine microalgae [62-65], in the protist Euglena gracilis [66;67], in 
oomycetes [68;69], in protozoan trypanosomes [70], and in a marine teleost fish [71].  
Albeit humans have the capacity to convert ALA to EPA and DHA, the efficiency of these 
conversions is low. Using a stable isotope tracer of ALA, the conversion rates of ALA to EPA 
(estimates are from 0.2 to 21%, depending on age and gender of the experimentee) and of 
ALA to DHA (estimates are from 0.05 to 9%, depending on age and gender of the 
experimentee) was determined in the plasma [72]. Hence, the conversion of ALA to EPA, 
especially the rate-limiting Δ6 desaturation, is the most restrictive step in this sequence and 
appears to strongly limit the production of EPA and DHA. Unlike LA, a large proportion of 
ingested ALA may be more readily degraded via β-oxidation then incorporated into the lipids 
[73;74]. The concentration of ALA in phospholipids in plasma and tissues is typically less 
than 0.5% of TFAs [75]. It seems most likely that this low content of ALA is not sufficient to 
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compete with LA for the Δ6 desaturase. Overall, ALA appears to be a limited source for 
longer chain n-3 PUFAs in humans. Thus, adequate dietary intake of n-3 LC-PUFAs, in 
particular DHA, may have physiological significance. 
 
 
Figure 5. Aerobic biosynthesis of the polyunsaturated fatty acids (PUFAs) arachidonic acid, 
eicosapentaenoic acid, and docosahexaenoic acid starting from stearic acid by a combination of 
alternating desaturation and elongation reactions.  
 
 
PUFA biosynthesis not necessarily requires the presence of fatty acid desaturases and 
elongases. In 1996, cloning, transfer, and expression of a gene cluster from the marine  
γ-Proteobacterium Shewanella pneumatophori SCRC-2738 in Escherichia coli led to 
heterologous EPA production [76]. Surprisingly, the cloned genes included no conserved 
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Figure x. Aerobic biosynthesis of polyunsaturated fatty acids (PUFAs) starting from stearic acid by a
combination of alternating desaturation and elongation reactions.
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sequences from fatty acid desaturase genes. These findings were very important and could be 
regarded as the first stage of research into alternative PUFA biosynthetic pathways. Detailed 
sequence analysis revealed that the gene cluster encodes iterative type I fatty acid synthase 
(FAS)/polyketide synthase (PKS)-like enzymes (Figure 6). Additional studies on heterologous 
expression of the genes demonstrated that EPA is produced via an anaerobic de novo 
synthesis from the substrates acetyl-CoA and/or malonyl-CoA and the coenzyme NADPH 
[77]. In the early 2000’s, PUFA (pfa) biosynthetic gene clusters encoding these multienzyme 
complexes, termed PUFA synthases, have also been identified and characterized from other 
marine γ-Proteobacteria, such as the EPA producer Photobacterium profundum SS9 [78] and 
the DHA producer Moritella marina MP-1 [79], as well as from the DHA and n-6 DPA 
producing microalgae Schizochytrium sp. ATCC 20888 [77;80] (Figure 6).  
 
 
Figure 6. PUFA biosynthetic gene clusters from marine γ-Proteobacteria and microalgae.  
(A) Shewanella pneumatophori SCRC-2738 (EPA producer), (B) Photobacterium profundum SS9 (EPA 
producer), (C) Moritella marina MP-1 (DHA producer), (D) Schizochytrium sp. ATCC 20888 (DHA and n-6 
DPA producer). 
 
 
The PUFA synthases from Shewanella pneumatophori SCRC-2738, Photobacterium 
profundum SS9, Moritella marina MP-1, and Schizochytrium sp. ATCC 20888 comprise 
enzymatic domains from FAS as well as from PKS (Figure 6). PKS is an evolutionary 
descendant of FAS, as both synthases share the same core of enzymatic activities [45;81]. 
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Hence, it is hardly surprising that LC-PUFA biosynthesis by PUFA synthases proceeds in a 
similar way as the biosynthesis of SFAs catalysed by FAS (Figure 7). Analogous to the fatty 
acid assembly line, the growing fatty acid chain is linked to the 4'-PP prosthetic group of ACP 
via a thioester bond. Therefore, the apo-form of ACP has to be posttranslationally activated to 
the holo-form by transfer of the 4'-PP moiety from CoA to an invariant serine residue. This 
reaction is catalysed by a 4'-phosphopantetheinyl transferase (PPTase) [50] (Figure 3). For 
Shewanella pneumatophori SCRC-2738, Photobacterium profundum SS9, and Moritella 
marina MP-1, Sfp-type PPTases have been found to be involved in LC-PUFA biosynthesis 
[82;83]. During PUFA biosynthesis, acetyl-CoA serves as starter molecule, whereas malonyl-
CoA, formed by carboxylation of acetyl-CoA using acetyl-CoA carboxylase (EC 6.4.1.2) 
[48], is required for all the elongation steps. The pathway is divided into two stages, initiation 
and cyclic elongation. In the initiation phase, an acyltransferase (AT) domain transfers the 
malonyl group of malonyl-CoA to an ACP. The first reaction in the elongation cycle is the 
decarboxylative Claisen condensation of malonyl-ACP with the acetyl group or the growing 
acyl chain at the active site cysteine of the ketosynthase (KS) domain. The β-keto group is 
then either fully reduced by sequential action of NADPH-dependent ketoreductase (KR) 
domain, PKS-like dehydratase (DH) domain, and NADPH-dependent enoyl reductase (ER) 
domain or only reduced to the trans double bond by the KR domain and a FabA-like DH 
domain and isomerized to the cis double bond by the latter domain. The intermediate then 
functions as a starter substrate for the next round of elongation with malonyl-ACP until the 
growing fatty acid chain with methylene-interrupted cis double bonds reaches its final length 
[84-86]. However, neither has the exact function and biosynthetic mechanism underlying 
every domain within the PUFA synthase complex yet been elucidated nor the relevant 
factor(s) that determine the nature of the final LC-PUFA product. The product is either 
released from ACP as free fatty acid by a discrete thioesterase [87;88] or the acyl chain is 
immediately directed from ACP into glycerophospholipids by various acyltransferase 
systems. Still, further studies are required to clarify the specific release mechanism. 
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Figure 7. Anaerobic biosynthesis of polyunsaturated fatty acids (PUFAs) by iterative type I fatty acid 
synthase (FAS)/polyketide synthase (PKS)-like PUFA synthases.  
The primer molecule (in the form of acetyl-CoA) undergoes several rounds of decarboxylative Claisen 
condensation reactions, resulting in the elongation of the fatty acyl chain by two carbons (derived from malonyl-
CoA) per cycle. Following each round of elongation, the β-keto group is either fully reduced or only reduced to 
the trans double bond which is then isomerized. Finally, an acyl chain with methylene-interrupted cis double 
bonds is synthesized. 
 
 
Taking a closer look at the domain organization of the PUFA synthases from Shewanella 
pneumatophori SCRC-2738, Photobacterium profundum SS9, Moritella marina MP-1, and 
Schizochytrium sp. ATCC 20888 (Figure 6) discloses that proteins PfaA and PFA1 represent 
iterative type I PKSs. These protein systems feature the presence of multiple active sites 
within a single polypeptide which are used repeatedly [89-91]. In concrete terms, the catalytic 
domains include a KS domain, an AT domain, tandem ACP domains, a KR domain, and a DH 
domain. Particularly, the tandem ACP domains are characteristic for PUFA synthases. Their 
number ranges from five to nine, and their solution structure reveals a beads-on-a-string 
configuration [92]. Proteins PfaC and PFA2 contain two KS domains which resemble KSα 
and KSβ of type II PKS. Type II PKSs are iteratively acting complexes of discrete 
monofunctional proteins [93]. In contrast to KSα, KSβ lacks the active site cysteine for the 
catalysis of the Claisen condensation and has also been termed chain length factor (CLF) [94-
96]. Other components of proteins PfaC and PFA3 are two DH domains which are 
homologous to the β-hydroxydecanoyl-ACP DH FabA from FAS of α- and γ-Proteobacteria, 
Figure x. Anaerobic biosynthesis of polyunsaturated fatty acids (PUFAs) by iterative type I fatty acid
synthase (FAS)/polyketide synthase (PKS)-like PUFA synthases.
The primer molecule (in the form of acetyl-CoA) undergoes several rounds of decarboxylative Claisen
condensation reactions, resulting in the elongation of the fatty acyl chain by two carbons (derived from malonyl-
CoA) per cycle. Following each round of elongation the β-keto group is either fully reduced or only reduced to
the trans double bond which is then isomerized. Finally, an acyl chain with methylene-interrupted cis double
bonds is synthesized.
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exhibiting both dehydratase and isomerase activity [52]. Adjacent to the FabA-like DH 
domains, two inactive DH' pseudo-domains have been recently identified, which might be 
responsible for the proper folding and the activity of the catalytic domains [97]. Interestingly, 
the ER domains of PfaD, PFA2, and PFA3 are phylogenetically distinct from ERs utilized in 
canonical fatty acid and polyketide biosynthesis. Instead, these ERs are homologous to trans-
ERs, such as PksE, involved in the biosynthesis of dihydrobacillaene from Bacillus subtilis 
[98;99], or TaN, involved in the biosynthesis of myxovirescin from Myxococcus xanthus 
DK1622 [100], among others.  
Since the discovery of the first pfa gene clusters, the abundance and wide distribution of 
pfa gene homologues, primarily in the marine habitat, could be demonstrated [101]. Extensive 
sequencing of microbial genomes has allowed for broad and advanced genome analyses 
among diverse microbial lineages and was enabled by inexpensive and rapid whole genome 
sequencing technologies called the next generation sequencing (NGS). The main principle in 
NGS involves the massively parallel sequencing of DNA molecules in a flow cell. The 
sequencing process takes place either in a continuous real-time manner or in a stepwise 
iterative process. Each clonal template or single molecule is independently sequenced and can 
be counted among the total sequences generated [102]. In a phylogenomic approach, all 
sequenced microbial genomes were analysed for the presence of FAS/PKS gene clusters 
homologous to those involved in LC-PUFA biosynthesis. At least 20 distinct types of pfa-like 
gene clusters have already been found in 45 microbial genera representing ten phyla, 
demonstrating the diversity and wide pervasion of these secondary fatty acid biosynthetic 
pathways. However, for most of the discovered pfa-like gene clusters, the biosynthetic 
products remain uncharacterized [103]. 
 
 
Myxobacteria – Not only prolific producers of secondary metabolites but also of PUFAs  
Myxobacteria are Gram-negative, rod-shaped slime bacteria belonging to the  
δ-Proteobacteria. Almost all myxobacteria are aerobic chemoorganotrophs [104]. They are 
commonly isolated from soil, dung, and decaying plant material but also from aquatic habitats 
and can inherently be found in all climate zones, vegetation belts, and altitudes [105]. A 
hallmark of myxobacterial behaviour is their ability to build a fruiting body by organizing the 
movements of thousands of cells under starvation conditions. Many of these cells then 
differentiate into myxospores, which are highly resistant to environmental stress factors as 
high temperature, desiccation, and UV radiation [106]. Myxobacteria are also noted for other 
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multicellular behaviours, such as swarming, rippling, elasticotaxis, and predation, which are 
unparalleled in the bacterial kingdom [107;108]. Moreover, they are prolific producers of 
novel secondary metabolites with imposing structural diversity, bioactivity, and modes-of-
action [109]. The vast majority of metabolites discovered to date are polyketides (PKs), such 
as the anti-fungal acetyl-CoA carboxylase inhibitor soraphen [110;111], non-ribosomally 
biosynthesized polypeptides (NRPs), such as the immunosuppressant and proteasome 
inhibitor argyrin [112;113], or hybrid PK/NRP metabolites. Intriguingly, more than 50% of 
the myxobacterial compounds incorporate both PK and NRP elements [114]. Interesting 
representatives are the cytotoxic inducer of tubulin polymerization epothilone [115;116] and 
the inhibitor of tubulin polymerization disorazol [117;118]. A notable example for structural 
diversity present within the basic scaffolds of myxobacterial compounds is the leupyrrin 
family of metabolites. The leupyrrins not only incorporate PK and NRP building blocks but 
an isoprenoid unit and a dicarboxylic acid [119-121]. In addition, some myxobacterial strains 
produce the lipophilic carboxylic acids maracin A or maracen A, which contain an ethinyl-
trans-vinyl ether (maracin A) or an α-chlorovinyl group (maracen A) as a very unusual 
structural element [122]. 
A sensible approach for the discovery of novel natural products is the exploitation of the 
myxobacterial biodiversity in order to find new producers. The phylogenetic classification of 
the novel myxobacterial isolates also comprises fatty acid analyses, since myxobacteria are 
equipped with a structural diversity in their fatty acids, which allows for their utilisation as 
biomarkers [123]. Thereby, it turned out that some myxobacteria are capable of producing 
PUFAs with a carbon chain length of ≥ C20. The strains Plesiocystis pacifica, Enhygromyxa 
salina, and Pseudenhygromyxa salsuginis from marine or estuarial environment were 
characterized for the production of up to 18% AA of TFAs [124-126]. In the terrestrial soil-
myxobacteria Phaselicystis flava and Sandaracinus amylolyticus, even up to 36% AA of 
TFAs have been found [127;128]. Remarkable amounts of EPA and DHA have been 
discovered in the novel terrestrial myxobacterial isolates termed Aetherobacter [129] (Figure 
8). As myxobacteria had turned out to abound in PK biosynthetic pathways, it can be 
speculated that PKS-like PUFA synthases might be involved in the biosynthesis of these  
LC-PUFAs. 
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Figure 8. Growth stages and potential for production of polyunsaturated fatty acids (PUFAs) of 
Aetherobacter fasciculatus (SBSr002) [129]. 
(A) Phase-dark vegetative cells, (B) Dissecting photomicrograph of swarming colony on agar, (C) Dissecting 
photomicrographs of fruiting bodies on agar, (D) Phase contrast photomicrographs of myxospores from crushed 
sporangioles, (E) GC-MS chromatogram of fatty acid methyl esters. Photos by courtesy of R. O. Garcia. 
 
 
Beyond the direct screening for new natural products, hidden biosynthetic potential of the 
genomes of both well-known and novel myxobacterial strains can be exploited via genome 
mining. Screening for biosynthetic gene clusters of new secondary metabolites as well as for 
pfa-like gene clusters is considerably facilitated if the complete genome sequence of the 
producer organism is available. The first myxobacterial genomes that were sequenced 
represent the genomes of M. xanthus DK1622, spanning 9.1 Mbp [130], and the genome of 
S. cellulosum So ce56, spanning 13.1 Mbp [131]. They are among the largest genomes yet 
known from bacteria. Nowadays, sequencing of the genomes from promising novel 
myxobacterial isolates is an established procedure, enabled by the rapid development of 
inexpensive and fast whole genome NGS technologies. Commonly, sequencing of 
myxobacterial genomes deploys 454 pyrosequencing or Illumina sequencing platforms. 
Illumina sequencing generates the highest throughput per run and lowest error rate of the 
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Figure x. Growth stages and production of polyunsaturated fatty acids (PUFAs) by Aetherobacter
fasciculatus (SBSr002) (Ref.).
(A) Phase-dark vegetative cells, (B) Dissecting photomicrograph of swarming colony on agar, (C) Dissecting
photomicrographs of fruiting bodies on agar, (D) Phase contrast photomicrographs of myxospores from crushed
sporangioles, (E) GC-MS chromatogram of fatty acid methyl esters. Photos by courtesy of R. O. Garcia.
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instruments but delivers shorter read lengths than those of the 454 sequencing [132]. 
However, assembly of the sequencing reads to longer contigs and scaffolds poses a challenge, 
since the large myxobacterial genomes comprise a plethora of repetitive sequences. In silico 
analysis of the obtained genome sequence often discloses that the myxobacterial strain 
encodes many more typical secondary metabolite biosynthetic gene clusters than expected 
based on the number of compounds previously isolated from the strain [130;131]. Different 
approaches have been elaborated for discovering the metabolic products of the so-called 
“cryptic” or “orphan” natural product biosynthetic gene clusters found within the genomes 
[133]. A rather generic approach for the determination of the products of cryptic biosynthetic 
gene clusters represents a gene knockout plus comparative metabolic profiling [134]. It 
involves targeted gene inactivations within the biosynthetic gene cluster hypothesized to be 
essential for metabolite biosynthesis. This process is followed by comparison of the 
metabolites in the culture supernatants or extracts of the wild type organism and the non-
producing mutant using appropriate analytical techniques, such as liquid chromatography-
mass spectrometry (LC-MS), and data evaluation supported by statistical tools. Metabolites 
present in the wild type but missing in the mutant are likely products of the cryptic gene 
cluster, which can be isolated and structurally characterized. Rhizopodin produced by 
Stigmatella aurantiaca Sg a15 [135] and myxoprincomide produced by M. xanthus DK1622 
[136] are examples of metabolites successfully discovered using this strategy.  
 
 
Synthetic Biotechnology approaches for the heterologous expression of polyketide 
biosynthetic genes – Characterization of the biosynthetic pathways and production 
enhancement 
Many natural PK producers are not readily amenable to a complete range of genetic 
methodologies without considerable time-consuming effort. Most of them are slow-growing 
compared with commonly used laboratory strains, often requiring a few weeks for both the 
accumulation of reasonable amounts of biomass and for a round of genetic manipulation. 
Based on these findings, lateral transfer of a pathway of interest into a well-developed 
surrogate host has become an attractive alternative to determine the products of orphan 
biosynthetic gene clusters, to overproduce natural products, and/or to modify biosynthetic 
pathways via genetic engineering. In case of the identification of an unknown product, the 
metabolic profiles of the heterologous host containing and lacking the cloned cryptic 
biosynthetic gene cluster are compared using appropriate analytical techniques. Metabolites 
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present in the host containing the gene cluster but absent in the host missing the cluster are 
likely products of the cryptic biosynthetic pathway, which can be purified and structurally 
characterized as in the first approach. Flaviolin produced by a type III PKS from S. cellulosum 
So ce56 which was expressed in Pseudomonas sp. as heterologous host [137] is an example of 
a metabolite that has been identified by this method. However, reconstitution of PK 
biosynthesis in heterologous hosts is challenging and imposes several requirements on the 
surrogate host. The recombinant genes have to be maintained and stably propagated as well as 
efficiently expressed via a suitable promoter in the host cell. As PKS genes are often GC-rich, 
it is additionally important that the GC-content and codon usage bias of the foreign genes and 
the host genome are matched to ensure a productive heterologous gene expression. The 
resulting gene products are often large multienzymes that require proper folding and assembly 
[138] along with posttranslational modification by a PPTase [50] to become functional. 
Besides, the biosynthetic precursors should be abundant in vivo at the correct time, and the 
host cell has to be protected against the possible toxicity of the overexpressed proteins or 
biosynthetic products.  
The common process of the heterologous expression of a biosynthetic gene cluster has 
been descriced [139;140] (Figure 9). The workflow typically starts with the isolation and 
cloning of the relevant genes. Traditionally, genomic libraries are constructed, using either 
cosmids/fosmids or bacterial artificial chromosomes (BACs), and screened for the genes of 
interest. Alternatively, new techniques have been developed that enable direct cloning of a 
gene cluster from the genomic DNA of the native producer into replicative plasmids for 
E. coli. In this case, cloning is accomplished either via transformation-associated 
recombination (TAR) in Saccharomyces cerevisiae [141;142] or via linear plus linear 
homologous recombination in E. coli [143]. The vectors can be further engineered by 
applying conventional cloning techniques or linear to circular homologous Red/ET 
recombination [144]. In doing so, partial gene clusters can be reconstituted, genes/domains 
can be inactivated, deleted, or replaced, and genetic elements adapted to the host organism, 
such as selection markers, genes for conjugation and/or integration, and heterologous 
promoters, can be inserted. Many different expression vectors are available for mobilisation 
and maintenance of the biosynthetic genes in the surrogate host. Depending on the chosen 
chassis, the genes can be located on autonomously replicating plasmids or on “suicide 
vectors”. The latter ones are not able to replicate in the host and can be designed for either 
site-specific integration into the genome via homologous recombination at a target locus or 
phage-mediated recombination at a specific recognition site or for random integration into the 
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genome via transposition. Despite successful heterologous expression of the biosynthetic 
genes, production yields of the natural product might be unsatisfactory as a result of 
insufficient amounts of precursors channelled into the recombinant pathway. This bottleneck 
can be encountered by precursor feeding or by metabolic engineering of the host organism in 
order to introduce genes encoding enzymes for precursor biosynthesis.  
The most straightforward way is the direct transfer of biosynthetic pathways from the 
native producers into related host organisms, such as from streptomycetes into related 
actinomycetes or from a myxobacterial native producer into a myxobacterial host strain. 
Usually, the original promoter structures, ribosome binding sites, and regulatory elements are 
functional in the closely related host organisms and can thus be used [145]. Nonetheless, 
exchange of the native promoter for a strong heterologous promoter often remarkably 
increases the production yield [140]. On the contrary, the genetically distant model strain 
E. coli is better studied from the physiological point of view and possesses the best developed 
molecular biology protocols, the most abundant genetic tool box, and well-optimized 
fermentation protocols using simple and inexpensive media. Additionally, pseudomonads also 
grow fast with simple nutrient demands, and their metabolic versatility has transformed them 
into promising organisms for the application in industrial biotechnology [146]. However, a 
drawback of these organisms is that they are not fertile producers of secondary metabolites. 
Hence, they often lack the intracellular machinery needed to make a wide range of natural 
products, such as a PPTase to activate ACPs from PKSs and/or biosynthetic pathways for the 
generation of special substrates for the PKSs. This might be a reason why there is a general 
tendency towards higher heterologous production levels of PKs when the host is 
phylogenetically close to the native producing strain [140]. Moreover, the high GC-content of 
PKS genes from actinomycetes and myxobacteria leads to an inappropriate bias in codon 
usage that usually causes poor translation of the proteins in host organisms with less GC-rich 
genomes. Ergo, engineering of natural PKS gene clusters and regulatory DNA sequences 
located on expression constructions via recombinant DNA technologies in order to optimally 
address the demands of a specific host organism is challenging and associated with several 
limitations. 
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Figure 9. Simplified workflow for the heterologous expression of either a native or a de novo designed and 
synthesized biosynthetic gene cluster. 
 
 
Advances in sequencing and error-free chemical synthesis of long DNA molecules enable 
sophisticated bottom-up engineering and construction of large biosynthetic pathways 
independent from physically existing DNA from natural sources. This emerging field of 
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Figure x. Simplified workflow for the heterologous expression of either a native or a de novo designed and
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research is subsumed under the term “Synthetic Biology”. By applying engineering principles 
to biology, new biological parts, such as enzymes, genetic circuits, and cells, can be designed 
as well as constructed, and existing, natural biological systems can be redesigned for useful 
purposes (Figure 9). The biotechnological production of huge amounts of artemisinin 
precursors in transgenic strains of both E. coli [147] and S. cerevisiae [148;149] is the most 
prominent example of how this approach improves manufacturing of natural products. Means 
of Synthetic Biology can also be applied to PK biosynthetic pathways. In practical terms, 
DNA encoding various sections of PKS genes can be synthesized inclusive of desired 
manipulations of the codon bias plus deletion or insertion of restriction sites without changing 
the encoded protein sequence. In this way, the complete erythromycin biosynthetic pathway, 
comprising 32 kb of contiguous DNA, was synthesized and assembled using conventional 
cloning techniques. Eventually, the artificial gene cluster was functionally expressed in E. coli 
[150;151]. Similarly, synthetic 58 kb epothilone biosynthetic pathways were constructed and 
functionally expressed in E. coli [138] and M. xanthus [152]. Unfortunately, the achieved 
production titres were found very low [152], even after engineering of the E. coli host strain 
[153]. Nevertheless, this method is very powerful and provides the possibility to generate a 
toolbox of several artificial PKS genes from different biosynthetic gene clusters. The 
combination of the synthetic genes or intragenic regions can then generate novel hybrid 
pathways to produce new compounds.  
 
 
 
Outline of the dissertation 
The aim of this thesis was to increase the body of knowledge of myxobacterial PUFA 
biosynthesis and to enhance the PUFA production yield by heterologous expression of the 
PUFA biosynthetic pathways. In doing so, PUFA biosynthetic pathways from different 
myxobacteria were identified and characterized. Either the native pathways were cloned by 
genetic engineering or artificial pathways were synthesised and assembled prior to their 
transfer and expression into various host organisms. The PUFA production rate could be 
further improved by metabolic engineering of the heterologous host. 
PUFA biosynthetic pathways from several terrestrial myxobacteria were deciphered and 
analysed in silico in comparison to PUFA biosynthetic pathways described from marine  
γ-Proteobacteria and microalgae. Two distinct types of PUFA biosynthetic gene clusters 
encoding PUFA synthases were identified, originating from linoleic acid producing 
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myxobacteria of the genus Sorangium as well as from species of the recently discovered 
myxobacterial genus Aetherobacter, that turned out to be prolific producers of EPA and DHA. 
This most likely represents the first detailed characterization of LC-PUFA production based 
on pfa gene clusters of non-marine origin. Evaluation of PUFA production profiles included 
the successful establishment of heterologous expression systems using M. xanthus as host 
strain. The insights gained by this study are presented in Chapter 1. 
Additionally, S. cellulosum strains not only producing LA but also PUFAs with a longer 
chain, mainly EPA, were identified. The corresponding novel PUFA biosynthetic pathway 
from terrestrial myxobacteria was deciphered and analysed in silico in comparison to the 
formerly known myxobacterial PUFA pathways. Evaluation of LC-PUFA production profiles, 
including application of the formerly established heterologous expression system using 
M. xanthus as host strain for selected pathways and hybrids thereof, provided indications how 
myxobacteria employ three different types of PUFA synthases to generate different fatty acid 
profiles. These findings are summarised in Chapter 2. 
Heterologous expression of the pfa gene cluster from Aetherobacter fasciculatus 
(SBSr002) was accomplished in the phylogenetically distant hosts E. coli and Pseudomonas 
putida. Using the same initial expression constructs, P. putida turned out to be the host strain 
with the higher heterologous production rate of n-6 DPA and DHA per se. Consequently, 
efforts were undertaken to further improve the yield of LC-PUFAs in P. putida. Modification 
of the expression constructs to increase the expression rate of the pfa genes as well as genetic 
and metabolic engineering of the strain then led to success, as illustrated in Chapter 3. 
Since advantages and potential of Synthetic Biology approaches for heterologous 
expression systems appear attractive and promising, they were applied to the optimization of 
recombinant LC-PUFA production. Hence, artificial pfa gene clusters originating from 
A. fasciculatus (SBSr002), responsible for the biosynthesis of mainly DHA, were redesigned, 
synthesized, and assembled for P. putida. Successful transfer of the expression constructs and 
heterologous expression accomplished in the engineered host strain. This instance most 
probably represents the first polyketide biosynthetic gene cluster adapted and synthesized for 
this microbe and is described in Chapter 4. 
Modern techniques connected with Synthetic Biology provide the opportunity to transfer 
and express entire gene clusters from a certain organism into entirely unrelated organisms 
with very different evolutionary histories. For this purpose, an artificial pfa gene cluster plus a 
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PPTase gene originating from A. fasciculatus (SBSr002) responsible for the biosynthesis of 
mainly DHA were redesigned, synthesized, and assembled for the oleaginous yeast Yarrowia 
lipolytica. Successful transfer of the expression construct and heterologous expression was 
accomplished in the host strain. It is highly likely that this example, reported in Chapter 5, 
represents the first polyketide biosynthetic gene cluster adapted and synthesized for this yeast. 
The essentiality of selected Pfa protein domains as well as the factor determining the chain 
length of the produced LC-PUFAs was investigated by heterologous expression of mutated or 
chimeric versions of myxobacterial pfa gene clusters in E. coli, P. putida, and Y. lipolytica. In 
addition, efforts were undertaken to prove the function of the unique 1-acylglycerol-3-
phosphate O-acyltransferase (AGPAT) domain from myxobacterial PUFA synthases in vitro. 
The results of these studies are displayed in Chapter 6. 
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Polyunsaturated fatty acid biosynthesis in 
myxobacteria: Different PUFA synthases and their 
product diversity 
 
Gemperlein K, Rachid S, Garcia RO, Wenzel SC, & Müller R (2014)  
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ABSTRACT 
Polyunsaturated fatty acids (PUFAs), particularly the omega-3 long-chain PUFAs (LC-
PUFAs) eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), are well known for 
their beneficial health effects. The obvious limitation of the present EPA/DHA key source, 
fish oil, demands for alternative and sustainable PUFA resources and several biotechnological 
approaches addressing this problem are currently under development. Different marine 
microorganisms are known to produce PUFAs de novo under strictly anaerobic conditions 
employing polyketide synthase (PKS)-like enzymes known as PUFA synthases. Here, we 
report for the first time the characterization of such PUFA synthases from terrestrial origin. 
Two distinct types of PUFA biosynthetic gene clusters were discovered, originating from 
linoleic acid producing myxobacteria of the genus Sorangium as well as from species of the 
recently discovered myxobacterial genus Aetherobacter, that turned out to be prolific 
producers of EPA and DHA. The identified biosynthetic pathways differ significantly from 
the marine systems in terms of gene organization, catalytic domain arrangement, and 
sequence identity of the encoded PUFA synthases. Notably, a unique domain, which most 
likely acts as 1-acylglycerol-3-phosphate O-acyltransferase, was identified in these 
myxobacterial PUFA synthases. As the native producer strains grow slowly, are difficult to 
handle, and genetic modification has proven difficult, synthetic biotechnology approaches 
were applied to establish a heterologous production platform in the myxobacterial model 
strain Myxococcus xanthus. 
 
 
 
INTRODUCTION 
Long-chain polyunsaturated fatty acids (LC-PUFAs), including n-3 and n-6 long-chain fatty 
acids, are inherent constituents of nutritional research and have gained increasing scientific 
interest over the past decade. Numerous studies address beneficial effects of LC-PUFAs on 
human health. In particular, the n-3 LC-PUFAs eicosapentaenoic acid (EPA, 20:5, n-3) and 
docosahexaenoic acid (DHA, 22:6, n-3) are associated with prevention and treatment of 
cardiovascular diseases, obesity, and diabetes due to their blood pressure-lowering and anti-
inflammatory properties [1]. They have been shown to inhibit the formation of pro-
inflammatory eicosanoids derived from n-6 long-chain fatty acids, such as arachidonic acid 
(AA, 20:4, n-6), and to promote the formation of endogenous anti-inflammatory and pro-
resolving lipid mediators [2;3]. 
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As awareness towards beneficial properties of n-3 LC-PUFAs increases, the demand for 
dietary PUFA supplements has risen intensely over the past few years and will most likely 
continue to grow significantly. Fish oil is the most abundant and widely used natural source 
for EPA and DHA these days. However, since the supply of high quality fish oil is 
significantly declining, it is necessary to establish alternative and sustainable biological 
sources [4]. Of great interest are the prokaryotic and eukaryotic microorganisms capable of 
producing LC-PUFAs in high amounts [5]. To make use of their biosynthetic capacity and to 
develop suitable biotechnological production processes, the characterization of the involved 
biosynthetic pathways is of crucial importance. The most prominent and predominant 
pathways in eukaryotic PUFA producers represent the aerobic pathways, that combine several 
oxygen-dependent desaturases and elongases for the conversion of saturated fatty acids into 
PUFAs [6]. An alternative pathway was discovered in marine microbes that employs iterative 
type I fatty acid synthase (FAS)/polyketide synthase (PKS)-like enzymes (PUFA synthases) 
for de novo biosynthesis of LC-PUFAs from acyl-CoA precursors under strictly anaerobic 
conditions [7-9] (Figure 2A). The biosynthetic machineries are encoded by PUFA (pfa) 
biosynthetic gene clusters, initially identified and characterized from marine γ-Proteobacteria 
and microalgae: Shewanella pneumatophori SCRC-2738 and Photobacterium profundum SS9 
both produce EPA [10;11], Moritella marina MP-1 is known as DHA producer [12], whereas 
Schizochytrium sp. ATCC 20888 produces both DHA and n-6 docosapentaenoic acid (DPA, 
22:5) [10;13]. The increasing availability of genome sequence data facilitates the screening 
for pfa-like gene clusters in other microbes. In a phylogenomic approach, the abundance and 
wide distribution of pfa gene homologues, especially in the marine habitat, could be 
demonstrated [14]. As a consequence, at least 20 distinct types of pfa-like gene clusters have 
already been found in numerous microbial genera. However, for most of them, the 
biosynthetic products remain uncharacterized [15]. 
A promising strategy to correlate biosynthetic pathway sequences with products is their 
transfer and expression in suitable heterologous host organisms, which was also applied on 
several marine PUFA pathways. Heterologous expression of pfa gene clusters from 
Shewanella pneumatophori SCRC-2738, M. marina MP-1, or Schizochytrium sp. in 
Escherichia coli and Synechococcus sp. led to the recombinant production of EPA, n-6 DPA, 
and/or DHA and hereby enabled the correlation of the pfa gene cluster with the respective 
LC-PUFA product [13;16-18]. In addition, the established expression systems provide a 
valuable basis for a more detailed characterization of the biosynthetic pathways and the 
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opportunity to further exploit these systems for the establishment of biotechnological PUFA 
production processes [14]. 
Here we discuss our studies on PUFA biosynthesis in myxobacteria, which represent, to 
the best of our knowledge, the first detailed characterization of LC-PUFA production based 
on pfa gene clusters of non-marine origin. PUFA biosynthetic pathways from several 
terrestrial myxobacteria were deciphered and analysed in silico in comparison to the described 
marine PUFA pathways. Evaluation of PUFA production profiles including the establishment 
of heterologous expression systems for selected pathways revealed insights in how 
myxobacteria employ two different types of PUFA synthases to generate different fatty acid 
profiles. 
 
 
 
EXPERIMENTAL PROCEDURES 
 
Culture conditions 
Aetherobacter sp. (SBSr001), Aetherobacter fasciculatus (SBSr002), Aetherobacter rufus 
(SBSr003), and Aetherobacter sp. (SBSr008) were obtained from the Department of 
Microbial Natural Products, Helmholtz Institute for Pharmaceutical Research Saarland, 
Helmholtz Centre for Infection Research and Pharmaceutical Biotechnology, Saarland 
University, Saarbrücken, Germany. They were grown in liquid MD1G-5gC-medium 
containing 0.5% casitone, 0.05% CaCl2 x 2 H2O, 0.2% MgSO4 x 7 H2O, and 0.35% glucose. 
The medium was adjusted to pH 7.0 with KOH. The cultures were incubated on a rotary 
shaker for 5-10 days at 30 °C and 200 rpm. 
S. cellulosum So ce56, So ce10, So ce1525, So ce377, So ce38, So ce487, So ce836, and 
So ceGT47 were generously provided by the Department of Microbial Drugs, Helmholtz 
Centre for Infection Research, Braunschweig, Germany. They were grown in liquid M-
medium containing 1% phytone peptone, 1% maltose, 0.1% CaCl2 x 2 H2O, 0.1% MgSO4 x  
7 H2O, and 50 mM HEPES. The medium was adjusted to pH 7.2 with NaOH and 
supplemented with 8 mg/l NaFe-EDTA after autoclaving. The cultures were incubated on a 
rotary shaker for 5-10 days at 30 °C and 200 rpm.  
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Myxococcus xanthus DK1622 [19] was grown in CTT-medium or on CTT-agar containing 
1% casitone, 10 mM Tris, 1 mM KPO4 buffer, 8 mM MgSO4 (and 1.5% agar). The medium 
was adjusted to pH 7.6. The cultures were incubated for 2-3 days at 30°C (and 200 rpm). 
Escherichia coli DH10B [20] was used for cloning experiments. E. coli GB05-dir [21] was 
used for direct cloning experiments. E. coli HS996/pSC101-BAD-gbaA (tet
R
) [22] was used 
for modification of a plasmid using Red/ET recombination. The cells were grown in LB-
medium or on LB-agar (1% tryptone, 0.5% yeast extract, 0.5% NaCl (1.5% agar)) at 30-37 °C 
(and 200 rpm) overnight. Antibiotics were used at the following concentrations: 100 µg/ml 
ampicillin, 80 µg/ml spectinomycin, 50 µg/ml kanamycin, 20 µg/ml zeocin, and 6 µg/ml 
tetracycline. 
 
 
Isolation of genomic DNA from myxobacteria 
100 ml of a culture were harvested at 8,000 rpm for 10 min at room temperature. After 
discarding the supernatant completely, the cells were washed once with 15 ml SET buffer 
(75 mM NaCl, 25 mM EDTA, 20 mM Tris-Cl pH 7.5), pelleted at 8,000 rpm for 10 min at 
room temperature, and resuspended in 5 ml SET buffer afterwards. 50 µl RNase A stock 
solution (10 mg/ml in sterile ddH2O) and 300 µl Proteinase K solution (10 mg/ml in 50 mM 
Tris-Cl pH 8.0, 1 mM CaCl2) were added, and the tube was inverted several times. 
Subsequently, 600 µl 10% SDS were added, and the tube was incubated first at 41 °C for 
1.5 h and afterwards at 55 °C for 1 h under rotation in a hybridization oven. Thereafter, one 
volume phenol:chloroform:isoamyl alcohol (25:24:1) was added, and the mixture was 
incubated at 5 rpm for 1 h on a tube rotator. The tube was centrifuged at 8,000 rpm for 5 min 
at room temperature, and the upper phase was transferred into a new tube by using an end-cut 
1 ml-tip. The extraction step with phenol:chloroform:isoamyl alcohol (25:24:1) was repeated 
once. Then, one volume chloroform:isoamyl alcohol (24:1) was added to the supernatant, and 
the mixture was incubated at 5 rpm for 1 h on a tube rotator. The tube was centrifuged at 
14,000 rpm for 10 min at room temperature, and 4 ml of the upper phase were transferred into 
a new tube by using an end-cut 1 ml-tip. 440 µl 3 M sodium acetate pH 7.5 were added, and 
the tube was inverted several times. After adding 11 ml ice-cold ethanol, the tube was 
inverted until the appearance of cotton-like DNA. The DNA was collected by wrapping 
around the tip of a Pasteur pipette. In order to wash the DNA, the tip of the pipette with DNA 
was immersed into a 2 ml tube containing 70% ethanol. The DNA pellet on the pipette was 
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dried by carefully attaching the inner site of a fresh 2 ml tube to remove the ethanol drops and 
suspended in 0.5-1 ml of 10 mM Tris-Cl pH 8.0. 
 
 
General molecular biology techniques  
Routine handling of nucleic acids, such as isolation of genomic and plasmid DNA, restriction 
endonuclease digestions, DNA ligations, and other DNA manipulations, were performed 
according to standard protocols [23]. All the enzymes were purchased from Thermo Scientific 
or New England Biolabs. 
 
 
Cloning of expression constructs for heterologous PUFA production using linear plus 
linear homologous recombination and linear plus circular homologous recombination 
For direct cloning of the pfa gene cluster from S. cellulosum So ce56, a 3.3 kb vector 
backbone containing the colE1 origin of replication, an ampicillin resistance gene, a 
tetracycline promoter plus a gene encoding the TetR transcriptional regulator, as well as the 
appropriate homology arms were amplified from plasmid pGB-amp-Ptet [21] using primers 
So ce-PKS-ET-up and So ce-PKS-ET-dn (Table 1). PCR was performed with Taq DNA 
polymerase (Thermo Scientific) and standard conditions according to the manufacturer’s 
protocol. The reactions contained 5% DMSO and were carried out in an Eppendorf 
Mastercycler under the following conditions: initial denaturation for 2 min at 95 °C; 30 cycles 
consisting of denaturation for 30 s at 95 °C, annealing for 20 s at 60 °C, and extension for 
1 min/kb at 72 °C; and a final extension for 10 min at 72 °C. For linear plus linear 
homologous recombination, 1.4 ml LB-medium in a 1.5 ml tube were inoculated with a GB05-
dir overnight culture and incubated in a heating block at 37 °C with shaking at 1,000 rpm until 
OD600 ~0.2. Afterwards, expression of recETgA was induced by adding 20 µl of 20%  
L-arabinose, and the incubation was continued at 37 °C and 1,000 rpm until OD600 ~0.5. The 
cells were harvested at 9,000 rpm for 30 s at 2 °C. After discarding the supernatant, the cells 
were resuspended in 1 ml ice-cooled sterile ddH2O on ice. The cells were spun down at  
9,000 rpm for 30 s at 2 °C, and the supernatant was discarded. The washing step was repeated 
once. The supernatant was discarded leaving around 20-30 µl sterile ddH2O in the tube, and the 
cells were resuspended with it. 0.5-1 µg of the PCR product plus 3-6 µg of genomic DNA of 
So ce56, completely digested with NheI and ScaI, were added. The cells were electroporated in 
an ice-cooled electroporation cuvette (1 mm) using an Eppendorf electroporator at 1,300 V. 1 ml 
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LB-medium was added into the cuvette, and the cell suspension was transferred back into the 
tube. After incubation in a heating block at 37 °C with shaking at 1,000 rpm for about 70 min, 
the cells were plated onto LB-agar containing 100 µg/ml ampicillin. The plates were incubated at 
37 °C overnight. The colonies that grew under selection for the antibiotic resistance gene were 
examined for the intended direct cloning product pGB-Ptet-Soce-PKS (Table 2) by restriction 
analysis with a set of different enzymes. Further modification of the vector backbone was 
performed by Red/ET recombineering using a DNA fragment containing the mariner 
transposase gene with corresponding inverted repeats, a blasticidin resistance gene, an origin 
of transfer, the p15A origin of replication, a neomycin resistance gene driven by Tn5 
promoter, as well as the appropriate homology arms derived from p15A-epo-IR-Tps-bsd-oriT-
IR-kan [24] digested with BamHI. For linear plus circular homologous recombination, 1.4 ml 
LB-medium in a 1.5 ml tube were inoculated with a HS996/pSC101-BAD-gbaA overnight 
culture harbouring the plasmid to be modified and incubated in a heating block at 30 °C with 
shaking at 1,000 rpm until OD600 ~0.2. Afterwards, expression of the recombinases was induced 
by adding 14 µl of 20% L-arabinose, and the incubation was continued at 37 °C and 1,000 rpm 
until OD600 ~0.4. The cells were harvested at 11,000 rpm for 30 s at 2 °C. After discarding the 
supernatant, the cells were resuspended in 1 ml ice-cooled sterile ddH2O on ice. The cells were 
spun down at 11,000 rpm for 30 s at 2 °C, and the supernatant was discarded. The washing step 
was repeated once. The supernatant was discarded leaving around 20-30 µl sterile ddH2O in the 
tube, and the cells were resuspended with it. 1.5 µl of the linear fragment with homology arms 
were added. The cells were electroporated in an ice-cooled electroporation cuvette (1 mm) using 
the Eppendorf electroporator at 1,350 V. 1 ml LB-medium was added into the cuvette, and the 
cell suspension was transferred back into the tube. The tube was incubated in a heating block at 
37 °C with shaking at 1,000 rpm for 70 min. Thereafter, the cells were plated onto LB-agar 
containing 100 µg/ml ampicillin and 50 µg/ml kanamycin. The plates were incubated at 37 °C 
overnight. The colonies that grew under selection for the antibiotic resistance genes were 
examined for the intended Red/ET cloning product pTps-p15A-Soce-PKS (Table 2) by 
restriction analysis and sequencing.  
Direct cloning of the pfa gene clusters from Aetherobacter fasciculatus (SBSr002) and 
Aetherobacter sp. (SBSr008) was carried out via a two-step, double recombination ‘fishing’ 
strategy. For the first linear plus linear homologous recombination, a 2.1 kb vector backbone 
containing the p15A origin of replication, an ampicillin resistance gene, as well as the 
appropriate homology arms were amplified from plasmid pACYC177 (New England Biolabs) 
using primers HA+pACYC177_fwd and HA+pACYC177_rev (Table 1). PCR was performed 
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with Taq DNA polymerase (Thermo Scientific) and standard conditions according to the 
manufacturer’s protocol. The reactions contained 8% glycerol and were carried out in an 
Eppendorf Mastercycler under the following conditions: initial denaturation for 3 min at 
95 °C; 30 cycles consisting of denaturation for 30 s at 95 °C, annealing for 30 s at 62 °C, and 
extension for 1 min/kb at 72 °C; and a final extension for 10 min at 72 °C. For the succeeding 
linear plus circular homologous recombination, a 1.2 kb DNA fragment containing a 
spectinomycin resistance gene with PacI restriction sites as well as the appropriate homology 
arms was amplified from plasmid pR6K-amp-spec (Gene Bridges) by PCR using primers 
HA+PacI+spectinomycin_fwd and HA+PacI+spectinomycin_rev (Table 1). PCR was 
performed with the PCR extender system (5 Prime) and standard conditions according to the 
manufacturer’s protocol. The reactions were carried out in an Eppendorf Mastercycler under 
the following conditions: initial denaturation for 3 min at 95 °C; 33 cycles consisting of 
denaturation for 1 min at 95 °C, annealing for 1 min at 62 °C, and extension for 1 min/kb at 
72 °C; and a final extension for 10 min at 72 °C. Linear plus linear homologous 
recombination was performed as described previously using 0.5-1 µg of the PCR product plus  
3-6 µg of genomic DNA of Aetherobacter fasciculatus (SBSr002) or Aetherobacter sp. 
(SBSr008), completely digested with ScaI. After electroporation the cells were cultivated in  
1 ml LB-medium in a heating block at 37 °C with shaking at 1,000 rpm for 70 min. Thereafter, 
100 µg/ml ampicillin were added, and the cells were incubated at 37 °C with shaking at 1,000 
rpm overnight. For the succeeding linear plus circular homologous recombination the next day, 
the cells from the first cloning step were used as preculture. Cell cultivation and preparation of 
electrocompetent cells were performed as described above. 0.5-1 µg of the PCR product was 
added to the electrocompetent cells. The electroporation conditions were the same as described 
previously. After incubation in a heating block at 37 °C with shaking at 1,000 rpm for about  
70 min, the cells were plated onto LB-agar containing 100 µg/ml ampicillin and 80 µg/ml 
spectinomycin. The plates were incubated at 37 °C overnight. The colonies that grew under 
selection for the antibiotic resistance genes were examined for the intended direct cloning 
products pPfaAf1 and pPfaAs1 (Table 2) by restriction analysis with a set of different 
enzymes. The spectinomycin resistance gene was subsequently removed via the introduced 
PacI restriction sites, generating plasmids pPfaAf2 and pPfaAs2 (Table 2). In order to 
introduce a heterologous promoter upstream of the pfa gene cluster in the expression construct 
pPfaAf2 and to exchange the GTG start codon of gene pfa1 for an ATG start codon, a 1.2 kb 
DNA fragment containing a tetracycline promoter downstream of a neomycin resistance gene 
driven by Tn5 promoter as well as the appropriate homology arms was amplified from 
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plasmid pTps-p15A-Soce-PKS using primers HA+neo
R
_fwd and HA+Ptet_rev (Table 1). PCR 
was performed with the PCR extender system (5 Prime) and standard conditions according to 
the manufacturer’s protocol. The reactions were carried out in an Eppendorf Mastercycler 
under the following conditions: initial denaturation for 3 min at 95 °C; 33 cycles consisting of 
denaturation for 1 min at 95 °C, annealing for 1 min at 62 °C, and extension for 1 min/kb at 
72 °C; and a final extension for 10 min at 72 °C. The linear plus circular homologous 
recombination was performed as described previously using 1.5 µl of the PCR product, 
resulting in plasmid pPfaAf-Ptet (Table 2). Plasmid pPfaAs-Ptet (Table 2) was constructed by 
exchange of the pfa gene cluster from Aetherobacter fasciculatus (SBSr002) located on 
plasmid pPfaAf-Ptet for the pfa gene cluster from Aetherobacter sp. (SBSr008) located on 
plasmid pPfaAs2 via Eco91I and PacI restriction sites. Afterwards, a zeocin resistance gene 
and the gene encoding the Mx9 integrase with attP site, both driven by Tn5 promoter derived 
from pMyx-zeo (S. C. Wenzel, unpublished), were inserted via PacI restriction sites, 
generating plasmids pPfaAf-Ptet-mx9.2 and pPfaAs-Ptet-mx9.2 (Table 2). 
 
Table 1. Primers used for linear plus linear homologous recombination or linear plus circular homologous 
recombination.  
For each primer, the homology arm is shown in italics and the introduced restriction site is underlined. 
 
Primer Sequence (5'3') 
So ce-PKS-ET-up 
CCGCTGCGCCAGATGCCGATCGGCTGGAGGCCGGCGCTGCGGATGACCT
GCGGATCCTCAATCATGCTGGGTGCCTCCTAGATTATTGTCGAACTATT 
So ce-PKS-ET-dn 
TGTAGGCATCAAAATCGTCGAGAAATCCCTGTCCGTCCGCCCGCCTACA
GCCGCAGATGGGCCGCAAGTATGGCTGTAGTAAGCTTGACCTGTGAAGT
GAAAAAT 
HA+pACYC177_fwd 
CAATATTTCGACGACCAGCGCTGCGCGGCGAAATATGGCGCGCTCTGGG
GCATCAGAAGGGCACTGGTGCAACGG 
HA+pACYC177_rev 
CGGGCGCCGCGGGATCCCGTACATCTACTTCGACGTGCTCGACGAGGAG
ATCGCTCACTGACTCGCTACGCTCGG 
HA+PacI+spectinomycin_fwd 
CTAAGGCCCCTTGTGCCCATTGAGGCACACGTCGAACGATTTCACCGTC
TTTAATTAAGGGAACAGAAAACGGATACCAAGGCG 
HA+PacI+spectinomycin_rev 
ATTTCCGCTCGCCGCAGTCGAACGACCGAGCGTAGCGAGTCAGTGAGCG
ATTAATTAACTGCATCCGATGCAAGTGTGTCGC 
HA+neo
R
_fwd 
CCCCAGAGCGCGCCATATTTCGCCGCGCAGCGCTGGTCGTCGAAATATT
GGACAGCAAGCGAACCGGAATTGCC 
HA+Ptet_rev 
GGCGAGCCCCCTTGAGCGTTCCATCTACCGATTGCAGACATGCTGGGTG
CCTCCTAGATTATTGTCG 
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Table 2. Plasmids and expression strains constructed in this study.  
oriV = origin of replication, oriT = origin of transfer, bla = ampicillin resistance gene, BSD = blasticidin 
resistance gene, nptII = neomycin resistance gene, aad9
 
= spectinomycin resistance gene, ble = zeocin resistance 
gene, Ptet = tetracycline promoter, tetR = gene encoding the tetracycline transcriptional regulator, PTn5 = Tn5 
promoter, tps = mariner transposase gene, IRs = inverted repeats, Mx9 int = Mx9 integrase gene with phage 
attachment site attP. 
 
Plasmid / Strain Characteristics 
pGB-Ptet-Soce-PKS 
Directly cloned pfa gene cluster from Sorangium cellulosum So ce56 
driven by Ptet plus tetR. colE1 oriV, bla 
pTps-p15A-Soce-PKS 
Derivative of pGB-Ptet-Soce-PKS in which colE1 oriV was replaced by 
tps plus IRs, BSD, oriT, p15A oriV, and PTn5-nptII by Red/ET 
recombineering 
pPfaAf1 
Directly cloned pfa gene cluster from Aetherobacter fasciculatus 
(SBSr002). p15A oriV, bla, aad9 
pPfaAf2 Derivative of pPfaAf1 in which aad9 was removed via PacI 
pPfaAf-Ptet 
Derivative of pPfaAf2 in which PTn5-nptII-Ptet was inserted upstream of 
the pfa gene cluster by Red/ET recombineering 
pPfaAf-Ptet-mx9.2 
Derivative of pPfaAf-Ptet in which PTn5-ble-Mx9 int was inserted via 
PacI  
pPfaAs1 
Directly cloned pfa gene cluster from Aetherobacter sp. (SBSr008). 
p15A oriV, bla, aad9 
pPfaAs2 Derivative of pPfaAf-Ptet in which aad9 was removed via PacI 
pPfaAs-Ptet 
Derivative of pPfaAf-Ptet in which the pfa gene cluster from 
A. fasciculatus (SBSr002) was replaced by the pfa gene cluster from 
Aetherobacter sp. (SBSr008) located on plasmid pPfaAs2 via Eco91I and 
PacI 
pPfaAs-Ptet-mx9.2 
Derivative of pPfaAs-Ptet in which PTn5-ble-Mx9 int was inserted via 
PacI  
M. xanthus DK1622::pTps-p15A-
Soce-PKS 
Myxococcus xanthus DK1622 with pTps-p15A-Soce-PKS randomly 
integrated into the genome  
M. xanthus DK1622::pPfaAf-Ptet-
mx9.2 
M. xanthus DK1622 with pPfaAf-Ptet-mx9.2 site-specifically integrated at 
Mx9 attB2 site of the genome  
M. xanthus DK1622::pPfaAs-Ptet-
mx9.2 
M. xanthus DK1622 with pPfaAs-Ptet-mx9.2 site-specifically integrated 
at Mx9 attB2 site of the genome  
 
 
 
Transformation of M. xanthus by electroporation and heterologous expression 
1.5 x 10
9
 cells from an overnight culture of M. xanthus DK1622 were harvested at 8,000 rpm for 
10 min. After discarding the supernatant, the cells were resuspended in 20 ml sterile ddH2O. The 
cells were spun down at 8,000 rpm for 10 min, and the supernatant was discarded. The cells were 
resuspended in 40 µl sterile ddH2O and transferred into a 2 ml tube. 2 µl of the expression 
plasmid were added. The cells were electroporated in an ice-cooled electroporation cuvette  
(1 mm) using a Bio-Rad electroporator at 650 V, 400 Ω, and 25 µF. 1 ml CTT-medium was 
added into the cuvette, and the cell suspension was transferred back into the tube. The tube 
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was incubated in a heating block at 30 °C with shaking at 1,000 rpm for about 5-8 h. Thereafter, 
the cells were mixed with 2-3 ml CTT-soft agar (CTT-medium plus 0.75% agar) containing  
60 µg/ml kanamycin plus 20 µg/ml zeocin and plated onto two CTT-agar plates containing  
60 µg/ml kanamycin plus 20 µg/ml zeocin. The plates were incubated at 30 °C for about 5 days. 
Thereafter, six colonies were transferred onto new CTT-agar plates containing 60 µg/ml 
kanamycin and 20 µg/ml zeocin. In order to verify the integration of the expression construct 
into the genome of M. xanthus via Mx9 attB sites, DNA from selected clones was isolated and 
used for PCR analyses [25]. The primers used are listed in Table 3. PCR was performed with 
Taq DNA polymerase (Thermo Scientific) and standard conditions according to the 
manufacturer’s protocol. The reactions contained 8% glycerol and were carried out in an 
Eppendorf Mastercycler under the following conditions: initial denaturation for 3 min at  
95 °C; 30 cycles consisting of denaturation for 30 s at 95 °C, annealing for 30 s at 56 °C, and 
extension for 1 min/kb at 72 °C; and a final extension for 10 min at 72 °C. Expression was 
carried out in 50 ml CTT-medium containing 60 µg/ml kanamycin and 20 µg/ml zeocin at  
30 °C. The cells were cultivated for 48 h and then harvested at 4,000 rpm for 10 min. 
 
Table 3. Primers used for the verification of the integration of expression constructs into the genome of 
M. xanthus DK1622 via Mx9 attB sites. 
 
Primer Sequence (5'3') 
Mx9attB1_up TGCCAGGGCTTACGGCTTC 
Mx9attB1_down CAGCACGGGTGCAGCAAC 
Mx9attB2_up TATCCCAGCAACCGCCGGAG 
Mx9attB2_down CGAGGTCCGGGACGCGCGCA 
Mx9attP_up GCGCCGAACTTAACAAGTTG 
Mx9attP_down TCCAGGTCCTCACGCTTGAC 
 
 
 
Extraction of cellular fatty acids 
The cellular fatty acids were extracted using the FAME method [26]. For this purpose, 50-
100 ml of a culture were harvested at 8,000 rpm for 10 min at room temperature. The cell 
pellet was transferred to a glass vial and dried in a vacuum concentrator. Subsequently, the 
cell dry weight was determined. 5 µl (50 µg) of n-3 DPA (Sigma-Aldrich) and 500 µl of a 
mixture of methanol, toluene, and sulphuric acid (50:50:2, v/v/v) were added. The vial was 
capped with a teflon-lined screw cap and incubated at 80 °C for 24-48 h. After the mixture 
was cooled to room temperature, 400 µl of an aqueous solution consisting of 0.5 M NH4HCO3 
and 2 M KCl were added, and the sample was vortexed for 30 s. Phase separation was 
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achieved by centrifugation at 4,000 rpm for 5 min at room temperature. 75 µl of the upper 
phase were mixed with 25 µl N-methyl-N-(trimethylsilyl)trifluoroacetamide (MSTFA) and 
incubated at 37 °C for 30 min. Subsequently, the sample was used for GC-MS analysis. 
 
 
Extraction and fractionation of lipids 
Extraction of lipids from microbial cells was carried out using the method of Bligh and Dyer 
[27], modified by Lewis et al. [28], on a small scale. In the first step, the cell pellet from a 
100 ml culture was transferred into a polypropylene tube. Successively, 4 ml chloroform, 8 ml 
methanol, and 3.2 ml 1% NaCl were added, and the tube was vortexed at high speed for 15 s 
after every addition. The sample was agitated on a tube rotator at 30 rpm overnight. 4 ml 
chloroform and 4 ml 1% NaCl were then added, and the tube was inverted 30 times. Phase 
separation was achieved by centrifugation at 4,000 rpm for 5 min at room temperature. The 
bottom layer containing the lipid extract was evaporated to dryness under a gentle stream of 
nitrogen and dissolved in 1 ml of a chloroform:methanol mixture (2:1, v/v). The lipid solution 
was fractionated by solid-phase extraction on a Strata SI-1 silica column with 100 mg sorbent 
mass (Phenomenex) equilibrated with chloroform + 1% acetic acid. Neutral lipids and free 
fatty acids were eluted from the column with 1 ml of chloroform + 1% acetic acid, glycolipids 
were eluted with 1.5 ml of an acetone:methanol mixture (9:1, v/v), and phospholipids were 
eluted with 1 ml methanol. For GC-MS analysis, the fractions were dried in a vacuum 
concentrator and further processed according to the FAME method described previously.  
 
 
Analysis of fatty acid methyl esters by GC-MS 
GC-MS was carried out on an Agilent 6890N gas chromatograph (Agilent Technologies) 
equipped with a 7683B split/splitless injector with autosampler (Agilent Technologies) and 
coupled to a 5973 electron impact mass selective detector (Agilent Technologies). Helium 
was used as the carrier gas at a flow rate of 1 ml/min. 1 µl of the sample was injected in split 
mode (split ratio, 10:1). The analytical column was a (5% phenyl)-methylpolysiloxane 
capillary column (Agilent J&W DB-5ht; 30 m x 0.25 mm i.d. x 0.1 µm film thickness, 
maximum temperature 400 °C; Agilent Technologies). The column temperature was kept at 
130 °C for 2.5 min, increased to 240 °C at a rate of 5 °C/min, then ramped to 300 °C at 
30 °C/min, and held at 300 °C for 5 min. Other temperatures were as follows: inlet, 275 °C; 
GC-MS transfer line, 280 °C; ion source, 230 °C; and quadrupole, 150 °C. The mass selective 
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detector was operated in scan mode, scanning the mass range from m/z 40 to 700. Scan 
control, data acquisition, and processing were performed by MSD ChemStation and AMDIS 
software, version 2.68, based on the fragmentation patterns and retention times, in comparison 
with Supelco 37 Component FAME Mix and LC-PUFAs (all Sigma-Aldrich) as reference 
standards, and NIST 08 library. Absolute amounts of PUFAs were quantified by integration 
of the peaks using MSD ChemStation and by subsequent calculation in relation to the integral 
of n-3 DPA and to cell dry weight. In case n-3 DPA was produced by the culture itself, the 
sample was spiked with n-3 DPA for the calculation of the absolute amounts of PUFAs. 
 
 
Bioinformatic analysis of DNA and protein sequences 
Prediction of open reading frames was performed with FramePlot 4.0 [29], and functional 
annotation of proteins was based on BlastP [30] and Pfam [31] searches. The Geneious 
software suite (Biomatters) [32] was used for in silico analyses of DNA and protein 
sequences. All sequence alignments were performed using Geneious and ClustalW [33].  
 
 
 
RESULTS AND DISCUSSION 
During continuous efforts to extend our myxobacterial strain collection with novel isolates, 
which optionally includes the analysis of their fatty acid profiles, PUFA producing 
myxobacteria were discovered [34] (Figure 1). This finding motivated us to screen available 
genome sequence data for putative PUFA biosynthetic pathways and to start further genome 
sequencing projects on selected myxobacterial isolates. By applying such a genome-mining 
approach, a putative pfa gene cluster could be identified in the genome sequence of 
Sorangium cellulosum So ce56 (genes sce0818, sce0819, and sce0820) [35]. The same type of 
pfa gene cluster could also be detected in the yet unpublished genome sequence data of the 
S. cellulosum strains So ce10 [36], So ce1525 [37], So ce377 [38], So ce38 [39], So ce487, 
So ce836, and So ceGT47, as well as in the recently published genome sequence of the 
alkaline-adaptive S. cellulosum strain So0157-2 [40]. GC-MS analysis of the fatty acid methyl 
esters (FAMEs) was carried out for all S. cellulosum strains mentioned above except for 
So0157-2. Interestingly, PUFA production was shown to be restricted to linoleic acid (LA, 
18:2, n-6; ca. 10% of total FAMEs) and eicosadienoic acid (EDA, 20:2, n-6) in trace amounts 
(< 1% of total FAMEs) in these strains. In addition to these identified producer strains, the 
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novel myxobacterial isolates of the genus Aetherobacter, belonging to the same bacterial 
family Polyangiaceae as the genus Sorangium (Figure 3), were recently described as prolific 
producers of LC-PUFAs [34;41]. FAME analysis carried out for Aetherobacter sp. (SBSr001) 
nov. ined., Aetherobacter fasciculatus sp. nov. ined. (SBSr002), Aetherobacter rufus sp. nov. 
ined. (SBSr003) [42], and Aetherobacter sp. nov. ined. (SBSr008) revealed the production of 
AA (ca. 1% of total FAMEs), EPA (ca. 7-10% of total FAMEs), and DHA (ca. 10-19% of 
total FAMEs) as well as of LA, γ-linolenic acid (GLA, 18:3, n-6), stearidonic acid (SDA, 
18:4, n-3), n-6 DPA, and n-3 DPA in trace amounts (< 1% of total FAMEs). Genome 
sequence data of all four Aetherobacter strains were generated allowing for the identification 
of a putative pfa gene cluster in each strain, which turned out to be similar to the pfa gene 
cluster from S. cellulosum strains.  
 
 
Figure 1. Structures of main polyunsaturated fatty acids (PUFAs) produced by myxobacteria. 
 
 
However, these identified myxobacterial PUFA biosynthetic gene clusters differ from the 
previously characterized pfa gene clusters from Shewanella pneumatophori SCRC-2738, 
P. profundum SS9, M. marina MP-1, and Schizochytrium sp. ATCC 20888. Unlike the PUFA 
pathways from the marine γ-Proteobacteria, the two types of myxobacterial pfa gene clusters 
only consist of three genes (pfa1, pfa2, and pfa3) arranged in a different order and encoding 
multifunctional PUFA synthases that also differ in their catalytic domain composition (Figure 
2). The pfaD homologue pfa1, encoding an enoyl reductase (ER), is located at the 5' end of 
the myxobacterial gene cluster. The downstream gene, pfa2, and its homologues pfaA and 
PFA1 encode multifunctional PKS enzymes that harbour a variable number of tandem acyl 
carrier protein (ACP) domains, which actually also differs among the two myxobacterial 
pathways. Another remarkable variation in the domain architecture is the location of the 
acyltransferase (AT) domain which is separately encoded by pfaB or PFA2 in PUFA 
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biosynthetic gene clusters from marine γ-Proteobacteria and microalgae but integrated in pfa3 
from Aetherobacter spp.. Interestingly, a corresponding domain could not be identified in the 
S. cellulosum pathway. The probably most significant deviation from the marine PUFA 
synthases can be observed at the carboxyl-terminus of Pfa3. In silico analyses revealed that it 
most likely contains a 1-acylglycerol-3-phosphate O-acyltransferase (AGPAT) (EC 2.3.1.51), 
which represents a unique and common characteristic of terrestrial myxobacterial PUFA 
synthases. The function of this enzyme is the acylation of the 2-position of 1-acylglycerol-3-
phosphate during glycerophospholipid biosynthesis, utilising either acyl-ACP or acyl-CoA 
thioesters as substrate [43] (Figure 2B). In addition to the three clustered pfa biosynthetic 
genes, a 4'-phosphopantetheinyl transferase (PPTase) for posttranslational modification of the 
ACP domains is required. A homologue of the Sfp-type PPTase encoding gene pfaE, which is 
assumed to be involved in the phosphopantetheinylation of PUFA synthases [44], was found 
at a separate locus within the genome of Sorangium cellulosum (sce5058) and Aetherobacter 
spp..  
Detailed comparison on the sequence level [45] revealed that the Pfa proteins from strains 
of the same genus, e.g. S. cellulosum So ce56 and So ce377 or A. fasciculatus (SBSr002) and 
Aetherobacter sp. (SBSr008), show a pairwise sequence identity of > 90%. Considering the 
fact that S. cellulosum So ce56 and A. fasciculatus (SBSr002) belong to two different bacterial 
genera with distinct PUFA production profiles (Figure 3), it is hardly surprising that the 
similarity between those strains is significantly lower (pairwise sequence identity of ≤ 60%). 
One of the most remarkable differences between the two types of myxobacterial pfa gene 
clusters is the presence of an AT domain within Pfa3 from Aetherobacter spp., which could 
not be identified in the S. cellulosum pathway (Figure 4). This finding possibly explains the 
lack of EPA and DHA production in Sorangium, a speculation supported by a recent study 
suggesting that the homologous AT domain encoded by pfaB from marine γ-Proteobacteria 
may play a role in determining the final PUFA product [46]. Comparison of myxobacterial 
Pfa proteins from S. cellulosum So ce56 or A. fasciculatus SBSr002 with homologous Pfa 
protein regions from Shewanella pneumatophori SCRC-2738, P. profundum SS9, M. marina 
MP-1, or Schizochytrium sp. ATCC 20888 disclosed a considerably low pairwise sequence 
identity of ≤ 45%. These values indicate that the function and the biosynthetic mechanism of 
the domains within the PUFA synthases of different origins is more conserved than their 
sequence. 
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Figure 2. Biosynthetic scheme for the anaerobic biosynthesis of polyunsaturated fatty acids (PUFAs) by 
iterative type I fatty acid synthase (FAS)/polyketide synthase (PKS)-like PUFA synthases.  
(A) The primer molecule acetyl-CoA undergoes several rounds of decarboxylative Claisen condensation 
reactions, resulting in the elongation of the fatty acyl chain by two carbons derived from malonyl-CoA per cycle. 
Following each round of elongation, the β-keto group is either fully reduced or only reduced to the trans double 
bond which is then isomerized. Finally, an acyl chain with methylene-interrupted cis double bonds is 
synthesized. (B) Reaction scheme for the acylation of the 2-position of 1-acylglycerol-3-phosphate catalysed by 
the unique 1-acylglycerol-3-phosphate O-acyltransferase (AGPAT) domain from myxobacteria using acyl-ACP 
as substrate during glycerophospholipid biosynthesis: AT = acyltransferase, ACP = acyl carrier protein,  
KS = ketosynthase, KR = ketoreductase, DH = dehydratase/isomerase, ER = enoyl reductase. 
 
 
However, as already highlighted before, a unique characteristic of terrestrial myxobacterial 
PUFA synthases is the presence of a putative AGPAT domain. This domain might catalyse 
the direct transfer of the synthesized fatty acid chains from the PUFA synthase into lipids 
(Figure 2B). Based on this, the majority of the synthesized PUFAs was expected to be bound 
in the lipid fraction. Therefore, extraction and fractionation of the lipids from A. fasciculatus 
(SBSr002), subsequent preparation of FAMEs by transesterification, and GC-MS analysis 
was carried out. Indeed, most of the synthesized DHA (54%) was incorporated into the 
phospholipids. Forty-three per cent of synthesized DHA were present in the fraction 
containing neutral lipids plus free fatty acids and three per cent in the glycolipid fraction. In 
contrast, anaerobic PUFA biosynthesis in marine organisms seems to involve the hydrolysis 
of the synthesized PUFA chains from the biosynthetic complex to produce free fatty acids as 
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primary products, which can then be further metabolized. For Schizochytrium sp. ATCC 
20888, it has been postulated that the AT domain encoded by PFA2 is involved in the release 
of the synthesized LC-PUFAs from the assembly line as free fatty acids [47]. For 
P. profundum SS9, a thioesterase, encoded in close proximity to the pfa gene cluster, was 
identified and shown to be capable of hydrolysing long-chain fatty acyl-CoA thioester bonds 
[48]. According to text book biochemistry, free fatty acid chains (released from marine PUFA 
synthases) have to be activated by conversion into the corresponding acyl-CoA thioesters for 
incorporation into lipids by acyl transferases like AGPAT. The presence of an integrated 
AGPAT domain in myxobacterial PUFA synthases, which is assumed to allow for the direct 
transfer of the biosynthetic products into lipids, seems to be a more efficient way compared to 
the marine systems. 
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Figure 3. Neighbour-joining tree of myxobacteria and selected marine γ-Proteobacteria inferred from 16S 
rRNA gene sequences showing the clades of PUFA producing strains with pfa gene clusters (encircled by 
dashed lines).  
The α-Proteobacterium Rhodobacter capsulatus ATCC 11166T was used as an outgroup to root the tree. 
GenBank accession number is indicated in parenthesis. The numbers at branch points indicate the per cent 
bootstrap support based on 1000 replicates. Bar, 0.05 substitutions per nucleotide position. 
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Figure 4. PUFA biosynthetic gene clusters from terrestrial myxobacteria and marine  
γ-Proteobacteria or microalgae.  
(A) Sorangium cellulosum So ce56 and So ce377 (produce mainly LA), (B) Aetherobacter sp. (SBSr001), 
Aetherobacter fasciculatus (SBSr002), Aetherobacter rufus (SBSr003), and Aetherobacter sp. (SBSr008) 
(produce mainly AA, EPA and DHA), (C) Shewanella pneumatophori SCRC-2738 (EPA producer),  
(D) Photobacterium profundum SS9 (EPA producer), (E) Moritella marina MP-1 (DHA producer),  
(F) Schizochytrium sp. ATCC 20888 (DHA and n-6 DPA producer). Two inactive DH' pseudo-domains, 
which have been recently discovered in pfaC of P. profundum SS9 [49], were identified adjacent to the 
FabA-like DH domains in every depicted gene cluster. 
 
 
In order to prove the functionality of the identified myxobacterial pfa gene clusters and to 
further exploit these systems for biotechnological PUFA production, we aimed to establish 
suitable synthetic biotechnology approaches. As the native producers, especially the strains of 
the recently discovered novel genus Aetherobacter, are not easy to handle, grow slowly, and 
are not accessible for genetic manipulation, we intended to express some of the identified 
pathways in a suitable host strain. As discussed in more detail below, heterologous expression 
of the pfa gene clusters from S. cellulosum So ce56, A. fasciculatus (SBSr002), and 
Aetherobacter sp. (SBSr008) was established in the myxobacterial model strain M. xanthus 
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DK1622, which required their initial cloning from chromosomal DNA of the native producer 
strains into plasmids and subsequent engineering of the constructs (Figure 5). For that reason, 
a recently described linear plus linear homologous recombination technique was applied, 
which allows for the direct cloning of a target fragment from a mixture of chromosomal DNA 
fragments [21]. By using this technology, the 17.2 kb pfa gene cluster from S. cellulosum 
So ce56 was cloned into a suitable vector backbone. During this step, the native promoter 
upstream of pfa1 was replaced with a tetracycline promoter. Further modification of the 
obtained plasmid pGB-Ptet-Soce-PKS was performed by linear plus circular homologous 
Red/ET recombination [50]. Thereby, the mariner transposase gene with corresponding 
inverted repeats and an additional Tn5 promoter located upstream of an adjacent neomycin 
resistance gene were inserted. The final expression construct pTps-p15A-Soce-PKS can be 
integrated randomly into the host chromosome by transposition. In parallel, the 16.2 kb pfa 
gene clusters from A. fasciculatus (SBSr002) and Aetherobacter sp. (SBSr008) were cloned 
applying a modified strategy: a two-step, double recombination ‘fishing’ approach [21]. The 
pfa gene clusters were cloned by linear plus linear homologous recombination from 
chromosomal DNA into a minimal vector backbone, in a similar manner as described before. 
However, immediately after this first cloning step, a second linear plus circular homologous 
recombination step was carried out to ‘fish’ for correct direct cloning products via a specific 
recombination event with a second resistance gene cassette. This modified procedure 
extremely facilitates the identification of correct recombinant constructs. After isolation and 
verification of the obtained plasmids pPfaAf1 (containing the pfa gene cluster from SBSr002) 
and pPfaAs1 (containing the pfa gene cluster from SBSr008), the spectinomycin resistance 
cassette was deleted via restriction digest and religation to generate the derivatives pPfaAf2 
and pPfaAs2. The construct pPfaAf2 was modified by an additional linear plus circular 
homologous recombination step to introduce the tetracycline promoter downstream of the 
neomycin resistance gene driven by Tn5 promoter from pTps-p15A-Soce-PKS upstream of 
pfa1. At the same time the GTG start codon of pfa1 was exchanged for the more common 
ATG start codon, resulting in plasmid pPfaAf-Ptet. A similar plasmid, pPfaAs-Ptet, was 
constructed by applying conventional cloning techniques to exchange the pfa gene cluster 
from A. fasciculatus (SBSr002) located on plasmid pPfaAf-Ptet for the pfa gene cluster from 
Aetherobacter sp. (SBSr008) located on plasmid pPfaAs2. In a final engineering step, a 
zeocin resistance gene and a gene encoding the Mx9 integrase with attP site [51], allowing for 
the site-specific integration into the host genome via the Mx9 phage attachment site, were 
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ligated into both constructs, yielding the expression plasmids pPfaAf-Ptet-mx9.2 and pPfaAs-
Ptet-mx9.2. 
 
 
Figure 5. Cloning strategy for the construction of expression plasmids for recombinant PUFA 
production in Myxococcus xanthus DK1622.  
(A) Cloning of the pfa gene cluster from Sorangium cellulosum So ce56, (B) Cloning of the pfa gene 
clusters from Aetherobacter fasciculatus (SBSr002) and Aetherobacter sp. (SBSr008). oriV = origin of 
replication, oriT = origin of transfer, bla = ampicillin resistance gene, BSD = blasticidin resistance gene, 
nptII = neomycin resistance gene, aad9
 
= spectinomycin resistance gene, ble = zeocin resistance gene, Ptet = 
tetracycline promoter, tetR = gene encoding the tetracycline transcriptional regulator, PTn5 = Tn5 
promoter, tps = mariner transposase gene, IRs = inverted repeats, Mx9int = Mx9 integrase gene with phage 
attachment site attP. 
 
 
The generated expression constructs pTps-p15A-Soce-PKS, pPfaAf-Ptet-mx9.2, and 
pPfaAs-Ptet-mx9.2 were transferred into M. xanthus DK1622 by electroporation. In 
case of pPfaAf-Ptet-mx9.2 or pPfaAs-Ptet-mx9.2, six resistant transformants were 
randomly selected to verify the correct integration via Mx9 attB sites by PCR analysis. 
Vector backbone modification
by Red/ET recombination
Direct cloning of the pfa gene
cluster by Red/ET recombination
pTps-p15A-Soce-PKS
PTn5 Ptet
bla    IR tps    oriT    IR nptII 
tetR       BSD  p15A
oriV
bla tetR
Ptet
colE1
oriV
pGB-Ptet-Soce-PKS
Genomic DNA of S. cellulosum So ce56
A
Vector backbone modifications
by conventional cloning
aad9      bla pfa1                       pfa2                                           pfa3
p15A
oriV
pPfaAf1 or pPfaAs1
bla pfa1                       pfa2                                           pfa3
p15A
oriV
pPfaAf2 or pPfaAs2
bla            pfa1                       pfa2                                           pfa3
p15A
oriV
PTn5 Ptet
pPfaAf-Ptet or pPfaAs-Ptet
pfa1                       pfa2                                           pfa3
p15A
oriV
PTn5 Ptet
pPfaAf-Ptet-mx9.2 or pPfaAs-Ptet-mx9.2
Direct cloning of the pfa gene clusters by
two-step double Red/ET recombination
Vector backbone modification and promoter
exchange by Red/ET recombination (pPfaAf2) 
or by conventional cloning (pPfaAs2)
Vector backbone modifications
by conventional cloning
pfa1                       pfa2                                           pfa3
Genomic DNA of A. fasciculatus (SBSr002) or A. sp. (SBSr008)
B
pfa1                         pfa2                                                pfa3
pfa1                         pfa2                                                pfa3
pfa1                         pfa2                                                pfa3
nptII
Mx9int ble      bla   nptII
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For every transformant, integration of the expression construct at the attB2 site [51] 
could be confirmed. Six transgenic clones of M. xanthus DK1622::pTps-p15A-Soce-
PKS, M. xanthus DK1622::pPfaAf-Ptet-mx9.2, and M. xanthus DK1622::pPfaAs-Ptet-
mx9.2, respectively, were cultivated in 50 ml scale at 30 °C. The cellular fatty acids 
were extracted via acidic methanolysis using the FAME method [26] and analysed by 
GC-MS (Figure 6 and Table 4). All transgenic clones of M. xanthus DK1622::pTps-
p15A-Soce-PKS produced LA but also GLA and oleic acid (OA, 18:1, n-9), a 
monounsaturated fatty acid (MUFA), as well as EDA and dihomo-γ-linolenic acid 
(DHGLA, 20:3, n-6) in trace amounts. These fatty acids are not present in M. xanthus 
DK1622 wild type. Production maximum was reached after two days. In contrast to 
this, S. cellulosum So ce56 produced significantly lower amounts of OA and LA after 
seven days of cultivation. All the six transgenic clones of M. xanthus 
DK1622::pPfaAf-Ptet-mx9.2 and M. xanthus DK1622::pPfaAs-Ptet-mx9.2, respectively, 
produced EPA and DHA, as well as AA, n-6 DPA, and n-3 DPA in trace amounts after 
two days of cultivation. In this case, production yields of AA, EPA, and DHA, 
achieved with the native producer strains A. fasciculatus (SBSr002) and Aetherobacter 
sp. (SBSr008) after seven days of cultivation surpass the PUFA production rate of the 
corresponding heterologous host strains. Nonetheless, M. xanthus DK1622 turned out 
to be a reliable expression host for PUFA synthases in our study. Contrary to other host 
strains, heterologous expression of an exogenous PPTase was not necessary since one 
of the two Sfp-type PPTase from M. xanthus DK1622 with broad substrate specificity, 
MxPpt1 or MxPpt2 [52], was obviously able to activate the tandem ACP domains of 
the PUFA synthases by posttranslational modification. 
Interestingly, when comparing the PUFA production profiles of the native producer 
S. cellulosum So ce56 and the corresponding transgenic host M. xanthus 
DK1622::pTps-p15A-Soce-PKS remarkable differences can be observed. The host 
strain produces not only OA and LA but also GLA. Feeding of 5 mg LA to a 50 ml 
culture of M. xanthus DK1622 and cultivation for two days showed that 22% of LA 
was converted into GLA probably catalysed by a linoleoyl-CoA desaturase  
(EC 1.14.19.3). On top of that, 65% of 5 mg OA fed to a 50 ml culture of M. xanthus 
DK1622 were converted after two days of cultivation into LA (44% of original OA) 
most likely by the action of an oleoyl-CoA-Δ12 desaturase (EC 1.14.19.6) and again 
subsequently converted into GLA (21% of original OA). Candidates for these 
desaturases could be identified by in silico analysis of the genome of M. xanthus 
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DK1622 [53], which comprises 16 genes encoding mostly uncharacterized fatty acid 
desaturases. The most obvious interpretation of these data is the assumption that the 
PUFA synthase of the analysed S. cellulosum strains seems to be responsible for the 
production of both OA plus LA or of simply OA which could be converted into LA by 
an oleoyl-CoA-Δ12 desaturase. The genome sequence of S. cellulosum So ce56 encodes 
at least five uncharacterized fatty acid desaturases [35]. Apparently, S. cellulosum does 
not express any active linoleoyl-CoA desaturase under the tested culture conditions. 
 
 
Figure 6. GC-MS chromatograms of fatty acid methyl esters from myxobacterial PUFA producers 
and heterologous hosts.  
(A) Sorangium cellulosum So ce56, (B + E) Myxococcus xanthus DK1622, (C) M. xanthus DK1622::pTps-
p15A-Soce-PKS, (D) Aetherobacter fasciculatus (SBSr002), (F) M. xanthus DK1622::pPfaAf-Ptet-mx9.2. 
Most prominent MUFA and PUFA methyl esters: (1) oleic acid methyl ester (18:1, n-9), (2) linoleic acid 
methyl ester (18:2, n-6), (3) γ-linolenic acid methyl ester (18:3, n-6), (4) arachidonic acid methyl ester 
(20:4, n-6), (5) eicosapentaenoic acid methyl ester (20:5, n-3), (6) docosahexaenoic acid methyl ester (22:6, 
n-3). 
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Table 4. Production of MUFAs and PUFAs with a carbon chain length of ≥ C18 by Sorangium 
cellulosum So ce56, Myxococcus xanthus DK1622::pTps-p15A-Soce-PKS, Aetherobacter fasciculatus 
(SBSr002), Aetherobacter sp. (SBSr008), M. xanthus DK1622::pPfaAf-Ptet-mx9.2, and M. xanthus 
DK1622::pPfaAs-Ptet-mx9.2.  
Cultivation was carried out for 7 days (for S. cellulosum and for Aetherobacter spp.) or for 2 days (for 
M. xanthus). The indicated values for M. xanthus are means of three samples of the best producing clones. 
 
MUFA or PUFA 
Absolute amount [mg/g cell dry weight] 
S. cellulosum  
So ce56 
M. xanthus 
DK1622::pTps-
p15A-Soce-PKS 
A. fasciculatus 
(SBSr002)/ 
Aetherobacter sp. 
(SBSr008) 
M. xanthus 
DK1622::pPfaAf-
Ptet-mx9.2/ 
M. xanthus 
DK1622::pPfaAs-
Ptet-mx9.2 
oleic acid 
(OA, 18:1, n-9) 
0.2 0.5 0.2 − 
linoleic acid 
(LA, 18:2, n-6) 
3.7 5.5 0.4 − 
γ-linolenic acid 
(GLA, 18:3, n-6) 
− 5.8  < 0.1 − 
stearidonic acid 
(SDA, 18:4, n-3) 
− −  < 0.1 − 
eicosadienoic acid 
(EDA, 20:2, n-6) 
  < 0.1  < 0.1 − − 
dihomo-γ-linolenic acid 
(DHGLA, 20:3, n-6) 
−  < 0.1 − − 
arachidonic acid 
(AA, 20:4, n-6) 
− − 0.5-1.0 < 0.1 
eicosapentaenoic acid 
(EPA, 20:5, n-3) 
− − 3.8 0.2 
docosapentaenoic acid 
(DPA, 22:5, n-6) 
− − 0.1 < 0.1 
docosapentaenoic acid 
(DPA, 22:5, n-3) 
− −  < 0.1 < 0.1 
docosahexaenoic acid 
(DHA, 22:6, n-3) 
− − 4.7-6.2 0.8 
 
 
In the case of the pfa pathways from Aetherobacter spp., it seems at first glance that 
the encoded PUFA synthase is able to synthesize a broad range of PUFAs since both 
the native producers A. fasciculatus (SBSr002) and Aetherobacter sp. (SBSr008) and 
the transgenic hosts M. xanthus DK1622::pPfaAf-Ptet-mx9.2 and M. xanthus 
DK1622::pPfaAs-Ptet-mx9.2 produce at least AA, EPA, and DHA. However, it has 
been shown that the EPA/DHA ratio rises in Aetherobacter spp. with increasing 
cultivation time [41]. In addition to this, feeding of 5 mg DHA to a 50 ml culture of 
M. xanthus DK1622 and cultivation for two days showed that > 95% of DHA was 
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converted mostly into EPA. From this data, it can be hypothesized that the PUFA 
synthase from Aetherobacter spp. may only produce DHA and some minor amounts of 
n-6 DPA and n-3 DPA as by-products. These C22 PUFAs then could be converted into 
the corresponding C20 PUFAs EPA or AA via β-oxidation plus 2,4-dienoyl-CoA 
reductase (EC 1.3.1.34) and Δ3-Δ2-enoyl-CoA isomerase (EC 5.3.3.8), needed for the 
oxidation of unsaturated fatty acids. However, further studies are required to clarify 
this issue. 
 
 
 
CONCLUSIONS 
In conclusion, for the first time PUFA synthases from terrestrial origin catalysing the 
biosynthesis of LC-PUFAs could be identified and characterized. They are encoded by 
two types of pfa gene clusters present in the genome of the closely related 
myxobacterial genera Sorangium and Aetherobacter. Although the organization of 
these gene clusters is very similar, the profiles of the produced fatty acids vary 
significantly. The presence of different types of PUFA biosynthetic pathways with 
such a product diversity within the same bacterial family is an outstanding aspect in the 
field of research on PUFA biosynthesis. By construction of functional hybrid PUFA 
pathways their exact biosynthetic mechanism and factors determining product 
specificity can now be studied. Consequently, the insights expected from such work 
would allow for the design of an enzymatic system for the targeted production of 
defined PUFAs. Another important aspect of the present work is the successful 
establishment of an expression platform for the heterologous PUFA production using 
the myxobacterial pfa gene clusters in the promising host Myxococcus xanthus via 
synthetic biotechnology approaches. These achievements pave the way for the 
heterologous PUFA production in host strains with fast growth characteristics, 
amenability to genetic modifications, and vast potential for industrial applications, like 
the GRAS certified microbe Pseudomonas putida KT2440 or oleaginous yeasts. 
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APPENDIX 
 
DNA sequences of the 16S ribosomal RNA from myxobacterial strains which are not 
deposited in any database and which were used for the construction of the phylogenetic 
tree by the neighbour-joining method 
 
>16S ribosomal RNA gene sequence from Sorangium cellulosum So ce10 
AGAGTTTGATCCTGGCTCAGAACGAACGTTAGCGGCGCGCTTAACACATGCAAGTCGAGCGAGAAAGGGCTTCGG
CCCCGGTAAAGCGGCGCACGGGTGAGTAACACGTAGGTAATCTGCCCCCAGGTGGTGGATAACGTTCCGAAAGGA
GCGCTAATACAGCATGAGACCACGTCCTCGAAAGGGGATGAGGTCAAAGCCGGCCTCTTCATGAAAGCTGGCGCC
AGGGGATGAGCCTGCGGCCCATCAGCTAGTTGGTAGGGTAATGGCCTACCAAGGCGAAGACGGGTAGCTGGTCTG
AGAGGATGATCAGCCACACTGGAACTGAGACACGGTCCAGACTCCTACGGGAGGCAGCAGTGGGGAATCTTGCGC
AATGGGCGAAAGCCTGACGCAGCGACGCCGCGTGAGTGATGAAGGCCTTCGGGTTGTAAAGCTCTGTGGAGGGGG
ACGAATAAGGGTTGGCTAACATCCAGCTCGATGACGGTACCCCTTTAGCAAGCACCGGCTAACTCTGTGCCAGCA
GCCGCGGTAAGACAGAGGGTGCAAACGTTGTTCGGAATTACTGGGCGTAAAGCGCATGTAGGCGGTTCGTAAAGT
CAGATGTGAAAGCCCTGGGCTTAACCCAGGAAGTGCATTTGAAACTCACGAACTTGAGTCCCGGAGAGGAAGGCG
GAATTCTCGGTGTAGAGGTGAAATTCGTAGATATCGAGAGGAACATCGGTGGCGAAGGCGGCCTTCTGGACGGTG
ACTGACGCTGAGATGCGAAAGCGTGGGGAGCAAACAGGATTAGATACCCTGGTAGTCCACGCCGTAAACGATGGG
TGCTAGGTGTCGCGGGCTTTGACTCCTGCGGTGCCGTAGCTAACGCATTAAGCACCCCGCCTGGGGAGTACGGCC
GCAAGGCTAAAACTCAAAGGAATTGACGGGGGCCCGCACAAGCGGTGGAGCATGTGGTTCAATTCGACGCAACGC
GCAGAACCTTACCTGGGCTAGAAAATGCAGGGACCTGGTTGAAAGATCGGGGTGCTCTTCGGAGAACCTGTAGTT
AGGTGCTGCATGGCTGTCGTCAGCTCGTGTCGTGAGATGTTGGGTTAAGTCCCGCAACGAGCGCAACCCCTATCG
TTAGTTGCCAGCGGTTCGGCCGGGCACTCTAGCGAGACTGCCGATATTTAAATCGGAGGAAGGTGGGGATGACGT
CAAGTCCTCATGGCCCTTATGTCCAGGGCTACACACGTGCTACAATGGGCGGTACAAACGGTTGCGAACTCGCGA
GGGGAAGCCAATCCGAAAAAACCGTCCTCAGTACGGATAAGAGTCTGCAACTCGACTCTTTGAAGTTGGAATCGC
TAGTAATCCCTGATCAGCAGGCAGGGGTGAATACGTTCCCGGGCCTTGTACACACCGCCCGTCACACCATGGGAG
TCGATTGCTCCAGAAGTGGCTACGCCAACCCGCAAGGGAGGCAGGCCCCCAAGGAGTGGTTGGTAACTGGGGTGA
AGTCGTAACAAGGTAGCCGTAGGGGAACCTGCGGCTGGATCACCTCCTTT 
 
 
>16S ribosomal RNA gene sequence from Sorangium cellulosum So ce1525 
AGAGTTTGATCCTGGCTCAGAACGAACGTTAGCGGCGCGCTTAACACATGCAAGTCGAGCGAGAAAGGGCTTCGG
CCCCGGTAAAGCGGCGCACGGGTGAGTAACACGTAGGTAATCTGCCCCCAGGTGGTGGATAACGTTCCGAAAGGA
GCGCTAATACAGCATGAGACCACGTCCTCGAGAGGGGATGAGGTCAAAGCCGGCCTCTTCACGAAAGCTGGCGCC
AGGGGATGAGCCTGCGGCCCATCAGCTAGTTGGTAGGGTAATGGCCTACCAAGGCGAAGACGGGTAGCTGGTCTG
AGAGGATGATCAGCCACACTGGAACTGAGACACGGTCCAGACTCCTACGGGAGGCAGCAGTGGGGAATCTTGCGC
AATGGGCGAAAGCCTGACGCAGCGACGCCGCGTGAGTGATGAAGGCCTTCGGGTTGTAAAGCTCTGTGGAGGGGG
ACGAATAAGGGTTGGCTAACATCCAGCTCGATGACGGTACCCCTTTAGCAAGCACCGGCTAACTCTGTGCCAGCA
GCCGCGGTAAGACAGAGGGTGCAAACGTTGTTCGGAATTACTGGGCGTAAAGCGCATGTAGGCGGTTCGTAAAGT
CAGATGTGAAAGCCCTGGGCTTAACCCAGGAAGTGCATTTGAAACTCACGAACTTGAGTCCCGGAGAGGAAGGCG
GAATTCTCGGTGTAGAGGTGAAATTCGTAGATATCGAGAGGAACATCGGTGGCGAAGGCGGCCTTCTGGACGGTG
ACTGACGCTGAGATGCGAAAGCGTGGGGAGCAAACAGGATTAGATACCCTGGTAGTCCACGCCGTAAACGATGGG
TGCTAGGTGTCGCGGGCTTTGACTCCTGCGGTGCCGTAGCTAACGCATTAAGCACCCCGCCTGGGGAGTACGGCC
GCAAGGCTAAAACTCAAAGGAATTGACGGGGGCCCGCACAAGCGGTGGAGCATGTGGTTCAATTCGACGCAACGC
GCAGAACCTTACCTGGGCTAGAAAATGCAGGGACCTGGTTGAAAGATCGGGGTGCTCTTCGGAGAACCTGTAGTT
AGGTGCTGCATGGCTGTCGTCAGCTCGTGTCGTGAGATGTTGGGTTAAGTCCCGCAACGAGCGCAACCCCTATCG
TTAGTTGCCAGCGGTTCGGCCGGGCACTCTAGCGAGACTGCCGATATTTAAATCGGAGGAAGGTGGGGATGACGT
CAAGTCCTCATGGCCCTTATGTCCAGGGCTACACACGTGCTACAATGGGCGGTACAAACGGTCGCGAACCCGCGA
GGGGAAGCCAATCCGAAAAAACCGTCCTCAGTACGGATAAGAGTCTGCAACTCGACTCTTTGAAGTTGGAATCGC
TAGTAATCCCTGATCAGCAGGCAGGGGTGAATACGTTCCCGGGCCTTGTACACACCGCCCGTCACACCATGGGAG
TCGATTGCTCCAGAAGTGGCTGCGCCAACCCGCAAGGGAGGCAGGCCCCCAAGGAGTGGTTGGTAACTGGGGTGA
AGTCGTAACAAGGTAGCCGTAGGGGAACCTGCGGCTGGATCACCTCCTTT 
 
CHAPTER 1: IDENTIFICATION OF PUFA SYNTHASES FROM TERRESTRIAL MYXOBACTERIA 
55 
 
>16S ribosomal RNA gene sequence from Sorangium cellulosum So ce377 
AGAGTTTGATCCTGGCTCAGAACGAACGTTAGCGGCGCGCTTAACACATGCAAGTCGAGCGAGAAAGGGCTTCGG
CCCCGGTAAAGCGGCGCACGGGTGAGTAACACGTAGGTAATCTGCCCCCAGGTGGTGGATAACGTTCCGAAAGGA
GCGCTAATACAGCATGAGACCACGCCTTCGAAAGAGGGTGAGGTCAAAGCCGGCCTCTTCACGAAAGCTGGCGCC
AGGGGATGAGCCTGCGGCCCATCAGCTAGTTGGTAGGGTAATGGCCTACCAAGGCGAAGACGGGTAGCTGGTCTG
AGAGGATGATCAGCCACACTGGAACTGAGACACGGTCCAGACTCCTACGGGAGGCAGCAGTGGGGAATCTTGCGC
AATGGGCGAAAGCCTGACGCAGCGACGCCGCGTGAGTGATGAAGGCCTTCGGGTTGTAAAGCTCTGTGGAGGGGG
ACGAATAAGGGTTGGCTAACATCCAGCTCGATGACGGTACCCCTTTAGCAAGCACCGGCTAACTCTGTGCCAGCA
GCCGCGGTAAGACAGAGGGTGCAAACGTTGTTCGGAATTACTGGGCGTAAAGCGCATGTAGGCGGTTCGTAAAGT
CAGATGTGAAAGCCCTGGGCTTAACCCAGGAAGTGCATTTGAAACTCACGAACTTGAGTCCCGGAGAGGAAGGCG
GAATTCTCGGTGTAGAGGTGAAATTCGTAGATATCGAGAGGAACATCGGTGGCGAAGGCGGCCTTCTGGACGGTG
ACTGACGCTGAGATGCGAAAGCGTGGGGAGCAAACAGGATTAGATACCCTGGTAGTCCACGCCGTAAACGATGGG
TGCTAGGTGTCGCGGGCTTTGACTCCTGCGGTGCCGTAGCTAACGCATTAAGCACCCCGCCTGGGGAGTACGGCC
GCAAGGCTAAAACTCAAAGGAATTGACGGGGGCCCGCACAAGCGGTGGAGCATGTGGTTCAATTCGACGCAACGC
GCAGAACCTTACCTGGGCTAGAAAATGCAGGAACCTGGTTGAAAGATCGGGGTGCTCTTCGGAGAACCTGTAGTT
AGGTGCTGCATGGCTGTCGTCAGCTCGTGTCGTGAGATGTTGGGTTAAGTCCCGCAACGAGCGCAACCCCTATCG
TTAGTTGCCAGCGGTTCGGCCGGGCACTCTAGCGAGACTGCCGATATTTAAATCGGAGGAAGGTGGGGATGACGT
CAAGTCCTCATGGCCCTTATGTCCAGGGCTACACACGTGCTACAATGGGCGGTACAGACGGTCGCGAACCCGCGA
GGGGGAGCCAATCCGAAAAAACCGTCCTCAGTACGGATAAGAGTCTGCAACTCGACTCTTTGAAGTTGGAATCGC
TAGTAATCCCTGATCAGCAGGCAGGGGTGAATACGTTCCCGGGCCTTGTACACACCGCCCGTCACACCATGGGAG
TCGATTGCTCCAGAAGTGGCTGCGCCAACCCGCAAGGGAGGCAGGCCCCCAAGGAGTGGTTGGTAACTGGGGTGA
AGTCGTAACAAGGTAGCCGTAGGGGAACCTGCGGCTGGATCACCTCCTTT 
 
 
>16S ribosomal RNA gene sequence from Sorangium cellulosum So ce38 
AGAGTTTGATCCTGGCTCAGAACGAACGTTAGCGGCGCGCTTAACACATGCAAGTCGAGCGAGAAAGGGCTTCGG
CCCCGGTAAAGCGGCGCACGGGTGAGTAACACGTAGGTAATCTGCCCCCAGGTGGTGGATAACGTTCCGAAAGGA
GCGCTAATACAGCATGAGACCACGTCCTCGAAAGGGGATGAGGTCAAAGCCGGCCTCTTCATGAAAGCTGGCGCC
AGGGGATGAGCCTGCGGCCCATCAGCTAGTTGGTAGGGTAATGGCCTACCAAGGCGAAGACGGGTAGCTGGTCTG
AGAGGATGATCAGCCACACTGGAACTGAGACACGGTCCAGACTCCTACGGGAGGCAGCAGTGGGGAATCTTGCGC
AATGGGCGAAAGCCTGACGCAGCGACGCCGCGTGAGTGATGAAGGCCTTCGGGTTGTAAAGCTCTGTGGAGGGGG
ACGAATAAGGGTTGGCTAACATCCAGCTCGATGACGGTACCCCTTTAGCAAGCACCGGCTAACTCTGTGCCAGCA
GCCGCGGTAAGACAGAGGGTGCAAACGTTGTTCGGAATTACTGGGCGTAAAGCGCATGTAGGCGGTTCGTAAAGT
CAGATGTGAAAGCCCTGGGCTTAACCCAGGAAGTGCATTTGAAACTCACGAACTTGAGTCCCGGAGAGGAAGGCG
GAATTCTCGGTGTAGAGGTGAAATTCGTAGATATCGAGAGGAACATCGGTGGCGAAGGCGGCCTTCTGGACGGTG
ACTGACGCTGAGATGCGAAAGCGTGGGGAGCAAACAGGATTAGATACCCTGGTAGTCCACGCCGTAAACGATGGG
TGCTAGGTGTCGCGGGCTTTGACTCCTGCGGTGCCGTAGCTAACGCATTAAGCACCCCGCCTGGGGAGTACGGCC
GCAAGGCTAAAACTCAAAGGAATTGACGGGGGCCCGCACAAGCGGTGGAGCATGTGGTTCAATTCGACGCAACGC
GCAGAACCTTACCTGGGCTAGAAAATGCAGGAACCTGGTTGAAAGATCGGGGTGCTCTTCGGAGAACCTGTAGTT
AGGTGCTGCATGGCTGTCGTCAGCTCGTGTCGTGAGATGTTGGGTTAAGTCCCGCAACGAGCGCAACCCCTATCG
TTAGTTGCCAGCGGTTCGGCCGGGCACTCTAGCGAGACTGCCGATATTTAAATCGGAGGAAGGTGGGGATGACGT
CAAGTCCTCATGGCCCTTATGTCCAGGGCTACACACGTGCTACAATGGGCGGTACAAACGGTCGCAAACTCGCGA
GAGCAAGCCAATCCGAAAAAACCGTCCTCAGTACGGATAAGAGTCTGCAACTCGACTCTTTGAAGTTGGAATCGC
TAGTAATCCCTGATCAGCAGGCAGGGGTGAATACGTTCCCGGGCCTTGTACACACCGCCCGTCACACCATGGGAG
TCGATTGCTCCAGAAGTGGCTACGCCAACCCGCAAGGGAGGCAGGCCCCCAAGGAGTGGTTGGTAACTGGGGTGA
AGTCGTAACAAGGTAGCCGTAGGGGAACCTGCGGCTGGATCACCTCCTTT 
 
 
>16S ribosomal RNA gene sequence from Sorangium cellulosum So ce836 
TGAGTTTGATTCCTGGCTCAGGACGAACGTTAGCGGCGCGCTTAACACATGCAAGTCGAGCGAGAAAGGGCTTCG
GCCCCGGTAAAGCGGCGCACGGGTGAGTAACACGTAGGTAATCTGCCCCCAGGTGGTGGATAACGTTCCGAAAGG
AGCGCTAATACAGCATGAGACCACGTCTTCGAAAGAGGATGAGGTCAAAGCCGGCCTCTTCACGAAAGCTGGCGC
CAGGGGATGAGCCTGCGGCCCATCAGCTAGTTGGTAGGGTAATGGCCTACCAAGGCGAAGACGGGTAGCTGGTCT
GAGAGGATGATCAGCCACACTGGAACTGAGACACGGTCCAGACTCCTACGGGAGGCAGCAGTGGGGAATCTTGCG
CAATGGGCGAAAGCCTGACGCAGCGACGCCGCGTGAGTGATGAAGGCCTTCGGGTTGTAAAGCTCTGTGGAGGGG
GACGAATAAGGGTTGGCTAACATCCAGCTCGATGACGGTACCCCTTTAGCAAGCACCGGCTAACTCTGTGCCAGC
AGCCGCGGTAAGACAGAGGGTGCAAACGTTGTTCGGAATTACTGGGCGTAAAGCGCATGTAGGCGGTTCGTAAAG
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TCAGATGTGAAAGCCCTGGGCTTAACCCAGGAAGTGCATTTGAAACTCACGAACTTGAGTCCCGGAGAGGAAGGC
GGAATTCTCGGTGTAGAGGTGAAATTCGTAGATATCGAGAGGAACATCGGTGGCGAAGGCGGCCTTCTGGACGGT
GACTGACGCTGAGATGCGAAAGCGTGGGGAGCAAACAGGATTAGATACCCTGGTAGTCCACGCCGTAAACGATGG
GTGCTAGGTGTCGCGGGCTTTGACTCCTGCGGTGCCGTAGCTAACGCATTAAGCACCCCGCCTGGGGAGTACGGC
CGCAAGGCTAAAACTCAAAGGAATTGACGGGGGCCCGCACAAGCGGTGGAGCATGTGGTTCAATTCGACGCAACG
CGCAGAACCTTACCTGGGCTAGAAAATGCAGGGACCTGGTTGAAAGATCGGGGTGCTCTTCGGAGAACCTGTAGT
TAGGTGCTGCATGGCTGTCGTCAGCTCGTGTCGTGAGATGTTGGGTTAAGTCCCGCAACGAGCGCAACCCCTATC
GTTAGTTGCCAGCGGTTCGGCCGGGCACTCTAGCGAGACTGCCGATATTTAAATCGGAGGAAGGTGGGGATGACG
TCAAGTCCTCATGGCCCTTATGTCCAGGGCTACACACGTGCTACAATGGGCGGTACAGACGGTCGCGAACCCGCG
AGGGGAAGCCAATCCGAAAAAACCGTCCTCAGTACGGATAAGAGTCTGCAACTCGACTCTTTGAAGTTGGAATCG
CTAGTAATCCCTGATCAGCAGGCAGGGGTGAATACGTTCCCGGGCCTTGTACACACCGCCCGTCACACCATGGGA
GTCGATTGCTCCAGAAGTGGCTGCGCCAACCCGCAAGGGAGGCAGGCCCCCAAGGAGTGGTTGGTAACTGGGGTG
AAGTCGTAACAAGGTAGCCGTAGGGGAACCTGCGGCTGGATCACCTCCTTA 
 
 
>16S ribosomal RNA gene sequence from Sorangium cellulosum So ceGT47 
AGAGTTTGATCCTGGCTCAGAACGAACGTTAGCGGCGCGCCTAACACATGCAAGTCGAGCGAGAAAGGGCTTCGG
CCCCGGTAAAGCGGCGCACGGGTGAGTAACACGTAGGTAATCTGCCCCCAGGTGGTGGATAACGTTCCGAAAGGA
GCGCTAATACAGCATGAGACCACGTCCTCGAAAGGGGATGAGGTCAAAGCCGGCCTCTTCATGAAAGCTGGCGCC
AGGGGATGAGCCTGCGGCCCATCAGCTAGTTGGTAGGGTAATGGCCTACCAAGGCGAAGACGGGTAGCTGGTCTG
AGAGGATGATCAGCCACACTGGAACTGAGACACGGTCCAGACTCCTACGGGAGGCAGCAGTGGGGAATCTTGCGC
AATGGGCGAAAGCCTGACGCAGCGACGCCGCGTGAGTGATGAAGGCCTTCGGGTTGTAAAGCTCTGTGGAGGGGG
ACGAATAAGGGTTGGCTAATATCCAGCTCGATGACGGTACCCCTTTAGCAAGCACCGGCTAACTCTGTGCCAGCA
GCCGCGGTAAGACAGAGGGTGCAAACGTTGTTCGGAATTACTGGGCGTAAAGCGCGTGTAGGCGGTCCGTAAAGT
CAGGTGTGAAAGCCCTGGGCTCAACCCAGGAAGTGCACTTGAAACTCACGGACTCGAGTCCCGGAGAGGAAGGCG
GAATTCTCGGTGTAGAGGTGAAATTCGTAGATATCGAGAGGAACATCGGTGGCGAAGGCGGCCTTCTGGACGGTG
ACTGACGCTGAGACGCGAAAGCGTGGGGAGCAAACAGGATTAGATACCCTGGTAGTCCACGCCGTAAACGATGGG
TGCTAGGTGTCGCGGGCTTTGACTCCTGCGGTGCCGTAGCTAACGCATTAAGCACCCCGCCTGGGGAGTACGGCC
GCAAGGCTAAAACTCAAAGGAATTGACGGGGGCCCGCACAAGCGGTGGAGCATGTGGTTCAATTCGACGCAACGC
GCAGAACCTTACCTGGGCTAGAAAATGCAGGGACCTGGTTGAAAGATCGGGGTGCTCTTCGGAGAACCTGTAGTT
AGGTGCTGCATGGCTGTCGTCAGCTCGTGTCGTGAGATGTTGGGTTAAGTCCCGCAACGAGCGCAACCCCTATCG
TTAGTTGCCAGCGGTTCGGCCGGGCACTCTAGCGAGACTGCCGATATTCAAATCGGAGGAAGGTGGGGATGACGT
CAAGTCCTCATGGCCCTTATGTCCAGGGCTACACACGTGCTACAATGGGCGGTACAAACGGTCGCGAACCCGCGA
GGGGGAGCCAATCCGAAAAAACCGTCCTCAGTACGGATAAGAGTCTGCAACTCGACTCTTTGAAGTTGGAATCGC
TAGTAATCCCTGATCAGCAGGCAGGGGTGAATACGTTCCCGGGCCTTGTACACACCGCCCGTCACACCATGGGAG
TCGATTGCTCCAGAAGTGGCTGCGCCAACCCGAAAGGGAGGCAGGCCCCCAAGGAGTGGTTGGTAACTGGGGTGA
AGTCGTAACAAGGTAGCCGTAGGGGAACCTGCGGCTGGATCACCTCCTTT 
 
 
>16S ribosomal RNA gene sequence from Sorangium cellulosum So ce487 
TGAGTTTGATTCCTGGCTCAGGACGAACGTTAGCGGCGCGCTTAACACATGCAAGTCGAGCGAGAAAGGGCTTCG
GCCCCGGTAAAGCGGCGCACGGGTGAGTAACACGTAGGTAATCTGCCCCCAGGTGGTGGATAACGTTCCGAAAGG
AGCGCTAATACAGCATGAGACCACGCCTTCGAAAGAGGGTGAGGTCAAAGCCGGCCTCTTCACGAAAGCTGGCGC
CAGGGGATGAGCCTGCGGCCCATCAGCTAGTTGGTAGGGTAATGGCCTACCAAGGCGAAGACGGGTAGCTGGTCT
GAGAGGATGATCAGCCACACTGGAACTGAGACACGGTCCAGACTCCTACGGGAGGCAGCAGTGGGGAATCTTGCG
CAATGGGCGAAAGCCTGACGCAGCGACGCCGCGTGAGTGATGAAGGCCTTCGGGTTGTAAAGCTCTGTGGAGGGG
GACGAATAAGGGTTGGCTAACATCCAGCTCGATGACGGTACCCCTTTAGCAAGCACCGGCTAACTCTGTGCCAGC
AGCCGCGGTAAGACAGAGGGTGCAAACGTTGTTCGGAATTACTGGGCGTAAAGCGCATGTAGGCGGTTCGTAAAG
TCAGATGTGAAAGCCCTGGGCTTAACCCAGGAAGTGCATTTGAAACTCACGAACTTGAGTCCCGGAGAGGAAGGC
GGAATTCTCGGTGTAGAGGTGAAATTCGTAGATATCGAGAGGAACATCGGTGGCGAAGGCGGCCCTTCTGGACGG
TGACTGACGCTGAGATGCGAAAGCGTGGGGAGCAAACAGGATTAGATACCCTGGTAGTCCACGCCGTAAACGATG
GGTGCTAGGTGTCGCGGGCTTTGACTCCTGCGGTGCCGTAGCTAACGCATTAAGCACCCCGCCTGGGGAGTACGG
CCGCAAGGCTAAAACTCAAAGGAATTGACGGGGGCCCGCACAAGCGGTGGAGCATGTGGTTCAATTCGACGCAAC
GCGCAGAACCTTACCTGGGCTAGAAAATGCAGGAACCTGGTTGAAAGATCGGGGTGCTCTTCGGAGAACCTGTAG
TTAGGTGCTGCATGGCTGTCGTCAGCTCGTGTCGTGAGATGTTGGGTTAAGTCCCGCAACGAGCGCAACCCCTAT
CGTTAGTTGCCAGCGGTTCGGCCGGGCACTCTAGCGAGACTGCCGATATTTAAATCGGAGGAAGGTGGGGATGAC
GTCAAGTCCTCATGGCCCTTATGTCCAGGGCTACACACGTGCTACAATGGGCGGTACAGACGGTCGCGAACCCGC
GAGGGGAAGCCAATCCGAAAAAACCGTCCTCAGTACGGATAAGAGTCTGCAACTCGACTCTTTGAAGTTGGAATC
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GCTAGTAATCCCTGATCAGCAGGCAGGGGTGAATACGTTCCCGGGCCTTGTACACACCGCCCGTCACACCATGGG
AGTCGATTGCTCCAGAAGTGGCTGCGCCAACCCGCAAGGGAGGCAGGCCCCCAAGGAGTGGTTGGTAACTGGGGT
GAAGTCGTAACAAGGTAGCCGTAGGGGAACCTGCGGCTGGCTCACCTCCTTAA 
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INTRODUCTION 
Various biosynthetic mechanisms are known for the production of long-chain polyunsaturated 
fatty acids (LC-PUFAs). The predominant aerobic pathways combine several oxygen-
dependent desaturases and elongases for the conversion of saturated fatty acids into 
unsaturated fatty acids [1]. However, LC-PUFAs can also be synthesized in an anaerobic 
manner, employing iterative type I fatty acid synthase (FAS)/polyketide synthase (PKS)-like 
enzymes (PUFA synthases) for de novo biosynthesis from acyl-CoA precursors [2-4]. These 
multienzyme complexes are encoded by PUFA (pfa) biosynthetic gene clusters, initially 
identified and characterized from marine γ-Proteobacteria and microalgae: Shewanella 
pneumatophori SCRC-2738 and Photobacterium profundum SS9 both produce 
eicosapentaenoic acid (EPA, 20:5, n-3) [5;6], Moritella marina MP-1 is known as 
docosahexaenoic acid (DHA, 22:6, n-3) producer [7], whereas Schizochytrium sp. ATCC 
20888 produces both DHA and n-6 docosapentaenoic acid (DPA, 22:5) [5;8]. The increasing 
availability of genome sequence data enabled the identification of at least 20 distinct types of 
pfa-like gene clusters, which are widely distributed especially within the marine habitat [9]. 
However, most of the encoded PUFA synthases and their biosynthetic products remain 
uncharacterized [10]. 
Interestingly, the first characterized PUFA synthases from terrestrial origin catalysing the 
biosynthesis of LC-PUFAs could be discovered in myxobacteria [11]. They are encoded by 
two types of pfa gene clusters found in the genome of the novel isolates Aetherobacter spp., 
identified as prolific producers of EPA and DHA [12;13], and of the linoleic acid (LA, 18:2, 
n-6) producing Sorangium cellulosum strains So ce56 (genes sce0818, sce0819, and sce0820) 
[14], So ce10 [15], So ce1525 [16], So ce307 [17], So ce377 [18], So ce38 [19], So ce487, 
So ce836, So ce969, and So ceGT47. Although the profiles of the produced fatty acids vary 
significantly among Aetherobacter and Sorangium, the structural organization of these gene 
clusters is very similar. In addition to the S. cellulosum strains mentioned above, So ce strains 
not only producing LA but also PUFAs with a longer chain, mainly EPA, were identified 
during screening of an in-house myxobacterial strain collection. Remarkably, these strains 
harbour an additional, novel PUFA biosynthetic pathway for the production of EPA and other 
LC-PUFAs, which was deciphered and analysed in silico in comparison to the formerly 
known myxobacterial PUFA pathways. Evaluation of LC-PUFA production profiles, 
including application of the established heterologous expression system using Myxococcus 
xanthus as host strain for selected pathways and hybrids thereof, provided indications how 
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myxobacteria employ three distinct types of PUFA synthases to generate different fatty acid 
profiles. 
 
 
 
EXPERIMENTAL PROCEDURES 
 
Culture conditions 
Sorangium cellulosum SBSo026 was isolated by the Department of Microbial Natural 
Products, Helmholtz Institute for Pharmaceutical Research Saarland, Helmholtz Centre for 
Infection Research and Pharmaceutical Biotechnology, Saarland University, Saarbrücken, 
Germany. It was grown in liquid HS-medium containing 0.15% casitone, 0.2% HEPES, 0.1% 
KNO3, and 0.1% MgSO4 x 7 H2O. The medium was adjusted to pH 7.2 with NaOH and 
supplemented with 0.00625% K2HPO4, 0.4% glucose, 0.0075% CaCl2 x 2 H2O, and 8 mg/l 
NaFe-EDTA after autoclaving. Alternatively, the strain could also be cultivated in liquid M-
medium containing 1% phytone peptone, 1% maltose, 0.1% CaCl2 x 2 H2O, 0.1% MgSO4 x  
7 H2O, and 50 mM HEPES. The medium was adjusted to pH 7.2 with NaOH and 
supplemented with 8 mg/l NaFe-EDTA after autoclaving. S. cellulosum So ce1128, So ce340 
and So ce427 were isolated by the Department of Microbial Drugs, Helmholtz Centre for 
Infection Research, Braunschweig, Germany, and were grown in liquid M-medium. The 
cultures were incubated on a rotary shaker for 5-10 days at 30 °C and 200 rpm.  
Escherichia coli DH10B [20] was used for cloning experiments. E. coli HS996/pSC101-
BAD-gbaA (tet
R
) [21] and GB05-red [22] were used for modification of a plasmid using 
Red/ET recombination. The cells were grown in LB-medium / on LB-agar (1% tryptone, 
0.5% yeast extract, 0.5% NaCl, (1.5% agar)) or in 2xYT-medium / on 2xYT-agar (1.6% 
tryptone, 1% yeast extract, 0.5% NaCl, (1.5% agar)) at 30-37 °C (and 200 rpm) overnight. 
Antibiotics were used at the following concentrations: 100 µg/ml ampicillin, 50 µg/ml 
kanamycin, 20 µg/ml zeocin, 12.5 µg/ml chloramphenicol, and 6-12.5 µg/ml tetracycline. 
Myxococcus xanthus DK1622 [23] was grown in CTT-medium or on CTT-agar containing 
1% casitone, 10 mM Tris, 1 mM KPO4 buffer, 8 mM MgSO4 (and 1.5% agar). The medium 
was adjusted to pH 7.6. The cultures were incubated for 2-3 days at 30°C (and 200 rpm). 
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General molecular biology techniques  
Routine handling of nucleic acids, such as isolation of genomic and plasmid DNA, restriction 
endonuclease digestions, DNA ligations, and other DNA manipulations, were performed 
according to standard protocols [24]. All the enzymes were purchased from Thermo Scientific 
or New England Biolabs. 
 
 
Isolation of genomic DNA from myxobacteria 
100 ml of a culture were harvested at 8,000 rpm for 10 min at room temperature. After 
discarding the supernatant completely, the cells were washed once with 15 ml SET buffer 
(75 mM NaCl, 25 mM EDTA, 20 mM Tris-Cl pH 7.5), pelleted at 8,000 rpm for 10 min at 
room temperature, and resuspended in 5 ml SET buffer afterwards. 50 µl RNase A stock 
solution (10 mg/ml in sterile ddH2O) and 300 µl Proteinase K solution (10 mg/ml in 50 mM 
Tris-Cl pH 8.0, 1 mM CaCl2) were added, and the tube was inverted several times. 
Subsequently, 600 µl 10% SDS were added, and the tube was incubated first at 41 °C for 
1.5 h and afterwards at 55 °C for 1 h under rotation in a hybridization oven. Thereafter, one 
volume phenol:chloroform:isoamyl alcohol (25:24:1) was added, and the mixture was 
incubated at 5 rpm for 1 h on a tube rotator. The tube was centrifuged at 8,000 rpm for 5 min 
at room temperature, and the upper phase was transferred into a new tube by using an end-cut 
1 ml-tip. The extraction step with phenol:chloroform:isoamyl alcohol (25:24:1) was repeated 
once. Then, one volume chloroform:isoamyl alcohol (24:1) was added to the supernatant, and 
the mixture was incubated at 5 rpm for 1 h on a tube rotator. The tube was centrifuged at 
14,000 rpm for 10 min at room temperature, and 4 ml of the upper phase were transferred into 
a new tube by using an end-cut 1 ml-tip. 440 µl 3 M sodium acetate pH 7.5 were added, and 
the tube was inverted several times. After adding 11 ml ice-cold ethanol, the tube was 
inverted until the appearance of cotton-like DNA. The DNA was collected by wrapping 
around the tip of a Pasteur pipette. In order to wash the DNA, the tip of the pipette with DNA 
was immersed into a 2 ml tube containing 70% ethanol. The DNA pellet on the pipette was 
dried by carefully attaching the inner site of a fresh 2 ml tube to remove the ethanol drops and 
suspended in 0.5-1 ml of 10 mM Tris-Cl pH 8.0. 
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Replicating of the fosmid library of S. cellulosum SBSo026 and spotting onto nylon 
membrane filters 
A fosmid library of S. cellulosum SBSo026 was obtained from CeBiTec, Bielefeld, and all the 
E. coli clones were transferred from 36 96-well microtitre plates into nine 384-well microtitre 
plates containing 2xYT-medium plus 10% 10x Hogness Modified Freezing Medium (4 mM 
MgSO4, 16 mM trisodium citrate, 68 mM (NH4)2SO4, 35% (w/v) glycerol, 260 mM K2HPO4, 
and 132 mM KH2PO4) using a QPix2 system (Molecular Devices). After growth at 37 °C for 
2 days, the clones were spotted onto two 222 x 222 mm positively charged nylon membrane 
filters (Performa II, Molecular Devices) with the QPix2 system. In order to enable clear-cut 
assignment of the transferred colonies to the corresponding clone position in the nine 384-
well microtitre plates, each clone from the microtitre plates was spotted twice in a defined 4x4 
array. The filters were placed onto 2xYT-agar containing 12.5 µg/ml chloramphenicol plus 
0.1% L-arabinose (to increase the copy number of fosmids per cell) and incubated at 30 °C 
overnight. For subsequent lysis of the cells, the filters were processed as follows: Whatman 
3MM Chr paper was soaked with denaturation solution (0.5 M NaOH, 1.5 M NaCl), 
neutralization solution (1.5 M NaCl, 1 M Tris-Cl pH 7.5) and 2x SSC solution (0.3 M NaCl, 
30 mM trisodium citrate; pH 7.0). The filters (bottom side) were transferred onto the 
Whatman 3MM Chr paper, initially soaked with denaturation solution and incubated for  
15 min. Subsequent incubation on neutralization solution (15 min) and 2x SSC (5 min) was 
carried out. The colonies were fixed on the filters through incubation at 80 °C for 1 h. The 
filters were equilibrated for 5 min in 2x SSC and treated with 25 ml Proteinase K solution  
(2 mg/ml in 2x SSC) for 2 h at 37 °C. In order to remove cell debris, the filters were washed 
in ddH2O, treated with ddH2O soaked tissues, then dried and stored at room temperature. 
 
 
Screening of the fosmid library of S. cellulosum SBSo026 for clones containing the pfa 
gene clusters by non-radioactive hybridization 
The 0.5 kb DNA probes 1, 2, and 3 were amplified from genomic DNA of S. cellulosum 
SBSo026 using primers So026_probe 1_fwd / So026_probe 1_rev, So026_probe 2_fwd / 
So026_probe 2_rev, and So026_probe 3_fwd / So026_probe 3_rev (Table 1). These primers 
were designed on the basis of sequences of homologous pfa gene clusters from the 
S. cellulosum strains So ce56 [14], So ce1525 [16], So ce377 [18], So ce38 [19], So ceGT47, 
and So ce427. PCR was performed with Phusion DNA polymerase (Thermo Scientific) and 
standard conditions according to the manufacturer’s protocol. The reactions contained 5% 
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DMSO and were carried out in an Eppendorf Mastercycler under the following conditions: 
initial denaturation for 2 min at 98 °C; 30 cycles consisting of denaturation for 15 s at 98 ºC, 
annealing for 20 s at 72ºC, and extension for 10 s/kb at 72ºC; and a final extension for 10 min 
at 72ºC. The amplified probes were cleaned up, denatured at 95 °C for 10 min and quickly 
chilled on ice. DIG-High Prime (Roche Applied Science) was mixed thoroughly, and 4 µl 
were added to 16 µl denatured DNA. The samples were incubated at 37 °C overnight. The 
reactions were stopped by adding 0.7 µl 0.5 M EDTA pH 8.0. The DNA was precipitated 
after addition of 80 µl ddH2O, 11 µl 3 M sodium acetate pH 7.5 plus 500 µl ice-cold ethanol 
at -80 °C for 30 min and subsequently spun down at 13,000 rpm for 1 min. After discarding the 
supernatant, the DNA pellets were washed with 700 µl 70% ethanol, dried, and resuspended in 
30 µl ddH2O. 
The filter was pre-hybridized in 25 ml DIG Easy Hyb solution (Roche Applied Science) at 
42 °C for 1 h under rotation in a hybridization oven. The DIG-labelled probe was denatured at 
95 °C for 10 min, directly cooled on ice, and added to 25 ml DIG Easy Hyb solution to obtain 
a hybridization solution with a final concentration of min. 7.5 ng/ml DIG-labelled probe. 
Hybridization of the filter was then performed in the fresh hybridization solution at 42 °C 
overnight under rotation. Afterwards, the filter was washed twice for 20 min with 25 ml 2x 
SSC washing buffer (2x SSC, 0.1% (v/v) SDS) at room temperature, followed by two rounds 
of stringent washing for 20 min with 25 ml 0.5x SSC (0.5x SSC, 0.1% (v/v) SDS) at 58 °C. 
The filter was subsequently incubated with 25 ml blocking solution (1% Blocking Reagent 
(Roche Applied Science) in maleic acid buffer (150 mM NaCl, 100 mM maleic acid; pH 7.5)) 
at room temperature for 1 h under rotation. Fab fragments from polyclonal anti-digoxigenin 
antibodies conjugated to alkaline phosphatase (Roche Applied Science) were added to 25 ml 
fresh blocking solution (1:10,000), and the filter was incubated in this solution at room 
temperature for 30 min under rotation. The filter was then washed twice with maleic acid 
buffer plus 0.3% (v/v) Tween 20 at room temperature for 15 min and briefly rinsed with 
maleic acid buffer. After incubation in detection buffer (100 mM NaCl, 100 mM Tris-Cl 
pH 9.5) for 2 min, the filter was covered with CDP-Star, ready-to-use (Roche Applied 
Science) and exposed to the gel documentation system to detect chemiluminescence. Prior to 
stripping, the filter was washed in ddH2O for 10 min. Thereafter, the filter was treated twice 
with stripping buffer (0.2 M NaOH, 0.1% (v/v) SDS) for 30 min at room temperature, washed 
twice in ddH2O for 5 min, dried, and stored at room temperature. 
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Cloning of expression constructs containing the pfa gene clusters from S. cellulosum 
SBSo026 for heterologous LC-PUFA production in M. xanthus 
For subcloning of the OA/LA-type pfa gene cluster of S. cellulosum SBSo026 from fosmid 
pCC1FOS B:I22 (Table 2) into a suitable expression construct for M. xanthus DK1622, a 
3.3 kb vector backbone containing the p15A origin of replication, an ampicillin resistance 
gene, a neomycin resistance gene driven by Tn5 promoter, a tetracycline promoter, as well as 
the appropriate homology arms was amplified from plasmid pPfaAf-Ptet [11] by PCR using 
primers HA+PacI+pACYC177-neo
R
-Ptet_fwd and HA+pACYC177-neo
R
-Ptet_rev (Table 1). 
PCR was performed with the PCR extender system (5 Prime) and standard conditions 
according to the manufacturer’s protocol. The reactions were carried out in an Eppendorf 
Mastercycler under the following conditions: initial denaturation for 2 min at 94 °C; 30 cycles 
consisting of denaturation for 20 s at 94 °C, annealing for 20 s at 62 °C, and extension for 
1 min/kb at 72 °C; and a final extension for 10 min at 72 °C. The linear plus circular 
homologous Red/ET recombineering was performed as described previously [11] using 1.5 µl 
of the PCR product, resulting in plasmid pPfaSo026-Ptet (Table 2). Afterwards, a zeocin 
resistance gene and the gene encoding the Mx9 integrase with attP site, both driven by Tn5 
promoter derived from pMyx-zeo (S. C. Wenzel, unpublished), were inserted via PacI 
restriction sites, generating plasmid pPfaSo026-Ptet-mx9.2 (Table 2). 
For subcloning of the AA/EPA-type pfa gene cluster of S. cellulosum SBSo026 from 
fosmid pCC1FOS C:C03 (Table 2) into a suitable expression construct for M. xanthus 
DK1622, a 2.1 kb vector backbone containing the p15A origin of replication, a tetracycline 
resistance gene, as well as the appropriate homology arms was amplified from plasmid 
pACYC184 (New England Biolabs) by PCR using primers HA+PacI+pACYC184_fwd and 
HA+Eco81I+pACYC184_rev (Table 1). PCR was performed with the PCR extender system 
(5 Prime) and standard conditions according to the manufacturer’s protocol. The reactions 
were carried out in an Eppendorf Mastercycler under the following conditions: initial 
denaturation for 2 min at 94 °C; 30 cycles consisting of denaturation for 20 s at 94 °C, 
annealing for 20 s at 62 °C, and extension for 1 min/kb at 72 °C; and a final extension for 
10 min at 72 °C. The linear plus circular homologous Red/ET recombineering was performed 
as described previously [11] using 1.5 µl of the PCR product, resulting in plasmid 
pPfa2So026_1 (Table 2). Plasmid pHybPfa1 (Table 2) was constructed by exchange of the 
genes pfa2 and pfa3 of the OA/LA-type pfa gene cluster located on plasmid pPfaSo026-Ptet 
for the AA/EPA-type pfa gene cluster located on plasmid pPfa2So026_1 via Eco81I and PacI 
restriction sites. Afterwards, a zeocin resistance gene and the gene encoding the Mx9 
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integrase with attP site, both driven by Tn5 promoter derived from pMyx-zeo (S. C. Wenzel, 
unpublished), were inserted via PacI restriction sites, generating plasmid pHybPfa1-mx9.2 
(Table 2). In order to eliminate pfa1 for the construction of a plasmid exclusively comprising 
the AA/EPA-type pfa gene cluster (pPfa2So026-Ptet-mx9.2) via overlap extension PCR, a 1.3 
kb DNA fragment comprising the neomycin resistance gene plus the tetracycline promoter 
and 0.8 kb of gene pfa2 were amplified from plasmid pHybPfa1 by PCR using primers neo
R
-
Ptet_AanI_fwd / neo
R
-Ptet+overlap_rev and pfa2_2_So026+overlap_fwd / 
pfa2_2_So026_PscI_rev (Table 1). PCR amplification of the two fragments was performed 
with Phusion DNA polymerase (Thermo Scientific) and standard conditions according to the 
manufacturer’s protocol. The reactions contained 5% DMSO and were carried out in an 
Eppendorf Mastercycler under the following conditions: initial denaturation for 2 min at 
98 °C; 30 cycles consisting of denaturation for 15 s at 98 °C, annealing for 20 s at 67 °C, and 
extension for 10 s/kb at 72 °C; and a final extension for 10 min at 72 °C. The subsequent 
overlap extension PCR of the 2 kb fragment was performed as described for the amplification 
of the two fragments to be spliced using primers neo
R
-Ptet_AanI_fwd and 
pfa2_2_So026_PscI_rev plus the two amplified fragments as templates. For the construction 
of plasmid pPfa2So026-Ptet-mx9.2 (Table 2), the neomycin resistance gene, the tetracycline 
promoter, gene pfa1, as well as parts of gene pfa2 of plasmid pHybPfa1-mx9.2 were replaced 
by the overlap extension PCR amplicon neo
R
-Ptet-5'pfa2 by conventional restriction digest and 
ligation using AanI and PscI restriction sites. 
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Table 1. Primers used for amplification of probes and for cloning of expression plasmids in this study.  
The homology arms are shown in italics and the introduced restriction sites are underlined. 
 
Primer Sequence (5'3') 
So026_probe 1_fwd TGCACGTGGTGCGCGAGACGCCG 
So026_probe 1_rev CCTCCGGGCGCGAGATCTTCGCG 
So026_probe 2_fwd CATCATCGCGGGGCTCGGGGCC 
So026_probe 2_rev AGCTTGCGCAGCCAGTCCGCCCG 
So026_probe 3_fwd CCACCGAGCTCGTCGGCGAGTTCGC 
So026_probe 3_rev CCGTGCTCCAGGAACACGCGCACGC 
HA+PacI+pACYC177-neo
R
-
Ptet_fwd 
AGGCCCTCGTCCAGCGCTTGCTCTGGCGTTCTGCCTGGCCCGGTCAGCT
TAATTAATCGCTCACTGACTCGC 
HA+pACYC177-neo
R
-Ptet_rev 
GAAGGCCGGCGCTGCGGAGGGCGTGCGGATTCTCTATCATTGCTGGGTG
CCTCCTAG 
HA+PacI+pACYC184_fwd 
TCAGTAATCCCGATTCCGGCAGAACGCCTTGTACTTCTCCTTCACGAGC
TTAATTAATCCGTTAGCGAGGTGCCG 
HA+Eco81I+pACYC184_rev 
CGCCCACGATGGCAACGGGAGTGTGCGGCATGTGGTACCCCTCAGGGCG
GAAATGGCTTACGAACG 
neo
R
-Ptet_AanI_fwd GAATTTTATAAACCGTGGAGCGGGCAATACTG 
neo
R
-Ptet+overlap_rev 
GATGGCAACGGGAGTGTGCGGCATTGCTGGGTGCCTCCTAGATTATTGT
C 
pfa2_2_So026+overlap_fwd 
GACAATAATCTAGGAGGCACCCAGCAATGCCGCACACTCCCGTTGCCAT
C 
pfa2_2_So026_PscI_rev GAAGCACATGTACATGAAGATGTCGTTCATGG 
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Table 2. Plasmids and expression strains constructed in this study.  
oriV = origin of replication, bla = ampicillin resistance gene, nptII = neomycin resistance gene, ble = zeocin 
resistance gene, tetA
 
= tetracycline resistance gene, Ptet = tetracycline promoter, PTn5 = Tn5 promoter, Mx9 int = 
Mx9 integrase gene with phage attachment site attP. 
 
Plasmid / Strain Characteristics 
pCC1FOS B:I22 
Derivative of pCC1FOS (Epicentre) with 38.7 kb of genomic DNA of 
Sorangium cellulosum SBSo026 including the OA/LA-type pfa gene 
cluster as insert  
pPfaSo026-Ptet 
Derivative of pPfaAf-Ptet [11] in which the pfa gene cluster of 
Aetherobacter fasciculatus (SBSr002) was replaced by the OA/LA-type 
pfa gene cluster of S. cellulosum SBSo026 located on fosmid pCC1FOS 
B:I22 by Red/ET recombineering. p15A oriV, bla, nptII 
pPfaSo026-Ptet-mx9.2 
Derivative of pPfaSo026-Ptet in which PTn5-ble-Mx9 int was inserted via 
PacI  
pCC1FOS C:C03 
Derivative of pCC1FOS (Epicentre) with 44 kb of genomic DNA of 
S. cellulosum SBSo026 including the AA/EPA-type pfa gene cluster as 
insert 
pPfa2So026_1 
AA/EPA-type pfa gene cluster of S. cellulosum SBSo026 subcloned from 
pCC1FOS C:C03 by Red/ET recombineering. p15A oriV, tetA 
pHybPfa1 
Derivative of pPfaSo026-Ptet in which the genes pfa2 and pfa3 of the 
OA/LA-type pfa gene cluster were replaced by the AA/EPA-type pfa 
gene cluster located on plasmid pPfa2So026_1 via Eco81I and PacI 
pHybPfa1-mx9.2 
Derivative of pHybPfa1 in which PTn5-ble-Mx9 int was inserted via 
PacI 
pPfa2So026-Ptet-mx9.2 
Derivative of pHybPfa1-mx9.2 in which a fragment comprising pfa1 was 
replaced by a corresponding fragment lacking pfa1 via AanI and PscI 
M. xanthus DK1622:: 
pPfaSo026-Ptet-mx9.2 
Myxococcus xanthus DK1622 with pPfaSo026-Ptet-mx9.2 site-
specifically integrated at Mx9 attB2 site of the genome 
M. xanthus DK1622::pHybPfa1-
mx9.2 
M. xanthus DK1622 with pHybPfa1-mx9.2 site-specifically integrated at 
Mx9 attB2 site of the genome  
M. xanthus DK1622:: 
pPfa2So026-Ptet-mx9.2 
M. xanthus DK1622 with pPfa2So026-Ptet-mx9.2  site-specifically 
integrated at Mx9 attB2 site of the genome  
 
 
 
Transformation of M. xanthus by electroporation and heterologous expression 
1.5 x 10
9
 cells from an overnight culture of M. xanthus DK1622 were harvested at 8,000 rpm for 
10 min. After discarding the supernatant, the cells were resuspended in 20 ml sterile ddH2O. The 
cells were spun down at 8,000 rpm for 10 min, and the supernatant was discarded. The cells were 
resuspended in 40 µl sterile ddH2O and transferred into a 2 ml tube. 2 µl of the expression 
plasmid were added. The cells were electroporated in an ice-cooled electroporation cuvette  
(1 mm) using a Bio-Rad electroporator at 650 V, 400 Ω, and 25 µF. 1 ml CTT-medium was 
added into the cuvette, and the cell suspension was transferred back into the tube. The tube 
was incubated in a heating block at 30 °C with shaking at 1,000 rpm for about 5-8 h. Thereafter, 
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the cells were mixed with 2-3 ml CTT-soft agar (CTT-medium plus 0.75% agar) containing  
60 µg/ml kanamycin plus 20 µg/ml zeocin and plated onto two CTT-agar plates containing  
60 µg/ml kanamycin plus 20 µg/ml zeocin. The plates were incubated at 30 °C for about 5 days. 
Thereafter, six colonies were transferred onto new CTT-agar plates containing 60 µg/ml 
kanamycin and 20 µg/ml zeocin. In order to verify the integration of the expression construct 
into the genome of M. xanthus via Mx9 attB sites, DNA from selected clones was isolated and 
used for PCR analyses [25]. The primers used are listed in Table 3. PCR was performed with 
Taq DNA polymerase (Thermo Scientific) and standard conditions according to the 
manufacturer’s protocol. The reactions contained 8% glycerol and were carried out in an 
Eppendorf Mastercycler under the following conditions: initial denaturation for 3 min at  
95 °C; 30 cycles consisting of denaturation for 30 s at 95 °C, annealing for 30 s at 56 °C, and 
extension for 1 min/kb at 72 °C; and a final extension for 10 min at 72 °C. The constructed 
strains are listed in Table 2. Expression was carried out in 50 ml CTT-medium containing  
60 µg/ml kanamycin and 20 µg/ml zeocin at 30 °C. The cells were cultivated for 48 h and 
then harvested at 4,000 rpm for 10 min. 
 
Table 3. Primers used for the verification of the integration of expression constructs into the genome of 
M. xanthus DK1622 via Mx9 attB sites. 
 
Primer Sequence (5'3') 
Mx9attB1_up TGCCAGGGCTTACGGCTTC 
Mx9attB1_down CAGCACGGGTGCAGCAAC 
Mx9attB2_up TATCCCAGCAACCGCCGGAG 
Mx9attB2_down CGAGGTCCGGGACGCGCGCA 
Mx9attP_up GCGCCGAACTTAACAAGTTG 
Mx9attP_down TCCAGGTCCTCACGCTTGAC 
 
 
 
Extraction of cellular fatty acids 
The cellular fatty acids were extracted using the FAME method [26]. For this purpose, 50 ml 
of a culture were harvested at 8,000 rpm for 10 min at room temperature. The cell pellet was 
transferred to a glass vial and dried in a vacuum concentrator. Subsequently, the cell dry 
weight was determined. 5 µl (50 µg) of DHA (Sigma-Aldrich) and 500 µl of a mixture of 
methanol, toluene, and sulphuric acid (50:50:2, v/v/v) were added. The vial was capped with a 
teflon-lined screw cap and incubated at 80 °C for 24-48 h. After the mixture was cooled to 
room temperature, 400 µl of an aqueous solution consisting of 0.5 M NH4HCO3 and 2 M KCl 
were added, and the sample was vortexed for 30 s. Phase separation was achieved by 
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centrifugation at 4,000 rpm for 5 min at room temperature. 75 µl of the upper phase were 
mixed with 25 µl N-methyl-N-(trimethylsilyl)trifluoroacetamide (MSTFA) and incubated at 
37 °C for 30 min. Subsequently, the sample was used for GC-MS analysis. 
 
 
Extraction and fractionation of lipids 
Extraction of lipids from microbial cells was carried out using the method of Bligh and Dyer 
[27], modified by Lewis et al. [28], on a small scale. In the first step, the cell pellet from a  
100 ml culture was transferred into a polypropylene tube. Successively, 4 ml chloroform, 8 ml 
methanol, and 3.2 ml 1% NaCl were added, and the tube was vortexed at high speed for 15 s 
after every addition. The sample was agitated on a tube rotator at 30 rpm overnight. 4 ml 
chloroform and 4 ml 1% NaCl were then added, and the tube was inverted 30 times. Phase 
separation was achieved by centrifugation at 4,000 rpm for 5 min at room temperature. The 
bottom layer containing the lipid extract was evaporated to dryness under a gentle stream of 
nitrogen and dissolved in 1 ml of a chloroform:methanol mixture (2:1, v/v). The lipid solution 
was fractionated by solid-phase extraction on a Strata SI-1 silica column with 100 mg sorbent 
mass (Phenomenex) equilibrated with chloroform + 1% acetic acid. Neutral lipids and free 
fatty acids were eluted from the column with 1 ml of chloroform + 1% acetic acid, glycolipids 
were eluted with 1.5 ml of an acetone:methanol mixture (9:1, v/v), and phospholipids were 
eluted with 1 ml methanol. For GC-MS analysis, the fractions were dried in a vacuum 
concentrator and further processed according to the FAME method described previously. 
 
 
Analysis of fatty acid methyl esters by GC-MS 
GC-MS was carried out on an Agilent 6890N gas chromatograph (Agilent Technologies) 
equipped with a 7683B split/splitless injector with autosampler (Agilent Technologies) and 
coupled to a 5973 electron impact mass selective detector (Agilent Technologies). Helium 
was used as the carrier gas at a flow rate of 1 ml/min. 1 µl of the sample was injected in split 
mode (split ratio, 10:1). The analytical column was a (5% phenyl)-methylpolysiloxane 
capillary column (Agilent J&W DB-5ht; 30 m x 0.25 mm i.d. x 0.1 µm film thickness, 
maximum temperature 400 °C; Agilent Technologies). The column temperature was kept at 
130 °C for 2.5 min, increased to 240 °C at a rate of 5 °C/min, then ramped to 300 °C at  
30 °C/min, and held at 300 °C for 5 min. Other temperatures were as follows: inlet, 275 °C; 
GC-MS transfer line, 280 °C; ion source, 230 °C; and quadrupole, 150 °C. The mass selective 
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detector was operated in scan mode, scanning the mass range from m/z 40 to 700. Scan 
control, data acquisition, and processing were performed by MSD ChemStation and AMDIS 
software, version 2.68, based on the fragmentation patterns and retention times, in comparison 
with Supelco 37 Component FAME Mix and LC-PUFAs (all Sigma-Aldrich) as reference 
standards, and NIST 08 library. Absolute amounts of PUFAs were quantified by integration 
of the peaks using MSD ChemStation and by subsequent calculation in relation to the integral 
of DHA and to cell dry weight.  
 
 
 
RESULTS AND DISCUSSION 
Among various myxobacterial species, the two genera Sorangium and Aetherobacter, 
belonging to the same bacterial family Polyangiaceae, were found to produce diverse types of 
PUFAs de novo, employing PUFA synthases encoded by pfa biosynthetic gene clusters 
[11;12]. Sorangium cellulosum So ce56 [29], So ce10 [15], So ce1525 [16], So ce307 [17], 
So ce377 [18], So ce38 [19], So ce487, So ce836, So ce969, and So ceGT47 are producers of 
LA (18:2, n-6; ca. 10% of total fatty acid methyl esters (FAMEs)) and eicosadienoic acid 
(EDA, 20:2, n-6) in trace amounts (< 1% of total FAMEs). The Aetherobacter species 
Aetherobacter sp. (SBSr001) nov. ined., Aetherobacter fasciculatus sp. nov. ined. (SBSr002), 
Aetherobacter rufus sp. nov. ined. (SBSr003) [30], and Aetherobacter sp. nov. ined. 
(SBSr008) produce arachidonic acid (AA, 20:4, n-6; ca. 1% of total FAMEs), EPA (20:5, n-3; 
ca. 7-10% of total FAMEs), and DHA (22:6, n-3; ca. 10-19% of total FAMEs), as well as LA, 
γ-linolenic acid (GLA, 18:3, n-6), stearidonic acid (SDA, 18:4, n-3), n-6/n-3 DPA (22:5) in 
trace amounts (< 1% of total FAMEs). Genome sequence data revealed the presence of a 
distinct type of pfa gene cluster in the analysed S. cellulosum strains, responsible for the 
production of LA and/or oleic acid (OA, 18:1; n-9) and of another type of pfa gene cluster in 
Aetherobacter strains, most likely responsible for the production of DHA, n-6 DPA, and n-3 
DPA (Figure 1), as proven by heterologous expression in M. xanthus. As a consequence, these 
gene clusters can be designated as OA/LA-type pfa gene cluster and DPA/DHA-type pfa gene 
cluster, respectively.  
During continuous efforts to discover novel myxobacterial isolates, which optionally 
includes the analysis of their fatty acid profiles, the prolific PUFA producer S. cellulosum 
strain SBSo026 was found. GC-MS analysis of the FAMEs carried out for this strain 
disclosed the production of LA (6.2% of total FAMEs) and EDA (1.3% of total FAMEs). 
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Additionally, EPA (7.1% of total FAMEs), as well as GLA, SDA, dihomo-γ-linolenic acid 
(DHGLA, 20:3, n-6), AA, eicosatetraenoic acid (ETA, 20:4, n-3), and n-3 DPA in trace 
amounts (< 1% of total FAMEs) could be detected. This high capability of S. cellulosum 
SBSo026 for production of various PUFA species stimulated sequencing and screening of the 
genome of this strain, which had been cloned in a fosmid library, for putative PUFA 
biosynthetic pathways. The fosmid library was screened for the OA/LA-type pfa gene cluster 
at low stringency using probe 1, which hybridizes at the 5' end of pfa1, and probe 2, which 
hybridizes at the 3' end of pfa3. This resulted in the identification of fosmid pCC1FOS B:I22, 
comprising a pfa gene cluster homologous to the OA/LA-type pfa gene cluster of 
S. cellulosum So ce56, So ce10, So ce1525, So ce307, So ce377, So ce38, So ce487, 
So ce836, So ce969, and So ceGT47 [11], plus flanking genes. The 17.2 kb OA/LA-type pfa 
gene cluster of S. cellulosum SBSo026 (Figure 1) was completely sequenced by primer 
walking or subcloning of fragments prior to Sanger sequencing. On top of that, an additional, 
second pfa gene cluster, only comprising genes pfa2 and pfa3 (Figure 1), was discovered in 
the genome sequence of S. cellulosum SBSo026. In order to detect fosmids harbouring the 
second PUFA biosynthetic pathway, probe 3, targeting the unique AT domain of pfa3, was 
used for hybridization at low stringency. Fosmids pCC1FOS C:C03, C:O01, A:I24, B:J03, 
A:L03, B:E08, E:O20, and A:F04, containing the 15.6 kb second pfa gene cluster (or parts 
thereof) plus adjacent genes, could be identified. Fosmid pCC1FOS C:C03 was completely 
sequenced by next generation sequencing. This second type of pfa gene cluster of 
S. cellulosum SBSo026 differs from the OA/LA-type pfa gene cluster in terms of number of 
the catalytic domains (Figure 1), which might be indicative of an extended genetic capability 
of the strain for production of diverse PUFA species. In order to check for the presence of the 
novel PUFA biosynthetic pathway among other S. cellulosum strains, all genome sequence 
data available from S. cellulosum strains (including the So ce strains mentioned previously 
plus So ce1128 [31], So ce340, So ce427, So ce690 [32], and So0157-2 [33]) was screened 
for pfa gene clusters. The formerly characterized OA/LA-type pfa gene cluster could be 
detected in every So ce strain already mentioned, whereas the second type of pfa gene cluster 
could exclusively be identified in the genome sequences of S. cellulosum SBSo026, 
So ce1128, So ce340, So ce427, and So ce690. FAME analysis unveiled that all So ce strains 
are capable of producing LA, but EPA production could only be observed for the strains 
harbouring two types of pfa gene clusters. Thus, the potential for EPA production is most 
likely coupled to the presence of this second pfa gene cluster, which seems to encode a novel 
PUFA synthase.  
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Figure 1. PUFA biosynthetic gene clusters from terrestrial myxobacteria of the Polyangiaceae family.  
(A) Sorangium cellulosum (OA/LA-type pfa gene cluster; the number of ACP domains is ranging from four to 
five), (B) Aetherobacter sp. (DPA/DHA-type pfa gene cluster), (C) Sorangium cellulosum (AA/EPA-type pfa 
gene cluster). 
 
 
Comparison of the two types of myxobacterial PUFA biosynthetic gene clusters of 
S. cellulosum and the DPA/DHA-type pfa gene cluster of Aetherobacter spp. disclosed that 
they share most of their functional elements (Figure 1). The most remarkable differences are 
the absence of gene pfa1 encoding an enoyl reductase (ER) in the second pfa gene cluster of 
S. cellulosum, the variable number of tandem acyl carrier protein (ACP) domains, and the lack 
of an acyltransferase (AT) domain within Pfa3 encoded by the OA/LA-type pfa gene cluster 
of Sorangium. As the ER domain is supposed to represent a crucial catalytic activity of PUFA 
synthases, Pfa1 encoded by the OA/LA-type pfa gene cluster is assumed to complement the 
activity of the PUFA synthase encoded by genes pfa2 and pfa3 of the second PUFA 
biosynthetic pathway identified in some S. cellulosum strains. Notably, an AT domain is 
present within Pfa3 encoded by the DPA/DHA-type pfa gene cluster of Aetherobacter spp. 
and the second pfa gene cluster of S. cellulosum which could not be identified in the OA/LA-
type PUFA synthase. This might explain the inability of the latter PUFA biosynthetic pathway 
to synthesize LC-PUFAs like EPA or DHA, a speculation supported by a recent study 
suggesting that the homologous AT domain from marine γ-Proteobacteria may play a role in 
determining the final LC-PUFA product [34]. Detailed analyses on the sequence level 
revealed that the Pfa proteins of the second PUFA synthases from S. cellulosum SBSo026, 
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So ce1128, So ce340, and So ce427 show a pairwise sequence identity of > 90% among the 
different producer strains. Comparison of the second PUFA synthase and the putative 
OA/LA-type PUFA synthase of S. cellulosum SBSo026 unveiled considerably lower 
similarity (pairwise sequence identity of ≤ 53%). This value is in the range of the observed 
low pairwise sequence identity of ≤ 63% when comparing the second PUFA synthase of 
S. cellulosum SBSo026 with the DPA/DHA-type PUFA synthase of A. fasciculatus 
(SBSr002). These data indicate that the sequences of myxobacterial PUFA synthases correlate 
significantly more with their product specificity than with their source, which implies that the 
second pfa gene cluster rather originates from horizontal gene transfer into a S. cellulosum 
ancestor already harbouring the OA/LA-type pfa gene cluster than results from a duplication 
event of this gene cluster. 
In order to prove the functionality and the product spectrum of the pfa gene clusters from 
the novel myxobacterial isolate S. cellulosum SBSo026, their heterologous expression was 
performed in the myxobacterial model strain M. xanthus DK1622, established for 
recombinant LC-PUFA production [11]. The practical application initially required the 
subcloning of the gene clusters from fosmids into suitable plasmids and subsequent 
engineering of the constructs. Cloning of the OA/LA-type pfa gene cluster from fosmid 
pCC1FOS B:I22 into a plasmid containing the p15A origin of replication and an ampicillin 
resistance gene was achieved by linear plus circular homologous Red/ET recombination [35] 
(Figure 2A). During this step, the native promoter upstream of pfa1 was replaced with a 
tetracycline promoter downstream of a neomycin resistance gene driven by Tn5 promoter. In 
a final engineering step, a zeocin resistance gene and a gene encoding the Mx9 integrase with 
attP site for the site-specific integration into the host genome via the Mx9 phage attachment 
site [36] were ligated into the obtained plasmid pPfaSo026-Ptet, yielding expression plasmid 
pPfaSo026-Ptet-mx9.2. In parallel, the second pfa gene cluster was cloned from fosmid 
pCC1FOS C:C03 into a plasmid containing the p15A origin of replication and a tetracycline 
resistance gene by linear plus circular homologous Red/ET recombination (Figure 2B). The 
backbone of the obtained plasmid pPfa2So026_1 was exchanged for the backbone of plasmid 
pPfaSo026-Ptet containing the p15A origin of replication and an ampicillin resistance gene by 
applying conventional cloning techniques. During this step, gene pfa1 of the OA/LA-type pfa 
gene cluster together with the upstream located tetracycline promoter and the neomycin 
resistance gene driven by Tn5 promoter was inserted in front of genes pfa2 and pfa3. 
Afterwards, a zeocin resistance gene and a gene encoding the Mx9 integrase with attP site 
were ligated into the obtained plasmid pHybPfa1, yielding expression plasmid  
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pHybPfa1-mx9.2. Gene pfa1 was deleted via restriction digest and religation to construct the 
derivative pPfa2So026-Ptet-mx9.2. 
 
 
Figure 2. Cloning strategy for the construction of expression plasmids for recombinant LC-PUFA 
production in Myxococcus xanthus DK1622.  
(A) Cloning of the OA/LA-type pfa gene cluster from Sorangium cellulosum SBSo026, (B) Cloning of the 
AA/EPA-type pfa gene cluster from S. cellulosum SBSo026 and construction of a hybrid pfa gene cluster. oriV = 
origin of replication, bla = ampicillin resistance gene, nptII = neomycin resistance gene, ble = zeocin resistance 
gene, tetA
 
= tetracycline resistance gene, Ptet = tetracycline promoter, PTn5 = Tn5 promoter, Mx9int = Mx9 
integrase gene with phage attachment site attP. Flanking genes on the fosmids are not illustrated. 
 
 
The generated expression constructs pPfaSo026-Ptet-mx9.2, pPfa2So026-Ptet-mx9.2, 
and pHybPfa1-mx9.2 were transferred into M. xanthus DK1622 by electroporation. Six 
kanamycin and zeocin resistant transformants of M. xanthus DK1622::pPfaSo026-Ptet-
mx9.2, M. xanthus DK1622::pPfa2So026-Ptet-mx9.2, or M. xanthus 
DK1622::pHybPfa1-mx9.2 were randomly selected to verify the correct integration via 
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(A) Cloning of the first pfa gene cluster from Sorangium cellulosum SBSo026, (B) Cloning of the second pfa
gene clusters from S. cellulosum SBSo026 and construction of a hybrid pfa gene cluster.
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Mx9 attB sites by PCR analysis. For every transformant, integration of the expression 
construct at the attB2 site [36] could be confirmed. The transgenic clones were 
cultivated in 50 ml scale at 30 °C for two days. The cellular fatty acids were extracted 
via acidic methanolysis using the FAME method [26] and analysed by GC-MS (Table 
4). All transgenic clones of M. xanthus DK1622::pPfaSo026-Ptet-mx9.2 were shown to 
produce OA, isomers of octadecenoic acid, LA, and GLA, but also EDA as well as 
DHGLA in trace amounts. These fatty acids are not present in M. xanthus DK1622 
wild type, which therefore provided functional proof that the designated OA/LA-type 
PUFA pathway can indeed direct the biosynthesis towards C18 MUFAs/PUFAs (and 
also C20 derivatives). However, in the native producer strain S. cellulosum SBSo026 
production of these fatty acids is clearly shifted to LA and EDA and only low amounts 
of OA, isomers of octadecenoic acid, GLA, as well as DHGLA can be detected after 
seven days of cultivation. When analysing the fatty acid profiles of the six transgenic 
clones of M. xanthus DK1622::pPfa2So026-Ptet-mx9.2, expressing genes pfa2 and pfa3 
of the second PUFA pathway, no deviation from the fatty acid profile of the expression 
host M. xanthus DK1622 wild type could be observed. This indicates that the PUFA 
synthase encoded by pfa2 and pfa3 is not fully functional most likely due to the lack of 
the ER activity encoded by pfa1 homologues. Indeed, when coexpressing Pfa1 by 
construction of a hybrid pathway (including pfa1 of the OA/LA-type PUFA gene 
cluster), production of PUFAs could be observed. All transgenic clones of M. xanthus 
DK1622::pHybPfa1-mx9.2 were shown to produce EPA and AA, as well as LA, GLA, 
SDA, DHGLA, ETA, and n-3 DPA in trace amounts. However, production yields of 
EPA achieved with the native producer strain after seven days of cultivation surpass 
the production rate of the heterologous host strain.  
Comparison of LC-PUFA production profiles of the transgenic hosts M. xanthus 
DK1622::pPfaSo026-Ptet-mx9.2, M. xanthus DK1622::pPfa2So026-Ptet-mx9.2, or M. xanthus 
DK1622::pHybPfa1-mx9.2 with the native producer S. cellulosum SBSo026 allows for 
drawing of several conclusions. The observed changes in the fatty acid profile after 
heterologous expression of the OA/LA-type pfa gene cluster from S. cellulosum SBSo026 are 
consistent with the results of the previously reported heterologous expression of the 
homologous pfa gene cluster from S. cellulosum So ce56 [11]. Together with the results of 
previously performed feeding experiments [11], it can be deduced that the OA/LA-type pfa 
gene cluster of Sorangium is most likely responsible for the production of EDA, isomers of 
octadecenoic acid, and either of both OA and LA or of merely OA, which could be converted 
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into LA by an oleoyl-CoA-Δ12 desaturase (EC 1.14.19.6). LA is then most likely converted 
into GLA in M. xanthus DK1622, probably catalysed by a linoleoyl-CoA desaturase  
(EC 1.14.19.3), whereas a Δ8 desaturase (EC 1.14.19.4) could convert EDA into DHGLA in 
M. xanthus DK1622. As expected, the PUFA synthase encoded by the incomplete, second pfa 
gene cluster of Sorangium turned out to be not functional in the absence of the third subunit 
encoding the required ER activity. However, Pfa1 encoded by the OA/LA-type pfa gene 
cluster was shown to effectively complement the multienzyme complex to reconstitute a 
functional PUFA synthase. This hybrid PUFA synthase most likely produces EPA and some 
minor amounts of AA, ETA, DHGLA, and n-3 DPA as by-products and can therefore be 
designated as AA/EPA-type PUFA synthase. The generated C20 PUFAs ETA and DHGLA 
could then be catabolized to the corresponding C18 PUFAs SDA and GLA via β-oxidation. 
However, further studies are required to obtain deeper insights into the cellular metabolism of 
the fatty acid products in the heterologous host as well as in the natural producer. 
 
Table 4. Production of MUFAs and PUFAs with a carbon chain length of ≥ C18 by Sorangium cellulosum 
SBSo026, Myxococcus xanthus DK1622::pPfaSo026-Ptet-mx9.2, and M. xanthus DK1622::pHybPfa1-
mx9.2. Cultivation was carried out in 50 ml HS-medium at 30 °C and 200 rpm for 7 days (for S. cellulosum) or 
in 50 ml CTT-medium at 30 °C and 200 rpm for 2 days (for M. xanthus). The indicated values for M. xanthus are 
means of three biological samples.  
 
MUFA or PUFA 
Absolute amount [mg/g cell dry weight] 
S. cellulosum SBSo026 
M. xanthus DK1622:: 
pPfaSo026-Ptet-mx9.2 
M. xanthus DK1622:: 
pHybPfa1-mx9.2 
oleic acid  
(OA, 18:1, n-9) 
0.1 0.1 − 
linoleic acid  
(LA, 18:2, n-6) 
3.3 0.9 < 0.1 
γ-linolenic acid  
(GLA, 18:3, n-6) 
< 0.1 1.1 < 0.1 
stearidonic acid  
(SDA, 18:4, n-3) 
0.2 − < 0.1 
eicosadienoic acid 
(EDA, 20:2, n-6) 
0.7 < 0.1 − 
dihomo-γ-linolenic acid 
(DHGLA, 20:3, n-6) 
< 0.1 < 0.1 < 0.1 
arachidonic acid  
(AA, 20:4, n-6) 
0.2 − 0.2 
eicosatetraenoic acid 
(ETA, 20:4, n-3) 
< 0.1 − < 0.1 
eicosapentaenoic acid 
(EPA, 20:5, n-3) 
3.7 − 1.2 
docosapentaenoic acid 
(DPA, 22:5, n-3) 
0.1 − < 0.1 
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Another very interesting feature associated with the presence of the AA/EPA-type pfa gene 
cluster was obtained when screening our database for the secondary metabolite profiles of the 
analysed Sorangium species. In contrast to the strains that only harbour the OA/LA-type pfa 
gene cluster, all S. cellulosum strains additionally comprising the AA/EPA-type pfa gene 
cluster were shown to produce maracin A or maracen A (Figure 3A). These secondary 
metabolites show a good activity against Mycobacterium tuberculosis and have a low 
cytotoxicity [31]. They represent lipophilic carboxylic acids with 19 carbon atoms, four to 
five trans double bonds, and one cis double bond. Maracin A contains an ethinyl-trans-vinyl 
ether as a very unusual structural element, whereas the alkinyl group is replaced by an  
α-chlorovinyl group in maracen A. Feeding experiments revealed the biosynthetic origin of 
this compound family containing nine complete acetate units plus a carboxyl group 
originating from another acetate unit [31]. When analysing the flanking regions of AA/EPA-
type pfa gene clusters, 18 genes could be identified, which are exclusively present in the 
genomes of the EPA producing So ce strains. In silico analyses based on homology searches 
indicate that these genes encode several proteins, possibly involved in the conversion of EPA 
into maracen/maracin. These include putative homologues of a Δ12-fatty acid dehydrogenase, 
a zinc-dependent alcohol dehydrogenase, a phospholipid/glycerol acyltransferase, four 
phospholipases, an enoyl-CoA hydratase, a cytochrome P450, a lipoxygenase, a lipase 
maturation factor, two PUFA isomerases, and five proteins of unknown function. By means of 
the identified putative enzyme activities, a hypothesis for the biosynthesis of maracin/maracen 
starting from EPA was developed: The 1-acylglycerol-3-phosphate O-acyltransferase 
(AGPAT) domain encoded by the AA/EPA-type pfa gene cluster most likely catalyses the 
incorporation of EPA from the assembly line into the phospholipids. The phospholipases 
encoded adjacently to the pfa genes could hydrolyse the ester bond between EPA and the 
phospholipids and thereby release the free LC-PUFA as precursor for maracin/maracen 
biosynthesis. Interestingly, extraction and fractionation of the lipids from S. cellulosum 
SBSo026, subsequent preparation of FAMEs by transesterification, and GC-MS analysis 
showed that most of the synthesized EPA (61%) was present in the fraction containing neutral 
lipids plus free fatty acids. 36% of produced EPA were incorporated into the phospholipids 
and 3% were present in the glycolipid fraction. The required isomerizations of the double 
bonds to enable maracin/maracen from EPA are assumed to be carried out by the PUFA 
isomerases. Incorporation of an oxygen atom to form the internal ether moiety via a 
hydroperoxide intermediate may be catalysed by the lipoxygenase and the cytochrome P450 
[37-39]. The enoyl-CoA hydratase and the alcohol dehydrogenase might participate in  
CHAPTER 2: IDENTIFICATION OF A SECOND PUFA SYNTHASE FROM SORANGIUM CELLULOSUM 
78 
 
α-oxidation of the C20 fatty acid derivative to generate a C19 chain, whereas the Δ12-fatty 
acid dehydrogenase might be involved in the oxidation of the cis double bond next to the 
ether group to a triple bond. However, further biochemical and genetic studies need to be 
performed to validate this theory and to elucidate the biosynthesis of maracin/maracen. 
 
 
Figure 3. (A) Structures of eicosapentaenoic acid (EPA), maracin A, and maracen A and (B) proposed 
biosynthesis of structural elements of maracin A/maracen A starting from EPA.  
Incorporation of an oxygen atom to form the internal ether bond via a hydroperoxide intermediate may be 
catalysed by the lipoxygenase and the cytochrome P450; α-oxidation of the C20 fatty acid derivative to generate 
a C19 chain might be catalysed with the involvement of the enoyl-CoA hydratase and the alcohol 
dehydrogenase, among others; the Δ12-fatty acid dehydrogenase might be involved in the oxidation of the cis 
double bond next to the ether group to a triple bond. The required isomerizations of the double bonds are 
assumed to be carried out by the PUFA isomerases. It is uncertain if all these reactions occur on the free 
carboxylic acids or on the corresponding acyl-CoA thioesters. 
Oxidation of the alkenyl
group to the alkinyl group
Eicosapentaenoic acid (EPA)
(C20H30O2)
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INTRODUCTION 
Long-chain polyunsaturated fatty acids (LC-PUFAs), especially eicosapentaenoic acid (EPA, 
20:5, n-3) and docosahexaenoic acid (DHA, 22:6, n-3), show advantageous effects on human 
health, like prevention and treatment of cardiovascular diseases, obesity, and diabetes [1]. As 
more and more people strive to benefit from these positive effects, the demand of n-3  
LC-PUFAs as dietary supplements has increased intensely over the past years - with upward 
tendency for the future. These days, most of EPA and DHA are obtained from oceanic fish 
and fish oil, but these natural sources are depleting and often contaminated with 
environmental toxins. In order to satisfy the demand for high-quality LC-PUFAs, the quest 
for alternative, sustainable sources is indispensable [2]. Fermentation of prokaryotic and 
eukaryotic microorganisms capable of producing EPA or DHA in high amounts might have 
the potential to permit industrial-scale production of LC-PUFAs [3]. Until recently, it was 
thought that PUFA-producing microbes are from marine origin. Some of them synthesize LC-
PUFAs de novo from acyl-CoA precursors by iteratively acting polyketide synthase (PKS)-
like enzymes known as PUFA synthases. These multienzyme complexes are encoded by 
PUFA (pfa) biosynthetic gene clusters [4-6]. Initially, the occurrence of pfa gene clusters was 
described in the marine γ-Proteobacteria Shewanella pneumatophori SCRC-2738 and 
Photobacterium profundum SS9 (EPA producers) [7;8], Moritella marina MP-1 (DHA 
producer) [9], and in the marine microalga Schizochytrium sp. ATCC 20888 (DHA and n-6 
docosapentaenoic acid (DPA, 22:5) producer) [7;10]. Establishment of optimal fermentation 
conditions for these marine microorganisms [11-13], treatment with the fatty acid synthase 
inhibitor cerulenin [14;15], or transposon mutagenesis [16] gave rise to an improved 
production of LC-PUFAs under laboratory conditions. In order to correlate the biosynthetic 
pathways with their products, to reduce the cultivation time, and/or to study LC-PUFA 
biosynthesis, several marine PUFA biosynthetic gene clusters were transferred and expressed 
into suitable host organisms. Thereby, recombinant production of EPA, n-6 DPA, and/or 
DHA could be accomplished with the pfa gene clusters from Shewanella sp., M. marina  
MP-1, or Schizochytrium sp. by use of Synechococcus sp., Lactococcus lactis ssp. cremoris, 
and the well-established host Escherichia coli [10;17-20]. Besides of optimizing the 
cultivation conditions for the latter host harbouring the pfa gene cluster from Shewanella 
strains [21;22], recombinant EPA production could be enhanced by substitution of native 
promoters with heterologous promoters to increase pfa gene expression levels [23] or by 
intracellular accumulation of a high-performance catalase [24]. 
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Recently, PUFA synthases catalysing the biosynthesis of LC-PUFAs could be identified 
and characterized from several terrestrial myxobacterial species. They were found to be 
encoded by two types of pfa gene clusters identified in the genomes of the linoleic acid (LA, 
18:2, n-6) producing myxobacteria Sorangium cellulosum as well as of the novel 
myxobacterial isolates Aetherobacter spp., described as prolific producers of EPA and DHA 
[25]. However, these native producer strains grow very slowly, are not easy to handle, and 
genetic modifications are difficult to implement. Cloning, transfer and heterologous 
expression of the pfa genes into the myxobacterial model strain Myxococcus xanthus has been 
demonstrated as a promising strategy to improve LC-PUFA production and to reduce 
cultivation times [25]. Another attractive host for recombinant LC-PUFA production 
represents Pseudomonas putida KT2440. The strain is generally recognized as safe (GRAS), 
highly robust in extreme environmental conditions, genetically well accessible, and grows 
rapidly. Compared to E. coli, GC-content of the genome and codon usage are more related to 
myxobacterial genes, and P. putida has already been successfully used for heterologous 
expression of complex natural product pathways from myxobacteria [26-29]. These studies 
also included metabolic engineering approaches to optimize the precursor supply for target 
compound biosynthesis [30]. 
In the present work, heterologous expression of the pfa gene cluster from Aetherobacter 
fasciculatus (SBSr002) in E. coli and P. putida was established. Using the same initial 
expression constructs, P. putida turned out to be the host strain with the higher production 
rate of recombinant n-6 DPA and DHA per se. Consequently, efforts to further improve 
production yields were focussed on P. putida. Modification of the expression constructs to 
increase the expression rate of the pfa genes combined with genetic and metabolic 
engineering of the strain then led to a significant increase in heterologous LC-PUFA 
production in P. putida. 
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EXPERIMENTAL PROCEDURES 
 
Culture conditions 
Escherichia coli DH10B [31] or SCS110 (Stratagene) were used for cloning experiments. 
E. coli HB101/pRK2013 [32] was used as helper strain for conjugation experiments. E. coli 
BL21(DE3) [33] was used for heterologous expression experiments. E. coli HS996/pSC101-
BAD-gbaA (tet
R
) [34] and GB05-red [35] were used for modification of a plasmid using 
Red/ET recombination. The cells were grown in LB-medium or on LB-agar (1% tryptone, 
0.5% yeast extract, 0.5% NaCl, (1.5% agar)) at 30-37 °C (and 200 rpm) overnight. Antibiotics 
were used at the following concentrations: 100 µg/ml ampicillin, 50 µg/ml kanamycin, 
34 µg/ml chloramphenicol, 20 µg/ml gentamicin, and 6-12.5 µg/ml tetracycline. 
Pseudomonas putida KT2440 [36] was cultivated in liquid LB-medium at 30 °C and 
200 rpm overnight. Conjugation was carried out onto PMM-agar plates containing 0.61% 
K2HPO4, 0.5% KH2PO4, 0.1% (NH4)2SO4, 0.66% disodium succinate, and 1.5% agar. The 
medium was adjusted to pH 7.0 and supplemented with 0.12% MgSO4 after autoclaving. 
Antibiotics were used at the following concentrations: 60 µg/ml kanamycin, 30 µg/ml 
tetracycline, and 20 µg/ml gentamicin. 
 
 
General molecular biology techniques  
Routine handling of nucleic acids, such as isolation of genomic and plasmid DNA, restriction 
endonuclease digestions, DNA ligations, and other DNA manipulations, were performed 
according to standard protocols [37]. All the enzymes were purchased from Thermo Scientific 
or New England Biolabs. 
 
 
Cloning of expression constructs containing the pfa gene cluster from A. fasciculatus 
(SBSr002) for heterologous LC-PUFA production in E. coli and P. putida 
In order to enable the insertion of heterologous promoters upstream of the pfa gene cluster, 
which was previously subcloned from chromosomal DNA of SBSr002, the expression 
construct pPfaAf2 [25] was modified via Red/ET recombineering. Thereby, the GTG start 
codon of gene pfa1 was exchanged for the more frequent ATG start codon. A 
chloramphenicol resistance gene flanked by SwaI and NdeI restriction sites as well as the 
appropriate homology arms (1.1 kb) were amplified from plasmid pACYC184 (New England 
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Biolabs) using primers HA+SwaI+chloramphenicol_fwd and HA+NdeI+chloramphenicol_rev 
(Table 1). PCR was performed with Taq DNA polymerase (Thermo Scientific) and standard 
conditions according to the manufacturer’s protocol. The reactions contained 8% glycerol and 
were carried out in an Eppendorf Mastercycler under the following conditions: initial 
denaturation for 3 min at 95 °C; 30 cycles consisting of denaturation for 30 s at 95 °C, 
annealing for 30 s at 62 °C, and extension for 1 min/kb at 72 °C; and a final extension for  
10 min at 72 °C. The linear plus circular homologous Red/ET recombineering was performed 
as described previously [25] using 1.5 µl of the PCR product, resulting in plasmid pPfaAf6 
(Table 2).  
The heterologous inducible promoter systems xylS-Pm, xylS-Pm*, and araC-PBAD were 
introduced upstream of the pfa gene cluster into plasmid pPfaAf6 via SwaI and NdeI 
restriction sites, generating plasmids pPfaAf7.1, pPfaAf7.1*, and pPfaAf7.4 (Table 2). The 
1.8 kb sequence of the xylS-Pm or the xylS-Pm* promoter system was amplified from plasmid 
pJB861 [38] using primers Pm_SwaI_fwd and Pm_NdeI_rev or Pm_NdeI_rev_2 (Table 1). 
The 1.3 kb sequence of the araC-PBAD promoter system was amplified from plasmid 
pBMTBX-2 [39] using primers PBAD_SwaI_fwd and PBAD_NdeI_rev (Table 1). PCR was 
performed with Phusion DNA polymerase (Thermo Scientific) and standard conditions 
according to the manufacturer’s protocol. The reactions contained 5% DMSO and were 
carried out in an Eppendorf Mastercycler under the following conditions: initial denaturation 
for 2 min at 98 °C; 30 cycles consisting of denaturation for 15 s at 98 °C, annealing for 20 s at 
56-60 °C, and extension for 10 s/kb at 72 °C; and a final extension for 10 min at 72 °C. 
Plasmid pPfaAf7.1** (Table 2) was created by introducing a xylS-Pm** promoter fragment 
into plasmid pPfaAf7.1 via MunI and NdeI restriction sites. The 1.3 kb sequence of the xylS-
Pm** promoter fragment was amplified from plasmid pPfaAf7.1* using primers ML2-2+LII-
11_MunI_fwd and ML2-2+LII-11_NdeI_rev_2 (Table 1). PCR was performed with Phusion 
DNA polymerase (Thermo Scientific) and standard conditions according to the 
manufacturer’s protocol. The reactions contained 5% DMSO and were carried out in an 
Eppendorf Mastercycler under the following conditions: initial denaturation for 2 min at 
98 °C; 30 cycles consisting of denaturation for 15 s at 98 °C, annealing for 20 s at 72 °C, and 
extension for 10 s/kb at 72 °C; and a final extension for 10 min at 72 °C. 
The backbone of plasmids pPfaAf7.1, pPfaAf7.1*, pPfaAf7.1**, and pPfaAf7.4 was 
exchanged for the backbone of the E. coli/Pseudomonas shuttle vector pJB861-SwaI-cm
R
-
PacI (Table 2) via SwaI and PacI restriction sites, yielding plasmids pJBPfaAf1, pJBPfaAf1*, 
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pJBPfaAf1**, and pJBPfaAf4 (Table 2). For the construction of plasmid pJB861-SwaI-cm
R
-
PacI by modification of plasmid pJB861, a chloramphenicol resistance gene with SwaI and 
PacI restriction sites as well as the appropriate homology arms (1.1 kb) was amplified from 
plasmid pACYC184 using primers HA+SwaI+cm
R
 for pJB861_fwd and HA+PacI+cm
R
 for 
pJB861_rev (Table 1). PCR was performed with Taq DNA polymerase (Thermo Scientific) 
and standard conditions according to the manufacturer’s protocol. The reactions contained 8% 
glycerol and were carried out in an Eppendorf Mastercycler under the following conditions: 
initial denaturation for 3 min at 95°C; 30 cycles consisting of denaturation for 30 s at 95ºC, 
annealing for 30 s at 62ºC, and extension for 10 s/kb at 72ºC; and a final extension for 10 min 
at 72ºC. The linear plus circular homologous Red/ET recombineering was performed as 
described previously [25] using 1.5 µl of the PCR product. 
Additionally, the backbone of plasmid pPfaAf7.1** was exchanged for the backbone of 
plasmid pJB861-SwaI-cm
R
-PacI-cop271C (Table 2) via SwaI and PacI restriction sites, 
resulting in plasmid pJB*PfaAf1** (Table 2). For the construction of a version of plasmid 
pJB861-SwaI-cm
R
-PacI with a mutated trfA gene, a fragment of trfA was amplified from 
plasmid pJB861-SwaI-cm
R
-PacI by overlap extension PCR using primers 
cop271C_NdeI_fwd_2 / cop271C_G to A_rev and cop271C_G to A_fwd / 
cop271C_EheI_rev_2 (Table 1). Thereby, the R271C copy-up point mutation, designated as 
cop271C, was introduced. PCR amplification of the 0.1 kb and 1 kb fragments to be spliced 
was performed with Phusion DNA polymerase (Thermo Scientific) and standard conditions 
according to the manufacturer’s protocol. The reactions contained 5% DMSO and were 
carried out in an Eppendorf Mastercycler under the following conditions: initial denaturation 
for 2 min at 98 °C; 30 cycles consisting of denaturation for 15 s at 98 °C, annealing for 20 s at 
72 °C, and extension for 10 s/kb at 72 °C; and a final extension for 10 min at 72 °C. For the 
subsequent overlap extension PCR using primers cop271C_NdeI_fwd_2 and 
cop271C_EheI_rev_2, the two amplified fragments were used as templates. PCR of the 1.1 kb 
DNA fragment was performed as described for the amplification of the two fragments to be 
spliced. The wild type version of trfA in plasmid pJB861-SwaI-cm
R
-PacI was exchanged for 
the mutated version of the gene via NdeI and EheI restriction sites, yielding plasmid pJB861-
SwaI-cm
R
-PacI-cop271C. 
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Cloning of expression constructs containing the gene encoding the  
4'-phosphopantetheinyl transferase (PPTase) AfPpt from A. fasciculatus (SBSr002) for 
heterologous LC-PUFA production in E. coli and P. putida 
The gene of the 4'-phosphopantetheinyl transferase (PPTase) AfPpt (0.8 kb) was amplified 
from genomic DNA of A. fasciculatus (SBSr002) using primers Afppt_fwd_NdeI and 
Afppt_rev_PacI (Table 1). PCR was performed with Phusion DNA polymerase (Thermo 
Scientific) and standard conditions according to the manufacturer’s protocol. The reactions 
contained 5% DMSO and were carried out in an Eppendorf Mastercycler under the following 
conditions: initial denaturation for 2 min at 98 °C; 30 cycles consisting of denaturation for  
15 s at 98 ºC, annealing for 20 s at 72 ºC, and extension for 10 s/kb at 72 ºC; and a final 
extension for 10 min at 72 ºC. Plasmids pPptAfA and pPptAfD (Table 2) were constructed by 
exchange of the pfa gene cluster from A. fasciculatus (SBSr002) located on plasmid 
pPfaAf7.1 or pPfaAf7.4, respectively, for Afppt via NdeI and PacI restriction sites. For the 
transfer and integration of the constructs into P. putida, an origin of transfer, a gene encoding 
the TetR transcriptional regulator, the tetracycline resistance gene tetA, and gene trpE 
encoding the anthranilate synthase component 1 from P. putida (4.2 kb) were amplified from 
cosmid CMch37 [26] using primers PseuInt_PacI_fwd and PseuInt_PacI_rev (Table 1). PCR 
was performed with Phusion DNA polymerase (Thermo Scientific) and standard conditions 
according to the manufacturer’s protocol. The reactions contained 5% DMSO and were 
carried out in an Eppendorf Mastercycler under the following conditions: initial denaturation 
for 2 min at 98 °C; 30 cycles consisting of denaturation for 15 s at 98 ºC, annealing for 20 s at 
72 ºC, and extension for 10 s/kb at 72 ºC; and a final extension for 10 min at 72 ºC. The PCR 
amplicon was inserted into plasmids pPptAfA and pPptAfD via PacI restriction sites, 
generating plasmids pPptAf1 and pPptAf4, respectively (Table 2). 
 
 
Cloning of a mutated and truncated version of the 2,4-dienoyl-CoA reductase gene fadH 
for inactivation in P. putida  
A mutated and truncated version of the 2,4-dienoyl-CoA reductase gene fadH from P. putida 
KT2440 (1.2 kb) was amplified from genomic DNA using primers fadH_KO_SwaI_fwd and 
fadH_KO_SacI_rev (Table 1). PCR was performed with Phusion DNA polymerase (Thermo 
Scientific) and standard conditions according to the manufacturer’s protocol. The reactions 
contained 5% DMSO and were carried out in an Eppendorf Mastercycler under the following 
conditions: initial denaturation for 2 min at 98 °C; 30 cycles consisting of denaturation for 
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15 s at 98 °C, annealing for 20 s at 72 °C, and extension for 10 s/kb at 72 °C; and a final 
extension for 10 min at 72 °C. Plasmid pfadH_KO-tet
R
 (Table 2) was constructed by 
exchange of xylS-Pm-Afppt-trpE located on plasmid pPfaPpt1 for the fadH_KO fragment via 
SwaI and SacI restriction sites. For replacement of the antibiotic resistance marker, the 
gentamicin resistance gene (0.8 kb) was amplified from plasmid pMycoMarHyg [40] using 
primers gm
R
_SalI_fwd and gm
R
_SacI_rev (Table 1). PCR was performed with Phusion DNA 
polymerase (Thermo Scientific) and standard conditions according to the manufacturer’s 
protocol. The reactions contained 5% DMSO and were carried out in an Eppendorf 
Mastercycler under the following conditions: initial denaturation for 2 min at 98 °C; 30 cycles 
consisting of denaturation for 15 s at 98 °C, annealing for 20 s at 72 °C, and extension for 
10 s/kb at 72 °C; and a final extension for 10 min at 72 °C. The tetracycline resistance gene of 
plasmid pfadH_KO-tet
R
 was exchanged for the gentamicin resistance gene via SalI and SacI 
restriction sites, yielding plasmid pfadH_KO-gm
R
 (Table 2). 
 
 
Cloning of constructs for the overexpression of endogenous glucose-6-phosphate 
dehydrogenase Zwf-1 and acetyl-CoA carboxylase ACC from P. putida 
The heterologous promoter Ptac (0.1 kb) was amplified from plasmid pGEX-6P-1 (GE 
Healthcare) using primers Ptac_REs_fwd and Ptac_NdeI_rev_2 (Table 1). PCR was performed 
with Phusion DNA polymerase (Thermo Scientific) and standard conditions according to the 
manufacturer’s protocol. The reactions contained 5% DMSO and were carried out in an 
Eppendorf Mastercycler under the following conditions: initial denaturation for 2 min at 
98°C; 30 cycles consisting of denaturation for 15 s at 98 ºC, annealing for 20 s at 63 ºC, and 
extension for 10 s/kb at 72 ºC; and a final extension for 10 min at 72 ºC. The PCR amplicon 
was ligated into plasmid pJET1.2 (Thermo Scientific), generating plasmid pJET1.2-Ptac 
(Table 2). The genes zwf-1 (1.5 kb), accA (1 kb), accD (0.9 kb), and accB-accC-1 (1.8 kb) 
from P. putida KT2440 were amplified from genomic DNA using primers zwf-1_NdeI_fwd / 
tonB+zwf-1_REs_rev, accA_NdeI_fwd / accA_KpnI+XbaI_rev, accD_NdeI_fwd / 
tonB+accD_REs_rev, and accB_NdeI_fwd / accC-1_XbaI_rev (Table 1). PCR was performed 
with Phusion DNA polymerase (Thermo Scientific) and standard conditions according to the 
manufacturer’s protocol. The reactions contained 5% DMSO and were carried out in an 
Eppendorf Mastercycler under the following conditions: initial denaturation for 2 min at  
98 °C; 30 cycles consisting of denaturation for 15 s at 98 °C, annealing for 20 s at 65-66 °C, 
and extension for 10 s/kb at 72 °C; and a final extension for 10 min at 72 °C. The genes were 
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introduced downstream of Ptac via NdeI and XbaI restriction sites into plasmid pJET1.2-Ptac, 
generating plasmids pJET1.2-Ptac-zwf-1-TtonB, pJET1.2-Ptac-accA, pJET1.2-Ptac-accD-TtonB, 
and pJET1.2-Ptac-accB-accC-1 (Table 2).  
Plasmid pME3 (Table 2) was constructed by insertion of Ptac-zwf-1-TtonB hydrolysed with 
SwaI and AanI into plasmid pPptAf1 linearized with AanI. Ptac-accA was inserted into 
plasmid pUC18 (Thermo Scientific) via BamHI and KpnI restriction sites, yielding plasmid 
pUC18-Ptac-accA (Table 2). Plasmid pUC18-Ptac-accA-Ptac-accD-TtonB (Table 2) was 
generated by insertion of Ptac-accD-TtonB into plasmid pUC18-Ptac-accA via KpnI and EcoRI 
restriction sites. In order to exchange of the BamHI restriction site for the BglII restriction site 
in plasmid pUC18-Ptac-accA-Ptac-accD-TtonB, a 0.6 kb fragment of Ptac-accA was amplified 
from plasmid pUC18-Ptac-accA using primers ME_BamHI to BglII_fwd and ME_BamHI to 
BglII_rev (Table 1). Thereby, the BamHI to BglII point mutations were introduced. PCR was 
performed with Phusion DNA polymerase (Thermo Scientific) and standard conditions 
according to the manufacturer’s protocol. The reactions contained 5% DMSO and were 
carried out in an Eppendorf Mastercycler under the following conditions: initial denaturation 
for 2 min at 98 °C; 30 cycles consisting of denaturation for 15 s at 98 ºC, annealing for 20 s at 
62 ºC, and extension for 10 s/kb at 72 ºC; and a final extension for 10 min at 72 ºC. The PCR 
amplicon was inserted into plasmid pUC18-Ptac-accA-Ptac-accD-TtonB via XbaI and Eco88I 
restriction sites. Plasmid pUC18-Ptac-accB-accC-1-Ptac-accA-Ptac-accD-TtonB (Table 2) was 
then constructed by insertion of Ptac-accB-accC-1 into plasmid pUC18-Ptac-accA-Ptac-accD-
TtonB via SdaI and BglII restriction sites. The fragment Ptac-accB-accC-1-Ptac-accA-Ptac-accD-
TtonB was then excised with SwaI and PacI, blunted, and inserted into plasmid pPptAf1 
linearized with AanI, resulting in plasmid pME2 (Table 2). 
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Table 1. Primers used for cloning of expression or knockout plasmids in this study.  
The homology arms are shown in italics and the introduced restriction sites are underlined. 
 
Primer Sequence (5'3') 
HA+SwaI+chloramphenicol_fwd 
CCCCAGAGCGCGCCATATTTCGCCGCGCAGCGCTGGTCGTCGAAATATT
GATTTAAATTTAACGACCCTGCCCTGAACCGACG 
HA+NdeI+chloramphenicol_rev 
GGCGAGCCCCCTTGAGCGTTCCATCTACCGATTGCAGACATATGAGTAA
GTTGGCAGCATCACCCGACGC 
Pm_SwaI_fwd CCAGTGATTTAAATCCTTCTTCGGCTACGTTCG 
Pm_NdeI_rev GCAATTCATATGTTCATGACTCC 
Pm_NdeI_rev_2 CATATGTTCATTACTCCATTATTGTGTATTCT 
PBAD_SwaI_fwd CTGCTATTTAAATGGAGGTCAGG 
PBAD_NdeI_rev TTACCCATATGGGTATATCTCCTTC 
ML2-2+LII-11_MunI_fwd CAATTGTTGTCACTGCATGCCCGATCAAGGACC 
ML2-2+LII-11_NdeI_rev_2 
CATATGTTCATTACTCCATTATTGTGTATTCTGTGCTAAACTATAAGGT
GTAGGC 
HA+SwaI+cm
R
 for pJB861_fwd 
AGATCCACATCCTTGAAGGCCGCAGCGACGAGCAGAAGGAAACCCTCAT
TTAAATAGTAAGTTGGCAGCATCACCCGACGC 
HA+PacI+cm
R
 for pJB861_rev 
ATGGTGACGTCACCGGTTCTAGATACCTAGGTGAGCTCTGGTACCGGCG
GTTAATTAACGACCCTGCCCTGAACCGACG 
cop271C_NdeI_fwd_2 TCCCATATGAATTTCGTGTAGTGGTCGCCAGC 
cop271C_G to A_rev GTCGCTGCTGCACTGCTTCCGCGTCC 
cop271C_G to A_fwd GGACGCGGAAGCAGTGCAGCAGCGAC 
cop271C_EheI_rev_2 CTGGGGCGCCCTCTGGTAAGGTTGG 
Afppt_fwd_NdeI AGGCCCATATGGCGCTCCTCGACCTCCC 
Afppt_rev_PacI CCATCTTAATTAATTACACGGCCAGGGTCGCGGG 
PseuInt_PacI_fwd CGTTACTTAATTAAGTGGATCCGCTTACGGCCAGCC 
PseuInt_PacI_rev GAGGTGTTAATTAACGGGGCTGGTGCTGGATCC 
fadH_KO_SwaI_fwd ATTTAAATGAGGTGCCCGCATTCCGTGACACGC 
fadH_KO_SacI_rev GAGCTCGGTCTCGTGGCAGGCC 
gm
R
_SalI_fwd CACCGTCGACACGGATGAAGGCACGAACCC 
gm
R
_SacI_rev GCCGAGCTCGGCTTGAACGAATTGTTAGGTGGC 
Ptac_REs_fwd 
CCTGCAGGATTTAAATGGTACCGGATCCAAATGAGCTGTTGACAATTAA
TCATCGG 
Ptac_NdeI_rev_2 CATATGTACTGTTTCCTGTGTGAAATTGTTATCC 
zwf-1_NdeI_fwd ACATCATATGGCCGCAATCAGTGTCG 
tonB+zwf-1_REs_rev 
TCAATCTAGAAGCTTATAAGTCAAAAGCCTCCGGTCGGAGGCTTTTGAC
TTCAGATATCCCCATACCACGC 
accA_NdeI_fwd TGACCATATGAACCCGAATTTCCTCGACTTCG 
accA_KpnI+XbaI_rev CAGAATCTAGAGGTACCTTAGAGGCCGTAGCTCATCAGG 
accD_NdeI_fwd AAAGCATATGAGCAACTGGTTAGTCGAC 
tonB+accD_REs_rev 
TTTCATCTAGAGAATTCTTAATTAAAGTCAAAAGCCTCCGACCGGAGGC
TTTTGACTTCACGCGACGGCAGCC 
accB_NdeI_fwd GATTACATATGGATATCCGTAAAGTCAAGAAACTG 
accC-1_XbaI_rev CACGATCTAGATCACTCCTGGTTGGCC 
ME_BamHI to BglII_fwd TCTAGAAGATCTAAATGAGCTGTTGAC 
ME_BamHI to BglII_rev CGTCGATGCCCGGGTAGG 
 
 
 
CHAPTER 3: RECOMBINANT PUFA PRODUCTION IN ESCHERICHIA COLI AND PSEUDOMONAS PUTIDA 
92 
 
Table 2. Plasmids constructed in this study.  
oriV = origin of replication, trfA = gene encoding replication initiation protein in RK2 replicons, oriT = origin of 
transfer, bla = ampicillin resistance gene, cat = chloramphenicol resistance gene, aph(3')-Ia = kanamycin 
resistance gene, tetA
 
= tetracycline resistance gene, aac(3)-Ia = gentamicin resistance gene, tetR = gene encoding 
the transcriptional regulator, trpE = gene encoding the anthranilate synthase component 1 from P. putida 
KT2440, Ptac = tac promoter, TtonB = tonB transcription terminator. 
 
Plasmid Characteristics 
pPfaAf6 
Derivative of pPfaAf2 [25] in which cat was inserted upstream of the pfa 
gene cluster of Aetherobacter fasciculatus (SBSr002) by Red/ET 
recombineering. p15A oriV, bla, cat 
pPfaAf7.1 
Derivative of pPfaAf6 in which cat was replaced by the xylS-Pm 
promoter system via SwaI and NdeI 
pPfaAf7.1* 
Derivative of pPfaAf6 in which cat was replaced by the xylS-Pm* 
promoter system (containing the mutated DNA-region LII-11 [41]) via 
SwaI and NdeI 
pPfaAf7.1** 
Derivative of pPfaAf7.1 in which the xylS-Pm promoter system was 
replaced by the xylS-Pm** promoter system (containing the mutated 
DNA-regions LII-11 [41] plus ML2-2 [42]) via MunI and NdeI 
pPfaAf7.4 
Derivative of pPfaAf6 in which cat was replaced by the araC-PBAD 
promoter system via SwaI and NdeI 
pJB861-SwaI-cm
R
-PacI 
Derivative of pJB861 [38] in which xylS-Pm was exchanged for cat 
flanked by SwaI and PacI restriction sites by Red/ET recombineering. 
RK2 oriT, RK2 oriV, trfA, aph(3')-Ia, cat 
pJB861-SwaI-cm
R
-PacI-cop271C 
Derivative of pJB861-SwaI-cm
R
-PacI in which trfA was replaced with 
trfA* (containing the RC copy-up point mutation cop271C) via NdeI 
and EheI 
pJBPfaAf1 
Derivative of pPfaAf7.1 in which the vector backbone was exchanged for 
the vector backbone of pJB861-SwaI-cm
R
-PacI via SwaI and PacI 
pJBPfaAf1* 
Derivative of pPfaAf7.1* in which the vector backbone was exchanged 
for the vector backbone of pJB861-SwaI-cm
R
-PacI via SwaI and PacI 
pJBPfaAf1** 
Derivative of pPfaAf7.1** in which the vector backbone was exchanged 
for the vector backbone of pJB861-SwaI-cm
R
-PacI via SwaI and PacI 
pJBPfaAf4 
Derivative of pPfaAf7.4 in which the vector backbone was exchanged for 
the vector backbone of pJB861-SwaI-cm
R
-PacI via SwaI and PacI 
pJB*PfaAf1** 
Derivative of pPfaAf7.1** in which the vector backbone was exchanged 
for the vector backbone of pJB861-SwaI-cm
R
-PacI-cop271C via SwaI 
and PacI 
pPptAfA 
Derivative of pPfaAf7.1 in which the pfa gene cluster was replaced by 
the gene encoding the PPTase AfPpt from A. fasciculatus (SBSr002) via 
NdeI and PacI 
pPptAfD 
Derivative of pPfaAf7.4 in which the pfa gene cluster was replaced by 
the gene encoding the PPTase AfPpt from A. fasciculatus (SBSr002) via 
NdeI and PacI 
pPptAf1 
Derivative of pPptAfA in which oriT-tetR-tetA-trpE was inserted via 
PacI 
pPptAf4 
Derivative of pPptAfD in which oriT-tetR-tetA-trpE was inserted via 
PacI 
pfadH_KO-tet
R
 
Derivative of pPptAf1 in which xylS-Pm-Afppt-trpE was replaced by 
fadH_KO (mutated and truncated version of the 2,4-dienoyl-CoA 
reductase gene fadH from P. putida KT2440) via SwaI and SacI 
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Continuation of Table 2. 
 
Plasmid Characteristics 
pfadH_KO-gm
R
 
Derivative of pfadH_KO-tet
R
 in which tetR-tetA was exchanged for 
aac(3)-Ia via SalI and SacI 
pJET1.2-Ptac Derivative of pJET1.2 (Thermo Scientific) in which Ptac was inserted 
pJET1.2-Ptac-zwf-1-TtonB 
Derivative of pJET1.2-Ptac in which zwf-1 (encoding the glucose-6-
phosphate dehydrogenase from P. putida KT2440) and TtonB were 
inserted downstream of Ptac via NdeI and XbaI  
pJET1.2-Ptac-accA 
Derivative of pJET1.2-Ptac in which accD (encoding the carboxyl 
transferase subunit alpha of the acetyl-CoA carboxylase from P. putida 
KT2440) was inserted downstream of Ptac via NdeI and XbaI 
pJET1.2-Ptac-accD-TtonB 
Derivative of pJET1.2-Ptac in which accD (encoding the carboxyl 
transferase subunit beta of the acetyl-CoA carboxylase from P. putida 
KT2440) and TtonB were inserted downstream of Ptac via NdeI and XbaI  
pJET1.2-Ptac-accB-accC-1 
Derivative of pJET1.2-Ptac in which accB-accC-1 (encoding the biotin 
carboxyl carrier protein subunit and the biotin carboxylase subunit of the 
acetyl-CoA carboxylase from P. putida KT2440) was inserted 
downstream of Ptac via NdeI and XbaI 
pUC18-Ptac-accA 
Derivative of pUC18 (Thermo Scientific) in which Ptac-accA from 
pJET1.2-Ptac-accA was inserted via BamHI and KpnI 
pUC18-Ptac-accA-Ptac-accD-TtonB 
Derivative of pUC18-Ptac-accA in which Ptac-accD-TtonB from pJET1.2-
Ptac-accD-TtonB was inserted via KpnI and EcoRI 
pUC18-Ptac-accB-accC-1-Ptac-
accA-Ptac-accD-TtonB 
Derivative of pUC18-Ptac-accA-Ptac-accD-TtonB in which the BamHI 
restriction site was replaced by a BglII restriction site and Ptac-accB-
accC-1 from pJET1.2-Ptac-accB-accC-1 was inserted via SdaI and BglII 
pME3 
Derivative of pPptAf1 in which Ptac-zwf-1-TtonB (excised from pJET1.2-
Ptac-zwf-1-TtonB via SwaI and AanI) was inserted via AanI 
pME2 
Derivative of pPptAf1 in which Ptac-accB-accC-1-Ptac-accA-Ptac-accD-
TtonB (excised from pUC18-Ptac-accB-accC-1-Ptac-accA-Ptac-accD-TtonB 
via SwaI and PacI plus blunted) was inserted via AanI 
 
 
 
Transformation of P. putida by triparental conjugation 
Expression plasmids and knockout plasmids were transferred into P. putida KT2440 by 
triparental conjugation. 1 ml of an overnight culture of the acceptor strain P. putida KT2440, 
the donor strain E. coli DH10B containing the final expression construct, and the helper strain 
E. coli HB101/pRK2013 were harvested at 13,000 rpm for 1 min. After discarding the 
supernatant, the cells were resuspended in 1 ml LB-medium in each case. The cells were spun 
down at 13,000 rpm for 1 min, and the supernatant was discarded. This wash step was repeated 
once. The cells were resuspended in 300 µl LB-medium in each case. The triparental mating 
was performed by combining 50 μl of each 300 µl suspension on a small area of a LB-agar 
plate [43]. After incubation at 37 °C for 4 h, the plate was transferred to 30 °C and incubated 
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overnight. The cells were scraped from the plate and resuspended in 1 ml sterile ddH2O. 10-
100 µl of this suspension was then plated out on PMM-agar containing 60 µg/ml kanamycin, 
and if necessary 30 μg/ml tetracycline, and 20 µg/ml gentamicin. The E. coli strains were 
additionally counterselected by 150 μg/ml ampicillin or 100 µg/ml hygromycin B, which 
P. putida is resistant to. The plates were incubated at 30 °C for 1-2 days. Transconjugants 
were verified by plasmid isolation and restriction analysis for replicative plasmids. The 
constructed strains are listed in Table 4. 
In order to verify the integration of the expression construct into the genome of P. putida 
via trpE, DNA from selected clones was isolated and used for PCR analyses. The primers 
used are listed in Table 3. PCR was performed with Taq DNA polymerase (Thermo 
Scientific) and standard conditions according to the manufacturer’s protocol. The reactions 
contained 8% glycerol and were carried out in an Eppendorf Mastercycler under the following 
conditions: initial denaturation for 3 min at 95 °C; 30 cycles consisting of denaturation for  
30 s at 95 °C, annealing for 30 s at 56 °C, and extension for 1 min/kb at 72 °C; and a final 
extension for 10 min at 72 °C.  
In order verify the knockout of fadH in the genome of P. putida via single crossover, DNA 
from selected clones was isolated and used for PCR analyses. The primers used are listed in 
Table 3. PCR was performed with Taq DNA polymerase (Thermo Scientific) and standard 
conditions according to the manufacturer’s protocol. The reactions contained 8% glycerol and 
were carried out in an Eppendorf Mastercycler under the following conditions: initial 
denaturation for 3 min at 95 °C; 30 cycles consisting of denaturation for 30 s at 95 °C, 
annealing for 30 s at 56 °C, and extension for 1 min/kb at 72 °C; and a final extension for  
10 min at 72 °C.  
 
Table 3. Primers used for the verification of the integration of expression constructs into the genome of 
P. putida KT2440 via trpE or for the verification of the knockout of fadH in the genome of P. putida via 
single crossover. 
 
Primer Sequence (5'3') 
trpE_genome_fwd CCGTCCGTTTGCCTGACC 
trpE_genome_rev CTCCTACGACGGCCTCG 
trpE_integration_fwd GCCGATCGCTGATCGTGG 
trpE_integration_rev GGCTGGTGCTGGATCCC 
fadH_genome_fwd AGCCTTCCCGACAGTCGC 
fadH_genome_rev GGTGGCTCGACACAGGC 
fadH_integration_fwd CCGTTGCACCAGTGCCC 
fadH_integration_rev GACCCAAGTACCGCCACC 
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Heterologous LC-PUFA production in E. coli and P. putida 
E. coli BL21(DE3) was cotransformed with the expression constructs pJBPfaAf1 plus 
pPptAfA, pJBPfaAf1* plus pPptAfA, or pJBPfaAf4 plus pPptAfD. The constructed strains 
are listed in Table 4. For heterologous LC-PUFA production, cultivation of the strains was 
carried out in 50 ml LB-medium containing 50 µg/ml kanamycin and 100 µg/ml ampicillin. 
The medium was inoculated with an overnight culture (1:100) and incubated at 37 °C. 
Expression of the Pfa proteins and AfPpt was induced at OD600 of 0.8 by addition of m-toluic 
acid to a final concentration of 2 mM in the case of pJBPfaAf1 plus pPptAfA and 
pJBPfaAf1* plus pPptAfA or of L-arabinose to a final concentration of 2% in the case of 
pJBPfaAf4 plus pPptAfD. After induction, the cells were cultivated at 16 °C and 200 rpm for 
24 h and then harvested at 8,000 rpm for 5 min. 
For heterologous LC-PUFA production in P. putida, cultivation was carried out in 50 ml 
LB-medium containing 60 µg/ml kanamycin, and if necessary 30 μg/ml tetracycline, and  
20 µg/ml gentamicin. The medium was inoculated with an overnight culture (1:100) and 
incubated at 30 °C for 4 h. Expression of the Pfa proteins or AfPpt was induced by addition of 
either m-toluic acid to a final concentration of 2 mM or of L-arabinose to a final concentration 
of 2%, depending on the heterologous promoter system used. After induction, the cells were 
cultivated at 16 °C and 200 rpm for 24 h and then harvested at 8,000 rpm for 5 min. 
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Table 4. Expression strains constructed in this study.  
 
Strain Characteristics 
E. coli BL21(DE3)/ 
pJBPfaAf1/pPptAfA 
Escherichia coli BL21(DE3) with replicative plasmids pJBPfaAf1 and 
pPptAfA 
E. coli BL21(DE3)/ 
pJBPfaAf1*/pPptAfA 
E. coli BL21(DE3) with replicative plasmids pJBPfaAf1* and pPptAfA 
E. coli BL21(DE3)/ 
pJBPfaAf4/pPptAfD 
E. coli BL21(DE3) with replicative plasmids pJBPfaAf4 and pPptAfD 
P. putida KT2440+ pJBPfaAf1 Pseudomonas putida KT2440 with replicative plasmid pJBPfaAf1 
P. putida KT2440::pPptAf1 
P. putida KT2440 with pPptAf1 site-specifically integrated into trpE 
within the genome  
P. putida KT2440::pPptAf1 + 
pJBPfaAf1 
P. putida KT2440::pPptAf1 with replicative plasmid pJBPfaAf1 
P. putida KT2440::pPptAf1 + 
pJBPfaAf1* 
P. putida KT2440::pPptAf1 with replicative plasmid pJBPfaAf1* 
P. putida KT2440::pPptAf1 + 
pJBPfaAf1** 
P. putida KT2440::pPptAf1 with replicative plasmid pJBPfaAf1** 
P. putida KT2440::pPptAf1 + 
pJB*PfaAf1** 
P. putida KT2440::pPptAf1 with replicative plasmid pJB*PfaAf1** 
P. putida KT2440::pfadH_KO 
P. putida KT2440 with knockout of fadH within the genome via single 
crossover 
P. putida KT2440::pfadH_KO + 
pJB*PfaAf1** 
P. putida KT2440::pfadH_KO with replicative plasmid pJB*PfaAf1** 
P. putida 
KT2440::pfadH_KO/pPptAf1 + 
pJB*PfaAf1** 
P. putida KT2440::pfadH_KO + pJB*PfaAf1** with pPptAf1 site-
specifically integrated into trpE within the genome 
P. putida 
KT2440::pfadH_KO/pME3 + 
pJB*PfaAf1** 
P. putida KT2440::pfadH_KO + pJB*PfaAf1** with pME3 site-
specifically integrated into trpE within the genome 
P. putida 
KT2440::pfadH_KO/pME2 + 
pJB*PfaAf1** 
P. putida KT2440::pfadH_KO + pJB*PfaAf1** with pME2 site-
specifically integrated into trpE within the genome 
P. putida 
KT2440::pfadH_KO/pME2 
P. putida KT2440::pfadH_KO/pME2 + pJB*PfaAf1** cured of plasmid 
pJB*PfaAf1** 
 
 
 
Extraction of cellular fatty acids 
The cellular fatty acids were extracted using the FAME method [44]. For this purpose, 50 ml 
of a culture were harvested at 8,000 rpm for 10 min at room temperature. The cell pellet was 
transferred to a glass vial and dried in a vacuum concentrator. Subsequently, the cell dry 
weight was determined. 5 µl (50 µg) of n-3 DPA (Sigma-Aldrich) and 500 µl of a mixture of 
methanol, toluene, and sulphuric acid (50:50:2, v/v/v) were added. The vial was capped with a 
teflon-lined screw cap and incubated at 80 °C for 24-48 h. After the mixture was cooled to 
room temperature, 400 µl of an aqueous solution consisting of 0.5 M NH4HCO3 and 2 M KCl 
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were added, and the sample was vortexed for 30 s. Phase separation was achieved by 
centrifugation at 4,000 rpm for 5 min at room temperature. 100 µl of the upper phase were 
used for GC-MS analysis. 
 
 
Analysis of fatty acid methyl esters by GC-MS 
GC-MS was carried out on an Agilent 6890N gas chromatograph (Agilent Technologies) 
equipped with a 7683B split/splitless injector with autosampler (Agilent Technologies) and 
coupled to a 5973 electron impact mass selective detector (Agilent Technologies). Helium 
was used as the carrier gas at a flow rate of 1 ml/min. 1 µl of the sample was injected in split 
mode (split ratio, 10:1). The analytical column was a (5% phenyl)-methylpolysiloxane 
capillary column (Agilent J&W DB-5ht; 30 m x 0.25 mm i.d. x 0.1 µm film thickness, 
maximum temperature 400 °C; Agilent Technologies). The column temperature was kept at 
130 °C for 2.5 min, increased to 240 °C at a rate of 5 °C/min, then ramped to 300 °C at  
30 °C/min, and held at 300 °C for 5 min. Other temperatures were as follows: inlet, 275 °C; 
GC-MS transfer line, 280 °C; ion source, 230 °C; and quadrupole, 150 °C. The mass selective 
detector was operated in scan mode, scanning the mass range from m/z 40 to 700. Scan 
control, data acquisition, and processing were performed by MSD ChemStation and AMDIS 
software, version 2.68, based on the fragmentation patterns and retention times, in comparison 
with Supelco 37 Component FAME Mix and LC-PUFAs (all Sigma-Aldrich) as reference 
standards, and NIST 08 library. Absolute amounts of PUFAs were quantified by integration 
of the peaks using MSD ChemStation and by subsequent calculation in relation to the integral 
of n-3 DPA and to cell dry weight. 
 
 
 
RESULTS AND DISCUSSION 
Recombinant LC-PUFA production using the DPA (22:5, n-6 or n-3)/DHA (22:6, n-3)-type 
pfa gene cluster from A. fasciculatus (SBSr002) has already been accomplished by cloning, 
transfer, and heterologous expression of the gene cluster in the myxobacterial model strain 
M. xanthus [25]. After this successful first proof of principle, approaches towards alternative 
heterologous expression platforms were initiated to move the pathway into hosts which show 
better growth characteristics and for which a considerable set of genetic tools is available. 
Consequently, two additional, more commonly used heterologous hosts, E. coli as well as the 
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GRAS strain P. putida KT2440, were investigated as expression strains for the myxobacterial 
DPA/DHA-type PUFA synthase.  
The initial strategy to achieve heterologous expression of the DPA/DHA-type pfa gene 
cluster from A. fasciculatus (SBSr002) in Pseudomonas was similar to a previously described 
approach applied for heterologous expression of a myxobacterial lipopeptide pathway [26]. It 
included the chromosomal integration of the expression construct into the trpE locus of the 
genome, encoding the anthranilate synthase component 1, via homologous recombination and 
the expression of the pathway genes under control of the heterologous xylS-Pm promoter 
system (details not shown). Unfortunately, this procedure did not result in a detectable 
heterologous LC-PUFA production in P. putida. On the supposition that the pfa gene dosage 
might be a bottleneck, an expression construct based on a medium-copy number replicative 
plasmid for P. putida, analogous to the construct used for successful heterologous expression 
of a chalcone synthase from S. cellulosum [27], was generated. The cloning procedure started 
from plasmid pPfaAf2, constructed previously [25], which contains the DPA/DHA-type pfa 
gene cluster of A. fasciculatus (SBSr002) (Figure 1A). This plasmid was modified by linear 
plus circular homologous Red/ET recombination [45] to replace dispensable DNA regions, 
inclusive of the native promoter upstream of pfa1, by a chloramphenicol resistance gene, 
resulting in plasmid pPfaAf6. By applying conventional cloning techniques, the 
chloramphenicol resistance gene was exchanged for the heterologous xylS-Pm promoter 
system. In a final engineering step, the backbone of the obtained plasmid pPfaAf7.1 was 
replaced by a backbone on the basis of the broad-host-range expression vector pJB861 [38], 
yielding expression plasmid pJBPfaAf1. This expression construct was transferred into 
P. putida KT2440 by triparental conjugation. The transgenic clones were cultivated in 50 ml 
LB-medium at 30 °C for 4 h. Expression of the Pfa proteins was induced by addition of  
m-toluic acid to a final concentration of 2 mM. After induction, the cells were cultivated at  
16 °C for 24 h. The cellular fatty acids were extracted via acidic methanolysis using the 
FAME method [44] and analysed by GC-MS. The transgenic strain P. putida KT2440 + 
pJBPfaAf1 was shown to produce 0.03 mg n-6 DPA/g cell dry weight (CDW) and 0.2 mg 
DHA/g CDW (Figure 2), demonstrating the applicability of P. putida as expression host for 
PUFA synthases. The only PPTase from P. putida KT2440, PP1183, exhibits broad substrate 
specificity [46] and was obviously able to (at least partially) activate the tandem ACP 
domains of the PUFA synthase by posttranslational modification. 
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Figure 1. Cloning strategy for the construction of plasmids for recombinant LC-PUFA production in 
Pseudomonas putida KT2440 and strain improvement by genetic/metabolic engineering.  
(A) Cloning of the pfa gene cluster from Aetherobacter fasciculatus (SBSr002) into replicative plasmids,  
(B) Cloning of the gene encoding the PPTase AfPpt from A. fasciculatus (SBSr002), into an integrative plasmid, 
(C) Cloning of fadH-KO, a mutated and truncated version of the 2,4-dienoyl-CoA reductase gene fadH from 
P. putida KT2440, into an integrative plasmid, (D) Cloning of zwf-1, accA, accB-C-1, and accD, encoding the 
glucose-6-phosphate dehydrogenase and the acetyl-CoA carboxylase from P. putida KT2440, into integrative 
plasmids. oriV = origin of replication, trfA = gene encoding replication initiation protein in RK2 replicons 
(trfA* = cop271C mutation included), oriT = origin of transfer, bla = ampicillin resistance gene,  
cat = chloramphenicol resistance gene, aphI = kanamycin resistance gene, tetA
 
= tetracycline resistance gene, 
aacI = gentamicin resistance gene, Pm = Pm promoter (Pm* = mutated 5'-UTR of version LII-11 [41] included; 
Pm** = mutated 5'-UTR of version LII-11 [41] plus the mutated core promoter region of version ML2-2 [42] 
included), xylS = gene encoding the transcriptional regulator for Pm promoter, tetR = gene encoding the 
tetracycline transcriptional regulator, trpE = gene encoding the anthranilate synthase component 1 from 
P. putida KT2440, Ptac = tac promoter. 
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Figure x. Cloning strategy for the construction of plasmids for recombinant PUFA production in
Pseudomonas putida KT2440 and strain improvement by genetic/metabolic engineering.
(A) Cloning of the pfa gene cluster from Aetherobacter fasciculatus (SBSr002) into replicative plasmids, (B)
Cloning of AfPpt, encoding the PPTase fro A. fasciculatus (SBSr002), into an integrative plasmid, (C) Cloning
of fadH-KO, a mutated and truncated version of the 2,4-dienoyl-CoA reductase gene fadH from P. putida
KT2440, into an inte rative plasmid, (D) Cloning of zwf-1, accA, accB-C-1, and accD, encodi g the glucose-6-
phosphate dehydrogenase and the acetyl-CoA carboxylase fr m P. putida KT2440, into integrative plasmids.
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However, as LC-PUFA production by strain P. putida KT2440 + pJBPfaAf1 was relatively 
low, it was assumed that posttranslational activation of the PUFA synthase might be not 
efficient and could be improved by coexpression of the native PPTase from A. fasciculatus 
(SBSr002). A corresponding gene, Afppt, which encodes a Sfp-type PPTase that likely 
catalyses phosphopantetheinylation of PUFA synthases, was identified in the myxobacterial 
PUFA producer strain and cloned into an integrative expression plasmid under control of the 
xylS-Pm promoter system (Figure 1B). In the first instance, the pfa gene cluster located on 
plasmid pPfaAf7.1 was replaced with Afppt by conventional cloning, generating plasmid 
pPptAfA. Afterwards, an origin of transfer (oriT) for conjugation purposes, a tetracycline 
resistance cassette for selection in P. putida, and trpE for chromosomal integration into 
P. putida via homologous recombination were inserted by conventional cloning, yielding 
plasmid pPptAf1 (Figure 1B). This plasmid was transferred into P. putida KT2440. Three out 
of many obtained tetracycline resistant clones were chosen, and the correct integration of 
pPptAf1 could be confirmed by PCR. After transformation of pJBPfaAf1 into P. putida 
KT2440::pPptAf1, heterologous expression of the Pfa proteins plus AfPpt and extraction as 
well as GC-MS analysis of the fatty acids were performed as described previously. 
Transgenic strain P. putida KT2440::pPptAf1 + pJBPfaAf1, additionally overexpressing the 
Sfp-type PPTase from A. fasciculatus (SBSr002), produces significantly higher amounts of 
LC-PUFAs (0.07 mg n-6 DPA/g CDW and 0.3 mg DHA/g CDW) than P. putida KT2440 + 
pJBPfaAf1 (Figure 2). This result indicates that the activity of the intrinsic PPTase PP1183 
from P. putida KT2440 is not sufficient to phosphopantetheinylate quantitatively all the acyl 
carrier protein (ACP) domains of the overexpressed PUFA synthases.  
In order to further optimize heterologous PUFA production, different cultivation 
conditions were evaluated, including the use of several complex or minimal liquid media 
(details not shown), at which cultivation in standard LB-medium served as reference. 
Bacterial growth was boosted in the rich, complex media, but the yield of LC-PUFAs was 
lower than in LB-medium. Using minimal media, growth was significantly impaired and 
absolute amounts of produced LC-PUFAs were not elevated. All in all, LB-medium seems to 
be the best medium for heterologous LC-PUFA production in P. putida, providing good 
growth characteristics for the bacteria and considerable LC-PUFA production titres. Feeding 
of fatty acid synthase inhibitors was reported as promising approach to increase the 
concentration of LC-PUFAs produced by the anaerobic biosynthetic pathway in marine 
bacteria [14;15]. Unfortunately, no clear, reproducible effect could be attained by feeding of 
cerulenin or thiolactomycin to the transgenic P. putida strains. The cultivation temperatures of 
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16 °C and 30 °C were tested for heterologous expression of AfPpt and/or the Pfa proteins in 
P. putida strains, with the result that LC-PUFA production could only be observed at a 
cultivation temperature of 16 °C. Investigations on the LC-PUFA production kinetics revealed 
that n-6 DPA and DHA continually accumulated within 24 h of cultivation at 16 °C and that 
the yield of these LC-PUFAs per 50 ml culture volume was only slightly increased after 
additional 24 h of cultivation.  
In another approach to further increase the LC-PUFA production rate, engineering of the 
expression constructs was selected as starting point. In the first place, the heterologous 
promoter system was chosen, as a promoter driving the expression of heterologous genes 
represents a determining factor for recombinant protein production. As a consequence, 
expression plasmids pPfaAf7.4, pJBPfaAf4, pPptAfD, and pPptAf4, all harbouring the  
araC-PBAD promoter system instead of the xylS-Pm promoter system, were constructed 
analogous to plasmids pPfaAf7.1, pJBPfaAf1, pPptAfA, and pPptAf1 mentioned previously. 
The expression constructs pJBPfaAf4 and pPptAf4 were transferred into P. putida KT2440. 
Heterologous expression of the Pfa proteins plus AfPpt and extraction as well as GC-MS 
analysis of the fatty acids were performed as described previously, except for the use of 2% 
L-arabinose instead of 2 mM m-toluic acid as inducer. P. putida KT2440::pPptAf4 + 
pJBPfaAf4 produces n-6 DPA and DHA in amounts comparable to the yield obtained with 
P. putida KT2440::pPptAf1 + pJBPfaAf1 (details not shown). This indicates that the araC-
PBAD promoter system was not superior to the xylS-Pm promoter system in P. putida. 
However, any downstream bottlenecks which would mask an effect in either direction cannot 
be excluded. In case of the xylS-Pm promoter system, large mutant libraries exist in E. coli, 
that were obtained by random mutagenesis of either the 5'-untranslated region (UTR) [41] or 
the core region [42] of Pm promoter. It has been shown that the mutated 5'-UTR of Pm 
promoter version LII-11 is related to an increase of reporter protein activity up to about  
20-fold and to an increase of reporter gene transcript amount of up to about seven-fold in 
E. coli [41]. These results encouraged introduction of the modified xylS-Pm* promoter system 
comprising the mutated 5'-UTR of version LII-11 upstream of the pfa gene cluster. Thereby, 
plasmids pPfaAf7.1* and pJBPfaAf1* were constructed (Figure 1A). Expression construct 
pJBPfaAf1* was then transferred into P. putida KT2440::pPptAf1. Heterologous expression 
of the Pfa proteins plus AfPpt and extraction as well as GC-MS analysis of the fatty acids 
were performed as described previously. P. putida KT2440::pPptAf1 + pJBPfaAf1* produces 
significantly higher amounts of LC-PUFAs (0.09 mg n-6 DPA/g CDW and 0.5 mg DHA/g 
CDW) than P. putida KT2440::pPptAf1 + pJBPfaAf1 (Figure 2), indicating a similar effect of 
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the mutated 5'-UTR of version LII-11 on gene expression for E. coli and P. putida. Additional 
exchange of the wild type Pm promoter upstream of Afppt for Pm* promoter did not result in 
further production enhancement (details not shown). Nonetheless, these results motivated 
further engineering of Pm* promoter, resulting in the construction of Pm** promoter by 
combining the mutated 5'-UTR of version LII-11 and the mutated core promoter region of 
version ML2-2. For Pm promoter version ML2-2, an increase of reporter protein activity up to 
about 13.5-fold and an increase of reporter gene transcript amount of up to about ten-fold in 
E. coli has been demonstrated [42]. Plasmids pPfaAf7.1** and pJBPfaAf1**, containing the 
xylS-Pm** promoter system upstream of the pfa gene cluster, were constructed (Figure 1A). 
Expression construct pJBPfaAf1** was then transferred into P. putida KT2440::pPptAf1. 
Heterologous expression of the Pfa proteins plus AfPpt and extraction as well as GC-MS 
analysis of the fatty acids were performed as described previously. Compared to P. putida 
KT2440::pPptAf1 + pJBPfaAf1*, the amounts of LC-PUFAs produced by P. putida 
KT2440::pPptAf1 + pJBPfaAf1** (0.1 mg n-6 DPA/g CDW and 0.5 mg DHA/g CDW) are 
only slightly higher (Figure 2). Thus, either the core promoter region of version ML2-2 has 
only a minor effect on gene expression in P. putida or the combination with the mutated  
5'-UTR of version LII-11 blocks the positive effect of this mutation. 
Apart from targeting the promoter region, genetic engineering was extended to the RK2 
replicon, which consists of an origin of replication (oriV) and gene trfA, whose gene product 
is required for initiation of replication [47]. It has been shown that the copy number of RK2 
based vectors can easily be raised by introducing an R271C point mutation into trfA [38]. 
Assuming that this copy-up mutation increases the pfa gene dosage which correlates with  
LC-PUFA production, the vector backbone of expression construct pJBPfaAf1** was 
exchanged for an identical vector backbone except for the R271C point mutation within trfA 
(Figure 1A). The resulting expression construct pJB*PfaAf1** was then transferred into 
P. putida KT2440::pPptAf1. Heterologous expression of the Pfa proteins plus AfPpt and 
extraction as well as GC-MS analysis of the fatty acids were performed as described 
previously. Compared to P. putida KT2440::pPptAf1 + pJBPfaAf1**, only slight 
improvements of LC-PUFA production can be attained with P. putida KT2440::pPptAf1 + 
pJB*PfaAf1** (0.1 mg n-6 DPA/g CDW and 0.6 mg DHA/g CDW) (Figure 2). A conclusive 
explanation for this result can hardly be found, as the copy numbers of plasmids pJBPfAf1** 
and pJB*PfaAf1** in P. putida have not been checked and as it is still unclear if the gene 
dose represents a bottleneck or if there are any other limitations in downstream cellular 
processes. 
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Figure 2. Recombinant production of n-6 DPA and DHA with the pfa gene cluster from Aetherobacter 
fasciculatus (SBSr002) by wild type and genetically/metabolically engineered Pseudomonas putida 
KT2440.  
Initial cultivation was carried out in 50 ml LB-medium at 30 °C for 4 h. After induction of gene expression, the 
cultivation was continued at 16 °C and 200 rpm for 24 h. The indicated values are means and standard deviations 
of three biological samples.  
 
 
Besides P. putida, E. coli was established as host for heterologous expression of the 
DPA/DHA-type Pfa proteins plus AfPpt from A. fasciculatus (SBSr002). It could be shown 
that expression of the Pfa proteins without coexpression of AfPpt did not lead to any 
detectable LC-PUFA production in E. coli (details not shown). Therefore, cotransformation of 
the expression constructs pJBPfaAf1 plus pPptAfA, pJBPfaAf1* plus pPptAfA, or pJBPfaAf4 
plus pPptAfD in E. coli BL21(DE3) was performed by electroporation. The transgenic clones 
were cultivated in 50 ml LB-medium at 37 °C. Expression of the Pfa proteins and AfPpt was 
induced at OD600 of 0.8 by addition of m-toluic acid to a final concentration of 2 mM in the 
case of pJBPfaAf1 plus pPptAfA and pJBPfaAf1* plus pPptAfA or of L-arabinose to a final 
concentration of 2% in the case of pJBPfaAf4 plus pPptAfD. After induction, the cells were 
cultivated at 16 °C for 24 h. The cellular fatty acids were extracted via acidic methanolysis 
using the FAME method [44] and analysed by GC-MS. Best production was obtained with 
E. coli BL21(DE3)/pJBPfaAf4/pPptAfD, which produces only 0.1 mg DHA/g CDW and trace 
amounts of n-6 DPA. Thus, the araC-PBAD promoter system was superior to the xylS-Pm 
promoter system in E. coli and/or L-arabinose more conducive to cell growth than m-toluic 
acid. Surprisingly, unlike for P. putida, no improvement of DHA production could be 
achieved with Pm* promoter compared to Pm promoter. This observation indicates that the 
Table x. Recombinant production of n-6 DPA and DHA with the pfa gene cluster from Aetherobacter
fasciculatus (SBSr002) by wild type and genetically/metabolically engineered Pseudomonas putida
KT2440.
Initial cultivation was carried out in 50 ml LB-medium at 30  C for 4 h. After induction of gene expression, the
cultivation was continued at 16  C and 200 rpm for 24 h. The indicated values are means and standard
deviations of three biological samples.
0.0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
m
g
 /
 g
 c
e
ll
d
ry
 w
e
ig
h
t
n-6 DPA
DHA
P. putida
KT2440 + 
pJBPfaAf1
P. putida 
KT2440::
pPptAf1 + 
pJBPfaAf1
P. putida 
KT2440::
pPptAf1 + 
pJBPfaAf1*
P. putida 
KT2440::
pPptAf1 + 
pJBPfaAf1**
P. putida 
KT2440::
pPptAf1 + 
pJB*PfaAf1**
P. putida 
KT2440::
pfadH_KO/
pPptAf1 + 
pJB*PfaAf1**
P. putida 
KT2440::
pfadH_KO/
pME3 + 
pJB*PfaAf1**
P. putida 
KT2440::
pfadH_KO/
pME2 + 
pJB*PfaAf1**
+
 3
2
7
%
CHAPTER 3: RECOMBINANT PUFA PRODUCTION IN ESCHERICHIA COLI AND PSEUDOMONAS PUTIDA 
104 
 
transcription rate of the pfa genes is probably not the bottleneck for recombinant LC-PUFA 
production in E. coli under the tested conditions. It is more likely that efficient translation of 
the GC-rich pfa- and Afppt-mRNAs is impaired in E. coli, whose codon usage differs 
significantly from those of myxobacteria. In contrast, the higher GC-content of the genome 
sequence and the codon usage of P. putida certainly make it more suitable for the expression 
of the GC-rich myxobacterial genes, which might explain the observed higher LC-PUFA 
production rates. However, additional factors might also play a significant role, e.g. mRNA 
stability, translational helper factors, precursor supply, product stability, to name but a few. 
P. putida can be clearly regarded as the better host strain, especially because of its higher 
heterologous production rate of LC-PUFAs per se. Accordingly, subsequent engineering 
approaches were targeted to P. putida and extended towards optimization of product stability 
and precursor supply. 
Interestingly, in some cultures of the transgenic strains of P. putida or E. coli expressing 
the recombinant PUFA biosynthetic pathway not only n-6 DPA and DHA were detected but 
also some trace amounts of arachidonic acid (AA, 20:4, n-6) and EPA (20:5, n-3). As it is 
hypothesized that the PUFA synthase of Aetherobacter spp. may only produce DHA and 
some minor amounts of DPA as by-products, AA and EPA could result from the degradation 
of these C22 PUFAs [25]. This speculation is supported by the finding that feeding of 5 mg 
DHA to a 50 ml culture of P. putida KT2440 and cultivation for 4 h at 30 °C plus 24 h at 
16 °C resulted in a conversion of > 74% of DHA into EPA. In order to convert DHA into 
EPA or n-6 DPA into AA via β-oxidation, the activity of the additional enzymes 2,4-dienoyl-
CoA reductase (EC 1.3.1.34) and Δ3-Δ2-enoyl-CoA isomerase (EC 5.3.3.8) is needed. As a 
consequence, gene fadH, encoding 2,4-dienoyl-CoA reductase, was inactivated by single 
crossover in the genome of P. putida to prevent the produced LC-PUFAs n-6 DPA and DHA 
from degradation. For this purpose, the xylS-Pm promoter system, Afppt, and trpE located on 
plasmid pPptAf1 were replaced by a version of fadH with frameshift mutations at the 5' end 
and with a truncation at the 3' end by conventional cloning, yielding plasmid pfadH_KO-tet
R
 
(Figure 1C). The tetracycline resistance gene of plasmid pfadH_KO-tet
R
 was exchanged for 
the gentamicin resistance gene (Figure 1C). The resulting plasmid pfadH_KO-gm
R
 was then 
transferred into P. putida KT2440. Three out of many obtained gentamicin resistant clones 
were chosen, and the correct knockout of fadH by single crossover could be confirmed by 
PCR. Repetition of the feeding experiment using DHA and the strain P. putida 
KT2440::pfadH_KO under the same cultivation conditions described previously resulted in a 
conversion of 31% of DHA into EPA. This suggests some residual activity of the mutated 
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gene or complementation of its function by other enzymes. After transformation of pPptAf1 
and pJB*PfaAf1** into P. putida KT2440::pfadH_KO, verification of the correct integration 
of pPptAf1, heterologous expression of the Pfa proteins plus AfPpt and extraction as well as 
GC-MS analysis of the fatty acids were performed as described above. Compared to P. putida 
KT2440::pPptAf1 + pJB*PfaAf1**, the mutated strain P. putida 
KT2440::pfadH_KO/pPptAf1 + pJB*PfaAf1** produces higher amounts of LC-PUFAs  
(0.1 mg n-6 DPA/g CDW and 0.7 mg DHA/g CDW) (Figure 2).  
In addition to the reduction of PUFA catabolism, optimization of the precursor supply for 
LC-PUFA biosynthesis via PUFA synthases was also aimed at. These multifunctional enzyme 
systems assemble their products based on the substrate malonyl-CoA and reduce its β-keto 
group with the essential reductant NADPH after each chain elongation step. Insufficient 
supply of these substrates could be a bottleneck in LC-PUFA biosynthesis and explain the 
rather moderate LC-PUFA yield in the transgenic P. putida strains. In order to overcome this 
problem, metabolic engineering approaches were applied to the host strain. Thereby, 
additional copies of the genes encoding either intrinsic acetyl-CoA carboxylase (EC 6.4.1.2) 
or glucose-6-phosphate dehydrogenase (EC 1.1.1.49) were integrated into the genome of 
P. putida KT2440 under control of the constitutive tac promoter. Acetyl-CoA carboxylase 
catalyses the first committing step in fatty acid biosynthesis by a two-step mechanism. In the 
first reaction, biotin carboxylase is involved in the ATP-dependent carboxylation of biotin 
with bicarbonate. The carboxyl group is then transferred to acetyl-CoA by carboxyl 
transferase, yielding malonyl-CoA in the second reaction [48]. Glucose-6-phosphate 
dehydrogenase represents an enzyme of the Entner-Doudoroff pathway, the predominant 
pathway for glucose catabolism in P. putida [49], and catalyses the oxidation of  
D-glucose-6-phosphate into 6-phospho-D-glucono-1,5-lactone under consumption of one 
equivalent of NADP
+
. Gene zwf-1 encoding the glucose-6-phosphate dehydrogenase from 
P. putida was cloned downstream of the tac promoter plus upstream of the tonB transcription 
terminator and inserted into plasmid pPptAf1 by applying conventional cloning techniques 
(Figure 1D). The resulting plasmid pME3 was then transferred into P. putida 
KT2440::pfadH_KO + pJB*PfaAf1**. The correct integration of pME3 could be confirmed 
for selected clones by PCR. Heterologous expression of the Pfa proteins, AfPpt, plus Zwf-1 
and extraction as well as GC-MS analysis of the fatty acids were performed as described 
previously. The engineered strain P. putida KT2440::pfadH_KO/pME3 + pJBPfaAf1** 
produces higher amounts of LC-PUFAs (0.2 mg n-6 DPA/g CDW and 0.8 mg DHA/g CDW) 
than P. putida KT2440::pfadH_KO/pPptAf1 + pJB*PfaAf1** (Figure 2). The acetyl-CoA 
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carboxylase from P. putida is encoded by the genes accA and accD plus an operon 
comprising genes accB-accC-1. The genes accA and accD encode the carboxyl transferase 
subunits α and β, whereas gene accC-1 encodes the biotin carboxylase and gene accB the 
biotin carboxyl carrier protein of the multienzyme complex. Each gene or operon was cloned 
downstream of the tac promoter plus upstream of the tonB transcription terminator in case of 
accD and assembled into cloning vector pUC18 by conventional cloning (Figure 1D).  
Ptac-accB-accC-1-Ptac-accA-Ptac-accD-TtonB was inserted into plasmid pPptAf1 by applying 
conventional cloning techniques (Figure 1D). The resulting plasmid pME2 was then 
transferred into P. putida KT2440::pfadH_KO + pJB*PfaAf1**. The correct integration of 
pME2 could be confirmed for selected clones by PCR. Heterologous expression of the Pfa 
proteins, AfPpt, AccB, AccC-1, AccA, plus AccD and extraction as well as GC-MS analysis 
of the fatty acids were performed as described previously. Compared to P. putida 
KT2440::pfadH_KO/pPptAf1 + pJB*PfaAf1** and P. putida KT2440::pfadH_KO/pME3 + 
pJBPfaAf1**, the engineered strain P. putida KT2440::pfadH_KO/pME2 + pJBPfaAf1** 
produces higher amounts of DHA (0.1 mg n-6 DPA/g CDW and 0.9 mg DHA/g CDW) 
(Figure 2). Hence, it can be deduced that limited supply of malonyl-CoA or NADPH 
represented a bottleneck for LC-PUFA biosynthesis, which could, at least partially, be 
eliminated by overexpression of acetyl-CoA carboxylase or glucose-6-phosphate 
dehydrogenase. As rational consequence of this result, collective overexpression of genes 
accB-accC-1, accA, and accD plus gene zwf-1 was attempted by assembly of the entire gene 
set onto one expression plasmid, which was transferred into P. putida (details not shown). 
Unfortunately, the resulting expression strain produces unexpectedly low amounts of  
LC-PUFAs (0.1 mg n-6 DPA/g CDW and 0.7 mg DHA/g CDW). The most obvious reason 
for this finding is probably the instability of the expression plasmid due to constitutive 
overexpression of five genes in E. coli and P. putida during cloning and transformation.  
In conclusion, recombinant LC-PUFA production could be successfully accomplished in 
E. coli and P. putida with the DPA/DHA-type pfa gene cluster from the myxobacterium 
A. fasciculatus (SBSr002). The latter host strain produces 0.05 mg n-6 DPA/l and 0.3 mg 
DHA/l with the initial expression construct. These yields could be increased to 0.2 mg n-6 
DPA/l and 1.3 mg DHA/l by stepwise optimization of the expression system over seven 
transgenic P. putida strains (Figure 2). Total DHA production yields are comparable to the 
LC-PUFA production rate achieved with the native producer strain A. fasciculatus (SBSr002), 
which produces 1.2-1.9 mg DHA/l as major PUFA species, but not until after seven days of 
cultivation. For the first time, extensive genetic engineering of expression plasmids 
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containing a pfa gene cluster combined with metabolic engineering of a host strain 
heterologously expressing a PUFA synthase were performed in a systematic manner. All 
these procedures eventually led to an increase in recombinant LC-PUFA production in 
P. putida of more than 300%.  
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PUFA production in Pseudomonas putida based on 
expression of artificial gene clusters encoding a 
myxobacterial PUFA synthase 
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INTRODUCTION 
In quest of a suitable microbial chassis for recombinant production of long-chain 
polyunsaturated fatty acids (LC-PUFAs) using a native myxobacterial pfa gene cluster, the 
Gram-negative and generally recognized as safe (GRAS) bacterium Pseudomonas putida 
KT2440 turned out to be a fast-growing, reliable, and robust host organism (Chapter 3). 
Recombinant production of docosahexaenoic acid (DHA, 22:6, n-3) and n-6 
docosapentaenoic acid (DPA, 22:5) could be successfully accomplished in P. putida with the 
DPA/DHA-type pfa gene cluster from the myxobacterium Aetherobacter fasciculatus 
(SBSr002). Moreover, the strain has proven to be accessible for genetic and metabolic 
engineering, which led to further improvements of the production yield of LC-PUFAs. 
Compared to Escherichia coli, P. putida turned out to be a better host strain for the expression 
of the native PUFA biosynthetic pathway from A. fasciculatus (SBSr002). However, there are 
some significant differences in the codon bias of the pfa gene cluster from A. fasciculatus 
(SBSr002) and the coding sequences in the genome of P. putida, which appear to interfere 
with optimal heterologous gene expression.  
Total synthesis of large DNA fragments to reconstitute complete gene cluster offers 
opportunities to holistically optimize DNA sequences of biosynthetic pathways for the chosen 
production host including codon bias adaptation and optimization of several other sequence 
parameters important for functional expression. On top of this, sophisticated constructional 
design of artificial pathways, e.g. including engineering of restriction sites, enables facile and 
flexible genetic manipulation of pathway components. Only three examples for using this 
modern technique on complex multimodular assembly lines are described in literature so far. 
The 32 kb erythromycin biosynthetic pathway has been redesigned, synthesized, and 
functionally expressed in E. coli [1;2]. Synthetic 58 kb epothilone biosynthetic pathways were 
constructed and functionally expressed in E. coli [3] and Myxococcus xanthus [4]. 
Unfortunately, the achieved production titres were found very low [4], even after engineering 
of the E. coli host strain [5]. Nonetheless, advantages and potential of Synthetic Biology 
approaches for heterologous expression systems appear attractive as well as promising and 
were therefore applied to the optimization of recombinant LC-PUFA production. Hence, 
artificial pfa gene clusters originating from A. fasciculatus (SBSr002) PUFA biosynthetic 
pathway [6] were redesigned, synthesized, and assembled for P. putida. To the best of our 
knowledge, this represents the first example for the application of gene synthesis on 
multifunctional PUFA synthases and the usage of Pseudomonas as expression host for 
complex, artificial polyketide synthase-like pathways. Different pfa pathway versions were 
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constructed and successful transfer of the expression plasmids and heterologous PUFA 
production was accomplished in the engineered host strain. 
 
 
 
EXPERIMENTAL PROCEDURES 
 
Sequence analysis and design of the synthetic gene clusters 
The sequence of the pfa gene cluster of A. fasciculatus (SBSr002) was analysed and compared 
to the genome sequence of P. putida KT2440 [7] retrieved from NCBI Genome RefSeq 
NC_002947 in collaboration with ATG:biosynthetics. Based on this, relevant parameters for 
constructional and functional sequence design were defined to generate artificial pathway 
versions using the proprietary evoMAG-GeneDesign software [4]. The sequence design 
process included engineering of restriction sites, adaptation of the codon usage, elimination of 
sequence repeats as well as rare codon clusters, engineering of Shine-Dalgarno (SD)‒anti-SD 
interactions, and introduction of hidden stop codons in unused frames. 
 
 
Culture conditions 
Escherichia coli DH10B [8] was used for cloning experiments. E. coli HB101/pRK2013 [9] 
was used as helper strain for conjugation experiments. The cells were grown in LB-medium 
or on LB-agar (1% tryptone, 0.5% yeast extract, 0.5% NaCl, (1.5% agar)) at 37 °C (and 
200 rpm) overnight. Kanamycin was used at the concentration of 50 µg/ml. 
Pseudomonas putida KT2440 [10] was cultivated in liquid LB-medium at 30 °C and 
200 rpm overnight. Conjugation was carried out onto PMM-agar plates containing 0.61% 
K2HPO4, 0.5% KH2PO4, 0.1% (NH4)2SO4, 0.66% disodium succinate, and 1.5% agar. The 
medium was adjusted to pH 7.0 and supplemented with 0.12% MgSO4 after autoclaving. 
Antibiotics were used at the following concentrations: 60 µg/ml kanamycin, 30 µg/ml 
tetracycline, and 20 µg/ml gentamicin. 
 
 
General molecular biology techniques  
Routine handling of nucleic acids, such as isolation of genomic and plasmid DNA, restriction 
endonuclease digestions, DNA ligations, and other DNA manipulations, were performed 
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according to standard protocols [11]. All the enzymes were purchased from Thermo Scientific 
or New England Biolabs. 
 
 
Cloning of expression constructs containing the synthetic pfa gene clusters originating 
from A. fasciculatus (SBSr002) for heterologous LC-PUFA production in P. putida 
For heterologous expression of artificial PUFA biosynthetic pathways in P. putida KT2440, 
three synthetic versions of the pfa gene cluster originating from A. fasciculatus (SBSr002) 
were designed. The synthetic DNA fragments were supplied by gene synthesis companies. 
For each version, the gene cluster is composed of seven building blocks, BB1-BB7, flanked 
by unique restriction sites (see appendix for sequences). Version 1 consists of the native DNA 
sequence of the pfa gene cluster; only constructional design was implemented. Therefore, 
SwaI, NheI, MunI, EcoRV, MluI, ScaI, SgrDI, BglII, FseI, AclI, ApaLI, FspI, SnaBI, BspEI, 
and PacI restriction sites were introduced for cloning purposes as well as for exchangeability 
of genes/domains and were excluded from any other unwanted position within the gene 
cluster. The resulting artificial version 1 of the pathway was further modified to generate 
version 2 by applying functional design approaches with special focus on sequence features 
affecting pfa gene translation (adaptation of the codon usage, elimination of sequence repeats 
as well as rare codon clusters, engineering of Shine-Dalgarno (SD)‒anti-SD interactions, and 
introduction of hidden stop codons in unused frames). In version 2a, a derivative of version 2, 
the overlap of the stop codon of pfa2 and the start codon of pfa3 was eliminated by 
introducing a 40 bp intergenic region, TR-pfa2-pfa3_V2, comprising a Shine-Dalgarno 
sequence (see appendix for sequence). 
A cloning plasmid with kanamycin resistance gene, p15A origin of replication, and 
restriction sites for assembly of the seven DNA building blocks was constructed. Therefore, a 
multiple cloning site comprising SwaI, MunI, MluI, BglII, AclI, ApaLI, SnaBI, and PacI 
restriction sites (0.1 kb) was amplified by PCR using overlapping primers  
MCS for pACYC_fwd_2 and MCS for pACYC_rev_2 (Table 1). PCR was performed with 
Phusion DNA polymerase (Thermo Scientific) and standard conditions according to the 
manufacturer’s protocol. The reactions contained 5% DMSO and were carried out in an 
Eppendorf Mastercycler under the following conditions: initial denaturation for 2 min at 
98 °C; 30 cycles consisting of denaturation for 15 s at 98 °C, annealing for 20 s at 72 °C, and 
extension for 10 s/kb at 72 °C; and a final extension for 10 min at 72 °C. The MCS was 
phosphorylated and ligated into plasmid pACYC177 (New England Biolabs), digested with 
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DraI and AanI and dephosphorylated, yielding plasmid pACYC_assembly_2 (Table 2). The 
seven DNA building blocks of version 1 and version 2 were stitched together in plasmid 
pACYC_assembly_2, respectively. The assembly procedure is explained in more detail 
below: BB1_V1 or BB1_V2 was inserted into pACYC_assembly_2 via SwaI and MunI 
restriction sites, generating plasmid pACYC_BB1_V1 or pACYC_BB1_V2 (Table 2); 
BB2_V1 or BB2_V2 was inserted into pACYC_BB1_V1 or pACYC_BB1_V2 via MunI and 
MluI restriction sites, generating plasmid pACYC_BB1+2_V1 or pACYC_BB1+2_V2 (Table 
2); BB3_V1 or BB3_V2 was inserted into pACYC_BB1+2_V1 or pACYC_BB1+2_V2 via 
MluI and BglII restriction sites, generating plasmid pACYC_BB1-3_V1 or pACYC_BB1-
3_V2 (Table 2); BB4_V1 or BB4_V2 was inserted into pACYC_BB1-3_V1 or 
pACYC_BB1-3_V2 via BglII and AclI restriction sites, generating plasmid pACYC_BB1-
4_V1 or pACYC_BB1-4_V2 (Table 2); BB5_V1 or BB5_V2 was inserted into 
pACYC_BB1-4_V1 or pACYC_BB1-4_V2 via AclI and ApaLI restriction sites, generating 
plasmid pACYC_BB1-5_V1 or pACYC_BB1-5_V2 (Table 2); BB6_V1 or BB6_V2 was 
inserted into pACYC_BB1-5_V1 or pACYC_BB1-5_V2 via ApaLI and SnaBI restriction 
sites, generating plasmid pACYC_BB1-6_V1 or pACYC_BB1-6_V2 (Table 2); BB7_V1 or 
BB7_V2 was inserted into pACYC_BB1-6_V1 or pACYC_BB1-6_V2 via SnaBI and PacI 
restriction sites, generating plasmid pACYC_BB1-7_V1 or pACYC_BB1-7_V2 (Table 2). 
TR-pfa2-pfa3_V2 was inserted into pACYC_BB1-7_V2 via FseI and AclI restriction sites, 
yielding plasmid pACYC_BB1-7_V2a (Table 2). The vector backbones of pACYC_BB1-
7_V1, pACYC_BB1-7_V2, and pACYC_BB1-7_V2a were exchanged for the backbone of 
plasmid pJB*PfaAf1** (Chapter 3) via PmlI and PacI restriction sites, resulting in plasmids 
pPm**SynPfaAf1, pPm**SynPfaAf2, and pPm**SynPfaAf2a (Table 2).  
 
Table 1. Primers used for cloning of the assembly plasmid in this study.  
The introduced restriction sites are underlined. 
 
Primer Sequence (5'3') 
MCS for pACYC_fwd_2 
GCCCTTCCGGCATTTAAATGCGCAATTGGCGACGCGTCGCAGATCTCGC
AACGTTGCGC 
MCS for pACYC_rev_2 
GGATCCTTAATTAACGCTACGTAGCGCGTGCACGCGCAACGTTGCGAGA
TCTGCGACGC 
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Table 2. Plasmids and expression strains constructed in this study.  
oriV = origin of replication, trfA = gene encoding replication initiation protein in RK2 replicons, oriT = origin of 
transfer, aph(3')-Ia = kanamycin resistance gene. 
 
Plasmid / Strain Characteristics 
pACYC_assembly_2 
Derivative of pACYC177 (New England Biolabs) in which a multiple 
cloning site comprising SwaI, MunI, MluI, BglII, AclI, ApaLI, SnaBI, and 
PacI restriction sites was inserted via DraI and AanI 
pACYC_BB1_V1 
Derivative of pACYC_assembly_2 in which BB1_V1 was inserted via 
SwaI and MunI 
pACYC_BB1+2_V1 
Derivative of pACYC_BB1_V1 in which BB2_V1 was inserted via MunI 
and MluI 
pACYC_BB1-3_V1 
Derivative of pACYC_BB1+2_V1 in which BB3_V1 was inserted via 
MluI and BglII 
pACYC_BB1-4_V1 
Derivative of pACYC_BB1-3_V1 in which BB4_V1 was inserted via 
BglII and AclI 
pACYC_BB1-5_V1 
Derivative of pACYC_BB1-4_V1 in which BB5_V1 was inserted via 
AclI and ApaLI 
pACYC_BB1-6_V1 
Derivative of pACYC_BB1-5_V1 in which BB6_V1 was inserted via 
ApaLI and SnaBI 
pACYC_BB1-7_V1 
Derivative of pACYC_BB1-6_V1 in which BB7_V1 was inserted via 
SnaBI and PacI 
pACYC_BB1_V2 
Derivative of pACYC_assembly_2 in which BB1_V2 was inserted via 
SwaI and MunI 
pACYC_BB1+2_V2 
Derivative of pACYC_BB1_V2 in which BB2_V2 was inserted via MunI 
and MluI 
pACYC_BB1-3_V2 
Derivative of pACYC_BB1+2_V2 in which BB3_V2 was inserted via 
MluI and BglII 
pACYC_BB1-4_V2 
Derivative of pACYC_BB1-3_V2 in which BB4_V2 was inserted via 
BglII and AclI 
pACYC_BB1-5_V2 
Derivative of pACYC_BB1-4_V2 in which BB5_V2 was inserted via 
AclI and ApaLI 
pACYC_BB1-6_V2 
Derivative of pACYC_BB1-5_V2 in which BB6_V2 was inserted via 
ApaLI and SnaBI 
pACYC_BB1-7_V2 
Derivative of pACYC_BB1-6_V2 in which BB7_V2 was inserted via 
SnaBI and PacI 
pACYC_BB1-7_V2a 
Derivative of pACYC_BB1-7_V2 in which TR-pfa2-pfa3_V2 was 
inserted via FseI and AclI 
pPm**SynPfaAf1 
Derivative of pACYC_BB1-7_V1 in which the vector backbone was 
exchanged for the vector backbone of pJB*PfaAf1** (Chapter 3) via 
PmlI and PacI. RK2 oriT, RK2 oriV, trfA*, aph(3')-Ia 
pPm**SynPfaAf2 
Derivative of pACYC_BB1-7_V2 in which the vector backbone was 
exchanged for the vector backbone of pJB*PfaAf1** (Chapter 3) via 
PmlI and PacI 
pPm**SynPfaAf2a 
Derivative of pACYC_BB1-7_V2a in which the vector backbone was 
exchanged for the vector backbone of pJB*PfaAf1** (Chapter 3) via 
PmlI and PacI 
P. putida 
KT2440::pfadH_KO/pME2 + 
pPm**SynPfaAf1 
P. putida KT2440::pfadH_KO/pME2 (Chapter 3) with replicative 
plasmid pPm**SynPfaAf1 
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Continuation of Table 2. 
 
Plasmid / Strain Characteristics 
P. putida 
KT2440::pfadH_KO/pME2 + 
pPm**SynPfaAf2 
P. putida KT2440::pfadH_KO/pME2 (Chapter 3) with replicative 
plasmid pPm**SynPfaAf2 
P. putida 
KT2440::pfadH_KO/pME2 + 
pPm**SynPfaAf2a 
P. putida KT2440::pfadH_KO/pME2 (Chapter 3) with replicative 
plasmid pPm**SynPfaAf2a 
 
 
 
Transformation of P. putida by triparental conjugation and heterologous expression 
Expression plasmids were transferred into P. putida KT2440 by triparental conjugation. 1 ml 
of an overnight culture of the acceptor strain P. putida KT2440::pfadH_KO/pME2, the donor 
strain E. coli DH10B containing the final expression construct, and the helper strain E. coli 
HB101/pRK2013 were harvested at 13,000 rpm for 1 min. After discarding the supernatant, the 
cells were resuspended in 1 ml LB-medium in each case. The cells were spun down at  
13,000 rpm for 1 min, and the supernatant was discarded. This wash step was repeated once. 
The cells were resuspended in 300 µl LB-medium in each case. The triparental mating was 
performed by combining 50 μl of each 300 µl suspension on a small area of a LB-agar plate 
[12]. After incubation at 37 °C for 4 h, the plate was transferred to 30 °C and incubated 
overnight. The cells were scraped from the plate and resuspended in 1 ml sterile ddH2O. 10-
100 µl of this suspension was then plated out on PMM-agar containing 60 µg/ml kanamycin, 
30 μg/ml tetracycline, and 20 µg/ml gentamicin. The E. coli strains were additionally 
counterselected by 150 μg/ml ampicillin, which P. putida is resistant to. The plates were 
incubated at 30 °C for 1-2 days. Transconjugants were verified by plasmid isolation and 
restriction analysis of the replicative plasmids. The constructed strains are listed in Table 2. 
For heterologous LC-PUFA production in P. putida, cultivation was carried out in 50 ml 
LB-medium containing 60 µg/ml kanamycin, 30 μg/ml tetracycline, and 20 µg/ml gentamicin. 
The medium was inoculated with an overnight culture (1:100) and incubated at 30 °C for 4 h. 
Expression of the Pfa proteins and AfPpt was induced by addition of m-toluic acid to a final 
concentration of 2 mM. After induction, the cells were cultivated at 16 °C and 200 rpm for  
24 h and then harvested at 8,000 rpm for 5 min. 
 
 
 
CHAPTER 4: EXPRESSION OF ARTIFICIAL PUFA BIOSYNTHETIC GENES IN PSEUDOMONAS PUTIDA 
118 
 
Extraction of cellular fatty acids 
The cellular fatty acids were extracted using the FAME method [13]. For this purpose, 50 ml 
of a culture were harvested at 8,000 rpm for 10 min at room temperature. The cell pellet was 
transferred to a glass vial and dried in a vacuum concentrator. Subsequently, the cell dry 
weight was determined. 5 µl (50 µg) of n-3 DPA (Sigma-Aldrich) and 500 µl of a mixture of 
methanol, toluene, and sulphuric acid (50:50:2, v/v/v) were added. The vial was capped with a 
teflon-lined screw cap and incubated at 80 °C for 24-48 h. After the mixture was cooled to 
room temperature, 400 µl of an aqueous solution consisting of 0.5 M NH4HCO3 and 2 M KCl 
were added, and the sample was vortexed for 30 s. Phase separation was achieved by 
centrifugation at 4,000 rpm for 5 min at room temperature. 100 µl of the upper phase were 
used for GC-MS analysis. 
 
 
Analysis of fatty acid methyl esters by GC-MS 
GC-MS was carried out on an Agilent 6890N gas chromatograph (Agilent Technologies) 
equipped with a 7683B split/splitless injector with autosampler (Agilent Technologies) and 
coupled to a 5973 electron impact mass selective detector (Agilent Technologies). Helium 
was used as the carrier gas at a flow rate of 1 ml/min. 1 µl of the sample was injected in split 
mode (split ratio, 10:1). The analytical column was a (5% phenyl)-methylpolysiloxane 
capillary column (Agilent J&W DB-5ht; 30 m x 0.25 mm i.d. x 0.1 µm film thickness, 
maximum temperature 400 °C; Agilent Technologies). The column temperature was kept at 
130 °C for 2.5 min, increased to 240 °C at a rate of 5 °C/min, then ramped to 300 °C at 
30 °C/min, and held at 300 °C for 5 min. Other temperatures were as follows: inlet, 275 °C; 
GC-MS transfer line, 280 °C; ion source, 230 °C; and quadrupole, 150 °C. The mass selective 
detector was operated in scan mode, scanning the mass range from m/z 40 to 700. Scan 
control, data acquisition, and processing were performed by MSD ChemStation and AMDIS 
software, version 2.68, based on the fragmentation patterns and retention times, in comparison 
with Supelco 37 Component FAME Mix and LC-PUFAs (all Sigma-Aldrich) as reference 
standards, and NIST 08 library. Absolute amounts of PUFAs were quantified by integration 
of the peaks using MSD ChemStation and by subsequent calculation in relation to the integral 
of n-3 DPA and to cell dry weight. 
 
 
 
CHAPTER 4: EXPRESSION OF ARTIFICIAL PUFA BIOSYNTHETIC GENES IN PSEUDOMONAS PUTIDA 
119 
 
RESULTS AND DISCUSSION 
Recombinant LC-PUFA production using the DPA (22:5, n-6 or n-3)/DHA (22:6, n-3)-type 
pfa gene cluster from A. fasciculatus (SBSr002) has already been successfully accomplished 
after cloning, transfer, and expression of the gene cluster in an engineered P. putida strain 
(Chapter 3). Thereby, production of n-6 DPA (0.1 mg/g CDW; 0.2 mg/l) and DHA (0.9 mg/g 
CDW; 1.3 mg/l) could finally be achieved after 28 h of cultivation. Here, in a new approach, 
three versions of a synthetic DPA/DHA-type pfa gene cluster based on the sequence of 
A. fasciculatus (SBSr002) were created for P. putida in order to achieve further yield 
improvements. Design and synthesis of the artificial DNA sequences were restricted to the 
three pfa genes, which were intended to be cloned into the same vector backbone used for 
expression of the native pfa gene cluster (pJB*PfaAf1**, containing engineered genetic 
elements for improved expression rates; Chapter 3). During sequence modulation processes, 
the pfa genes were subjected to the algorithms of the proprietary evoMAG-GeneDesign 
software by ATG:biosynthetics. The software applies concepts of evolutionary algorithms 
[14;15] to generate artificial sequences according to predefined multivariate sequence 
parameter values. Degeneracy of the genetic code allows for the substitution of synonymous 
codons by silent mutations in order to generate the artificial sequence based on the native 
template without altering the amino acid sequence. The resulting artificial sequence of the 
16.2 kb pfa gene cluster from A. fasciculatus (SBSr002) was dissected into seven DNA 
fragments, which could be supplied by gene synthesis companies despite their high GC-
content (Figure 1). 
 
 
Figure 1. Design, synthesis, and cloning of a synthetic pfa gene cluster originating from Aetherobacter 
fasciculatus (SBSr002) for recombinant LC-PUFA production in Pseudomonas putida KT2440.  
oriV = origin of replication, trfA* = gene encoding replication initiation protein in RK2 replicons, cop271C 
mutation included, oriT = origin of transfer, aphI = kanamycin resistance gene, Pm** = Pm promoter, mutated 
5'-UTR of version LII-11 [16] plus the mutated core promoter region of version ML2-2 [17] included,  
xylS = gene encoding the transcriptional regulator for Pm promoter. 
Figure x. Design, synthesis, and cloning of a synthetic pfa gene cluster originated from Aetherobacter
fasciculatus (SBSr002) for recombinant PUFA production in Pseudomonas putida KT2440.
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The sequence design process involved engineering of restriction sites to allow for pathway 
assembly and interchangeability of inter- and intragenic regions. During this procedure, 69 
codons were affected by synonymous substitutions to generate the artificial gene cluster 
version 1, which is still highly similar to the native pfa gene cluster from A. fasciculatus 
(SBSr002). Based on the same constructional sequence design, yet another artificial pfa gene 
cluster sequence (version 2) was generated to additionally consider several functional 
sequence parameters, especially those affecting pfa gene translation (Figure 2), as well as 
some general aspects of sequence optimization (e.g. avoidance of sequence repeats, mRNA 
stabilities). Comparison of the codon usage of the original cluster sequence and the codon 
table of P. putida led to the application of a 10% exclusion threshold (Figure 2A). The 
resulting artificial codon usage table only contains 48 instead of 61 sense codons. 
Renormalization of the synonymous codon fractions from the genome sequence of P. putida 
had to be performed to ensure that the sum of each subset of codons for the same amino acid 
equals 1. Eventually, high adaptation of the codon usage of the artificial cluster sequence 
version 2 to the reduced and renormalized table could be achieved. Another important 
parameter affecting translational elongation represents the local codon adaptation index 
(CAI), which is a measure for the deviation of the synonymous codon usage bias of a given 
coding sequence with respect to a reference set of genes [18]. After sequence adaptation, the 
local CAI shows a clearly smoothed shape without any distinct peaks as found for the native 
sequence (Figure 2B). In the modified sequence version 2, the gradient between start and stop 
codon of each coding DNA sequence was 0.05, which is intended to enhance the ribosome 
occupancy along the mRNA to shield the transcript from degradation [19]. In general, the 
speed of ribosomal protein synthesis and the resulting translational elongation rate depends on 
several factors, including the availability of aminoacyl-tRNAs, but also on certain sequence 
features of the mRNA template, e.g. rare codon clusters [20] or internal Shine-Dalgarno 
sequences [21]. These sequence features are often assigned to temporal separation of 
translation of segments within the peptide chain and proper cotranslational folding of proteins 
with direct impact on their solubility and activity [22]. However, the search for relevant rare 
codon clusters within the native pfa genes did not reveal any conspicuous candidates. Thus, 
rare codon clusters were eliminated (Figure 2C) and Shine-Dalgarno (SD)‒anti-SD 
interactions were attenuated (Figure 2D) during the codon adaptation procedure to design the 
synthetic gene cluster version 2. Another important factor to be considered is the metabolic 
cost of translational miselongation upon a frameshift [23]. In order to cause early termination 
of translation of incorrect reading frames, the ribosome must encounter an off-frame stop 
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codon. Hence, stop codons were accumulated in the two unused frames of the artificial cluster 
sequence version 2 (Figure 2E).  
 
 
Figure 2. Comparison of the native pfa gene cluster sequence from Aetherobacter fasciculatus (SBSr002) 
with the artificial sequence (version 2) adapted for expression in Pseudomonas putida.  
(A) Codon usage of the original cluster sequence (left blue bars) compared to the codon table of Pseudomonas 
putida (left red bars) and codon usage of the modified cluster sequence version 2 (right blue bars) compared to 
the reduced and renormalized codon table of Pseudomonas putida (right red bars; the cut-off for the synonymous 
codon fractions was 0.1), (B) Course of the local codon adaptation index (CAI); in the modified sequence 
version 2, the gradient between start and stop codon of each coding DNA sequence (CDS) was 0.05, (C) Rare 
codon clusters according to Clarke and Clark [20]; additional violet triangles: tandem-repeats of codons below 
average usage frequency, (D) Shine-Dalgarno (SD)‒anti-SD interactions, (E) Hidden stop codons in unused 
frames. Untranslated regions between the protein coding regions were excluded from the graphs in (B) and (C). 
 
 
 
 
Figure x. Comparison of the native and the artificial sequence (version 2) of the pfa gene cluster
originated from Aetherobacter fasciculatus (SBSr002). (A) Codon usage of the original cluster sequence (blue
bars) compared to the codon table of Pseudomonas putida (red bars) and codon usage of the modified cluster
sequence version 2 compared to the reduced and renormalized codon table of Pseudomonas putida (the cut-off
for the synonymous codon fractions was 0.1), (B) Course of the local codon adaptation index (CAI); in the
modified sequence version 2 the gradient between start and stop codon of each coding DNA sequence (CDS)
was 0.05, (C) Rare codons clusters according to Clarke and Clark (Ref); additional violet triangles: tandem-
repeats of codons below average usage frequency, (D) Shine-Dalgarno (SD)‒anti-SD interactions, (E) Hidden
stop codons in unused frames. Untranslated regions between the protein coding regions were excluded from the
graphs in (B) and (C).
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The myxobacterial pfa gene clusters are characterized by an overlap of the 3' end of gene 
pfa2 and the 5' end of gene pfa3 by four bases, indicating a translational coupling (Figure 3). 
A putative Shine-Dalgarno sequence for pfa3 is located 8 bp upstream of the stop codon of 
pfa2. For the synthetic gene cluster version 2, the minimum free energy of the mRNA 
secondary structure comprising 60 bp upstream and 37 bp downstream of the start codon of 
pfa3 is calculated as -31.7 kcal/mol, based on predictions from the RNAfold web server [24]. 
In the artificial gene cluster version 2a, a derivative of version 2, the overlap of pfa2 and pfa3 
was eliminated by introducing a 40 bp intergenic transition region, comprising a Shine-
Dalgarno sequence 7 bp upstream of the start codon of pfa3 (Figure 3). The minimum free 
energy of the predicted mRNA secondary structure ranging from 17 bp upstream of the stop 
codon of pfa2 to 37 bp downstream of the start codon of pfa3 is calculated as -11.7 kcal/mol. 
This should result in an optimization of the translation initiation rate. 
 
 
Figure 3. Minimum free energy (MFE) structures of the mRNAs transcribed from the 3' end of synthetic 
gene pfa2 and the 5' end of synthetic gene pfa3, as predicted by RNAfold web server [24].  
In version 2 the genes pfa2 and pfa3 overlap by four bases, whereas in version 2a the genes are separated by a  
40 bp intergenic region. The structures are coloured by base-pairing probabilities. For unpaired regions, the 
colour denotes the probability of being unpaired. 
 
 
 
Putative Shine-
Dalgarno sequence
Start codon of pfa3
Stop codon of pfa2
Start codon
of pfa3
Stop codon of pfa2
Shine-Dalgarno
sequence
Version 2 Version 2a
Figure x. MFE (minimum free nergy) structures of th mRNAs transcribed from the 3' end of synthetic
gene pfa2 and the 5' end of synthetic gene pfa3, as predicted by RNAfold web server
(http://rna.tbi.univ e.ac.at/cgi-bin/RNAfold.cgi). In version 2 the genes pfa2 and pfa3 overlap in four bases,
whereas in version 2a the genes are separated by a 40 bp intergenic region. The structures are colored by base-
pairing probabilities. For unpaired regions the color denotes the probability of being unpaired.
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Practical implementation of the heterologous expression of the artificial pfa gene clusters 
in P. putida started with reconstitution of the entire pathway by assembly of the DNA 
building blocks obtained from gene synthesis companies (Figure 1). For this purpose, a 
pACYC-derived assembly plasmid was constructed by insertion of a suitable multiple cloning 
site. The DNA building blocks of version 1 and version 2, respectively, were assembled 
stepwise by conventional cloning techniques using unique restriction sites engineered during 
the constructional sequence design process. Gene cluster version 2 was further modified to 
incorporate an artificial intergenic transition region between genes pfa2 and pfa3 by replacing 
the respective fragment for a modified version in DNA building block 4 to yield version 2a. 
The backbones of the resulting plasmids pACYC_BB1-7_V1, pACYC_BB1-7_V2, or 
pACYC_BB1-7_V2a were then exchanged for the vector backbone of pJB*PfaAf1** 
(Chapter 3). It is derived from the broad-host-range expression vector pJB861 with a copy-up 
point mutation [25]. Heterologous expression of the pfa genes is driven by the xylS-Pm 
promoter system with mutations in the 5'-untranslated region [16] plus the core region [17] of 
Pm promoter. The resulting plasmids pPm**SynPfaAf1, pPm**SynPfaAf2, or 
pPm**SynPfaAf2a were transferred into P. putida KT2440::pfadH_KO/pME2 by triparental 
conjugation. This strain has been engineered for improved LC-PUFA production (Chapter 3). 
Gene fadH encoding 2,4-dienoyl-CoA reductase was inactivated in the genome of P. putida 
KT2440::pfadH_KO/pME2 to prevent the produced LC-PUFAs from degradation;  
4'-phosphopantetheinyl transferase AfPpt from A. fasciculatus (SBSr002) and  
glucose-6-phosphate dehydrogenase from P. putida were overexpressed to increase the 
phosphopantetheinylation of PUFA synthases and the supply of the substrate malonyl-CoA, 
respectively. The transgenic clones were cultivated in 50 ml LB-medium at 30 °C for 4 h. 
Expression of the Pfa proteins plus AfPpt was induced by addition of m-toluic acid to a final 
concentration of 2 mM. After induction, the cells were cultivated at 16 °C for 24 h. The 
cellular fatty acids were extracted via acidic methanolysis using the FAME method [13] and 
analysed by GC-MS. PUFA production was analysed in comparison to strain P. putida 
KT2440::pfadH_KO/pME2 + pJB*PfaAf1** (Chapter 3) expressing the native pfa gene 
cluster from A. fasciculatus (SBSr002) under the same conditions to yield 0.1 mg n-6 DPA/g 
cell dry weight (CDW) and 0.9 mg DHA/g CDW (Figure 4). Surprisingly, strain P. putida 
KT2440::pfadH_KO/pME2 + pPm**SynPfaAf1, expressing artificial pfa gene cluster version 
1, turned out to produce LC-PUFAs in significantly lower amounts (0.1 mg n-6 DPA/g CDW 
and 0.5 mg DHA/g CDW) (Figure 4). The only differences between these two strains are 
silent mutations in 69 codons within the pfa genes modified by silent mutations during 
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constructional sequence design, which was not expected to have a negative impact on their 
functional expression. However, reproducible lower production yields from several clones of 
P. putida KT2440::pfadH_KO/pME2 + pPm**SynPfaAf1 indicate that one or more of these 
point mutations affect pfa gene expression on the transcriptional and/or translational level. On 
the contrary, after applying additional changes to the DNA sequence to better adapt the pfa 
genes for expression in P. putida with special emphasis on optimization of translational 
elongation, a clearly positive effect on recombinant LC-PUFA production was observed. 
Strain P. putida KT2440::pfadH_KO/pME2 + pPm**SynPfaAf2 containing the artificial pfa 
gene cluster version 2 produces 0.3 mg n-6 DPA/g CDW and 1.2 mg DHA/g CDW. Further 
engineering of the synthetic gene cluster version 2 into version 2a included the optimization 
of the translation initiation rate on pfa3-mRNA. The corresponding strain P. putida 
KT2440::pfadH_KO/pME2 + pPm**SynPfaAf2a shows only a slight but not significant 
improvement of DHA production (0.2 mg n-6 DPA/g CDW and 1.4 mg DHA/g CDW). From 
all these data, it can be deduced that the outcome of heterologous expression of artificial gene 
cluster sequences rationally designed by introducing silent point mutations is still far from 
being easily predictable, as many cellular processes affecting gene expression and stability of 
foreign DNA are not yet sufficiently studied. However, the application of additional, 
functional sequence design approaches on the first synthetic gene cluster (version 1) led to the 
development of optimized pathways (version 2/2a) that allow for much higher PUFA 
production with yield improvements of around 180%. However, all the strains with artificial 
pfa gene clusters show a high standard deviation between distinct clones, which is not the 
case for different clones of strains with the native pfa gene cluster (Figure 4).  
In conclusion, recombinant LC-PUFA production could be successfully accomplished in 
P. putida by design, construction and heterologous expression of artificial DPA/DHA-type 
pfa gene clusters originating from the myxobacterium A. fasciculatus (SBSr002). 
Sophisticated functional sequence design for P. putida led to a production of 0.4 mg n-6 
DPA/l and 3 mg DHA/l, which surpass the LC-PUFA production rate achieved with the 
native myxobacterial producer (1.2-1.9 mg DHA/l as major PUFA species after seven days of 
cultivation). Using the first polyketide biosynthetic gene cluster modulated and synthesized 
for this microbe, an increase in LC-PUFA production of more than 50% could be attained 
compared to heterologous expression of the native pfa gene cluster. 
CHAPTER 4: EXPRESSION OF ARTIFICIAL PUFA BIOSYNTHETIC GENES IN PSEUDOMONAS PUTIDA 
125 
 
 
Figure 4. Recombinant production of n-6 DPA and DHA by metabolically engineered Pseudomonas putida 
KT2440 with native or synthetic pfa gene clusters originating from Aetherobacter fasciculatus (SBSr002). 
Initial cultivation was carried out in 50 ml LB-medium at 30 °C for 4 h. After induction of gene expression, the 
cultivation was continued at 16 °C and 200 rpm for 24 h. The indicated values are means and standard deviations 
of three biological samples.  
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APPENDIX 
 
DNA sequences of the synthetic building blocks 
 
>BB1_V1 
ATTTAAATATGTCTGCAATCGGTAGATGGAACGCTCAAGGGGGCTCGCCGGAGCTCACCCCTGCGGCGATGGTCG
CGGCGATAGCGCGTTGTCGAGAGTCGTTGCACGTGGTGCGCGACGGGGAGTCCGGGCGGATCGGCCTGGGCGTGG
GGGGCGAGCTGCTCCCCCCCGGCGAGCGCCGCGCGGGCGAGTACACGCTTGTGGCTAGCCTGCCGCCGCTGTTCC
CCGAGTGGCTCGGTGACCGCTCGTTCTGCGAGGTACACGGGGTCCGCTTCCCCTACGTCGCCGGCGAGATGGCCA
ACGGCATTGCCACCGTGGAGATGGTCGTGGCCATGAGCCGGAGCGGGATGCTCGGCTTCTTCGGCGCCGCGGGCC
TGGGCTTCTCCCGGGTCGAGGCCGCGGTGGAGACGCTCCGCGCCACGCTGGGGGACGAGGCGCCGTGGGGGGTGA
ACCTCATCCACTCACCGAACGAGGCCTCGCTGGAGAACCGCGTCGCCGATCTGCTGATCGAGAGCGGGGTGCGGC
GCATCTCGGTGTCGGCCTTCATGGCGCTGACGCCGGCGGTGGTGCGCTGCGCGGCGCGCGGGCTGCGGCTCGACG
CGGCGGGGCGGATCGTGCGGCCGCGGCACATCTTCGCCAAGCTCTCGCGGCGCGAGGTGGCGCTGCCGTTCCTCT
CCCCCGCGCCGGAGGAGATGCTGCGCGCCCTCGTCGCCAGCGGCGGGTTGACGGAGGAAGAGGCCCGCCTCGCCG
CGAAGATCCCGGTGGCCGAGGACATCACCGTCGAGGCCGACTCCGGCGGTCACACCGACAACCAGGCGCTGGTGG
CGCTGCTCCCGACGATCTTGCAGCTCCGCGACGAGCTGGCGGACAAGTACGACTACACGCGGCCGATCCGCGTCG
GCGCGGCGGGTGGGCTCGGGACGCCGACGGCGGTCGCCGCGGCGTTCTCGCTCGGCGCGGCCTACGTCGTCACCG
GCTCGGTCAACCAGGCGGCGCTGGAGTCCGGCCTCTCCGACGAGGGCAAGCGGATGCTGGCGCAGGCCGAGGTCG
CCGACGTGATCATGGCGCCCGCGGCCGATATGTTCGAGCTCGGGGTCAAGCTCCAGGTGCTGCGGCGCGGGAGCA
TGTTCGGCGTGCGCGCGGCCAAGCTCTACGAGGCGTACCACGCGCACCCCTCGCTCGAGGCCATCCCCGACGCGC
TGCGGGCGCGGCTCGAGCGCGAGGTCTTGCACGCGACCTTCGACGGCATCTGGGCGGAGACGCGGGCCTTCTGGG
AGGCGCGCGATCCCGAGCAGGTCGCGCTGGCGGCGCGGGATCCCAAGCACCGGATGGCGCTGGTCTTCCGCTGGT
ACCTCGGCATGGCGAGCCGCTGGGCCATCGCCGGCGAGGCGTCGCGGCGGGCCGACTACCAAATCTGGTGCGGGC
CGGCGATGGGGGCCTTCAACTCCTGGGTCCGCGGCTCGTTCCTCGAAGATCCCAAGCAGCGCGGCGTGGTGGCGA
TCGCGCTCAACCTGCTCGAGGGCGCGGCCGTCGTCACCCGCGCCCACCAATTG 
 
 
>BB2_V1 
CAATTGCGGACCTACGGCGTGCCCGTGCCGGCCGCCGCGTTCGACTTTCGACCTCGTCCGCTCGCTTGAGCGCTC
GGCTTCACCTTCACTCGACAGGTCTTCGCATGACTCAGGTTCCGGTCGCCATCGTCGGCGTGGGCGCGCTCTTTC
CGGGCTCGCCCGACGGTGCAGGCTTCTGGCGCGATATCGTCGCGTCACGCGATCTCGTCTCCGACGTCCCCCCGG
GGCACTGGCTGATCGAGGACTACTACGATCCCGATCCCTCGGCGCCGGACAAGACCTACTCCAAGCGCGGGGCCT
TCCTCGGCGAGACGGCCTTCGATCCGCTGGAGTTCGGCGTGGTGCCGAGCTCGCTCCCGACCACCGACACCGCGC
AGCTGCTGGCGCTGATCGTGGCGCGGCGGGTGCTCGACGACGCGACCCAGGGGCGCTTCGCTTCCATCGATCGAT
CGCGCATCGGCGTCGTCCTCGGCGTGACCTCGGGGCAAGAGCTCCTCGGCACGATGGTGAGCCGGCTCCAGCGGC
CGGTGTGGCTCAAGGCGCTGCGCGACGACGGCGTGCCCGAGGCCGACGCGCAGCGGATCTGCGATCGGATCACCA
ACGAGTACGTGCCCTGGAAGGAGTCGACGTTCCCCGGGCTCCTCGGCAACGTGGTCGCCGGGCGCATCGCCAACC
GCTTCGATCTCGGCGGCACCAACTGCGTCACCGACGCGGCGTGCGCGAGCTCGCTCGCGGCGCTCTCGATCGCCA
TGAACGAGCTGGCGCTCGGGCAGTCGGATCTCGTGATCACCGGCGGGGTGGACACGATGAACGACATCCTGATGT
ATACCTGCTTCAGCAAGACCCCGGCGCTCTCGAAGTCGGGCGACTGCCGCCCCTTCTCCGACGCCGCCGACGGGA
CGCTGCTCGGCGAGGGCCTGGCGATGTTCGCGCTCAAGCGCCTCACCGACGCCGAGCGCGACGGGGATCGCGTCT
ACGCGGTGATCCGCGGCCTGGGATCGTCGTCGGACGGGCGGAGCAAGAGCGTGTACGCGCCGGTGCCGGAAGGGC
AGGCCAAGGCGCTGGTGCGGGCCTACGAGGCGGCCGGCTACGGCGCGGACACGGTGGAGCTGGTCGAGGCGCACG
GCACCGCGACCAAGGCCGGCGACGCGGCGGAGTTCGGCGGCCTCAAGCTGGCGTTCGAGGCGAGCGGGCGCGCGG
ATCACCAGTGGTGCGCGCTCGGATCGGTGAAATCGCAGATCGGGCACACCAAGTCGGCGGCCGGCGCGGCGGGCC
TCTTCAAGGCGGTGATGGCGCTGCACCACAAGGTCCTGCCGCCGACGATCAAGGTCGATCGCCCCAACCCCGAGC
TGGCGATCGAGGCGAGCCCGTTCTACCTCAACACGCAGGCGCGGCCCTGGGTACGCAACGCGCAGCACCTGCGGC
GGGCCTCGGTCTCGAGCTTCGGCTTCGGCGGGAGCAACTTCCACGTAACGCTGGAGGAGTACGCCGGCACGGCGG
AGCCGGCGGCGCGCCTGCGGACCGCGCCGACGGAGCTCTTCGTGATCTCGGCGCCCTCGGCGGCGGAGGTCCTCG
CGCGCGCCGGCAAGCTCGCCGAGCTCGCGGACAAAGAGGGCACGACGACGGCGGCGCGGACCTCGCAGCGCGACT
TCGTGACGGCGGATCACGCGCGGCTCTCCATCGTGGCGAGCGACGCCGCGGATCTGCGCGCCAAGCTCGAGCAAG
CGCGCTCGCTCCTGTCGGCGCGCCCCGAGGAGGCGTTCTCGACGCCGACCGGCGTCCACTTCGCGGTGGGCGCGG
CGGCGGGCGGCGTGGCGTTCCTCTTCCCCGGGCAGGGGAGCCAGTACGTGGGCATGGGCGCCGACGTGGCCATGG
AGCACGGCGTCGCGCTCGACGCCTGGGACGCGGCGGCGGGCCTGGTCGAGACCGCGGGGCTGCGCGACGTGGTCT
TCCCGCGCCCGGCCTTCACCGACGAGGCGCGAGCCGAGCAGGCGCAGCTCTTGACGGCGACCGAGTGGGCGCAGC
CHAPTER 4: EXPRESSION OF ARTIFICIAL PUFA BIOSYNTHETIC GENES IN PSEUDOMONAS PUTIDA 
129 
 
CGGCGATCGCCACGGCGAGCCTCGCGCTCCTCGCGGTGCTGCGGGCGGTCGGCGTCCGCCCGTCGAGCGTCGCCG
GTCACAGCCTGGGCGAGCTCACCGCGCTCGCCGCGGCCGATGCTTTGAGCACCAACGATCTCGTGGCCACGGCGC
GCAAGCGCGGCCAGCTCATGAACGCGGCGTCGAGCACGCCGGGGGCGATGACCGCGGTGGCGCGGCCCCTCGCCG
AGGTGCAGGCCCTCCTCGAGCGCCTCCAGAGCGAGGTGGTGGTGGCCAACCACAACCACCCGACCCAGGTCGTCC
TCGCCGGCGAGACCGCCGCGATCGAGGCGGTCGAGGCCGAGCTCGCGCGCCAGGGGATCACCGCCAAGCGGCTCC
CGGTCGCCACGGCGTTCCACAGCCAGGTCGTGGCCGGGGCGACGGCGCCCTTCGCCGAGCACCTCGCCGGGATCG
CGGTGAAGGCGCCGGCCATCGACGTGCTCTCCAACAGCGAGGCCGCGGCCTACCCGTCGGATCCCGACGCGGTGC
GCGCGCTCCTCGCCGGGCAGATCACGCGCTCGGTCCGCTTCGTCGAGGTGGTCGAGGCGATGTGGGCGCGCGGGG
CGCGCATCTTCGTGGAGGTCGGCCCCTCGGCGGTGCTGACCGAGCTCTGCGCGCGGATCCTCGGCGAGCGGCCGC
ACCTGGCGATCGCCATGGATCGCAAGGGCAAGCACGGCGTGACCGCGCTCCAGGACGCGCTCGGGCGCCTCGCCG
CGGCCGGCGTGGCCATCGACTTCGCCCCGCTGTGGGCGCCGTTCGGCCCGCCCGCGGCGCCGAAACGCGT 
 
 
>BB3_V1 
ACGCGTGCCGGCGATGTCGATGATGATCAACGGCGCGAACTACGGGAAGGTCTACCCGCCCAAGGGCGGCGCCGC
GGCGCTGCCGCCGCCGAACCCGCCGCGCCCGGTCGTTGCTGCTGCAACGATCGCCGCGGCGCCGAGCTCGGCGGC
CAAGGCTCCGGTCGTTGCTGCTGCAACGATCGCGGCGGCGCCGATCCCGGCGGCCAAGGCTCCGGTCGTTGCTGC
TGCAACGATCGCGGCGCGCCCCGCGGCGGCGCCCGAGTCGCGGCCGGTCGTCGCGGCTGCCCCGGCCCCTGCGCC
GGTTGTGGCGGCGCCCGCGTCGGCGGCGGCGGCGCTGTCGGCGCCGGGTCAGCTCGGCTGGATCGAGGCGTACCA
GGAGTCGCAGCGGCAGCTCACCGAGGCGCACGCGAGCTACGTGCGGACGATGGCGTCGGGGCACGAGGCGTTCCT
CACGACGATGGAGGCCTCGTTCATCGGGCTCGGCGGCCTGCTCGGCGCGCCGGCTTCGGTGTCCGCGGTCGCCCC
GCGGAGCGCAGCGGCTCCGGTGCTCGCGCAGCCGGTCGCGGTCGCTCCGGCTCCGGTGCTCGCGCCGGCTCCGGT
GCCCGCGCCCGCTCCGACTCCGGTGCTCGCTCCGGCTCCCGCTCCAGTACTGGCGCCTGCGCCTGTCGCCGCGGT
GGCGAAGGCGGCTCCCGCGCCGGTGATGGCGCCCGCGGCGCCGTCAATCGATCTCCAGGCGCTGCTGCTCGACGT
GGTCGCGGACAAGACCGGCTACCCCGCCGAGATGCTCGGTATGCACATGGAGCTCGAGGCCGATCTCGGCATCGA
CTCCATCAAGCGCGTCGAGATCCTCTCCGCCATGCGGAAGCGCGCGCCCAACCTCCCGGAGGTCGTCGCCTCCGA
GATGGCCACGCTCCGCACCCTCGGGCAGATCGTCGAGTACATGCGCGAGCGGTCCGGTGCGCTGACGGCTGCGAC
TCACGAGACGCTGGTTCCCGCGACGGCAGAGGCTGCGACCCAGGCGGCTCCGGCGCTCGGCGATCTCCAGGCGCT
GCTGCTCGACGTGGTCGCGGACAAGACCGGCTACCCCGCCGAGATGCTCGGGATGCACATGGAGCTCGAGGCCGA
TCTCGGCATCGACTCCATCAAGCGCGTCGAGATCCTCTCCGCCATGCGTAAACGCGCGCCCAACCTCCCGGAGGT
CGTCGCCTCCGAGATGGCCACGCTCCGCACGCTCGGGCAGATCGTCGAGTACATGCGCGACCGCTCCGGCGCGAC
GGCGGCTCCGGTGAAGGCAGCGCCTGCGCCTGCGCCTGCGCCTGCGGCGGCTCCGACGAAGGAAGCGCCGACGCT
GGCGGATCTGCAAACGCTGCTGCTCAGCGTCGTCGCGGACAAGACCGGCTACCCCGCCGAGATGCTCGGTATGCA
CATGGAGCTCGAGGCCGATCTCGGCATCGACTCCATCAAGCGCGTCGAGATCCTCTCCGCCATGCGTAAACGCGC
GCCCAACCTCCCGGAGGTCGTCGCCTCCGAGATGGCCACGCTCCGTACGCTCGGGCAGATCGTCGAGTACATGCG
CGACCGCTCCGGCGGGCACAGCGTGGCGGCCACGACACCGGCACCGGCTCCGGCGTCGACGCTCGCTCCGGCGGC
GAGCCGGATCGGTCGCTACGTGGTGGGCACGCGCGAGGAGGCGGCGAGCGGGCTGGCGATGGGCGGCGTGCTCGG
CGCGCGGCGCTTCGTCATCACCAACGAAGGGACGGGCATCGCGCAGGCGCTGGTGCGGGCGCTGCAAGAGCGCGG
CGTCAGCAGCGAGGTCGTGACCGAGGTGCCGGCGGACGCCGACGCGGTGGTGTTCCTCGGCGGGTTGCGGACCCT
CGTGGACGTCGACACGGCCATCGCGATCAACCGCGAGGCGTTCCTCGCGGCGCGCGCTGTGGCCAGTGTGTTCTC
GCGCGACGGCGGCGCCTTCGTGACGGTCCAGGACACGGGCGGCGATCTCGGGATCGAGGCGCGCGAGCCGCGGGC
AGCGTGGCTCGCGGGCGTGGCCGCGCTGGCGCGGACGGCGCAGCTCGAGTGGCCGAAGGCCTCGGTGAAGGCAGT
GGACGTCGAGCGCGGCGGGCGCAGCTCCGAGGAGATCGCCGCGGCGATCGCCGAGGAGATCT 
 
>BB4_V1 
AGATCTTGACCGGCGGCGGCGCGCTCGAGGTCGGCCTGACGGCGGCCGGCGCGCGGCGCGTCCCCGAGGTCGTGC
AGCGCGCGGTGGGCGAGCGGACCCCGGTCCTCGCTCGCAGCTCGGTCGTCGTCGCCTCCGGCGGGGCCCGCGGCG
TCACCGCCACGGCGCTGATCGCGCTGGCGCGCCACGCGCAGCCGAAGCTGGTGATCCTCGGGCGATCCGCGCTCG
AGGCGGAGCCGGCGGCCTGCCTCGGCGTGCGCGGCGACGCGGCGCTCAAGCGCGCCTTGCTCGAGGACGCGCGCG
CGCAGGGCCGGACGGCGACCATCGCCGAGATCGGCGCCCACGTAGCGCGCATCTCCGCGAGCCGCGAGGTGCTGG
AGACGCTCGCGGCGATCAAGGCCGCGGGCGGCGAGGCGCGCTACCTCGCAGTCGACGTCACCGACGCCGATCGCC
TCCGCCTCGCGCTGGAAGAGGTCCGGCGCGACTGGGGCCCGATCACCGCCGTCGTCCACGGCGCCGGCGTCCTCG
CCGACAAGCGGATCGAGGACAAAACGCCCGAGCAGTTCGATCGGGTCTTCGACACCAAGGTCCTCGGGCTGCGCG
CGCTGCTCGCCGCGACCGAGGGCGATCCGCTGCGCGCGATCATCCTCTTCTCCTCGGTCGCCGCGCGCGCGGGCA
ACGTCGGCCAGTGCGACTACGCCATGGCCAACGAGATCCTCAACAAGGTGGCCATCGCCGAGCGGCGGCGGCGCG
GCGGCGCTTGCACCGTCAAGTCCCTCGGCTGGGGCCCCTGGGAGGGCGGGATGGTGACGCCCGCGCTCAAGGGTC
ACTTCGAATCGATGGGCGTGGCGCTGATCCCGCTGGCCGAGGGCGCCGAGCACTTCATCGCCGAGATCGAGGGCT
CCGCCGACGAGATCGAGCTGGTGATCGGCGGCGGCGCCGACGGCAGCGCCATCCGCGGGGACGCCGAGCCGACGA
TCCACTTCGGGGTCTCGGTCTCGGATCGCACGAGCCCGTGGCTCGCCGATCACCGCGTCGCTGGTCGCCGCGTCA
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TCCCTGTCGCCGTCGTGATCGAGTGGTTCACCCGCGCGGTCACGGCGCTCCAGGGCCGCGCCGCGGTGAGCCTCC
GCGACGTCAAGGTGCTGCGCGGGATCAAGCTCCCCGCCGGCGACGCCGCGGCCTCGTTCTCGATCGGCTGCCGCA
AGCTCGCCGAGGGCAAGATCGAGCTCACGCTCCACGGGGCCGACGGCGCCCTGCACTACCGCGCGAGCGCCGAGC
CCCGGGGCGCGGCGCTGAAGCCCGAGGGCGCCGCGCCTCCGCTCGCGGCGTGGGGCGATCGGCCGATCTACGACG
GCGGGCTGCTCTTCCACGGGCCGCGCTTCCACGCGATCCACAGCATCGAGGGCGCCTCGGCCGAAGGGATCCGCG
CCACGCTCACCGGCGCGCGCGAGCTCGGCTGGCCGGGCGAAGCGCAGCGCACCGATCCGGCGATTGTCGACGGCG
CGCTCCAGCTCGCGCTGCTCTGGACGCGCGAGCGCCTCGGTCAGGCCTCGCTCCCGATGGCCATCGCGGCCTTCG
ACTGGCAGGCCTCGGGGCCGGTCGAAGGTCCAGTGCGCGCGGTCGTTCAAGGGCGCGAGGCCGACAGCGCTCATG
CGGTCTGCGACGTGTGGCTCGAGGACGCGCGCGGCGCGATCGTCGGCGCGCTCCGCGGCGTCGAGACCATCGTGC
GGCCGGCCGAGGTCCGCGCGCCGCACCTCGTGGAGACAGGGCCAGCCTCGTGACCTTCGAACCGATCGCGATCGT
CGGGCAGGCCTGCACGCTCCCCGGCGCGCTGACGCCGGAGGCGCTGTGGGCCAACGTT 
 
 
>BB5_V1 
AACGTTCTCCGCGGCGAGAGCGCCGTGACCTCGCCGCCGGAGGGCCGCTGGCGCCTCCCGGCGTGGCACGCGATG
GGGAAGCCGGGCGCGCAGGAAGAGCGCGCCTGGTCCGACGCCGGAGGCTATGTCCGCGGCTTCGAATCGGCCTTC
GATCCCGGCGGCCTGCGCCTCCCGGAGGCCGAGCTCCGCGGCCTCGATCCGGTGTTCCAGTGGACGCTCCACACC
GCGCGCGCGGCCCTGCGCTCCGCGGGGATGGAGGGGCCGTCGGCGCGCGCCGGGCTCGTCCTCGGCAACCTCTCG
TTCCCGACGGCGTCGATGTCGCGCTACGCCGAGAGCGTCTGGCTCGAGGCGCTGGGCAAGGAGCTCCTCGGCGGG
CGCGCCGCGGCGCAGGCCGGCGTCACCCACCCCGACGCGCACAACCGCTTCATGTCCGGGCTCCCCGCGCACCTC
GCCGCGCAGGCCCTCGGGCTCGGCGGGGGCGCCTTCGCGCTCGACGCCGCCTGCGCCTCGTCGCTCTACGCGATC
AAGCTCGCCTGCGACCGGCTCCAGGATCGCGCTACTGATCTGATGCTGGCCGGCGCCGTCAACGCCGCCGACAGC
CTCTTCCTCCACATCGGGTTCTCGGCCCTCTCGGCGATGAGCCGCACCGGCCAGTCGCGCCCGTTTCACCGCGAG
GCCGACGGCCTCGTCCCCTCGGAGGGGGCCGTCTTCTTCGCGCTCCAGCGCCTCGACGACGCGCGCGCCGCCGGC
CGCCGCGTCCTCGGGATCATCCGCGGCGTCGGCCTCTCCAACGACGGGCGCGGCCGCGGCCTCCTCGCGCCCTCG
GAGGAGGGACAGATCCGCGCCATGCGCCTGGCCTACGCCGCGGCGGGGCTCACGCCCTCCGACGTGAGCTTCGTC
GAGTGCCACGCCACCGGCACGCCCGTCGGTGACGCCACCGAGATTCGGAGCCTCAGCGAGGTCTTCGCCGGGTGC
CGCGACGTGCCCATCGGCTCGCTCAAGTCCAACCTCGGCCACCTCATCACCGCCGCGGGCGGCGCCGGCTTGATC
AAGGTCCTCGGATCGTTCACCGCCGAAACGATCGCGCCGACGATCCACGCCGGCGCTTCGATCCCCGAGCTCGCC
GGGTCGCCGGTCCGCCTCGTCACGCAGGCCGAGCCCTGGCGCGCGGCGGGCCGCCGCATCGCCGCGATCAGCGCC
TTCGGGTTCGGCGGCAACAACGCCCACCTGATCGTCGAGCAGGACGACGGCCGCGCCACGGCGCCGCGGGCCGCA
GCGCCGCGATCCGCGCCGGCGCCGATCGCCGTCATCAGCCTCGGCGCCAGGATCGGCGACACCACCGGCCGCGAC
GAGGCCGCGCGCGCGCTGCTCTCCGGCGCGGGCTGGGGCAGCCGCCGCGAGGCGGTCACGGTCGAGCTCGAGGGG
CTGCGCTTCCCGCCGCGCGATCTCGAGCAGACGCTCCCGCAGCAGCTCCTCGTGCTCGAAGCGGGGCGCGAGGCG
ATCCGCGGGCTCTCGCTCCCGCGCGATCGCACCGCCGTGCTCATCGGCATGGGCGCCGATCCCGAGGTCGCGCGC
TACGGCGCTCGCTGGCGCCTGCCCGCGTTCGCCGACGCCTGGGCGGCCGCCGGGCTCCCCGTGTCCAGCGCCTGG
ACCGAGGCCGCGCGCGACGCCGTGCAAGAGCAGCACGGCGCGGCCGGCGTCGTCGGCGCCATGCCCAACATCCCG
GCCAACCGCCTCAGCAGCCAGCTCGATCTCGCCGGGCCGAGCTTCACCATCTCCTCGGAGGAGCTCTCCGGCGTC
GTCGCCCTGCAGCTCGCCGCGCGCGCGCTGCGCTCGGGCGAGATCGACGCGGCCCTCGTCGGCGCCGTCGATCTC
GCCGATCAGATCGTCCACCGCAAGGCGCTGGGCGAGCTCGGCCTCGAGCCCCGCGCCGGCGACGCCGCGGTCGCG
CTCGTGCTCAAGCGCCTCACCGACGTGCGGAAGAGCGAGAAGGTCCTGGCGATCCTCGACGAGGGCATCGTGGAT
GCGTCCAGCGATCCCGCGCGCCTCCGCGTCGGCGACGGCGGCGCCGATCTCGATCCCTTCGCCACCACGGGCAAG
CCGCACGCGGCGGCGGGCCTCGTCCACGTCGCCGCCGCCGTGCTCGCGCTGCACCACGGCGCGCGCCCCGCCCCC
GGGCGCGCCTCCATGCCCTGGGTCGGCCCCCGCCACGCCGAGGTGACGACGCAGGCCCTCGGCGATCAGGCGGCG
ACGATCCACCTCCGCGGCGGCGGCCTCGCCGCGCCGCTGCTGCTCGACGCCACGCCGCAGATCCATGTCTTCGCC
GGCGCCGATCGCGAGGCCGTGCTCCGCGCCCTCAGCGACGGGCGCGAGGGCCTCGACGGCCCGGCGCGCGCGGTG
ATCGTGGCCGGCTCGCGCGAGGAGCTCGAGGCGCGCCGCGCCGACGCCCTCCGCGCCGCCGAGCGCAACGCCCCC
ATGCCCGACGGCGTCTTCCTCCGCGATCGCCCCGTCGCGGGCGAGCTCGCCTTCGTCTTCGCAGGCGCCGCCGCG
GCGTACCCGAGCATGGGCCGTGCAC 
 
 
>BB6_V1 
GTGCACTGGCGCTCGCGCTCCCCGACGTGATGGCGCGCCTCGGCAACCGGCTCTCGACGCTGCCCGCGGTGATCG
ACTGGATCCACGGCGCGCCCCGCGAGCCGCGCCACCCGCTCGAGCAGCTCTGGGCGTCGTCGTTCCTCTGCCAGC
TCCACGCCGAGATCACCCGCGTCGACCTCGGGCTCCGCCCCAGCGCGACCATCGGCTACTCCTCCGGCGAGAGCA
ATGCGCTCTTCGCCATGGGCGCCTGGCGCGACCTCGACGCCATGATGCACGAGGCCTGGACCGAGCCGCTGCTGA
CCACGGAGCTCGTCGGCGACTACGCCGCGGCGCGCCGCCTCTGGGCGCGCTCCGGCGTCACCAGCCCCGCGGCGA
CGTGGGCCGCGTGGGTCATCGCCGCGCCCGTGGACGACGTGCGCCGCGCCCTCACGGGCGAGCCGCTCGCGCACC
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TCACCATCATCAACACCGCCGAGGAGTGCGTGATCGGCGGCGAGGCCTCCGCGTGCGAACGTGTCGTCGCGCGGC
TCGGCAAGAACCTCGCGCTGCCGCTCAGCTACGCCATGGCCTCGCACTGCCCCGAGGTCGCCGAGGCGCGCGAGG
CGTGGATCAAGATGCACCGCCGCGCCACCTTCGACGTCCCCGGCGTTCGCATCTACTCCGCCGGCGCCGAGCAGG
CCTTCGCCCCCACCGCCGACGCCGCCGCGATGGCCATCACCGGCCAGGCCGTCGACACGCTCGATTTCCCCCGCG
TGATCGAGCGCGCCTACGCCGACGGCGTCCGCGTCTTCGTCGAGCACGGCCCGCGCGGCCTCTGCAGCCGCTGGA
TCGCGCGCATCCTCGGCGCGCGCGAGCACCTCGTCGTCCCGCTCGACGTCGCCGGGCAGCAGCCGGTCCGCCAGC
TCGTGAGCGCCGTGGCCCAGCTCATCGCCGCCGGCGTGCCCGTCGCCGCCGACGCCCTCCTCGCCAGGCTCGCGC
CGCCTCCCCCGGCGCGCGCCTCGGGCCCCACGCTCACCGTGCGTGCGCACCCTCCTGACATTCACTTCCCGACGG
CCCCTGCCATGCAACTGATGCCGCCCGCGCCCCTTCTCCCGCCGGTGCTCGCCGACAACCCCGCGCCGCGCACGG
AGCGGAGCTTCACCGGGCGGTCGGCGCTGCGAGAGGACGCGCCCGACGGCGTCCCCTCGCCTCGCCTCCCCGTGT
TCGCGAGGCTCGCGCCGGTGTTCACCCACACCGAGCCGGTGTTCACGCACGTCGAGCCGGCGCTCGCGAGCCCTG
AGCCGGCGGTCACGCACCCCGAGCCGGTGATCGCGCACGCCGAGCCGGCGCTCACACACGCCGAGCCCGCGCTCG
CGAGCCCCGCGGATGGCCAGCACGCCTCCATCGCCGCGCGCGGCGCCGCCGTGAGCGCGGGGATCGCCGCCGCCC
ATCGCGCCTACGTCGAGGCGCAAGGCGCCGTTCACGCCCGCTTCCTCGCGCTCTCGGGCTCCTTGCTCTCGCGCC
TCGCCGCCGCCCCGACAGCCGCCGCCTTCCCGGCGCCTGCTCCCTCGCTCGCGCCGCAGCCCGCCGCCCTCCCGG
CGCCCGCTCCGCAGGCCGCCCCGCCGCAGCGCCTCACCGCCCCCACCCTCGTGGTCGCTCGGCCGGTCGCGCCGC
CCGCCCCGACGCCGGTGCCCGCCGCCGTGGCCGCGTTCGCTCCCGCGCCGATCTCGGCTCCGGCCTCCACCCTGC
CCGCGCCGTCCCTGCTCCGCTCCACGCTCCCCGGGCCCAAGTTCTCGCGCGCGGATCTCGAGGTCCTGGCCTCGG
GCTCGATCTCCTCGATCTTCGGCCCCCAGTTCGCCGGCCAGGATGGCTATGCCAAACAATGTCGGATGCCGGAGC
CCCCGCTCCTGCTCGCCGATCGCGTCACTGGCATCGACGCTGTCCCCGGCTCGATGGACACGGGCACCATCTGGA
CCGAGACCGACGTCAAGCACGACAGCTGGTATCTCCACCAGGGCCGGATGCCGACTGGCATCGTGATCGAGTCCG
GCCAGGCGGATCTCCTCCTGATCTCCTGGCTCGGTATCGACGCCCTCAACAAGGGGGAGCGCGTCTATCGCCTCC
TCGGCTGCGAGGCCACCTATCACGGCGAGCTGCCAAAGCCGGGCGACACGCTCGTCTACGAGATCCACATCGACG
GCCACGCCGAGCAGGGCGACGTGCGGCTGTTCTTCTTCCACTACGACTGCCGCATCAACGGCGAGCTGCGGATCT
CGGTACGTA 
 
 
>BB7_V1 
TACGTAATGGCCAGGCCGGGTTCTTCACCTATCAAGAGCTCGCCAACTCCGGCGGAGTGCTCTGGGACGCCGACG
GCGCGCCCCACGAGGCGACAGGCCCCCTCGATCCGCCTCAAGTGATCTGCGAGAAGCAGTCCTTCACCTCGGCCG
AGGTCCTCGCCTTCTCCGAGGGGGACGCCTACGCCTGCTTCGGGCGCGGCTTCGAGCGCGCGCAGACGCACGTTC
GCACGCCGCGCATCCAGGACGGGCCGATGCGGCTCCTCGATCGCGTCACCCACTTCGATCCTCGCGGCGGGCCCT
GGGGGCGCGGCTACCTGCGCGCCGAGGCCAAGCTCTCGCCCGACGACTGGTTCTTGCGAGGGCACTTCAAGAACG
ATCCCTGTATGCCAGGGACGCTGATCCTCGAGGCCTGCGTGCAGGCCATGGCCTTCTATCTCTGCGCCATGGGCT
ACTCCATCGATCGCGACGGCTGGCGCTTCGAGCCTGTCCCCGGCCAGAAGAGCCCGATGCGCTGCCGCGGCCAGG
CCAGCGTGACCTCGCGGGAGATCGTCTACGAAATCTTCGTCCACGAGGTCACGAGCGGGCCTATCCCCAGCGTCA
AGGTCGACATGCTCTGCACGGTCGACGGCCTCAAGGCCTTCCACGGCGAGCGCGTCGGCCTGCGCCTCGTCCCCG
CCTGGCCCCTCGACGACTGGCGACAGGCCCCCGTCGCCCCGCAGAGCCTGCACCGCCGCCCCAAGCAGATCGCCC
CTCTCGGCGGGATCCTCGGCCACGTCGAGACCCGGCCGGTGCCCTCGGTCAACGGCTTTGCCTTCGACTACGCCT
CGCTCATCGCCTGCGCCTGGGGCAAGCCCTCGCAGGCCTTCGGGCCGATGTACGCGCCCTTCGACGGCACTCGCC
GCGTCGCCCGCCTGCCCGGGCCGCCTTATCACTTCATCACGCGCATCATCTCGGTCGAGGGCCCGATCGGCGTCC
CCCAGCCCGGCGCCGAGGTCGAGGTCGAGTACGACGTCCCCCACGACGCCTGGTATTTCGCGGAGAACGGCGCGC
GCACCATGCCGTTCTGCGTCCTGCTCGAGGCCGCGCTCCAGCCCTGCGGCTGGCTGGCGAGCTACATCGGCAGCG
CCCTCACCACCGAGGACGATCTGCTCTTCCGCAACCTCGACGGGACTGGCACCGTCCTCGCGGAGATCACCCCCG
AGTCCGGCACGCTGCGGACCCACGTCAAGGTGGTCGAGGTCTCGCAGTCCGCGGGGATGATCATCGAGACCTTCG
AAGTCGAGTGCTTCGTCGGCGAAGCCCACGTTTACACGCTGCGTACCGTCTTTGGCTTCTTCCCCAAATCGGCCT
TCGACAACCAGGTCGGACTCCCCGTCTCCGCCGAGGCCCGCGCCCGGATCGAGCGTCAAGCCACCTCGACCATCG
ATCTGGCTCCAGAGCCGCCGCGCTACTTCGCCGGCGCCCCTCGCCTCCCCGAAGCGATGCTGTGCATGTTGGATC
GCATCACCGCGTTCGAGCCGACCGGCGGCCTCAAGGGCCTTGGCTATGGCCGCGCCGAGAAGACGGTCAAACCCG
GGGAGTGGTCCTTCAAAGCCCACTTCTTCCAGGATCCCGTCCAGCCGGGCTCCCTCGGCCTCGAGGCCCTGCTCC
AGCTCCTTCAGGCGTGGATGATCGACGCCGGTGACGCCGAGGGTATCCCGGGCGCGCGCTTCGAACCCATCGCCG
TCGGCCGCCCGATGACCTGGAAATACCGCGGCCAGGTCGTCCCCAAGAACCTCCTCGTGACGGTGGAGATCGACA
TCACCGAGCGCGGCACCGACGATCGCGGGCGCTTCGCCCTGGCCGAGGGCTCGCTCTGGGTCGACGGCAAGCGCA
TCTACGGCGCGAAGAACCTCGGGATGCGCGTCGTCGCCGGTCCGGAACGCCCGCCGCCCGGCTCGCCGCCTTCGC
CCGCTTCGCCGACCGCGCCGACCGCGCCCCCTTCGCCGCCTGCCCCGACGGTGCCGGCTGCGCTGGCTGCGCCGC
CTTCGCGCGATCTCGCCTCGTTTCGAAGCTTCTGGCGCGCCTCGATCGGGGTCGGGCCCTGGCCGATCGAGGACC
TCTACATCGCCCTGGTCGAGCGCTTCCTCGGCCGGATCGTCATCGCCGATCCGGTCGCCTTCTCGCGCGTCCACG
GCCGCGGCTGCCTCTACGTCGCCAACCACCAGGTCGCGCTGGAGTCGCTGATCTTCATCATGGTCGCCTCGGCGA
TCTCCGGCACGCGGACGATGGCGCTCGCCAAGGCCGAACATCAGGAGTCGTGGCTCGGGCGCCTGATCACCCGCG
GCATCGCCTACCCCGGCGTCACCGATCCAGGCCTCATCACCTTCTTCGACCGCGAGGATCACGCCTCCTTCGCCC
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GCATCGCCGAGCAGGCCACGCGCGATCTCGCGGCCTCGACCAAGAGCGTGCTCGTCCACGTCGAGGGCACGCGCG
CCATCTCGTGCCGCACCCCCGTCACCCGCCTCGGCGCCTCGGTGATCGACATGGCGCTGGCCGCCGGCGCGCCCA
TCGTCCCGGTCCGCTTCGCGCGCGGCCTGCCCGAGAGCGACTCCCCCGAGCGCCTCGATTTCCCGCTCGGCTACG
GCCGCCAGGACATCTACTTCGGCGCCCCGATCGAGCCCGCCGAGCTCGCGCGCCTCCCGCTCAAGGACCGCAAGG
ACGCCTTGCTCACGGCCCTCAACACGCTCGGCCCCGGCGCGAGCGACACGCCCTCCGACCCCGACCCGAGCTTCG
CCGCCCAGGTCGAGGCCTGGCGAGCCCGCACCGGCTGCGCCATCGAAGATGCCGTGTTCTATGCCACCCTCGCCG
GAGCGTCAGCCCCGGAGTCGGAGGGCGTGCAGCGGTTACTGGAGGGCGCGAGAACGGGGAAGCTGGTTATCGGGA
GTGGGGAGAAGGATCGCTGGCTGGGGGAGTTTGCGCGGAGCCTGTTTGGATCGGCGGATGCGACGCTCTTGGTGG
AGGGCGGCTGAGAGCGTGTTTACGGCGCGAATACGTGCCAGGTTCGGGACCCTCACCCCAACCCCTCTCCCGCGG
GGAGAGGGGCTCGGATCTGCTGCGAGGATCTTCCCCCTCTACCCTCGGGAGAGGGGGACCGAGGGGGTGAGGGAG
CCACGTAACGGCCTGTCAAATACGCGCTAAGGCCCCTTGTGCCCATTGAGGCACACGTCGAACGATTTCACCGTC
TTTAATTAA 
 
 
>BB1_V2 
ATTTAAATATGTCTGCAATCGGTAGATGGAACGCTCAAGGGGGCTCGCCGGAGCTCACCCCTGCGGCGATGGTCG
CGGCGATAGCGCGTTGTCGAGAGTCGTTGCACGTGGTGCGCGACGGGGAGTCCGGGCGGATCGGCCTGGGCGTGG
GGGGCGAGCTGCTCCCCCCCGGCGAGCGCCGCGCGGGCGAGTACACGCTTGTGGCTAGCCTGCCGCCCCTGTTCC
CAGAGTGGCTGGGCGACCGCAGCTTCTGTGAAGTGCATGGCGTCCGCTTCCCGTATGTTGCAGGCGAGATGGCTA
ACGGCATCGCGACCGTAGAGATGGTCGTGGCCATGAGCCGCAGCGGGATGCTCGGGTTCTTCGGTGCCGCCGGGC
TGGGCTTCAGCCGGGTCGAAGCCGCCGTCGAGACCCTGCGCGCCACCTTGGGTGATGAGGCGCCCTGGGGCGTCA
ATCTGATCCACAGCCCAAATGAGGCCTCGCTGGAAAACCGCGTCGCCGACCTGTTGATTGAGTCGGGCGTGCGTC
GTATTAGCGTGTCGGCCTTCATGGCGCTGACCCCGGCCGTTGTCCGCTGCGCCGCACGCGGGTTGCGCCTGGACG
CCGCAGGCCGCATCGTCCGCCCACGCCACATTTTCGCTAAGCTGAGCCGCCGTGAAGTCGCGCTGCCGTTCTTGA
GCCCCGCCCCTGAAGAGATGCTGCGTGCGCTGGTGGCCTCGGGTGGCTTGACCGAAGAAGAGGCGCGGCTGGCGG
CCAAGATTCCCGTCGCTGAAGACATCACCGTGGAAGCTGACAGCGGCGGCCATACGGATAACCAGGCCCTCGTAG
CGCTGCTGCCGACGATCCTGCAGCTGCGTGACGAGCTGGCCGATAAGTATGACTACACGCGGCCGATCCGCGTAG
GCGCTGCGGGTGGCCTGGGTACCCCGACCGCTGTGGCCGCCGCATTCTCCCTGGGCGCGGCCTACGTTGTGACCG
GTAGCGTGAACCAGGCGGCCCTCGAGTCGGGTCTGTCCGACGAAGGTAAACGGATGCTGGCCCAGGCCGAAGTCG
CAGATGTGATCATGGCGCCGGCAGCGGATATGTTTGAGCTGGGCGTGAAACTGCAGGTGTTGCGGCGCGGCTCCA
TGTTCGGCGTCCGTGCCGCCAAGCTGTATGAGGCTTACCATGCACACCCGTCCCTCGAAGCCATCCCGGACGCCC
TGCGCGCACGCCTCGAGCGTGAAGTGCTCCACGCAACCTTCGACGGGATTTGGGCCGAGACCCGGGCGTTCTGGG
AAGCCCGGGACCCTGAGCAGGTAGCGCTGGCCGCTCGCGATCCCAAGCACCGCATGGCGCTGGTGTTTCGTTGGT
ACTTGGGCATGGCTTCCCGCTGGGCGATCGCCGGTGAAGCCTCGCGCCGCGCAGATTACCAAATCTGGTGCGGGC
CGGCAATGGGCGCGTTTAACAGCTGGGTCCGTGGCTCGTTCCTCGAAGACCCTAAGCAGCGCGGCGTGGTAGCCA
TCGCGCTGAACTTGCTCGAAGGCGCCGCCGTTGTGACGCGGGCCCACCAATTG 
 
 
>BB2_V2 
CAATTGCGTACCTACGGCGTGCCAGTGCCGGCCGCCGCGTTTGACTTCCGCCCGCGCCCCCTGGCGTGAAAGACA
GAGTAGACAGAACACAGGGAGGTAATTAAATGACGCAGGTACCGGTAGCAATCGTAGGGGTAGGGGCCCTGTTCC
CGGGCAGCCCTGACGGCGCCGGCTTCTGGCGTGATATCGTGGCGAGCCGCGATCTGGTTTCGGACGTTCCCCCTG
GCCACTGGTTGATCGAAGATTACTACGACCCGGACCCTAGCGCGCCCGACAAAACCTACAGCAAGCGTGGTGCGT
TCCTCGGCGAGACGGCGTTCGACCCGCTCGAGTTCGGTGTGGTGCCGAGCTCGCTCCCGACCACGGACACCGCCC
AGCTCCTGGCGTTGATCGTGGCGCGTCGCGTTCTGGATGACGCCACCCAGGGTCGCTTCGCAAGCATTGACCGCT
CCCGCATCGGCGTAGTGCTGGGCGTCACGTCCGGCCAAGAGCTCCTGGGCACCATGGTCAGCCGCCTCCAACGCC
CGGTGTGGTTGAAGGCCCTCCGCGACGACGGCGTACCTGAGGCCGATGCCCAACGGATCTGCGACCGCATCACGA
ACGAGTACGTTCCGTGGAAAGAGTCCACCTTCCCAGGGCTGCTGGGCAACGTGGTAGCAGGCCGCATTGCCAACC
GCTTTGACTTGGGCGGCACGAACTGCGTCACGGACGCCGCGTGCGCCAGCAGCCTGGCAGCGTTGAGCATCGCCA
TGAATGAGCTGGCTTTGGGTCAGTCGGACCTGGTCATCACGGGCGGCGTCGACACGATGAACGACATCCTCATGT
ATACCTGCTTCTCCAAGACGCCAGCTCTGAGCAAGAGCGGTGATTGCCGGCCGTTCAGCGACGCCGCAGACGGCA
CCTTGCTGGGCGAAGGTTTGGCGATGTTCGCGTTGAAGCGCCTCACCGATGCCGAGCGTGACGGCGACCGCGTTT
ACGCGGTGATCCGCGGCCTCGGCTCGTCGTCCGACGGGCGTAGCAAGTCGGTCTATGCCCCCGTGCCCGAAGGCC
AGGCGAAAGCCCTCGTGCGCGCGTACGAAGCGGCCGGGTATGGCGCCGACACGGTCGAGCTGGTAGAAGCACACG
GCACCGCGACCAAGGCTGGTGACGCCGCAGAGTTCGGCGGCTTGAAACTGGCGTTCGAAGCCTCCGGGCGCGCAG
ACCACCAGTGGTGCGCTCTGGGTAGCGTGAAGTCGCAGATCGGGCACACGAAATCGGCCGCGGGCGCAGCTGGCC
TGTTCAAGGCTGTGATGGCTCTGCACCATAAGGTCCTGCCGCCGACGATCAAGGTCGATCGGCCGAACCCCGAGT
TGGCGATTGAGGCGTCGCCCTTCTACTTGAACACCCAAGCCCGCCCGTGGGTGCGTAACGCGCAGCATCTGCGGC
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GCGCGAGCGTTTCGTCGTTTGGGTTCGGCGGCTCGAACTTCCATGTGACCCTCGAAGAGTACGCCGGGACCGCTG
AGCCGGCTGCACGCCTGCGTACCGCGCCCACCGAGCTGTTCGTAATCTCCGCCCCGAGCGCAGCCGAAGTGTTGG
CCCGCGCAGGTAAGTTGGCCGAGCTGGCTGACAAAGAAGGCACCACCACCGCAGCGCGTACCTCCCAGCGCGATT
TCGTCACCGCAGATCACGCGCGGCTGAGCATCGTTGCCAGCGACGCGGCCGACCTGCGTGCTAAGCTCGAGCAGG
CACGCAGCTTGCTGAGCGCGCGCCCCGAAGAGGCCTTTAGCACGCCCACCGGCGTGCATTTTGCCGTGGGTGCAG
CGGCCGGCGGTGTGGCCTTCCTCTTCCCCGGCCAGGGTTCGCAGTACGTCGGTATGGGCGCTGACGTAGCCATGG
AACACGGTGTCGCGCTGGATGCATGGGACGCGGCCGCCGGGCTGGTCGAAACCGCGGGCTTGCGTGACGTCGTGT
TCCCTCGCCCAGCCTTTACCGATGAGGCCCGCGCAGAGCAGGCACAGCTCCTGACCGCCACCGAGTGGGCTCAGC
CCGCCATCGCAACGGCGTCGCTGGCGCTGCTCGCGGTGCTGCGTGCCGTCGGCGTGCGTCCGTCGAGCGTCGCCG
GGCATAGCCTGGGCGAGCTCACGGCCCTGGCGGCTGCGGACGCGCTGTCCACCAACGATCTGGTGGCGACCGCGC
GCAAGCGTGGGCAGCTGATGAATGCGGCGTCGTCGACCCCTGGCGCGATGACCGCCGTGGCACGGCCGCTGGCTG
AAGTCCAGGCGCTGCTGGAACGGCTGCAGTCCGAAGTAGTCGTGGCAAACCACAATCACCCCACCCAAGTGGTGC
TCGCCGGTGAGACCGCCGCGATCGAAGCCGTCGAAGCAGAGCTCGCGCGCCAGGGTATCACGGCTAAGCGCCTGC
CAGTGGCAACCGCCTTCCATTCGCAGGTCGTCGCCGGTGCCACCGCGCCCTTCGCTGAGCACCTCGCCGGGATCG
CGGTGAAAGCCCCCGCGATCGACGTGTTGAGCAATAGCGAAGCCGCGGCGTACCCTAGCGACCCGGACGCTGTCC
GGGCCCTCCTGGCCGGGCAGATCACCCGCAGCGTTCGGTTCGTGGAAGTCGTTGAGGCGATGTGGGCTCGCGGCG
CCCGGATCTTCGTTGAAGTCGGGCCCAGCGCGGTGCTGACCGAGTTGTGCGCGCGCATTCTGGGCGAGCGGCCTC
ACCTGGCGATCGCTATGGACCGCAAAGGTAAACACGGTGTGACCGCGCTGCAGGACGCCCTCGGCCGTTTGGCCG
CAGCCGGCGTAGCCATCGATTTCGCACCGCTGTGGGCCCCATTCGGCCCTCCCGCCGCTCCGAAACGCGT 
 
 
>BB3_V2 
ACGCGTGCCGGCTATGTCCATGATGATTAACGGCGCTAACTACGGTAAGGTCTACCCGCCTAAGGGCGGTGCAGC
CGCCTTGCCGCCTCCGAACCCGCCGCGTCCTGTCGTGGCCGCTGCCACCATCGCTGCCGCCCCCAGCTCCGCCGC
GAAAGCCCCCGTGGTAGCCGCAGCCACCATCGCCGCTGCGCCGATCCCGGCGGCTAAGGCGCCGGTCGTCGCCGC
AGCCACCATTGCAGCCCGCCCGGCAGCCGCCCCTGAAAGCCGCCCGGTCGTAGCCGCCGCACCAGCCCCAGCCCC
GGTCGTGGCAGCCCCAGCCAGCGCAGCCGCAGCCTTGTCGGCCCCGGGCCAACTGGGCTGGATTGAGGCGTACCA
AGAGTCGCAACGCCAGCTGACGGAAGCCCACGCAAGCTATGTTCGGACCATGGCGTCGGGCCATGAGGCGTTTCT
GACCACGATGGAAGCCAGCTTCATTGGGCTGGGCGGCTTGCTGGGTGCCCCTGCCTCCGTGAGCGCAGTGGCCCC
TCGTAGCGCCGCCGCACCAGTGCTGGCCCAGCCGGTAGCCGTGGCTCCGGCCCCGGTTCTGGCACCGGCACCGGT
GCCAGCCCCAGCCCCGACCCCAGTGTTGGCCCCGGCCCCGGCACCAGTACTGGCCCCGGCACCGGTGGCAGCCGT
TGCCAAGGCCGCGCCGGCACCGGTAATGGCCCCCGCCGCCCCTAGCATCGATTTGCAGGCCCTGCTCCTGGACGT
CGTCGCGGATAAGACGGGCTACCCCGCAGAGATGCTCGGGATGCATATGGAACTGGAAGCCGATTTGGGCATTGA
CTCGATCAAGCGCGTTGAGATTCTGAGCGCAATGCGTAAGCGCGCGCCCAACTTGCCCGAAGTTGTGGCCTCCGA
GATGGCCACCCTGCGGACCCTCGGGCAAATCGTGGAATATATGCGCGAGCGCAGCGGTGCTTTGACCGCGGCCAC
CCATGAGACCCTCGTCCCGGCCACGGCCGAAGCGGCTACCCAGGCTGCCCCGGCGTTGGGCGACCTCCAGGCGCT
GCTGCTGGATGTAGTGGCAGACAAGACCGGCTATCCGGCTGAGATGCTCGGTATGCACATGGAATTGGAAGCAGA
CCTGGGTATCGATTCCATCAAGCGGGTCGAAATCTTGAGCGCCATGCGGAAGCGCGCTCCCAACCTGCCTGAAGT
GGTCGCGTCGGAAATGGCAACGCTGCGTACCTTGGGTCAGATCGTCGAGTACATGCGTGATCGTTCGGGCGCCAC
CGCCGCCCCGGTAAAGGCCGCGCCAGCCCCAGCACCAGCACCGGCCGCCGCACCGACCAAAGAAGCCCCGACCCT
CGCCGACCTGCAGACGTTGCTGCTGTCCGTGGTAGCTGACAAGACCGGGTACCCAGCGGAAATGTTGGGTATGCA
CATGGAACTGGAAGCGGATCTCGGCATCGACAGCATTAAACGTGTCGAGATCCTCTCGGCTATGCGTAAACGCGC
CCCGAACCTGCCGGAAGTGGTAGCAAGCGAGATGGCTACCCTCCGCACCCTCGGCCAGATTGTAGAGTATATGCG
GGACCGCAGCGGCGGCCATAGCGTGGCTGCCACCACCCCAGCCCCAGCGCCAGCGTCGACGCTGGCACCGGCGGC
GAGCCGCATTGGCCGCTACGTCGTCGGGACCCGCGAAGAGGCGGCCAGCGGGTTGGCAATGGGCGGCGTTTTGGG
CGCGCGCCGGTTCGTGATCACCAATGAAGGGACCGGCATCGCGCAGGCCTTGGTCCGGGCGCTGCAGGAACGTGG
CGTTTCGTCCGAAGTTGTGACCGAAGTGCCGGCTGACGCGGACGCGGTAGTGTTCCTGGGCGGTTTGCGTACCCT
GGTTGACGTCGACACCGCGATTGCTATCAACCGCGAAGCGTTCCTGGCAGCTCGCGCCGTCGCGTCGGTCTTCTC
CCGTGACGGCGGCGCATTCGTGACGGTTCAAGATACCGGCGGCGACCTGGGCATTGAGGCACGCGAGCCACGCGC
CGCATGGTTGGCCGGCGTTGCGGCCCTGGCCCGTACGGCACAGCTGGAATGGCCGAAAGCGAGCGTTAAGGCCGT
TGACGTAGAGCGTGGCGGTCGCTCGTCCGAAGAGATCGCGGCAGCCATCGCTGAAGAGATCT 
 
 
 
>BB4_V2 
AGATCTTGACGGGCGGCGGCGCGTTGGAAGTGGGCCTGACGGCAGCCGGCGCTCGTCGTGTGCCGGAAGTGGTTC
AGCGCGCGGTCGGTGAGCGGACCCCCGTCCTGGCCCGGTCCAGCGTGGTCGTCGCTTCGGGCGGTGCCCGCGGTG
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TGACCGCGACGGCCTTGATCGCGCTCGCCCGCCACGCGCAGCCCAAGTTGGTCATCTTGGGCCGCAGCGCCCTCG
AAGCTGAGCCGGCGGCCTGTTTGGGCGTGCGTGGTGACGCCGCGCTGAAGCGGGCTCTGCTGGAAGATGCGCGCG
CGCAGGGTCGTACCGCCACCATTGCAGAGATCGGCGCACACGTCGCCCGTATCAGCGCTTCGCGTGAAGTGTTGG
AAACCCTCGCCGCTATCAAAGCGGCCGGCGGCGAAGCGCGCTACTTGGCTGTGGACGTGACCGATGCGGATCGTC
TGCGGTTGGCCCTCGAAGAGGTCCGGCGCGACTGGGGCCCGATCACGGCCGTAGTGCATGGCGCTGGCGTGCTCG
CGGATAAGCGGATTGAAGACAAGACGCCCGAGCAGTTCGACCGCGTTTTCGATACCAAAGTGCTCGGCTTGCGGG
CGCTGCTGGCGGCTACCGAAGGCGACCCCCTCCGCGCGATCATCCTGTTCAGCTCCGTAGCGGCCCGCGCGGGTA
ATGTCGGGCAGTGCGATTATGCGATGGCGAACGAGATTCTGAACAAGGTCGCGATCGCTGAGCGTCGCCGTCGCG
GTGGCGCTTGCACCGTGAAATCGTTGGGTTGGGGTCCCTGGGAAGGCGGTATGGTCACCCCCGCGCTGAAAGGGC
ACTTTGAGAGCATGGGCGTTGCCCTGATTCCACTGGCAGAAGGCGCAGAGCACTTTATTGCCGAGATCGAAGGCT
CCGCAGATGAGATTGAGCTGGTGATTGGCGGCGGCGCAGATGGGTCGGCGATCCGCGGTGATGCGGAACCCACCA
TCCACTTTGGTGTGAGCGTCTCCGACCGCACGTCGCCCTGGCTGGCTGACCATCGTGTCGCCGGGCGCCGTGTGA
TCCCGGTCGCTGTCGTCATCGAGTGGTTTACGCGGGCCGTGACCGCGTTGCAGGGTCGCGCCGCAGTGAGCTTGC
GTGACGTCAAGGTGCTCCGCGGCATCAAGCTCCCAGCCGGTGACGCGGCGGCCTCGTTCTCGATCGGGTGTCGCA
AGTTGGCTGAAGGTAAGATCGAGCTGACCCTGCATGGCGCTGACGGTGCATTGCACTACCGTGCAAGCGCGGAAC
CGCGCGGCGCCGCTCTGAAGCCCGAAGGTGCAGCCCCTCCCCTGGCGGCGTGGGGTGACCGGCCTATCTACGATG
GCGGTCTGCTGTTCCACGGGCCTCGCTTCCACGCAATCCACTCCATTGAAGGCGCTTCGGCTGAAGGCATTCGCG
CCACCTTGACCGGTGCCCGCGAGCTCGGTTGGCCCGGCGAAGCCCAACGCACGGACCCCGCTATCGTCGATGGCG
CGCTCCAGCTGGCGCTGCTCTGGACGCGCGAGCGGCTGGGCCAAGCCTCCCTGCCCATGGCTATCGCGGCCTTTG
ACTGGCAAGCGTCGGGCCCGGTAGAAGGGCCGGTTCGCGCCGTGGTCCAAGGGCGCGAAGCCGATAGCGCTCACG
CGGTCTGCGATGTGTGGCTCGAAGATGCCCGTGGTGCGATCGTAGGCGCCCTCCGCGGTGTCGAGACCATCGTCC
GGCCGGCCGAAGTCCGGGCTCCGCACCTCGTGGAGACAGGGCCAGCCTCGTGACGTTCGAACCCATTGCAATCGT
AGGCCAAGCTTGCACCCTGCCGGGCGCTCTGACCCCGGAAGCCCTGTGGGCCAACGTT 
 
 
>BB5_V2 
AACGTTCTGCGCGGTGAGAGCGCTGTGACCTCCCCTCCCGAAGGCCGTTGGCGCCTCCCGGCCTGGCACGCGATG
GGTAAGCCGGGCGCGCAAGAAGAGCGTGCCTGGTCCGATGCCGGCGGCTACGTCCGTGGGTTCGAATCCGCCTTC
GACCCAGGCGGCTTGCGCCTGCCGGAAGCTGAGTTGCGTGGCCTGGACCCGGTCTTCCAGTGGACCTTGCACACC
GCACGCGCCGCACTGCGCTCGGCTGGCATGGAAGGCCCGAGCGCACGGGCCGGTCTGGTCCTGGGTAACCTGAGC
TTCCCAACCGCGTCCATGTCGCGCTACGCGGAATCGGTGTGGCTCGAAGCCCTGGGTAAAGAGCTGCTGGGCGGT
CGCGCAGCCGCACAGGCTGGCGTGACCCACCCCGACGCCCATAACCGCTTTATGAGCGGTCTGCCGGCGCATTTG
GCCGCCCAGGCCCTGGGCTTGGGTGGCGGCGCCTTCGCTCTGGACGCTGCCTGCGCGAGCAGCCTCTACGCCATC
AAGCTCGCCTGTGACCGCCTGCAAGATCGCGCCACCGATCTGATGCTCGCGGGCGCCGTGAACGCAGCCGATAGC
CTGTTTCTCCACATCGGCTTCTCGGCCCTGAGCGCTATGAGCCGGACCGGGCAGTCGCGCCCCTTCCATCGCGAA
GCTGATGGCCTGGTGCCAAGCGAAGGCGCGGTGTTCTTCGCACTGCAGCGGCTCGATGACGCCCGTGCCGCCGGT
CGCCGCGTTCTGGGCATCATCCGCGGTGTGGGCCTGAGCAATGACGGTCGCGGCCGCGGGTTGCTGGCACCGAGC
GAAGAGGGCCAGATCCGGGCGATGCGCTTGGCGTACGCGGCCGCGGGCTTGACCCCGTCGGACGTTAGCTTCGTC
GAGTGCCATGCGACGGGCACCCCGGTTGGCGACGCGACGGAAATCCGCAGCCTGTCCGAAGTCTTCGCCGGGTGC
CGTGACGTCCCCATCGGCTCGCTGAAATCGAACCTCGGCCACCTCATCACCGCCGCGGGCGGTGCCGGCCTGATC
AAGGTCTTGGGTAGCTTTACCGCCGAGACCATTGCCCCAACCATCCACGCGGGTGCCTCGATCCCTGAGCTGGCC
GGGTCGCCCGTGCGCCTGGTAACCCAGGCCGAACCGTGGCGTGCTGCGGGCCGCCGCATTGCCGCAATCTCCGCG
TTTGGCTTCGGCGGCAACAACGCCCACCTGATCGTTGAGCAAGACGATGGCCGCGCAACCGCCCCACGCGCTGCA
GCTCCGCGTAGCGCCCCAGCCCCGATCGCCGTGATCTCCCTGGGCGCGCGCATCGGCGATACCACCGGCCGTGAT
GAAGCGGCCCGGGCACTGTTGAGCGGCGCGGGTTGGGGTAGCCGCCGTGAAGCCGTGACCGTCGAGCTCGAAGGC
CTGCGCTTCCCTCCGCGTGACCTCGAGCAGACGCTGCCGCAGCAGCTCCTGGTGCTCGAAGCAGGCCGCGAAGCG
ATCCGTGGCCTGAGCCTGCCCCGTGACCGCACCGCGGTCTTGATTGGCATGGGCGCGGACCCTGAAGTGGCACGC
TACGGTGCGCGCTGGCGCCTGCCGGCCTTTGCCGACGCCTGGGCAGCGGCCGGGTTGCCCGTGAGCAGCGCCTGG
ACCGAAGCTGCGCGTGACGCGGTCCAGGAACAGCATGGCGCTGCGGGCGTGGTCGGCGCGATGCCTAACATCCCC
GCCAACCGGCTGAGCTCCCAGCTGGATCTCGCTGGCCCGAGCTTTACCATCTCCAGCGAAGAGCTGAGCGGCGTC
GTGGCGCTGCAACTCGCCGCCCGCGCCTTGCGCTCCGGTGAGATCGACGCCGCCCTCGTAGGCGCCGTCGACCTG
GCTGACCAGATCGTCCACCGTAAGGCGCTGGGTGAGCTGGGCCTCGAGCCGCGCGCGGGTGATGCGGCTGTGGCC
CTGGTGTTGAAGCGCCTGACGGATGTGCGGAAGTCGGAAAAGGTGCTGGCGATCCTCGATGAAGGCATCGTGGAT
GCTTCGTCGGACCCGGCGCGCCTGCGCGTAGGTGATGGCGGCGCGGACCTGGACCCGTTCGCTACCACGGGTAAA
CCGCACGCCGCCGCCGGGCTGGTGCATGTAGCCGCCGCCGTGTTGGCCCTGCACCACGGCGCACGCCCAGCACCG
GGTCGTGCCTCGATGCCGTGGGTCGGGCCTCGCCACGCCGAAGTGACGACCCAGGCGCTGGGTGACCAGGCGGCC
ACGATCCATCTGCGTGGCGGTGGCTTGGCCGCCCCGCTGCTGTTGGACGCCACGCCGCAGATCCACGTTTTTGCC
GGTGCTGACCGCGAAGCCGTGCTCCGCGCGCTGAGCGACGGCCGCGAAGGCCTCGACGGCCCAGCGCGCGCAGTG
ATCGTGGCCGGTTCCCGCGAAGAGTTGGAAGCGCGCCGCGCTGATGCCCTGCGCGCAGCCGAGCGGAACGCCCCG
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ATGCCTGACGGCGTCTTCCTCCGCGACCGGCCGGTAGCGGGCGAGCTGGCCTTTGTCTTCGCGGGCGCAGCCGCC
GCATACCCGAGCATGGGCCGTGCAC 
 
 
>BB6_V2 
GTGCACTGGCCCTGGCCCTGCCTGACGTGATGGCTCGGCTCGGCAACCGGCTGTCCACCCTGCCCGCGGTGATCG
ATTGGATCCATGGCGCGCCCCGTGAACCGCGGCATCCGCTCGAACAGCTGTGGGCCTCCTCGTTCCTGTGCCAGT
TGCACGCTGAGATCACGCGCGTAGACTTGGGCCTGCGCCCGAGCGCGACGATCGGGTACAGCAGCGGTGAGAGCA
ATGCGCTGTTCGCGATGGGCGCATGGCGTGATCTGGACGCGATGATGCATGAGGCATGGACCGAGCCGTTGCTCA
CCACCGAACTGGTTGGCGACTATGCAGCCGCCCGTCGTCTGTGGGCGCGTAGCGGCGTGACCAGCCCGGCTGCGA
CCTGGGCGGCATGGGTGATTGCGGCCCCCGTGGATGACGTGCGCCGCGCCTTGACCGGCGAGCCCTTGGCGCACT
TGACGATCATCAACACCGCTGAAGAGTGCGTGATTGGCGGTGAAGCCTCCGCCTGCGAGCGCGTCGTCGCGCGTT
TGGGTAAGAATCTGGCCCTGCCGCTGAGCTATGCTATGGCGAGCCACTGCCCGGAAGTAGCTGAGGCCCGCGAAG
CATGGATCAAAATGCACCGTCGGGCGACCTTCGATGTGCCCGGTGTCCGCATCTATTCGGCCGGCGCTGAGCAGG
CCTTTGCCCCCACCGCCGATGCGGCCGCGATGGCGATCACGGGCCAAGCCGTAGATACCCTGGATTTCCCGCGTG
TGATTGAGCGCGCGTACGCCGACGGTGTGCGTGTCTTCGTCGAGCACGGGCCACGCGGGCTCTGCAGCCGCTGGA
TCGCCCGGATCCTGGGCGCTCGTGAGCACCTGGTAGTGCCTCTGGACGTCGCGGGCCAGCAGCCAGTTCGCCAGC
TGGTTAGCGCGGTCGCGCAGCTGATCGCCGCTGGCGTGCCGGTCGCCGCTGACGCACTGCTGGCACGCCTGGCCC
CGCCTCCACCTGCCCGTGCCAGCGGTCCCACCCTGACCGTGCGTGCGCACCCGCCTGACATCCACTTCCCTACCG
CGCCCGCGATGCAGCTGATGCCCCCAGCGCCCTTGCTGCCGCCTGTCCTGGCCGATAACCCGGCACCGCGCACCG
AGCGCTCCTTCACCGGTCGGTCGGCCCTGCGTGAAGACGCGCCTGACGGCGTTCCTAGCCCGCGCTTGCCGGTCT
TCGCGCGGCTGGCCCCGGTGTTCACCCACACGGAACCGGTCTTCACGCATGTAGAGCCGGCCTTGGCGAGCCCGG
AACCCGCGGTCACGCATCCCGAGCCCGTGATTGCCCACGCCGAACCGGCCCTGACCCACGCTGAACCAGCACTCG
CTTCGCCGGCAGACGGCCAGCACGCAAGCATCGCCGCCCGTGGCGCCGCTGTAAGCGCCGGCATCGCAGCCGCCC
ATCGCGCGTACGTTGAGGCGCAAGGCGCCGTCCATGCGCGCTTCTTGGCCTTGAGCGGCTCGCTGCTGAGCCGTC
TGGCCGCTGCACCGACCGCCGCCGCATTCCCGGCCCCAGCACCTAGCCTGGCGCCCCAACCGGCAGCCCTGCCAG
CCCCAGCCCCACAGGCAGCCCCGCCACAGCGCTTGACCGCCCCGACCCTGGTCGTGGCACGTCCAGTGGCACCGC
CGGCCCCAACCCCGGTTCCGGCAGCCGTAGCCGCCTTCGCCCCGGCACCGATTAGCGCGCCGGCAAGCACGCTCC
CGGCACCGAGCCTGCTGCGCTCCACCCTCCCCGGCCCGAAGTTCTCCCGCGCGGACTTGGAAGTGCTGGCTTCGG
GCTCCATTAGCTCGATCTTCGGCCCACAGTTCGCGGGTCAAGATGGCTACGCGAAGCAGTGCCGGATGCCCGAGC
CGCCTCTGCTGCTGGCAGACCGGGTGACCGGGATTGACGCCGTGCCCGGTAGCATGGATACGGGTACCATCTGGA
CCGAGACGGACGTCAAGCATGACAGCTGGTATCTGCATCAAGGGCGTATGCCGACCGGGATCGTAATCGAGAGCG
GCCAGGCTGATCTCCTGCTGATCTCGTGGCTGGGTATCGACGCTCTGAACAAGGGTGAGCGCGTCTATCGCTTGC
TCGGGTGCGAAGCTACCTACCACGGCGAGCTGCCTAAGCCCGGCGACACGCTGGTGTATGAGATCCACATTGATG
GGCACGCAGAGCAAGGCGACGTGCGCTTGTTCTTCTTCCATTACGACTGTCGGATCAACGGCGAGCTCCGCATCA
GCGTACGTA 
 
 
>BB7_V2 
TACGTAATGGCCAGGCCGGGTTTTTCACCTACCAGGAACTGGCGAACTCGGGCGGTGTCCTCTGGGACGCAGACG
GCGCGCCGCATGAAGCAACCGGCCCCCTGGATCCCCCGCAAGTAATCTGCGAAAAGCAGTCCTTCACCTCGGCAG
AAGTGCTGGCTTTCAGCGAAGGTGATGCGTATGCCTGCTTCGGCCGCGGTTTTGAGCGGGCGCAGACGCACGTCC
GCACCCCGCGGATCCAAGATGGCCCGATGCGGCTGTTGGACCGCGTGACCCATTTCGATCCACGCGGTGGCCCCT
GGGGTCGTGGCTACCTCCGCGCTGAGGCCAAACTGAGCCCCGACGACTGGTTCCTCCGCGGGCACTTCAAGAATG
ACCCGTGTATGCCTGGCACCTTGATTCTGGAAGCGTGCGTGCAGGCGATGGCGTTCTATTTGTGCGCGATGGGCT
ATTCGATCGATCGCGACGGGTGGCGCTTTGAGCCCGTGCCTGGCCAGAAATCGCCCATGCGGTGCCGCGGCCAGG
CGAGCGTAACCTCCCGTGAGATCGTTTACGAGATTTTCGTCCACGAAGTCACCTCCGGGCCGATCCCGAGCGTGA
AAGTCGACATGCTCTGCACCGTTGACGGTTTGAAAGCGTTCCACGGTGAGCGCGTCGGTCTGCGCCTCGTGCCGG
CCTGGCCGCTGGATGACTGGCGCCAGGCTCCCGTAGCTCCGCAGTCGTTGCATCGTCGCCCGAAGCAAATCGCCC
CCTTGGGCGGCATCCTGGGCCACGTCGAGACGCGCCCCGTCCCTAGCGTGAACGGGTTTGCCTTTGACTACGCGA
GCCTCATCGCGTGCGCCTGGGGCAAGCCTAGCCAGGCGTTTGGGCCGATGTACGCCCCTTTCGACGGGACCCGCC
GGGTAGCCCGTTTGCCGGGCCCACCGTACCACTTCATCACCCGGATCATTAGCGTCGAAGGGCCTATCGGCGTCC
CCCAGCCCGGCGCAGAAGTCGAAGTAGAGTATGACGTGCCCCACGATGCGTGGTACTTCGCTGAGAACGGTGCGC
GCACGATGCCCTTTTGCGTCCTGCTGGAAGCGGCGCTCCAGCCGTGTGGCTGGCTGGCGTCGTACATCGGCTCGG
CGTTGACGACCGAAGATGACCTGTTGTTCCGTAATCTCGACGGCACCGGGACCGTGCTGGCCGAGATCACCCCAG
AATCCGGGACCCTCCGCACCCATGTGAAGGTCGTTGAAGTCTCGCAGTCCGCCGGGATGATTATCGAGACCTTCG
AAGTTGAGTGTTTCGTAGGCGAAGCGCACGTCTATACCCTGCGGACCGTGTTCGGGTTCTTCCCCAAGTCCGCGT
TCGACAATCAGGTCGGGCTGCCTGTGAGCGCTGAGGCGCGTGCCCGCATTGAACGCCAGGCCACCTCCACCATCG
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ACTTGGCGCCTGAGCCACCGCGGTACTTCGCTGGCGCCCCGCGCTTGCCCGAAGCGATGCTGTGTATGCTGGATC
GTATCACCGCCTTTGAGCCGACGGGCGGTTTGAAGGGTCTGGGCTACGGGCGCGCCGAGAAGACGGTGAAACCAG
GTGAGTGGTCCTTCAAAGCCCACTTTTTCCAAGACCCGGTGCAACCGGGCTCCCTCGGCCTCGAAGCGCTGCTCC
AGCTGCTGCAGGCGTGGATGATTGACGCAGGTGACGCCGAAGGCATTCCCGGCGCGCGCTTTGAGCCAATCGCTG
TGGGCCGTCCCATGACCTGGAAGTACCGTGGCCAGGTTGTGCCTAAGAACCTCCTGGTGACGGTCGAGATTGACA
TTACCGAGCGTGGCACCGACGATCGCGGGCGGTTCGCGCTGGCCGAAGGCTCCTTGTGGGTCGACGGTAAACGCA
TCTACGGTGCGAAGAACCTGGGTATGCGCGTAGTTGCGGGTCCGGAACGCCCGCCACCGGGTAGCCCACCGAGCC
CTGCCTCGCCGACCGCCCCAACCGCCCCTCCAAGCCCGCCCGCTCCAACCGTGCCTGCCGCCCTGGCAGCTCCGC
CGTCGCGTGACCTGGCCTCGTTCCGGTCGTTCTGGCGCGCCTCGATTGGCGTAGGGCCCTGGCCGATTGAAGACC
TCTACATCGCATTGGTCGAGCGCTTCCTGGGTCGCATCGTGATCGCAGACCCCGTGGCATTCAGCCGGGTCCACG
GGCGCGGGTGCCTGTATGTGGCTAACCATCAGGTCGCCCTCGAGAGCTTGATCTTCATTATGGTCGCCTCGGCGA
TCTCCGGCACCCGCACGATGGCACTCGCCAAGGCTGAGCACCAAGAGTCCTGGCTGGGCCGGCTGATTACCCGCG
GGATCGCCTACCCAGGCGTGACCGATCCAGGGTTGATCACCTTCTTCGACCGTGAAGATCATGCCTCGTTCGCAC
GTATCGCTGAGCAGGCCACGCGCGACTTGGCGGCGTCGACCAAAAGCGTGCTGGTCCACGTTGAAGGTACCCGGG
CCATCAGCTGCCGGACGCCCGTGACCCGGCTGGGTGCATCGGTGATTGACATGGCGCTGGCCGCAGGCGCCCCGA
TCGTGCCAGTTCGCTTCGCACGCGGGCTGCCCGAGTCGGATAGCCCCGAGCGGCTCGACTTCCCGTTGGGCTACG
GGCGCCAGGACATCTACTTCGGTGCGCCAATCGAGCCGGCTGAATTGGCCCGCCTGCCCTTGAAGGATCGTAAGG
ACGCACTGTTGACCGCCCTGAACACCTTGGGTCCGGGCGCCTCCGACACGCCCTCGGACCCCGATCCGTCGTTCG
CGGCGCAGGTTGAGGCATGGCGTGCCCGCACCGGGTGCGCCATTGAAGACGCGGTGTTCTACGCGACCTTGGCTG
GTGCCTCGGCGCCAGAGAGCGAAGGTGTGCAACGGCTGCTCGAAGGCGCCCGCACCGGCAAACTGGTAATCGGTA
GCGGTGAGAAGGATCGCTGGCTCGGTGAGTTCGCCCGGTCGCTGTTTGGGTCGGCCGACGCTACCCTGCTGGTCG
AAGGCGGCTGAGAGCGTGTTTACGGCGCGAATACGTGCCAGGTTCGGGACCCTCACCCCAACCCCTCTCCCGCGG
GGAGAGGGGCTCGGATCTGCTGCGAGGATCTTCCCCCTCTACCCTCGGGAGAGGGGGACCGAGGGGGTGAGGGAG
CCACGTAACGGCCTGTCAAATACGCGCTAAGGCCCCTTGTGCCCATTGAGGCACACGTCGAACGATTTCACCGTC
TTTAATTAA 
 
 
>TR-pfa2-pfa3_V2 
GGCCGGCCGAAGTCCGGGCTCCGCATCTGGTTGAGACCGGGCCCGCGAGCTGAAACTAAATACAACAACACAACA
AAATAAGGAGGATACATCATGACGTTCGAACCCATTGCAATCGTAGGCCAAGCTTGCACCCTGCCGGGCGCTCTG
ACCCCGGAAGCCCTGTGGGCCAACGTT 
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INTRODUCTION 
Application of the hemiascomycetous yeast Yarrowia lipolytica has awakened a strong 
industrial interest due to its capacity to grow efficiently on hydrophobic substrates (e.g. 
alkanes, fatty acids, and oils) as a sole carbon source and to produce high amounts of organic 
acids, especially citric acid [1]. Developments of genetic and cellular tools have contributed to 
the establishment of Y. lipolytica as an amenable host for heterologous protein production [2-
4]. Since this yeast is considered as non-pathogenic, several processes based on Y. lipolytica 
were classified as generally recognized as safe (GRAS) by the food and drug administration 
(FDA).  
Y. lipolytica is classified among the oleaginous yeasts because of its ability to accumulate 
large amounts of lipids (up to 50% of its cell dry weight, depending on the growth conditions) 
[5]. Beyond the essential amount of lipids required for membrane composition of cells and 
organelles, oleaginous microorganisms produce lipids above about 20% of their cell mass to 
accumulate them as reserve storage [6]. The fatty acid biosynthetic pathway in most 
oleaginous microorganisms is principally the same as found in non-oleaginous species, as 
exemplified by Saccharomyces cerevisiae. The crucial difference between oleaginous and 
non-oleaginous yeasts is unveiled during cultivation in a medium with an excessive carbon to 
nitrogen ratio [7;8]: For oleaginous yeasts, the catalytic growth rate slows down quickly, 
whereas carbon assimilation slows down more gradually. The carbon flux is then 
preferentially channelled toward lipid biosynthesis, leading to an accumulation of 
triacylglycerols within discrete lipid bodies in the cells. On the contrary, non-oleaginous 
yeasts tend to cease further cell proliferation under nitrogen-limited conditions, and the 
carbon flux into the cell is diverted into synthesis of various polysaccharides.  
A hypothesis for the biochemical basis of lipid accumulation in oleaginous yeasts is 
represented by the following metabolic pathway: Nitrogen limitation leads to an activation of 
AMP deaminase (EC 3.5.4.6), resulting in a decrease of AMP concentration and an increase 
of ammonium concentration in mitochondria [9]. Consequently, isocitrate dehydrogenase  
(EC 1.1.1.41) is stopped from working due to its strict dependence on the presence of AMP in 
oleaginous yeasts [10]. As isocitrate cannot be metabolized, it accumulates and is rapidly 
interconverted with citrate by aconitase (EC 4.2.1.3). Citrate is exported from mitochondria 
into the cytosol by the citrate shuttle and metabolized into acetyl-CoA plus oxaloacetate via a 
cytosolic ATP:citrate lyase (EC 2.3.3.8). This enzyme has not yet been found in any non-
oleaginous microorganism [11]. Oxaloacetate is then reduced by malate dehydrogenase  
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(EC 1.1.1.37) to malate, which is next converted into pyruvate via oxidative decarboxylation 
catalysed be the NADP
+
-malic enzyme (EC 1.1.1.40). In addition to this enzyme, glucose-6-
phosphate dehydrogenase (EC 1.1.1.49) and 6-phosphogluconate dehydrogenase  
(EC 1.1.1.44) of the pentose phosphate pathway are considered as major suppliers of NADPH 
for fatty acid biosynthesis [12]. Acetyl-CoA and NADPH are directly channelled into 
synthesis of fatty acids, which are esterified with glycerol to triacylglycerols and incorporated 
into fatty acid droplets. 
Obviously, Y. lipolytica seems to be a promising host strain for recombinant production of 
polyunsaturated fatty acids (PUFAs), which could be already demonstrated in previous 
studies. By expression of a bifunctional Δ12/ω3 desaturase from Fusarium moniliforme in 
Y. lipolytica, 28% α-linolenic acid (ALA, 18:3, n-3) of total fatty acids (TFAs) could be 
produced [13]. Production of 20% γ-linolenic acid (GLA, 18:3, n-6) of TFAs was obtained by 
overexpression of Δ6 and Δ12 desaturases from Mortierella alpina [14]. Similarly, optimal 
fermentation conditions yielded production of 44% trans-10,cis-12-conjugated linoleic acid 
(CLA) of TFAs by overexpression of Δ12 desaturase from M. alpina and a linoleic acid 
isomerase gene from Propionibacterium acnes, which was codon-optimized for Y. lipolytica 
[15]. Recently, an engineered Y. lipolytica strain was published that produces 56.6% 
eicosapentaenoic acid (EPA, 20:5, n-3) and less than 5% saturated fatty acids of TFAs, which 
are the highest and the lowest percentages, respectively, among known EPA sources. These 
levels were achieved by four gene knockouts in the yeast genome and by overexpression of 
twenty desaturase genes, eight elongase genes, and two cholinephosphotransferase genes of 
different origins, which were codon-optimized for Y. lipolytica [16]. All these examples made 
use of enzymes from the aerobic PUFA biosynthetic pathways, which, in contrast to 
anaerobically acting PUFA synthase complexes, are not encoded by a gene cluster and do not 
enable de novo PUFA biosynthesis. 
Modern techniques connected with Synthetic Biology provide the opportunity to transfer 
and express not only single genes but entire gene clusters from a certain organism into 
entirely unrelated organisms with very different evolutionary histories. For this purpose, 
complete biosynthetic pathways can be synthesized and assembled from DNA sequences that 
were holistically optimized for the chosen production host including codon bias adaptation. 
On top of this, sophisticated design of artificial pathways allows for facilitated genetic 
manipulation of pathway elements, such as the interchange of DNA sections. Hence, an 
artificial long-chain PUFA (LC-PUFA) biosynthetic gene cluster encoding iteratively acting 
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polyketide synthase (PKS)-like enzymes plus a 4'-phosphopantetheinyl transferase (PPTase) 
gene originating from A. fasciculatus (SBSr002) for the biosynthesis of docosapentaenoic 
acid (DPA, 22:5) and docosahexaenoic acid (DHA, 22:6, n-3) [17] were redesigned, 
synthesized, and assembled for Y. lipolytica. Successful transfer of the expression construct 
and heterologous expression was accomplished in the host strain. To the best of our 
knowledge, this example represents the first polyketide-like biosynthetic gene cluster adapted 
and synthesized for this yeast. 
 
 
 
EXPERIMENTAL PROCEDURES 
 
Sequence analysis and design of the synthetic gene clusters 
The sequences of the pfa gene cluster plus the gene encoding the PPTase AfPpt from 
A. fasciculatus (SBSr002) were analysed and compared to the genome sequence of 
Y. lipolytica CLIB 122 [18] retrieved from NCBI Genome RefSeq NC_006067, NC_006068, 
NC_006069, NC_006070, NC_006071, and NC_006072 in collaboration with 
ATG:biosynthetics. Based on this, relevant parameters for constructional and functional 
sequence design were defined to generate artificial pathway versions using the proprietary 
evoMAG-GeneDesign software [19]. The sequence design process included engineering of 
restriction sites, adaptation of the codon usage, elimination of sequence repeats as well as rare 
codon clusters, elimination of potential donor splice signals, and introduction of hidden stop 
codons in unused frames.  
 
 
Culture conditions 
Escherichia coli DH10B [20] was used for cloning experiments. E. coli HS996/pSC101-
BAD-gbaA (tet
R
) [21] were used for modification of a plasmid using Red/ET recombination. 
The cells were grown in LB-medium or on LB-agar (1% tryptone, 0.5% yeast extract, 0.5% 
NaCl, (1.5% agar)) at 30-37 °C (and 200 rpm) overnight. Antibiotics were used at the 
following concentrations: 100 µg/ml ampicillin, 50 µg/ml kanamycin, 34 µg/ml 
chloramphenicol, and 6 µg/ml tetracycline. 
Auxotrophic Yarrowia lipolytica Po1g (CLIB 725) [3] and Po1h (CLIB 882) [2] were 
obtained from Centre International de Ressources Microbiennes (CIRM)-Levures, Institut 
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National de la Recherche Agronomique (INRA), AgroParisTech, Thiverval-Grignon, France. 
They were grown in YPD-medium or on YPD-agar containing 1% yeast extract, 2% peptone, 
and 2% dextrose. Prototrophic transformants were grown in minimal medium YNB 
containing 0.67% yeast nitrogen base (with 75% (NH4)2SO4 and without amino acids), and 50 
mM KPO4 buffer pH 6.8. Different carbon sources were used: YNB-N5000 contains 1% 
glucose, YNBD contains 2% glucose, YNBD8 contains 8% glucose, YNBG contains 2% 
(w/v) glycerol, and YNBO contains 3% (w/v) oleic acid (oleic acid was emulsified by 
sonication in the presence of 0.1% Tween 80). The cultures were incubated for 1-7 days at 16-
30 °C (and 200 rpm). 
 
 
Isolation of genomic DNA from Y. lipolytica 
Isolation of genomic DNA from yeast cells was carried out using the method of Hoffman and 
Winston [22]. In the first step, 50 ml of a culture of Y. lipolytica grown at 28 °C for 3 days 
were harvested by centrifugation at 8,000 rpm for 5 min. The cell pellet was resuspended in 
500 µl sterile ddH2O and transferred into a 2 ml tube. The sample was centrifuged at  
15,000 rpm for 1 min, the supernatant was decanted, and the tube was briefly vortexed to 
resuspend the pellet in the residual liquid. 200 μl lysis buffer (2% Triton X-100, 1% SDS,  
100 mM NaCl, 1 mM EDTA, and 10 mM Tris-Cl pH 8.0), 200 µl phenol:chloroform:isoamyl 
alcohol (25:24:1), plus 0.3 g acid-washed glass beads (425-600 µm) were added to the cells. 
The tube was vortexed for 3 min. Afterwards, 200 μl TE buffer (10 mM Tris-Cl pH 8.0 and  
1 mM EDTA) were added, and the sample was centrifuged at 15,000 rpm for 5 min. The 
upper aqueous phase was transferred to a tube containing 1 ml ice-cold ethanol and mixed by 
inversion. The sample was centrifuged at 15,000 rpm for 2 min, and the supernatant was 
discarded. The pellet was resuspended in 400 µl TE buffer plus 30 µg RNase A. After 
incubation at 37 °C for 15 min, 44 µl 4 M ammonium acetate and 1 ml ice-cold ethanol were 
added, and the tube was inverted to mix. Genomic DNA was precipitated at -20 °C for 2 min 
to increase yield. The sample was centrifuged at 15,000 rpm for 2 min, and the supernatant 
was discarded. The pellet was washed with 700 µl 70% ethanol, centrifuged at 15,000 rpm for 
1 min, and the supernatant was discarded. The dried DNA was resuspended in 50 μl 10 mM 
Tris-Cl pH 8.0. 
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General molecular biology techniques  
Routine handling of nucleic acids, such as isolation of genomic and plasmid DNA, restriction 
endonuclease digestions, DNA ligations, and other DNA manipulations, were performed 
according to standard protocols [23]. All the enzymes were purchased from Thermo Scientific 
or New England Biolabs. 
 
 
Cloning of expression constructs containing the synthetic pfa gene cluster and the  
4'-phosphopantetheinyl transferase (PPTase) gene originating from A. fasciculatus 
(SBSr002) for heterologous LC-PUFA production in Y. lipolytica 
For the heterologous expression of artificial PUFA biosynthetic pathways in Y. lipolytica, four 
building blocks containing the three pfa genes as well as the gene encoding the PPTase AfPpt 
originating from A. fasciculatus (SBSr002) were designed and supplied by gene synthesis 
companies. Each building block contains one of the four genes flanked by the strong hybrid 
hp4d promoter [3] plus LIP2 terminator for Y. lipolytica. Moreover, non-coding sequences 
were attached to each building block allowing for the connection of the transcription units by 
200 bp intergenic linkers (see appendix for sequences). In the course of constructional design, 
the unique SdaI, ApaLI, NcoI, SalI, AclI, KpnI, FseI, XmaJI, and PacI restriction sites were 
introduced for cloning purposes as well as for exchangeability of genes/domains and were 
excluded from any other unwanted position within the gene cluster. In addition to this, the 
four coding sequences were optimized by applying functional design approaches with special 
focus on sequence features affecting translational elongation (adaptation of the codon usage, 
elimination of sequence repeats as well as rare codon clusters, engineering of Shine-Dalgarno 
(SD)‒anti-SD interactions, and introduction of hidden stop codons in unused frames).  
A cloning plasmid with kanamycin resistance gene, p15A origin of replication, and 
restriction sites for assembly of the four DNA building blocks was constructed. Therefore, a 
multiple cloning site comprising DraI, SdaI, ApaLI, NcoI, SalI, AclI, AatII, NgoMIV, XmaJI, 
PacI, and BamHI restriction sites (0.1 kb) was amplified by PCR using overlapping primers 
MCS for pACYC_fwd and MCS for pACYC_rev (Table 1). PCR was performed with 
Phusion DNA polymerase (Thermo Scientific) and standard conditions according to the 
manufacturer’s protocol. The reactions contained 5% DMSO and were carried out in an 
Eppendorf Mastercycler under the following conditions: initial denaturation for 2 min at 
98 °C; 30 cycles consisting of denaturation for 15 s at 98 °C, annealing for 20 s at 72 °C, and 
extension for 10 s/kb at 72 °C; and a final extension for 10 min at 72 °C. The MCS was 
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inserted into plasmid pACYC177 via DraI and BamHI restriction sites, yielding plasmid 
pACYC_assembly (Table 2). The four building blocks were stitched together in plasmid 
pACYC_assembly. The assembly procedure is explained in more detail below: building block 
1 was inserted into pACYC_assembly via SdaI and ApaLI restriction sites, generating 
plasmid pACYC_building_block_1 (Table 2); building block 4 was inserted into 
pACYC_building_block_1 via XmaJI and PacI restriction sites, generating plasmid 
pACYC_building_block_1+4 (Table 2); building block 2 was inserted into 
pACYC_building_block_1+4 via ApaLI and AclI restriction sites, generating plasmid 
pACYC_building_block_1+2+4 (Table 2); building block 3 was inserted into 
pACYC_building_block_1+2+4 via AclI and XmaJI restriction sites, generating plasmid 
pACYC_building_block_1-4 (Table 2). The backbone of plasmid pACYC_building_block_1-
4 was exchanged for the backbones of plasmids pINA1269-SdaI-cm
R
-PacI, pINA1312-SdaI-
cm
R
-PacI, and pINA1292-SdaI-cm
R
-PacI (Table 2) via SdaI and PacI restriction sites, 
yielding plasmids pSynPfaPptAf1, pSynPfaPptAf2, and pSynPfaPptAf3 (Table 2). For the 
construction of plasmids pINA1269-SdaI-cm
R
-PacI, pINA1312-SdaI-cm
R
-PacI, and 
pINA1292-SdaI-cm
R
-PacI by modification of plasmids pINA1269 [3], pINA1312, and 
pINA1292 [4], a 1.2 kb DNA fragment containing a chloramphenicol resistance gene with 
SdaI and PacI restriction sites as well as the appropriate homology arms was amplified from 
plasmid pACYC184 (New England Biolabs) using primers HA+SdaI+cm
R 
for 
pINA1269_fwd / HA+PacI+cm
R 
for pINA1269_rev, HA+SdaI+cm
R 
for pINA1312_fwd / 
HA+PacI+cm
R 
for pINA1292+1312_rev, and HA+SdaI+cm
R 
for pINA1292_fwd / 
HA+PacI+cm
R 
for pINA1292+1312_rev (Table 1). PCR was performed with Taq DNA 
polymerase (Thermo Scientific) and standard conditions according to the manufacturer’s 
protocol. The reactions contained 8% glycerol and were carried out in an Eppendorf 
Mastercycler under the following conditions: initial denaturation for 3 min at 95 °C; 30 cycles 
consisting of denaturation for 30 s at 95 °C, annealing for 30 s at 62 °C, and extension for 1 
min/kb at 72 °C; and a final extension for 10 min at 72 °C. The linear plus circular 
homologous Red/ET recombineering was performed as described previously [17] using 1.5 µl 
of the PCR product.  
A synthetic version of gene mcherry (0.7 kb), serving as reporter gene, was amplified from 
plasmid pPm1-mcherry-rppA (K. Gemperlein, unpublished) using primers mcherry_A_fwd 
and mcherry_BamHI_rev (Table 1). PCR was performed with Phusion DNA polymerase 
(Thermo Scientific) and standard conditions according to the manufacturer’s protocol. The 
reactions contained 5% DMSO and were carried out in an Eppendorf Mastercycler under the 
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following conditions: initial denaturation for 2 min at 98°C; 30 cycles consisting of 
denaturation for 15 s at 98ºC, annealing for 20 s at 67ºC, and extension for 10 s/kb at 72ºC; 
and a final extension for 10 min at 72ºC. The PCR amplicon was inserted into plasmid 
pINA1312 via PmlI and BamHI restriction sites, yielding plasmid pINA1312-mcherry (Table 
2). For the fusion of hp4d-mcherry and LIP2t, the strong hybrid promoter hp4d in front of 
mcherry plus overlapping sequence was amplified as the first fragment (1.3 kb) from plasmid 
pINA1312-mcherry using primers UAS1B_Psp1406I_fwd and mcherry+LIP2t overlap_rev 
(Table 1). The second fragment (0.1 kb) contained the LIP2 terminator from Y. lipolytica plus 
overlapping sequence and was amplified from plasmid pACYC_building_block_1 using 
primers LIP2t+mcherry overlap_fwd and LIP2t_Psp1406I_rev (Table 1). PCR amplification 
of the two fragments to be spliced was performed with Phusion DNA polymerase (Thermo 
Scientific) and standard conditions according to the manufacturer’s protocol. The reactions 
contained 5% DMSO and were carried out in an Eppendorf Mastercycler under the following 
conditions: initial denaturation for 2 min at 98 °C; 20 cycles consisting of denaturation for 
15 s at 98 °C, annealing for 20 s at 64 °C, and extension for 10 s/kb at 72 °C; and a final 
extension for 10 min at 72 °C. For the subsequent overlap extension PCR using primers 
UAS1B_Psp1406I_fwd and LIP2t_Psp1406I_rev, the two amplified fragments were used as 
templates. PCR of the 1.4 kb fragment was performed as described for the amplification of the 
two fragments to be spliced. Plasmid pSynPfaPptAf2mc (Table 2) was constructed by 
insertion of hp4d-mcherry-LIP2t into plasmid pSynPfaPptAf2 via AclI restriction site. 
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Table 1. Primers used for cloning of assembly and expression plasmids in this study.  
The homology arms are shown in italics and the introduced restriction sites are underlined. 
 
Primer Sequence (5'3') 
MCS for pACYC_fwd 
TTTAAACCTGCAGGGCGGTGCACGCGCCATGGCGCGTCGACCGCAACGT
TGCGCGACG 
MCS for pACYC_rev 
GGATCCTTAATTAACGCCTAGGGCGCGCCGGCGCGCGACGTCGCGCAAC
GTTGCGGTCGACGC 
HA+SdaI+cm
R 
for 
pINA1269_fwd 
CAGCCCAGTAGTAGGTTGAGGCCGTTGAGCACCGCCGCCGCAAGGAATG
GCCTGCAGGATTTAACGACCCTGCCCTGAACCGACG 
HA+PacI+cm
R 
for 
pINA1269_rev 
GAATTCTCATGTTTGACAGCTTATCATCGATGATAAGCTGTCAAACATG
ATTAATTAAGTAAGTTGGCAGCATCACCCGACGC 
HA+SdaI+cm
R 
for 
pINA1312_fwd 
GAGACTGAAATAAATTTAGTCTGCAGCCCAAGCTAGCTTATCGATACGC
GCCTGCAGGATTTAACGACCCTGCCCTGAACCGACG 
HA+SdaI+cm
R 
for 
pINA1292_fwd 
CGAGCTTCGTAGGAGGGCATTTTGGTATCAAGCTAGCTTATCGATACGC
GCCTGCAGGATTTAACGACCCTGCCCTGAACCGACG 
HA+PacI+cm
R 
for 
pINA1292+1312_rev 
TACCCTGTCGGATGACTAACTCTCCAGAGCGAGTGTTACACATGGAATT
CTTAATTAAGTAAGTTGGCAGCATCACCCGACGC 
mcherry_A_fwd AATGGTGAGCAAGGGCGAGGAGG 
mcherry_BamHI_rev CCTTAGGATCCTCACTTGTACAGCTCGTCCATGC 
UAS1B_Psp1406I_fwd AAGAACGTTAGCTTATCGATACGCGTGC 
mcherry+LIP2t overlap_rev 
GGTAGAAGTTGTAAAGAGTGATAAATAGCTCACTTGTACAGCTCGTCCA
TG 
LIP2t+mcherry overlap_fwd 
CATGGACGAGCTGTACAAGTGAGCTATTTATCACTCTTTACAACTTCTA
CC 
LIP2t_Psp1406I_rev ATCCAACGTTGGTTTCGATTTGTCTTAGAGG 
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Table 2. Plasmids and expression strains constructed in this study.  
oriV = origin of replication, bla = ampicillin resistance gene, cat = chloramphenicol resistance gene, aph(3')-IIa 
= kanamycin resistance gene, LEU2 = 3-isopropylmalate dehydrogenase from Y. lipolytica, URA3 = orotidine 5'-
phosphate decarboxylase from Y. lipolytica, zeta = long terminal repeats (LTRs) of the retrotransposon Ylt1 
from Y. lipolytica, hp4d = hybrid promoter comprising four copies of the distal upstream activating sequence 
from the XPR2 promoter in front of a minimal LEU2 promoter from Y. lipolytica, XPR2t = terminator of gene 
XPR2 encoding an alkaline extracellular protease from Y. lipolytica, LIP2t = terminator of gene LIP2 encoding 
an extracellular lipase from Y. lipolytica. 
 
Plasmid / Strain Characteristics 
pACYC_assembly 
Derivative of pACYC177 (New England Biolabs) in which a multiple 
cloning site comprising SdaI, ApaLI, NcoI, SalI, AclI, AatII, NgoMIV, 
XmaJI, and PacI restriction sites was inserted via DraI and BamHI 
pACYC_building_block_1 
Derivative of pACYC_assembly in which building block 1 was inserted 
via SdaI and ApaLI 
pACYC_building_block_1+4 
Derivative of pACYC_building_block_1 in which building block 4 was 
inserted via XmaJI and PacI 
pACYC_building_block_1+2+4 
Derivative of pACYC_building_block_1+4 in which building block 2 
was inserted via ApaLI and AclI 
pACYC_building_block_1-4 
Derivative of pACYC_building_block_1+2+4 in which building block 3 
was inserted via AclI and XmaJI 
pINA1269-SdaI-cm
R
-PacI 
Derivative of pINA1269 [3] in which hp4d and XPR2t were exchanged 
for cat flanked by SdaI and PacI restriction sites by Red/ET 
recombineering. pMB1 oriV, bla, cat, LEU2. 
pINA1312-SdaI-cm
R
-PacI 
Derivative of pINA1312 [4] in which hp4d and XPR2t were exchanged 
for cat flanked by SdaI and PacI restriction sites by Red/ET 
recombineering. pMB1 oriV, aph(3')-IIa, cat, URA3, zeta. 
pINA1292-SdaI-cm
R
-PacI 
Derivative of pINA1292 [4] in which hp4d and XPR2t were exchanged 
for cat flanked by SdaI and PacI restriction sites by Red/ET 
recombineering. pMB1 oriV, aph(3')-IIa, cat, URA3, zeta. 
pINA1312-mcherry 
Derivative of pINA1312 [4] in which mcherry was inserted via PmlI and 
BamHI 
pSynPfaPptAf1 
Derivative of pACYC_building_block_1-4 in which the vector backbone 
was exchanged for the vector backbone of pINA1269-SdaI-cmR-PacI via 
SdaI and PacI 
pSynPfaPptAf2 
Derivative of pACYC_building_block_1-4 in which the vector backbone 
was exchanged for the vector backbone of pINA1312-SdaI-cmR-PacI via 
SdaI and PacI 
pSynPfaPptAf3 
Derivative of pACYC_building_block_1-4 in which the vector backbone 
was exchanged for the vector backbone of pINA1292-SdaI-cmR-PacI via 
SdaI and PacI 
pSynPfaPptAf2mc 
Derivative of pSynPfaPptAf2 in which hp4d-mcherry-LIP2t was inserted 
via AclI 
Y. lipolytica 
Po1g::pSynPfaPptAf1 clones 
Y. lipolytica Po1g with pSynPfaPptAf1 randomly integrated in the 
genome 
Y. lipolytica 
Po1h::pSynPfaPptAf2 clones 
Y. lipolytica Po1h with pSynPfaPptAf2 randomly integrated in the 
genome 
Y. lipolytica 
Po1h::pSynPfaPptAf2mc clones 
Y. lipolytica Po1h with pSynPfaPptAf2mc randomly integrated in the 
genome 
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Transformation of Y. lipolytica by lithium acetate-mediated heat shock transformation and 
heterologous expression 
Transformation of Y. lipolytica was carried out using a protocol developed by M.-T. Le Dall, 
modified by C. Madzak (Laboratoire de Microbiologie de l'Alimentation au Service de la 
Santé (MICALIS), AgroParisTech, Thiverval-Grignon, France; personal communication). 
One loopful of Y. lipolytica cells from a YPD-agar plate grown at 30 °C overnight were 
resuspended in 1 ml TE buffer in a sterile tube. The cells were centrifuged at 10,000 rpm for 
1 min, and the supernatant was discarded. After resuspension in 600 l 0.1 M lithium acetate 
pH 6.0, the cells were incubated at 28 °C for 1 h in a water bath. The samples were 
centrifuged at 3,000 rpm for 2 min, the supernatant was discarded, and the cells were softly 
resuspended in 80 l 0.1 M lithium acetate pH 6.0. 40 µl of competent cells were mixed with 
2 µl herring testes carrier DNA (10 mg/ml in TE buffer, denatured) and 3 µl linearized 
plasmid DNA to be transformed. The samples were incubated at 28 °C for 15 min in a water 
bath, and 350 μl 40% PEG 4000 in 0.1 M lithium acetate pH 6.0 plus 16 µl 1 M dithiothreitol 
(DTT) were added. After incubation of the cells at 28 °C for 1 h in a water bath, 40 µl DMSO 
were added. Subsequently, heat shock was carried out at 39 °C for 10 min in a heating block. 
600 l 0.1 M lithium acetate pH 6.0 were then added, and the cells were plated onto YNB-
N5000-agar. The plates were incubated at 30 °C for 2 days to four weeks. Thereafter, selected 
colonies were transferred onto new YNB-N5000-agar plates. The constructed strains are listed 
in Table 2. Expression was carried out in 50 ml YNB-medium inoculated with an overnight 
culture starting from OD600 = 0.1. The cells were cultivated at 28 °C and 200 rpm for 90-168 h 
and then harvested at 4,000 rpm for 5 min. 
 
 
Extraction of cellular fatty acids 
The cellular fatty acids were extracted using the FAME method [24]. For this purpose, 50 ml 
of a culture were harvested at 8,000 rpm for 10 min at room temperature. The cell pellet was 
transferred to a glass vial and dried in a vacuum concentrator. Subsequently, the cell dry 
weight was determined. 5 µl (50 µg) of n-3 DPA (Sigma-Aldrich) and 500 µl of a mixture of 
methanol, toluene, and sulphuric acid (50:50:2, v/v/v) were added. The vial was capped with a 
teflon-lined screw cap and incubated at 80 °C for 24-48 h. After the mixture was cooled to 
room temperature, 400 µl of an aqueous solution consisting of 0.5 M NH4HCO3 and 2 M KCl 
were added, and the sample was vortexed for 30 s. Phase separation was achieved by 
centrifugation at 4,000 rpm for 5 min at room temperature. 75 µl of the upper phase were 
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mixed with 25 µl N-methyl-N-(trimethylsilyl)trifluoroacetamide (MSTFA) and incubated at 
37 °C for 30 min. Subsequently, the sample was used for GC-MS analysis. 
 
 
Extraction and fractionation of lipids 
Extraction of lipids from microbial cells was carried out using the method of Bligh and Dyer 
[25], modified by Lewis et al. [26], on a small scale. In the first step, the cell pellet from a 
15 ml culture was transferred into a polypropylene tube. Successively, 4 ml chloroform, 8 ml 
methanol, and 3.2 ml 1% NaCl were added, and the tube was vortexed at high speed for 15 s 
after every addition. The sample was agitated on a tube rotator at 30 rpm overnight. 4 ml 
chloroform and 4 ml 1% NaCl were then added, and the tube was inverted 30 times. Phase 
separation was achieved by centrifugation at 4,000 rpm for 5 min at room temperature. The 
bottom layer containing the lipid extract was evaporated to dryness under a gentle stream of 
nitrogen and dissolved in 1 ml of a chloroform:methanol mixture (2:1, v/v). The lipid solution 
was fractionated by solid-phase extraction on a Strata SI-1 silica column with 100 mg sorbent 
mass (Phenomenex) equilibrated with chloroform + 1% acetic acid. Neutral lipids and free 
fatty acids were eluted from the column with 1 ml of chloroform + 1% acetic acid, glycolipids 
were eluted with 1.5 ml of an acetone:methanol mixture (9:1, v/v), and phospholipids were 
eluted with 1 ml methanol. For GC-MS analysis, the fractions were dried in a vacuum 
concentrator and further processed according to the FAME method described previously. 
 
 
Analysis of fatty acid methyl esters by GC-MS 
GC-MS was carried out on an Agilent 6890N gas chromatograph (Agilent Technologies) 
equipped with a 7683B split/splitless injector with autosampler (Agilent Technologies) and 
coupled to a 5973 electron impact mass selective detector (Agilent Technologies). Helium 
was used as the carrier gas at a flow rate of 1 ml/min. 1 µl of the sample was injected in split 
mode (split ratio, 10:1). The analytical column was a (5% phenyl)-methylpolysiloxane 
capillary column (Agilent J&W DB-5ht; 30 m x 0.25 mm i.d. x 0.1 µm film thickness, 
maximum temperature 400 °C; Agilent Technologies). The column temperature was kept at 
130 °C for 2.5 min, increased to 240 °C at a rate of 5 °C/min, then ramped to 300 °C at 
30 °C/min, and held at 300 °C for 5 min. Other temperatures were as follows: inlet, 275 °C; 
GC-MS transfer line, 280 °C; ion source, 230 °C; and quadrupole, 150 °C. The mass selective 
detector was operated in scan mode, scanning the mass range from m/z 40 to 700. Scan 
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control, data acquisition, and processing were performed by MSD ChemStation and AMDIS 
software, version 2.68, based on the fragmentation patterns and retention times, in comparison 
with Supelco 37 Component FAME Mix and LC-PUFAs (all Sigma-Aldrich) as reference 
standards, and NIST 08 library. Absolute amounts of PUFAs were quantified by integration 
of the peaks using MSD ChemStation and by subsequent calculation in relation to the integral 
of n-3 DPA and to cell dry weight. In case n-3 DPA was produced by the culture itself, the 
sample was spiked with n-3 DPA for the calculation of the absolute amounts of PUFAs. 
 
 
Fluorescence measurements 
The fluorescence of mCherry produced by yeast cells grown on YNB-N5000-agar plates was 
determined using a Molecular Dynamics Typhoon 9410 Variable Mode Imager (Amersham 
Biosciences/GE Healthcare). An excitation wavelength of 532 nm ± 8 nm and an emission 
wavelength of 580 nm ± 15 nm were used. 
The fluorescence of mCherry produced by yeast cells grown in liquid YNBD-medium was 
determined using an Infinite 200 PRO microplate reader (Tecan). Ahead of the measurements, 
20 µl of the cultures were mixed with 180 µl YNBD-medium in a 96-well microtitre plate. An 
excitation wavelength of 587 nm and an emission wavelength of 610 nm were used. For data 
analysis, the obtained values were normalized by autofluorescence background subtraction. 
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RESULTS AND DISCUSSION 
Development of heterologous expression platforms for recombinant LC-PUFA production 
using the DPA (22:5, n-6 or n-3)/DHA (22:6, n-3)-type pfa gene cluster from A. fasciculatus 
(SBSr002) ([17]; Chapter 3 and 4) served as proof of principle and paved the way for the 
establishment of a more promising host organism. By exploiting the potential of Synthetic 
Biology, myxobacterial PUFA biosynthetic pathways can thereby be introduced and 
expressed into an entirely unrelated organism with a very different evolutionary history. In 
this context, the oleaginous yeast Y. lipolytica was focussed on as expression host of choice, 
since it features GRAS designation, fast growth characteristics, accessibility for genetic 
manipulation, and ability to accumulate large amounts of lipids.  
For the heterologous expression of the DPA/DHA-type Pfa proteins and the PPTase AfPpt 
from A. fasciculatus (SBSr002) in the oleaginous yeast Y. lipolytica, synthetic versions of the 
three pfa genes and Afppt were created. Each gene is flanked by the strong hybrid hp4d 
promoter [3] and the LIP2 terminator for Y. lipolytica to construct single transcription units 
(Figure 1). Moreover, non-coding sequences were attached allowing for the connection of 
each transcription unit by 200 bp intergenic linkers. During sequence modulation processes, 
the myxobacterial genes were subjected to the algorithms of the proprietary evoMAG-
GeneDesign software by ATG:biosynthetics. The software applies concepts of evolutionary 
algorithms [27;28] to generate sequences which take into account predefined multivariate 
sequence parameter values. Degeneracy of the genetic code allows for the substitution of 
synonymous codons by silent mutations in order to generate the artificial sequence based on 
the native template without altering the amino acid sequence. For practical reasons, the 
20.2 kb gene cluster was dissected into smaller DNA fragments, which were supplied by gene 
synthesis companies (Figure 1). Constructive sequence requirements for pathway assembly 
from the synthetic DNA building blocks and for future interchangeability of inter- and 
intragenic regions were specified and implemented by insertion of restriction enzyme sites at 
any required position within the sequence by silent point mutations. In parallel, interfering 
restriction sites had to be eliminated from the sequences. 
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Figure 1. Design, synthesis, and cloning of a synthetic pfa gene cluster originating from Aetherobacter 
fasciculatus (SBSr002) for recombinant LC-PUFA production in Yarrowia lipolytica Po1g or Po1h.  
The region encircled by the dashed line was excised from pSynPfaPptAf2 and pSynPfaPptAf3 prior to 
transformation into Y. lipolytica. oriV = origin of replication, bla = ampicillin resistance gene, aphI and aphII = 
kanamycin resistance genes, LEU2 = 3-isopropylmalate dehydrogenase from Y. lipolytica, URA3 = orotidine 5'-
phosphate decarboxylase from Y. lipolytica, zeta = long terminal repeats (LTRs) of the retrotransposon Ylt1 
from Y. lipolytica, hp4d = hybrid promoter comprising four copies of the distal upstream activating sequence 
from the XPR2 promoter in front of a minimal LEU2 promoter from Y. lipolytica, LIP2t = terminator of gene 
LIP2 encoding an extracellular lipase from Y. lipolytica. 
 
 
In order to satisfy constructional demands, the complete sequence was adapted for specific 
requirements of the host Y. lipolytica in the context of functional sequence design. Moreover, 
general sequence requirements for gene design and gene synthesis (e.g. avoidance of 
sequence repeats, mRNA stabilities) were considered in the construction process of the 
synthetic gene cluster. In the process of sequence optimization, different parameters were 
addressed in detail (Figure 2). Comparison of the codon usage of the original cluster sequence 
and the codon table of Y. lipolytica led to the application of a 20% exclusion threshold (Figure 
2A). The resulting artificial codon usage table only contains 39 instead of 61 sense codons. 
Renormalization of the synonymous codon fractions from the genome sequence of 
Y. lipolytica had to be performed to ensure that the sum of each subset of codons for the same 
amino acid equals 1. Eventually, high adaptation of the codon usage of the artificial genes to 
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the reduced and renormalized table could be achieved. As Y. lipolytica shows a higher 
preference for AT-rich codons than myxobacteria, the mean GC-content of the coding 
sequences was lowered from 73% to 61% (Figure 2B). Another important parameter affecting 
translational elongation represents the local codon adaptation index (CAI), which is a measure 
for the deviation of the synonymous codon usage bias of a given coding sequence with respect 
to a reference set of genes [29]. After sequence adaptation, the local CAI shows a clearly 
smoothed shape without any distinct peaks as found for the native sequence (Figure 2C). In 
the artificial sequences, the gradient between start and stop codon of each coding DNA 
sequence was 0.05, which is intended to enhance the ribosome occupancy along the mRNA to 
shield the transcript from degradation [30]. In general, the speed of the ribosomes and the 
resulting translational elongation rate depends on several factors, including the availability of 
aminoacyl-tRNAs, but also on certain sequence features of the mRNA template, e.g. rare 
codon clusters [20] and tandem-repeats of codons below average usage frequency. These 
sequence features are often assigned to temporally separate translation of segments within the 
peptide chain and enable proper cotranslational folding of proteins with direct impact on their 
solubility and activity [31]. However, the search for relevant rare codon clusters within the 
native genes did not reveal any conspicuous candidates. Thus, they were eliminated from the 
synthetic genes (Figure 2D). Moreover, quantity and strength of specific sequences within the 
artificial genes which could be recognized as donor splice sites by Y. lipolytica [32] were 
reduced to avoid splicing of the intronless pre-mRNAs (Figure 2E). Another important factor 
to be considered is the metabolic cost of translational miselongation upon a frameshift [33]. In 
order to cause early termination of translation of incorrect reading frames, the ribosome must 
encounter an off-frame stop codon. Hence, stop codons were accumulated in the unused 
frames of the artificial cluster sequence (Figure 2F). 
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Figure 2. Comparison of the native and the artificial sequence of gene pfa2 for Yarrowia lipolytica 
originating from Aetherobacter fasciculatus (SBSr002).  
(A) Codon usage of the original sequence (left blue bars) compared to the codon table of Yarrowia lipolytica 
(left red bars) and codon usage of the modified sequence (right blue bars) compared to the reduced and 
renormalized codon table of Yarrowia lipolytica (right red bars; the cut-off for the synonymous codon fractions 
was 0.2), (B) Course of the GC-content, (C) Course of the local codon adaptation index (CAI); in the modified 
coding DNA sequence (CDS), the gradient between start and stop codon was 0.05, (D) Rare codon clusters 
according to Clarke and Clark [34]; additional violet triangles: tandem-repeats of codons below average usage 
frequency, (E) Potential donor splice signals (higher values reflect higher probabilities of cryptic splice sites),  
(F) Hidden stop codons in unused frames. 
 
 
Practical implementation of the heterologous expression of the artificial pfa gene cluster in 
Y. lipolytica started with reconstitution of the entire pathway by assembly of the DNA 
Original sequence Modified sequence
A
B
C
D
E
F
Figure x. Comparison of the native and the artificial sequence of gene pfa2 originated from Aetherobacter
fasciculatus (SBSr002). (A) Codon usage of the original sequence (blue bars) compared to the codon table of
Yarrowia lipolytica (red bars) and codon usage of the modified sequence compared to the reduced and
renormalized codon table of Yarrowia lipolytica (the cut-off for the synonymous codon fractions was 0.2), (B)
Course of the GC-content, (C) Course of the local codon adaptation index (CAI); in the modified coding DNA
sequence (CDS) the gradient between start and stop codon was 0.05, (D) Rare codons clusters according to
Clarke and Clark (Ref); additional violet triangles: tandem-repeats of codons below average usage frequency,
(E) Potential donor splice signals (higher values reflect higher probabilities of cryptic splice sites), (F) Hidden
stop codons in unused frames.
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building blocks supplied by a gene synthesis company (Figure 1). For this purpose, a 
pACYC-derived assembly plasmid was constructed by insertion of a suitable multiple cloning 
site, and the DNA building blocks were assembled stepwise by conventional cloning 
techniques using unique restriction sites engineered during the constructional sequence design 
process. The backbone of the resulting plasmid pACYC_building block 1-4 was then 
exchanged for a backbone on the basis of the Y. lipolytica shuttle vectors pINA1269 [3], 
pINA1312, and pINA1292 [4]. The resulting plasmid pSynPfaPptAf1 was linearized with 
NotI and transferred into Y. lipolytica Po1g [3] by lithium acetate-mediated heat shock 
transformation, whereas the “yeast cassette” of plasmid pSynPfaPptAf2 or pSynPfaPptAf3, 
generated via hydrolysis with NotI, was transferred into Y. lipolytica Po1h [2]. Numerous 
clones were obtained for the monocopy vector pSynPfaPptAf1, designed to be integrated at 
the pBR322 docking platform into the genome of Po1g strain, and for the monocopy auto-
cloning vector pSynPfaPptAf2, able to promote random integration into the genome of Po1h 
strain. In case of the multicopy auto-cloning vector pSynPfaPptAf3, able to promote ectopic 
integration of multiple copies of the integration construct into the genome of Po1h strain, no 
transformants were attained due to unknown reasons. In an initial screening, 17 transformants 
of Y. lipolytica Po1g::pSynPfaPptAf1 and 38 transformants of Y. lipolytica 
Po1h::pSynPfaPptAf2 were cultivated in 50 ml YNB-N5000-medium at 28 °C for 90 h. hp4d-
driven expression of the synthetic genes was supposed to start at the entry into stationary 
phase. The cellular fatty acids were extracted via acidic methanolysis using the FAME 
method [24] and analysed by GC-MS. Three Y. lipolytica Po1g::pSynPfaPptAf1 clones 
(clones A-C) and eleven Y. lipolytica Po1h::pSynPfaPptAf2 clones (clones A-K) were all 
shown to produce DHA. However, significant deviations in DHA production yields (up to 25-
fold difference) among different transformants could be observed (Figure 3). 
In order to investigate the extreme variability among the DHA producing clones and the 
occurrence of a large number of non-producing transformants (14 out of 17 and 27 out of 38 
analysed clones) on the genotype level, next generation sequencing approaches were applied. 
The genomes of the 14 DHA producers as well as of two non-producing clones of 
Y. lipolytica Po1g::pSynPfaPptAf1 and of Y. lipolytica Po1h::pSynPfaPptAf2, respectively, 
were sequenced. The integration sites of the constructs were mapped according to the genome 
sequence of Y. lipolytica CLIB 122 [18] (Table 3). In all DHA producers that have been 
sequenced, the expression constructs are integrated into different loci, which are widely 
distributed among the six chromosomes of Y. lipolytica. In case of the four non-producers, the 
expression constructs are either incompletely integrated into the genome or contain a 
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missense mutation. Interestingly, for none of the Y. lipolytica Po1g::pSynPfaPptAf1 clones, 
the presumed integration of the construct into the pBR322 docking platform located at 
chromosome C of Po1g strain was observed. With a few exceptions, either the integration site 
of the 5' end or of the 3' end of the linear expression construct could be identified, whereas the 
other end of the construct appears to be integrated into repetitive sequences which cannot be 
mapped due to the limited length of the sequencing reads. Only in case of Y. lipolytica 
Po1g::pSynPfaPptAf1 clone C and Y. lipolytica Po1h::pSynPfaPptAf2 clone C, the integration 
sites for both ends of the linear expression construct could be mapped. Unfortunately, for 
Y. lipolytica Po1h::pSynPfaPptAf2 clones H and I, both ends of the expression construct were 
integrated into repetitive sequences within the genome which cannot be mapped. The copy 
number of the transgenes integrated in the genome was determined by analysis of the 
integration site as well as by quantification of the coverage with sequence reads compared to 
surrounding genomic regions. For Y. lipolytica Po1g::pSynPfaPptAf1 clone A and 
Y. lipolytica Po1h::pSynPfaPptAf2 clones D plus F, duplications and inversions of parts of the 
expression constructs could be observed, but an obvious correlation between gene duplication 
and enhanced recombinant LC-PUFA production rate is not discernible. As gene expression 
in eukaryotes is a complex process regulated at multiple levels, transcription of transgenes is 
not only influenced by recombinant promoters and regulatory DNA elements but also by the 
local action of enhancers and other regulatory elements at the integration site [35]. Moreover, 
epigenetic effects, such as compartmentalization of the chromosomes into various types of 
chromatin domains, affect gene transcription levels depending on the spatial positioning of the 
transgenes within the genome [36]. Thus, the high variability of DHA production by the 
different transformants most likely results from position effects due to random integration of 
the expression constructs into various loci. 
The transgenic strain Y. lipolytica Po1h::pSynPfaPptAf2 clone C, that showed the highest 
DHA yields in the initial analysis (Figure 3), was selected for studies on production 
optimization starting with the evaluation of different cultivation conditions. Fermentation 
studies using several complex and minimal liquid media (details not shown) revealed that 
growth of the yeast cells and lipid accumulation were boosted in rich, complex media, but 
DHA production was strongly reduced or even undetectable. Using minimal YNB-media, 
growth rate was inferior, but the amounts of recombinant produced LC-PUFAs were elevated 
depending on the carbon source: Glucose or glycerol at a concentration of 2% (w/v) led to an 
increase in heterologous LC-PUFA production. Raising the glucose concentration to 8% or 
feeding of 3% (w/v) oleic acid resulted in an accumulation of lipids up to 19% of the cell dry 
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weight but impaired recombinant LC-PUFA production. Cultivation at different temperatures 
(16 °C, 25 °C, 28 °C, and 30 °C) revealed that heterologous LC-PUFA production at 28 °C 
clearly surpassed the production rate at the other temperatures. Investigations on the 
production kinetics showed that DHA continually accumulated with progressive cultivation 
time. In conclusion, initial approaches for production optimization resulted in the cultivation 
of Y. lipolytica Po1h::pSynPfaPptAf2 clone C in 50 ml YNBD-medium (containing 2% 
glucose) at 28 °C for 168 h and in an improved recombinant LC-PUFA production (Table 4). 
Remarkable amounts of DHA and some minor amounts of n-6 DPA, n-3 DPA, EPA (20:5, n-
3), arachidonic acid (AA, 20:4, n-6), and eicosatetraenoic acid (ETA, 20:4, n-3) could be 
achieved. Production yields clearly surpass the heterologous LC-PUFA production rate 
achieved with the native producer strain A. fasciculatus (SBSr002), which produces ca. 7-10% 
EPA of TFAs / 3.8-4.3 mg EPA/g cell dry weight (CDW) / 1 mg EPA/l and ca. 10-19% DHA 
of TFAs / 4.7-6.2 mg DHA/g CDW / 1.2-1.9 mg DHA/l as major PUFA species after seven 
days of cultivation. The total amount of fatty acids accounts for 11% of the cell dry weight of 
Y. lipolytica Po1h::pSynPfaPptAf2 clone C under the preferred cultivation conditions. 
Extraction and fractionation of the lipids, subsequent preparation of fatty acid methyl esters 
(FAMEs) by transesterification, and GC-MS analysis showed that most of the synthesized 
DHA (83%) is incorporated into the phospholipids. 15% of synthesized DHA are present in 
the fraction containing neutral lipids plus free fatty acids and 2% in the glycolipid fraction. 
 
 
Figure 3. Recombinant DHA production by Yarrowia lipolytica Po1g or Po1h with the synthetic pfa gene 
clusters originating from Aetherobacter fasciculatus (SBSr002). 
Cultivation was carried out in 50 ml YNB-N5000-medium at 28 °C for 90 h. The DHA content is presented as a 
relative value and was set at 100% (≙ 0.4 mg/g CDW) for the best producing clone Po1h::pSynPfaPptAf2 clone 
C. The indicated values are means and standard deviations of three biological samples. 
Table x. Recombinant DHA production by Yarrowia lipolytica Po1g or Po1h with the synthetic pfa gene
clus ers originated from Aetherobacter fasciculat s (SBSr002).
Culti tion was carri d out in 50 ml YNB-N5000 at 28 C for 90 h. The DHA content is presented as a relative
value and was set at 100% for the best pro ucing cl e Po1h::pSynPfaPptAf2 clone C. The indicated values are
means and standard deviations of three biological samples.
0
20
40
60
80
100
120
140
1 2 3 4 5 6 7 8 9 10 11 12 13 14
D
H
A
 c
o
n
te
n
t 
[%
]
Po1g::
pSynPfa
PptAf1 
clone A 
Po1g::
pSynPfa
PptAf1 
clone C 
Po1h::
pSynPfa
PptAf2 
clone A 
Po1h::
pSynPfa
PptAf2 
clone B 
Po1h::
pSynPfa
PptAf2 
clone C 
Po1h::
pSynPfa
PptAf2 
clone D 
Po1h::
pSynPfa
PptAf2 
clone E 
Po1h::
pSynPfa
PptAf2 
clone F 
Po1h::
pSynPfa
PptAf2 
clone G 
Po1h::
pSynPfa
PptAf2 
clone H 
Po1h::
pSynPfa
PptAf2 
clone I 
Po1h::
pSynPfa
PptAf2 
clone J 
Po1h::
pSynPfa
PptAf2 
clone K 
Po1g::
pSynPfa
PptAf1 
clone B 
CHAPTER 5: RECOMBINANT PUFA PRODUCTION IN YARROWIA LIPOLYTICA 
157 
 
Table 3. Characteristics of the integration of the synthetic pfa gene cluster originating from Aetherobacter 
fasciculatus (SBSr002) into the genome of Yarrowia lipolytica Po1g or Po1h, as examined by genome 
sequencing.  
 
Transgenic strain 
Integration site Copy number of the integrated 
genes Chromosome Gene locus 
Po1g::pSynPfaPptAf1 
clone A 
F within YALI0F09537g 
1x: pfa1, pfa2, and first half of 
pfa3; 2x: second half of pfa3 and 
ppt due to duplication and 
inversion within the construct 
Po1g::pSynPfaPptAf1 
clone B 
E near YALI0E08822g 1x 
Po1g::pSynPfaPptAf1 
clone C 
E 
between YALI0E05005g 
and YALI0E05027g 
1x 
Po1h::pSynPfaPptAf2 
clone A 
E within YALI0E26763g 1x 
Po1h::pSynPfaPptAf2 
clone B 
A within YALI0A03597g 1x 
Po1h::pSynPfaPptAf2 
clone C 
C within YALI0C05907g 1x 
Po1h::pSynPfaPptAf2 
clone D 
C 
between YALI0C10208g 
and YALI0C10230g 
1x: pfa1 and first third of pfa2; 2x: 
two-thirds of pfa2, pfa3, and ppt 
due to duplication and inversion 
within the construct 
Po1h::pSynPfaPptAf2 
clone E 
F near YALI0F17270g 1x 
Po1h::pSynPfaPptAf2 
clone F 
A near YALI0A08448g 
1x: pfa1, pfa2, pfa3, and first half 
of ppt; 2x second half of ppt due to 
duplication and inversion within 
the construct 
Po1h::pSynPfaPptAf2 
clone G 
E within YALI0E35200g 1x 
Po1h::pSynPfaPptAf2 
clone H 
repetitive sequence which cannot be mapped probably 1x 
Po1h::pSynPfaPptAf2 
clone I 
repetitive sequence which cannot be mapped probably 1x 
Po1h::pSynPfaPptAf2 
clone J 
F 
between YALI0F06974g 
and YALI0F07018g 
1x 
Po1h::pSynPfaPptAf2 
clone K 
E within YALI0E26433g 1x 
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Table 4. Fatty acid composition of Yarrowia lipolytica Po1h::pSynPfaPptAf2 clone C. 
Cultivation was carried out in 50 ml YNBD-medium + 50 mM potassium phosphate buffer pH 6.8 at 28 °C and 
200 rpm for 168 h. The indicated values are means of three biological samples. The recombinant produced 
PUFAs are shown in bold. 
 
Fatty acid 
Relative amount 
[% of total fatty acids] 
Absolute amount 
[mg/g cell dry weight] 
Yield 
[mg/l] 
14:0 0.02 0.02 0.13 
15:0 0.10 0.10 0.76 
16:0 9.22  10.15  79.15 
16:1 5.59 6.05  46.60 
16:0 2-OH 0.72 0.77 5.80 
17:0 0.17 0.17 1.23 
17:1 0.37 0.38 2.75 
18:0 4.29 4.84  38.40 
18:1  55.51  60.90   473.26 
18:2 8.73 9.72  76.35 
20:0 0.09 0.10 0.75 
20:1 0.16 0.17 1.22 
20:2 0.02 0.02 0.19 
20:4 n-6 0.06 0.06 0.48 
20:4 n-3 0.01 0.01 0.08 
20:5 0.14 0.14 1.03 
22:0 0.15 0.16 1.24 
22:5 n-6 0.21 0.21 1.56 
22:5 n-3 0.10 0.10 0.70 
22:6 8.89 9.35  70.41 
22:0 2-OH 0.03 0.03 0.22 
24:0 1.11 1.23 9.60 
24:0 2-OH 4.15 4.39  33.23 
26:0 0.16 0.19 1.46 
 
 
As shown earlier in the chapter, the low rate of recombinant LC-PUFA producers among 
the Y. lipolytica transformants and the high variability of DHA production between the 
producing clones were caused by truncated expression constructs still comprising the 
selection marker or by position effects associated with random integration, respectively. A 
powerful traditional approach to study the influence of the local environment on gene 
expression represents the integration of reporter genes into different chromosomal sites [37]. 
Following this strategy, incorporation of a fluorescence gene into the LC-PUFA expression 
construct was aimed at. A reporter gene expression cassette consisting of mcherry flanked by 
the same promoter and transcriptional terminator as used for the pfa genes and Afppt (strong 
hybrid hp4d promoter [3] plus LIP2 terminator) was constructed and inserted into the linker 
region between genes pfa2 and pfa3 of plasmid pSynPfaPptAf2 by conventional cloning 
(Figure 1). By positioning of the reporter gene in the centre of plasmid pSynPfaPptAf2mc, a 
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linkage between integration of not only the outer regions comprising the auxotrophic marker 
but even the middle parts of the “yeast cassette” and mCherry fluorescence was attempted to 
be established. The “yeast cassette” of plasmid pSynPfaPptAf2mc was transferred into  
Y. lipolytica Po1h [2] by lithium acetate-mediated heat shock transformation. Ten transformants 
of Y. lipolytica Po1h::pSynPfaPptAf2mc which exhibited intensive mCherry fluorescence on 
agar plate plus Y. lipolytica Po1h::pSynPfaPptAf2 clone C, as a reference, were cultivated in  
1 ml YNBD-medium at 28 °C for 92 h. The mCherry fluorescence signal from the liquid 
cultures was quantified by photometry; the cellular fatty acids were extracted via acidic 
methanolysis using the FAME method [24] and analysed by GC-MS. Six Y. lipolytica 
Po1h::pSynPfaPptAf2mc clones produce DHA in similar amounts as Y. lipolytica 
Po1h::pSynPfaPptAf2 clone C with deviations of ± 30%, as determined by ratios of DHA and 
endogenous fatty acids. Two clones produce 48% or 6% of the DHA amount synthesized by 
the reference strain, whereas two transformants do not show any production of recombinant 
LC-PUFAs. DHA production and mCherry fluorescence correlate for almost all of the 
transformants, except for those clones exhibiting a very low or no DHA production. In these 
cases, mCherry fluorescence reaches elevated values falsely indicating a superior recombinant 
LC-PUFA production. The discrepancy between the anticipated high LC-PUFA production 
yield based on the reporter signal and the actual low amounts of detected DHA in some clones 
might be due to duplication of mcherry, which would result in a higher fluorescence as 
consequence of the increased gene dosage. Regarding the clones which do not produce any 
recombinant LC-PUFAs, the integrated PUFA biosynthetic pathway might be either truncated 
or mutated, but without affecting the functionality of the mcherry reporter gene. All in all, the 
use of the reporter gene within the LC-PUFA expression construct enabled the identification 
of DHA producing transformants with a probability of 80%. Three quarters of the producing 
clones synthesize half or more of the DHA amount produced by the best transformant. In 
comparison, the use of the parent expression construct pSynPfaPptAf2 led to an identification 
rate for a DHA producing transformant of only 29%, and merely 40% of the producing clones 
synthesize half or more of the DHA amount produced by the best transformant (Figure 3). 
The best producing strain harbouring the mcherry construct, Y. lipolytica 
Po1h::pSynPfaPptAf2mc clone A, was cultivated in 50 ml YNBD-medium at 28 °C for 168 h, 
analogous to the reference strain Y. lipolytica Po1h::pSynPfaPptAf2 clone C. Production of 
7.1% DHA of TFAs / 6.0 mg DHA/g CDW / 41.0 mg DHA/l and some minor amounts of n-6 
DPA, n-3 DPA, EPA, AA, and ETA could be achieved, as determined in triplicates. The 
relative amounts of recombinant produced LC-PUFAs are comparable to the recombinant LC-
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PUFA production by Y. lipolytica Po1h::pSynPfaPptAf2 clone C, considering the standard 
deviations, but the absolute amounts and the yields are inferior (Table 4) due to a faster and 
denser growth and a higher lipid content of the latter strain. 
In conclusion, recombinant LC-PUFA production could be successfully accomplished in 
Y. lipolytica with an artificial DPA/DHA-type pfa gene cluster plus PPTase gene originating 
from the myxobacterium A. fasciculatus (SBSr002). Using the first polyketide biosynthetic 
gene cluster modulated and synthesized for this yeast, a 40-fold increase in DHA yield per 
litre of fermentation broth compared to the native myxobacterial producer could be attained. 
Twelve different integration sites of the LC-PUFA expression construct could be identified 
within the genomes of the Y. lipolytica transformants. They confer a high variability of DHA 
production with up to 25-fold differences. The identified integration site for the best 
producing clone allows for stable propagation and high transcription rates of the LC-PUFA 
genes and, most probably, of any heterologous gene. However, site-specific integration of a 
(large) expression construct into the genome of Yarrowia turned out to be challenging. 
Therefore, inclusion of a reporter gene into the artificial LC-PUFA expression construct to be 
ectopically integrated enables a facilitated and rapid identification of proficient recombinant 
LC-PUFA producers. Application of this system might be useful for the heterologous 
expression of different recombinant genes in the future.  
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APPENDIX 
 
DNA sequences of the synthetic building blocks 
 
>building block 1 
CCTGCAGGCATGCTGAGGTGTCTCACAAGTGCCGTGCAGTCCCGCCCCCACTTGCTTCTCTTTGTGTGTAGTGTA
CGTACATTATCGAGACCGTTGTTCCCGCCCACCTCGATCCGGCATGCTGAGGTGTCTCACAAGTGCCGTGCAGTC
CCGCCCCCACTTGCTTCTCTTTGTGTGTAGTGTACGTACATTATCGAGACCGTTGTTCCCGCCCACCTCGATCCG
GCATGCTGAGGTGTCTCACAAGTGCCGTGCAGTCCCGCCCCCACTTGCTTCTCTTTGTGTGTAGTGTACGTACAT
TATCGAGACCGTTGTTCCCGCCCACCTCGATCCGGCATGCTGAGGTGTCTCACAAGTGCCGTGCAGTCCCGCCCC
CACTTGCTTCTCTTTGTGTGTAGTGTACGTACATTATCGAGACCGTTGTTCCCGCCCACCTCGATCCGGCATGCA
CTGATCACGGGCAAAAGTGCGTATATATACAAGAGCGTTTGCCAGCCACAGATTTTCACTCCACACACCACATCA
CACATACAACCACACACATCCACAATGTCCGCTATTGGCCGATGGAATGCTCAAGGAGGATCTCCTGAGCTGACC
CCCGCTGCTATGGTGGCCGCTATCGCTCGATGTCGAGAATCTCTGCACGTCGTGCGAGACGGCGAATCTGGCCGA
ATCGGCCTGGGCGTGGGCGGAGAACTGCTGCCCCCTGGAGAGCGACGAGCCGGAGAATACACCCTGGTGGCCTCT
CTGCCTCCCCTCTTCCCTGAATGGCTGGGCGACCGATCTTTCTGCGAGGTCCACGGCGTTCGATTTCCCTACGTT
GCTGGAGAGATGGCTAACGGAATCGCTACTGTCGAGATGGTTGTGGCCATGTCCCGATCCGGCATGCTGGGTTTC
TTCGGTGCTGCTGGTCTCGGCTTCTCCCGAGTCGAGGCTGCCGTCGAGACTCTGCGAGCCACTCTGGGTGACGAG
GCCCCTTGGGGCGTGAACCTGATCCACTCTCCCAATGAGGCTTCCCTGGAGAACCGAGTCGCCGATCTCCTCATT
GAATCTGGCGTGCGACGAATCTCCGTGTCCGCCTTCATGGCCCTGACTCCTGCCGTTGTCCGATGCGCTGCTCGA
GGCCTCCGACTGGACGCTGCCGGACGAATTGTTCGACCCCGACATATTTTTGCTAAGCTGTCCCGACGAGAGGTT
GCCCTGCCCTTTCTCTCCCCCGCTCCCGAGGAGATGCTCCGAGCTCTCGTTGCTTCCGGCGGACTGACTGAGGAG
GAAGCCCGACTCGCCGCCAAGATCCCCGTGGCTGAGGATATCACCGTCGAGGCTGACTCTGGTGGTCATACCGAC
AACCAGGCTCTGGTCGCCCTGCTCCCCACTATCCTCCAGCTGCGAGACGAGCTGGCTGACAAATACGACTACACC
CGACCTATCCGAGTTGGAGCCGCTGGTGGTCTCGGCACCCCTACCGCCGTCGCTGCTGCTTTTTCCCTGGGTGCC
GCCTACGTCGTGACCGGATCTGTGAACCAAGCCGCTCTGGAATCTGGCCTGTCTGATGAGGGAAAGCGAATGCTC
GCTCAGGCTGAGGTCGCCGACGTTATCATGGCCCCTGCTGCTGATATGTTTGAGCTCGGCGTGAAGCTGCAGGTC
CTGCGACGAGGTTCTATGTTTGGTGTTCGAGCCGCCAAGCTCTATGAGGCCTACCACGCCCATCCCTCTCTCGAG
GCCATTCCCGATGCTCTGCGAGCTCGACTGGAACGAGAGGTCCTCCATGCTACCTTTGACGGAATTTGGGCTGAG
ACTCGAGCTTTCTGGGAGGCCCGAGATCCTGAACAGGTCGCCCTGGCTGCTCGAGACCCCAAGCACCGAATGGCT
CTCGTGTTCCGATGGTATCTCGGAATGGCCTCCCGATGGGCTATTGCTGGAGAAGCTTCTCGACGAGCTGACTAC
CAAATTTGGTGTGGTCCTGCTATGGGAGCCTTTAACTCCTGGGTCCGAGGATCCTTCCTGGAAGATCCTAAACAG
CGAGGCGTGGTGGCCATTGCCCTGAACCTGCTCGAGGGTGCCGCCGTTGTCACTCGAGCTCACCAGCTCCGAACC
TACGGCGTTCCTGTTCCTGCCGCCGCCTTTGATTTCCGACCTCGACCCCTCGCCTAAGCTATTTATCACTCTTTA
CAACTTCTACCTCAACTATCTACTTTAATAAATGAATATCGTTTATTCTCTATGATTACTGTATATGCGTTCCTC
TAAGACAAATCGAAACCGGATCCGGCGCGCCGATCCGCCTGATGCGGTATTTTCTCCTTACGCATCTGTGCGGTA
TTTCACACCGCATATATGGTGCAC 
 
 
>building block 2 
GTGCACTCTCAGTACAATCTGCTCTGATGCCGCATAGTTAAGCCAGCCCCGACACCCGCCAACACCCGCTGACGC
GCCCTGACGGGCTTGCGCTCGGCTTCACCTTCACTCGACAGGTCTTCGCCATGCTGAGGTGTCTCACAAGTGCCG
TGCAGTCCCGCCCCCACTTGCTTCTCTTTGTGTGTAGTGTACGTACATTATCGAGACCGTTGTTCCCGCCCACCT
CGATCCGGCATGCTGAGGTGTCTCACAAGTGCCGTGCAGTCCCGCCCCCACTTGCTTCTCTTTGTGTGTAGTGTA
CGTACATTATCGAGACCGTTGTTCCCGCCCACCTCGATCCGGCATGCTGAGGTGTCTCACAAGTGCCGTGCAGTC
CCGCCCCCACTTGCTTCTCTTTGTGTGTAGTGTACGTACATTATCGAGACCGTTGTTCCCGCCCACCTCGATCCG
GCATGCTGAGGTGTCTCACAAGTGCCGTGCAGTCCCGCCCCCACTTGCTTCTCTTTGTGTGTAGTGTACGTACAT
TATCGAGACCGTTGTTCCCGCCCACCTCGATCCGGCATGCACTGATCACGGGCAAAAGTGCGTATATATACAAGA
GCGTTTGCCAGCCACAGATTTTCACTCCACACACCACATCACACATACAACCACACACATCCACAATGACCCAAG
TCCCCGTTGCTATTGTCGGAGTCGGCGCCCTGTTCCCCGGATCTCCCGACGGTGCCGGATTCTGGCGAGATATTG
TGGCTTCCCGAGATCTCGTCTCTGATGTCCCTCCCGGACACTGGCTGATTGAGGACTACTACGACCCCGACCCCT
CCGCCCCTGACAAGACTTATTCCAAGCGAGGCGCCTTCCTCGGAGAGACTGCCTTCGACCCCCTGGAATTCGGCG
TCGTGCCCTCTTCCCTGCCCACCACTGACACCGCTCAGCTCCTCGCTCTGATTGTGGCTCGACGAGTCCTGGATG
ACGCTACTCAGGGTCGATTCGCTTCCATTGACCGATCCCGAATTGGCGTCGTTCTCGGCGTGACCTCCGGACAGG
AGCTGCTGGGCACTATGGTTTCCCGACTGCAGCGACCTGTTTGGCTGAAGGCCCTCCGAGACGACGGCGTCCCCG
AAGCTGACGCTCAGCGAATCTGTGACCGAATCACTAACGAATACGTCCCCTGGAAGGAATCTACCTTCCCTGGAC
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TCCTGGGAAACGTCGTGGCTGGTCGAATTGCCAACCGATTCGACCTCGGTGGAACCAACTGCGTGACTGATGCCG
CCTGCGCCTCTTCCCTCGCTGCCCTGTCCATCGCCATGAACGAGCTGGCCCTCGGCCAATCTGACCTGGTCATCA
CCGGTGGCGTGGACACTATGAATGACATTCTGATGTACACCTGCTTCTCCAAGACTCCCGCTCTGTCTAAATCTG
GCGATTGCCGACCCTTCTCTGACGCCGCCGACGGCACTCTGCTGGGCGAAGGCCTGGCTATGTTCGCCCTGAAGC
GACTCACCGACGCTGAGCGAGATGGAGACCGAGTCTACGCCGTGATCCGAGGTCTCGGATCTTCTTCTGACGGCC
GATCTAAATCTGTCTATGCCCCCGTGCCTGAGGGCCAGGCCAAAGCCCTCGTGCGAGCCTACGAGGCCGCTGGAT
ACGGTGCTGACACCGTCGAGCTGGTCGAGGCCCACGGCACCGCTACCAAGGCTGGAGACGCCGCCGAATTTGGCG
GACTGAAGCTGGCCTTTGAGGCCTCTGGTCGAGCTGACCATCAGTGGTGTGCTCTGGGTTCCGTTAAGTCTCAAA
TCGGCCACACCAAATCTGCCGCCGGAGCCGCCGGACTCTTTAAGGCCGTGATGGCTCTCCACCACAAGGTCCTGC
CTCCCACCATCAAGGTTGACCGACCCAACCCCGAGCTCGCCATTGAGGCCTCCCCCTTTTACCTGAACACTCAAG
CCCGACCTTGGGTCCGAAACGCTCAGCATCTGCGACGAGCTTCCGTCTCTTCTTTTGGTTTCGGCGGTTCTAACT
TTCATGTGACCCTGGAGGAATACGCTGGCACTGCTGAGCCTGCTGCCCGACTGCGAACCGCTCCCACCGAGCTGT
TTGTGATTTCCGCCCCTTCCGCTGCTGAGGTCCTGGCTCGAGCCGGAAAGCTCGCCGAACTGGCCGATAAGGAGG
GAACCACTACCGCCGCCCGAACTTCCCAGCGAGACTTCGTGACTGCTGACCATGCCCGACTCTCTATCGTTGCCT
CTGATGCCGCCGATCTCCGAGCCAAGCTCGAGCAGGCTCGATCTCTCCTCTCTGCCCGACCTGAGGAGGCTTTCT
CTACCCCTACCGGCGTTCACTTTGCTGTGGGCGCTGCCGCCGGAGGCGTTGCCTTTCTGTTCCCTGGCCAGGGAT
CTCAATACGTGGGAATGGGAGCTGACGTTGCTATGGAGCACGGCGTGGCCCTGGATGCCTGGGACGCTGCTGCTG
GCCTGGTCGAAACCGCTGGACTCCGAGATGTGGTGTTCCCCCGACCCGCCTTTACTGATGAGGCCCGAGCCGAGC
AGGCCCAGCTGCTGACTGCCACCGAATGGGCCCAGCCCGCTATCGCTACTGCCTCTCTGGCCCTCCTCGCTGTGC
TGCGAGCCGTCGGTGTCCGACCTTCCTCCGTGGCCGGACACTCCCTCGGTGAACTGACCGCTCTGGCTGCTGCTG
ACGCCCTCTCCACCAACGATCTCGTGGCCACTGCCCGAAAGCGAGGCCAGCTGATGAATGCCGCCTCTTCTACCC
CCGGAGCCATGACCGCCGTTGCTCGACCTCTGGCTGAGGTCCAGGCTCTGCTCGAGCGACTGCAATCTGAGGTCG
TGGTGGCCAACCATAACCACCCCACTCAGGTCGTGCTCGCCGGAGAAACCGCCGCCATCGAAGCTGTGGAGGCCG
AACTGGCCCGACAGGGAATCACCGCTAAGCGACTCCCCGTTGCCACCGCCTTCCATTCTCAGGTCGTGGCTGGAG
CCACCGCCCCCTTTGCCGAACACCTCGCCGGAATCGCTGTGAAGGCTCCTGCCATCGATGTGCTGTCTAACTCTG
AAGCTGCCGCTTACCCCTCCGATCCTGACGCTGTCCGAGCTCTCCTCGCTGGACAGATCACCCGATCTGTGCGAT
TTGTTGAGGTCGTGGAGGCTATGTGGGCTCGAGGCGCTCGAATTTTCGTTGAGGTCGGACCCTCTGCCGTGCTGA
CTGAACTCTGTGCCCGAATCCTCGGCGAACGACCCCACCTCGCTATTGCTATGGATCGAAAGGGAAAGCACGGCG
TGACCGCCCTCCAAGATGCTCTGGGCCGACTGGCCGCCGCTGGCGTGGCCATTGATTTTGCTCCCCTGTGGGCCC
CTTTCGGACCCCCTGCCGCTCCTAAGCGAGTCCCCGCTATGTCCATGATGATCAATGGCGCTAACTACGGCAAGG
TCTACCCTCCCAAAGGCGGTGCCGCTGCCCTGCCTCCCCCTAACCCTCCTCGACCTGTGGTCGCTGCCGCTACCA
TCGCCGCTGCTCCCTCTTCCGCTGCCAAGGCTCCCGTCGTTGCCGCTGCCACCATTGCTGCCGCCCCCATCCCTG
CCGCTAAAGCCCCCGTGGTGGCTGCCGCCACTATCGCTGCTCGACCCGCCGCTGCTCCTGAATCTCGACCCGTCG
TGGCCGCTGCCCCTGCTCCTGCTCCTGTTGTGGCTGCCCCTGCTTCCGCTGCCGCTGCTCTGTCCGCTCCTGGCC
AGCTGGGCTGGATTGAGGCCTACCAGGAATCCCAGCGACAGCTGACCGAAGCTCATGCTTCTTACGTTCGAACCA
TGGCCTCTGGTCATGAGGCTTTCCTGACCACTATGGAAGCCTCCTTTATCGGACTCGGCGGACTGCTCGGTGCTC
CCGCCTCTGTGTCCGCCGTTGCCCCTCGATCTGCTGCCGCCCCCGTTCTGGCTCAGCCTGTGGCCGTGGCTCCTG
CTCCTGTCCTCGCCCCTGCTCCCGTTCCCGCCCCTGCTCCTACTCCTGTGCTGGCCCCCGCTCCTGCTCCTGTGC
TGGCTCCTGCTCCTGTGGCTGCCGTGGCTAAGGCTGCCCCTGCCCCCGTGATGGCTCCTGCTGCCCCTTCTATCG
ACCTGCAAGCTCTGCTGCTCGACGTGGTCGCCGATAAGACCGGCTATCCCGCTGAGATGCTGGGCATGCACATGG
AGCTCGAAGCTGACCTGGGCATCGACTCTATTAAGCGAGTTGAAATCCTGTCTGCTATGCGAAAGCGAGCCCCCA
ATCTCCCCGAGGTTGTCGCTTCTGAGATGGCCACCCTCCGAACCCTGGGCCAGATTGTTGAATATATGCGAGAGC
GATCCGGAGCCCTGACCGCCGCTACCCACGAGACTCTGGTTCCCGCTACCGCTGAGGCCGCTACTCAGGCCGCCC
CTGCTCTGGGAGATCTGCAGGCCCTCCTCCTGGACGTTGTGGCCGACAAAACCGGATACCCTGCCGAGATGCTCG
GAATGCACATGGAACTCGAGGCCGACCTCGGAATTGACTCCATCAAGCGAGTCGAAATCCTCTCCGCCATGCGAA
AACGAGCCCCTAACCTGCCCGAGGTCGTTGCTTCCGAGATGGCTACCCTGCGAACTCTCGGACAGATCGTGGAAT
ACATGCGAGACCGATCTGGTGCTACTGCCGCCCCTGTGAAGGCTGCTCCTGCTCCTGCTCCTGCCCCTGCCGCTG
CTCCCACCAAGGAGGCTCCCACCCTCGCTGACCTCCAGACTCTCCTGCTGTCTGTCGTTGCTGACAAGACTGGTT
ACCCCGCCGAAATGCTGGGAATGCATATGGAGCTGGAGGCCGATCTGGGTATTGATTCCATTAAACGAGTCGAGA
TTCTGTCTGCCATGCGAAAGCGAGCTCCCAACCTCCCTGAGGTGGTGGCCTCTGAAATGGCCACTCTGCGAACCC
TCGGTCAAATTGTCGAATACATGCGAGATCGATCTGGCGGACACTCTGTGGCTGCCACCACCCCTGCTCCCGCCC
CCGCTTCCACTCTGGCTCCTGCTGCTTCCCGAATTGGTCGATACGTCGTCGGAACTCGAGAGGAAGCCGCCTCCG
GACTCGCTATGGGTGGTGTTCTGGGTGCTCGACGATTCGTGATCACTAACGAAGGCACTGGCATCGCTCAGGCTC
TCGTCCGAGCTCTCCAGGAGCGAGGCGTTTCCTCCGAGGTCGTGACCGAGGTCCCCGCTGACGCCGATGCTGTGG
TTTTCCTGGGAGGACTCCGAACTCTGGTCGACGTTGATACTGCCATCGCCATCAATCGAGAGGCTTTCCTCGCTG
CCCGAGCCGTGGCTTCCGTGTTTTCCCGAGATGGTGGCGCTTTCGTGACTGTCCAGGACACCGGTGGCGACCTCG
GCATTGAAGCTCGAGAGCCCCGAGCCGCTTGGCTGGCTGGCGTTGCTGCTCTGGCCCGAACCGCCCAACTGGAAT
GGCCCAAGGCCTCTGTGAAAGCCGTCGATGTGGAGCGAGGTGGTCGATCCTCTGAGGAGATTGCTGCTGCCATCG
CTGAGGAAATCCTGACTGGTGGTGGTGCCCTCGAGGTCGGACTGACCGCTGCTGGAGCCCGACGAGTCCCTGAGG
TTGTGCAGCGAGCTGTTGGAGAGCGAACTCCTGTTCTCGCTCGATCCTCTGTGGTTGTGGCTTCCGGTGGTGCTC
GAGGCGTTACCGCCACTGCCCTGATCGCCCTCGCTCGACATGCTCAGCCTAAGCTCGTGATCCTCGGTCGATCCG
CCCTCGAGGCTGAACCCGCCGCCTGTCTGGGTGTCCGAGGAGATGCCGCCCTGAAACGAGCCCTGCTGGAGGACG
CTCGAGCCCAAGGTCGAACCGCCACTATTGCTGAGATTGGTGCCCATGTTGCCCGAATTTCCGCTTCCCGAGAGG
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TTCTGGAGACTCTCGCTGCCATTAAGGCCGCCGGTGGCGAAGCCCGATACCTCGCTGTTGACGTGACCGATGCCG
ACCGACTCCGACTCGCCCTCGAGGAGGTCCGACGAGACTGGGGTCCTATTACTGCTGTTGTGCATGGTGCTGGCG
TCCTCGCCGATAAGCGAATCGAGGACAAGACCCCCGAACAATTCGACCGAGTCTTCGATACCAAGGTCCTGGGAC
TCCGAGCCCTCCTGGCTGCTACCGAGGGTGACCCCCTCCGAGCTATTATTCTCTTTTCTTCTGTGGCCGCCCGAG
CTGGCAACGTCGGCCAATGCGACTATGCTATGGCCAACGAAATCCTGAATAAGGTCGCCATCGCTGAGCGACGAC
GACGAGGTGGCGCTTGTACCGTGAAATCTCTGGGCTGGGGTCCCTGGGAAGGCGGAATGGTCACCCCCGCCCTGA
AAGGCCACTTCGAATCTATGGGCGTGGCCCTGATCCCCCTGGCTGAAGGAGCCGAACACTTCATCGCTGAGATCG
AAGGATCCGCTGACGAAATTGAGCTCGTGATCGGTGGCGGTGCTGATGGATCCGCCATTCGAGGCGACGCTGAGC
CTACCATTCACTTTGGCGTTTCCGTTTCCGATCGAACTTCCCCTTGGCTCGCTGACCATCGAGTCGCCGGACGAC
GAGTCATCCCCGTCGCTGTTGTGATTGAATGGTTTACCCGAGCTGTGACTGCTCTCCAGGGTCGAGCTGCTGTTT
CTCTGCGAGATGTTAAGGTCCTGCGAGGAATCAAGCTCCCCGCTGGCGACGCTGCCGCTTCCTTTTCTATCGGTT
GTCGAAAACTGGCCGAGGGCAAAATTGAACTGACCCTGCACGGCGCCGATGGAGCCCTCCATTACCGAGCTTCCG
CTGAGCCCCGAGGCGCTGCCCTGAAACCCGAGGGAGCTGCTCCTCCCCTGGCTGCTTGGGGCGACCGACCCATCT
ATGACGGTGGCCTCCTCTTCCACGGTCCTCGATTTCATGCTATTCATTCCATTGAGGGAGCTTCCGCTGAAGGAA
TTCGAGCTACTCTGACCGGAGCTCGAGAGCTCGGATGGCCCGGAGAGGCCCAACGAACTGATCCCGCTATTGTGG
ACGGAGCTCTGCAGCTGGCCCTGCTGTGGACTCGAGAACGACTCGGCCAAGCCTCTCTGCCTATGGCCATTGCCG
CCTTTGATTGGCAAGCCTCCGGTCCCGTGGAAGGTCCCGTCCGAGCCGTGGTTCAGGGTCGAGAGGCTGACTCCG
CCCACGCTGTTTGCGATGTTTGGCTCGAGGACGCTCGAGGAGCTATCGTTGGAGCTCTCCGAGGTGTCGAGACCA
TTGTTCGACCTGCTGAGGTCCGAGCTCCTCACCTCGTGGAGACCGGTCCCGCTTCTTAAGCTATTTATCACTCTT
TACAACTTCTACCTCAACTATCTACTTTAATAAATGAATATCGTTTATTCTCTATGATTACTGTATATGCGTTCC
TCTAAGACAAATCGAAACCACGCCAGCAAGACGTAGCCCAGCGCGTCGGCCGCCATGCGGGCGATAATGGCCTGC
TTCTCGCCGAAACGTT 
 
 
>building block 3 
AACGTTTGGTGGCGGGACCAGTGACGAAGGCTTGAGCGAGGGCGTGCAAGATTCCGAATACCGCAAGCGACAGGC
CGATCATCGTCGCGCTCCAGCGAAAGCGGTCCTCGCCGAAAATGACCCAGAGCGCTGCCCATGCTGAGGTGTCTC
ACAAGTGCCGTGCAGTCCCGCCCCCACTTGCTTCTCTTTGTGTGTAGTGTACGTACATTATCGAGACCGTTGTTC
CCGCCCACCTCGATCCGGCATGCTGAGGTGTCTCACAAGTGCCGTGCAGTCCCGCCCCCACTTGCTTCTCTTTGT
GTGTAGTGTACGTACATTATCGAGACCGTTGTTCCCGCCCACCTCGATCCGGCATGCTGAGGTGTCTCACAAGTG
CCGTGCAGTCCCGCCCCCACTTGCTTCTCTTTGTGTGTAGTGTACGTACATTATCGAGACCGTTGTTCCCGCCCA
CCTCGATCCGGCATGCTGAGGTGTCTCACAAGTGCCGTGCAGTCCCGCCCCCACTTGCTTCTCTTTGTGTGTAGT
GTACGTACATTATCGAGACCGTTGTTCCCGCCCACCTCGATCCGGCATGCACTGATCACGGGCAAAAGTGCGTAT
ATATACAAGAGCGTTTGCCAGCCACAGATTTTCACTCCACACACCACATCACACATACAACCACACACATCCACA
ATGACCTTTGAACCTATTGCTATCGTCGGACAAGCCTGTACCCTGCCCGGAGCTCTCACCCCTGAGGCTCTGTGG
GCCAACGTCCTGCGAGGCGAATCTGCCGTGACCTCTCCTCCTGAGGGACGATGGCGACTGCCTGCTTGGCACGCT
ATGGGAAAGCCCGGCGCCCAGGAGGAGCGAGCTTGGTCTGATGCTGGAGGATACGTCCGAGGATTCGAATCTGCT
TTCGACCCTGGTGGCCTCCGACTGCCCGAAGCTGAGCTGCGAGGCCTCGACCCCGTTTTTCAGTGGACTCTGCAT
ACCGCCCGAGCCGCTCTGCGATCTGCCGGAATGGAGGGCCCCTCTGCCCGAGCTGGCCTCGTCCTCGGCAACCTG
TCCTTCCCCACCGCTTCCATGTCCCGATACGCTGAATCCGTCTGGCTCGAGGCTCTGGGAAAGGAGCTGCTCGGT
GGACGAGCCGCCGCCCAAGCTGGCGTGACTCATCCCGACGCCCATAACCGATTCATGTCTGGCCTGCCCGCCCAT
CTGGCTGCTCAGGCTCTGGGACTGGGCGGTGGAGCCTTCGCCCTGGATGCTGCTTGTGCCTCCTCTCTCTACGCT
ATTAAGCTCGCCTGCGACCGACTGCAGGATCGAGCCACCGATCTGATGCTGGCTGGTGCCGTGAACGCCGCTGAT
TCTCTGTTTCTCCATATCGGATTTTCTGCCCTGTCCGCCATGTCCCGAACCGGACAGTCTCGACCTTTCCACCGA
GAAGCCGACGGCCTCGTGCCCTCTGAAGGAGCTGTGTTCTTTGCCCTCCAGCGACTCGACGATGCCCGAGCCGCC
GGACGACGAGTCCTGGGAATTATCCGAGGCGTTGGTCTCTCTAACGACGGTCGAGGACGAGGACTGCTCGCTCCT
TCTGAGGAAGGCCAGATCCGAGCTATGCGACTCGCTTACGCTGCCGCCGGACTGACCCCCTCTGACGTGTCCTTC
GTCGAATGCCATGCCACCGGAACTCCCGTTGGAGACGCCACTGAGATCCGATCCCTGTCCGAGGTCTTTGCTGGT
TGTCGAGACGTGCCCATCGGCTCTCTGAAGTCTAATCTGGGCCATCTCATCACCGCCGCTGGTGGTGCTGGACTG
ATTAAGGTCCTGGGTTCCTTCACCGCTGAGACTATCGCCCCTACCATCCATGCCGGAGCTTCCATCCCTGAGCTG
GCCGGATCCCCTGTGCGACTCGTGACTCAGGCTGAACCCTGGCGAGCTGCTGGCCGACGAATTGCCGCCATCTCC
GCCTTTGGTTTCGGAGGCAACAACGCCCATCTGATTGTTGAGCAAGACGACGGACGAGCTACTGCTCCCCGAGCT
GCTGCCCCTCGATCTGCTCCCGCCCCTATTGCCGTGATCTCCCTGGGTGCCCGAATCGGAGATACCACCGGACGA
GATGAGGCTGCCCGAGCTCTCCTGTCTGGCGCTGGCTGGGGTTCCCGACGAGAGGCTGTGACCGTTGAGCTGGAG
GGTCTCCGATTTCCCCCTCGAGATCTGGAGCAAACCCTGCCCCAGCAGCTGCTGGTCCTCGAGGCTGGTCGAGAG
GCTATCCGAGGCCTCTCCCTGCCCCGAGATCGAACCGCCGTTCTGATCGGAATGGGTGCTGACCCCGAGGTCGCT
CGATACGGCGCTCGATGGCGACTCCCCGCCTTTGCTGATGCCTGGGCCGCTGCTGGTCTCCCCGTGTCCTCTGCC
TGGACTGAGGCTGCTCGAGACGCTGTGCAGGAACAGCATGGAGCCGCCGGTGTCGTCGGCGCCATGCCCAACATC
CCCGCTAACCGACTCTCCTCTCAGCTCGACCTCGCTGGCCCCTCCTTTACTATTTCCTCTGAGGAGCTCTCCGGT
GTCGTGGCTCTCCAGCTCGCCGCTCGAGCCCTGCGATCCGGAGAGATCGATGCCGCCCTGGTCGGAGCTGTTGAT
CHAPTER 5: RECOMBINANT PUFA PRODUCTION IN YARROWIA LIPOLYTICA 
166 
 
CTGGCCGATCAGATCGTCCACCGAAAGGCCCTGGGAGAGCTCGGCCTGGAGCCTCGAGCTGGAGACGCTGCCGTG
GCCCTGGTGCTGAAACGACTGACCGATGTCCGAAAATCTGAGAAGGTCCTGGCCATTCTGGATGAGGGCATCGTG
GACGCCTCCTCCGATCCCGCCCGACTCCGAGTCGGAGACGGTGGCGCTGACCTGGATCCTTTCGCTACCACCGGC
AAGCCTCACGCCGCTGCTGGCCTCGTGCATGTGGCTGCCGCTGTCCTGGCTCTGCATCACGGAGCTCGACCTGCT
CCTGGTCGAGCTTCTATGCCTTGGGTCGGACCCCGACACGCTGAGGTGACCACTCAGGCCCTCGGCGATCAGGCT
GCCACCATCCACCTCCGAGGCGGCGGTCTCGCTGCTCCTCTCCTGCTGGACGCTACCCCTCAGATCCACGTCTTC
GCCGGAGCCGACCGAGAAGCCGTTCTGCGAGCCCTCTCTGATGGCCGAGAAGGCCTGGACGGTCCCGCCCGAGCT
GTGATTGTGGCTGGTTCTCGAGAGGAGCTCGAAGCTCGACGAGCCGACGCTCTGCGAGCCGCTGAGCGAAACGCT
CCCATGCCCGATGGCGTGTTTCTCCGAGATCGACCCGTGGCCGGAGAGCTGGCTTTTGTGTTTGCTGGCGCCGCC
GCCGCTTATCCCTCTATGGGTCGAGCCCTCGCCCTGGCCCTCCCTGACGTGATGGCTCGACTGGGCAATCGACTG
TCTACCCTGCCTGCTGTGATTGACTGGATTCATGGAGCCCCTCGAGAGCCTCGACACCCCCTCGAGCAGCTCTGG
GCTTCTTCTTTCCTCTGTCAGCTCCACGCCGAAATTACCCGAGTTGACCTCGGCCTGCGACCCTCTGCCACTATC
GGCTATTCTTCTGGCGAATCTAACGCCCTCTTCGCTATGGGAGCCTGGCGAGACCTCGACGCCATGATGCATGAA
GCCTGGACCGAGCCTCTGCTGACCACCGAGCTCGTGGGAGATTACGCCGCTGCTCGACGACTCTGGGCTCGATCC
GGTGTTACCTCCCCCGCCGCCACTTGGGCTGCTTGGGTTATCGCCGCCCCTGTTGACGATGTCCGACGAGCCCTG
ACTGGAGAGCCCCTCGCCCACCTGACCATTATTAACACTGCTGAAGAGTGTGTGATTGGAGGAGAGGCCTCCGCT
TGCGAGCGAGTCGTCGCCCGACTCGGAAAGAATCTGGCCCTCCCCCTCTCCTACGCTATGGCTTCCCATTGCCCT
GAGGTTGCCGAGGCTCGAGAGGCTTGGATTAAGATGCATCGACGAGCTACCTTTGACGTTCCCGGTGTCCGAATT
TACTCCGCTGGAGCTGAGCAGGCCTTTGCCCCTACTGCCGACGCCGCCGCTATGGCCATTACTGGTCAAGCCGTG
GACACCCTGGACTTCCCTCGAGTGATTGAGCGAGCCTATGCCGATGGCGTTCGAGTCTTCGTTGAGCACGGACCC
CGAGGACTCTGCTCCCGATGGATTGCCCGAATTCTCGGAGCCCGAGAGCATCTCGTGGTGCCCCTCGACGTTGCT
GGCCAGCAACCCGTCCGACAGCTCGTCTCTGCCGTGGCTCAGCTGATTGCCGCTGGCGTGCCCGTTGCTGCTGAC
GCTCTCCTCGCTCGACTCGCCCCTCCCCCTCCTGCTCGAGCCTCTGGACCCACCCTGACCGTCCGAGCCCACCCT
CCTGACATCCATTTTCCTACCGCTCCTGCTATGCAGCTGATGCCCCCTGCTCCTCTCCTGCCCCCTGTTCTGGCC
GACAACCCCGCCCCTCGAACTGAACGATCTTTCACTGGTCGATCCGCTCTGCGAGAGGACGCTCCTGACGGTGTT
CCCTCTCCCCGACTGCCTGTTTTCGCCCGACTGGCCCCCGTGTTTACCCATACCGAACCTGTGTTCACTCACGTG
GAGCCCGCTCTCGCCTCTCCCGAACCTGCCGTGACCCACCCTGAGCCCGTTATCGCTCATGCTGAGCCCGCCCTG
ACCCACGCCGAACCTGCTCTGGCTTCCCCCGCCGATGGCCAACACGCTTCTATCGCCGCTCGAGGAGCCGCCGTC
TCCGCCGGAATTGCTGCTGCCCACCGAGCTTACGTTGAGGCTCAGGGTGCCGTTCACGCCCGATTCCTCGCTCTC
TCTGGTTCTCTGCTGTCCCGACTGGCTGCCGCTCCCACCGCTGCCGCTTTCCCTGCTCCTGCTCCCTCTCTGGCT
CCTCAACCTGCCGCTCTGCCTGCCCCCGCTCCTCAGGCTGCTCCTCCTCAGCGACTGACCGCTCCCACTCTGGTG
GTGGCCCGACCCGTTGCTCCTCCCGCTCCTACTCCCGTGCCTGCCGCTGTGGCTGCCTTTGCCCCTGCTCCCATT
TCTGCCCCCGCCTCTACCCTGCCCGCCCCTTCTCTGCTCCGATCTACTCTCCCCGGTCCTAAATTCTCCCGAGCC
GATCTGGAGGTTCTGGCCTCTGGTTCCATCTCCTCCATCTTCGGCCCCCAATTCGCCGGACAAGACGGCTACGCC
AAGCAATGTCGAATGCCCGAGCCCCCTCTGCTCCTGGCTGACCGAGTGACTGGAATCGACGCCGTCCCCGGTTCT
ATGGATACTGGAACCATCTGGACTGAGACTGACGTCAAGCATGACTCTTGGTACCTCCACCAAGGCCGAATGCCT
ACCGGCATCGTGATCGAATCTGGCCAGGCCGATCTCCTGCTCATTTCTTGGCTGGGCATTGACGCCCTGAACAAA
GGCGAACGAGTCTACCGACTCCTGGGATGCGAGGCCACCTATCACGGCGAGCTCCCCAAGCCTGGAGACACCCTG
GTTTACGAGATTCACATTGACGGACATGCTGAGCAAGGAGACGTTCGACTGTTCTTTTTCCACTACGACTGTCGA
ATTAACGGAGAACTGCGAATTTCTGTGCGAAACGGCCAAGCTGGTTTCTTCACTTACCAGGAACTGGCCAACTCT
GGCGGTGTCCTCTGGGATGCTGACGGCGCTCCCCACGAGGCTACTGGTCCCCTCGACCCTCCCCAGGTGATCTGC
GAGAAGCAATCCTTTACCTCCGCTGAGGTCCTGGCCTTTTCTGAGGGAGACGCTTACGCCTGCTTCGGACGAGGT
TTTGAACGAGCCCAAACCCACGTCCGAACTCCCCGAATTCAGGACGGTCCTATGCGACTCCTGGATCGAGTGACT
CACTTTGATCCCCGAGGTGGACCTTGGGGTCGAGGATACCTCCGAGCTGAGGCCAAGCTCTCCCCCGATGACTGG
TTTCTGCGAGGCCATTTTAAGAACGACCCCTGCATGCCTGGCACTCTGATTCTGGAAGCCTGTGTTCAGGCTATG
GCCTTCTATCTGTGTGCTATGGGCTACTCTATCGATCGAGATGGCTGGCGATTTGAGCCTGTGCCCGGCCAAAAA
TCTCCCATGCGATGCCGAGGCCAGGCTTCCGTGACCTCCCGAGAAATTGTCTACGAGATCTTTGTCCACGAGGTC
ACCTCCGGCCCTATTCCTTCTGTTAAGGTCGATATGCTCTGTACCGTGGATGGACTGAAAGCCTTCCACGGAGAG
CGAGTTGGACTGCGACTCGTTCCCGCCTGGCCCCTGGACGACTGGCGACAAGCCCCCGTTGCCCCTCAATCTCTG
CACCGACGACCTAAGCAGATCGCTCCCCTCGGTGGCATTCTCGGACACGTTGAGACTCGACCCGTCCCCTCCGTG
AACGGTTTTGCCTTCGATTATGCCTCCCTGATCGCCTGTGCCTGGGGCAAACCCTCTCAGGCCTTCGGTCCTATG
TACGCTCCCTTTGACGGAACTCGACGAGTCGCCCGACTCCCTGGTCCCCCTTACCACTTTATCACTCGAATTATC
TCCGTCGAAGGTCCTATCGGCGTTCCCCAGCCCGGCGCCGAGGTTGAGGTCGAATACGACGTTCCTCACGATGCT
TGGTACTTTGCCGAGAACGGTGCCCGAACCATGCCCTTTTGCGTGCTCCTGGAAGCTGCCCTCCAGCCCTGCGGA
TGGCTCGCCTCCTACATTGGTTCCGCCCTGACCACTGAAGATGACCTGCTGTTCCGAAATCTCGACGGCACCGGC
ACCGTGCTGGCTGAAATCACCCCCGAATCTGGCACCCTCCGAACCCACGTGAAGGTCGTGGAGGTCTCCCAATCT
GCTGGCATGATCATCGAAACCTTCGAGGTTGAATGTTTCGTGGGCGAGGCCCACGTCTATACCCTGCGAACCGTG
TTCGGCTTCTTCCCCAAATCTGCCTTTGACAATCAGGTCGGACTGCCTGTCTCCGCCGAGGCCCGAGCTCGAATT
GAGCGACAGGCTACTTCTACCATTGATCTCGCTCCCGAACCCCCTCGATACTTTGCCGGAGCTCCTCGACTCCCT
GAGGCTATGCTGTGCATGCTCGATCGAATTACCGCTTTCGAGCCCACTGGTGGACTGAAGGGTCTCGGCTACGGT
CGAGCTGAAAAGACCGTTAAGCCCGGAGAATGGTCCTTCAAGGCCCATTTCTTTCAGGATCCCGTTCAGCCCGGA
TCCCTCGGCCTCGAAGCTCTGCTCCAGCTGCTGCAGGCTTGGATGATTGACGCTGGAGATGCCGAGGGCATCCCT
GGTGCTCGATTCGAACCCATCGCCGTGGGCCGACCCATGACCTGGAAATATCGAGGCCAGGTCGTGCCTAAGAAC
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CTCCTCGTGACCGTGGAGATTGATATCACTGAGCGAGGAACTGATGACCGAGGTCGATTTGCCCTCGCTGAGGGT
TCTCTGTGGGTGGACGGCAAACGAATCTACGGCGCCAAGAATCTCGGCATGCGAGTTGTGGCCGGCCCTGAGCGA
CCTCCCCCTGGTTCTCCCCCTTCCCCTGCTTCCCCTACTGCCCCTACCGCCCCTCCCTCTCCCCCTGCTCCCACT
GTTCCCGCTGCCCTCGCCGCTCCTCCTTCCCGAGATCTGGCTTCCTTTCGATCCTTCTGGCGAGCTTCCATTGGT
GTCGGTCCTTGGCCTATTGAAGACCTCTATATCGCCCTGGTGGAGCGATTCCTCGGCCGAATCGTGATCGCTGAT
CCTGTCGCCTTCTCCCGAGTCCACGGTCGAGGCTGCCTCTATGTCGCTAACCACCAGGTCGCCCTGGAATCCCTG
ATTTTTATTATGGTCGCTTCTGCCATTTCCGGAACTCGAACTATGGCTCTCGCTAAAGCCGAGCACCAGGAATCC
TGGCTGGGCCGACTGATCACTCGAGGAATCGCCTACCCTGGTGTCACTGATCCCGGACTGATCACTTTCTTTGAC
CGAGAGGACCATGCTTCCTTTGCTCGAATTGCTGAACAGGCTACCCGAGACCTCGCCGCTTCTACCAAATCCGTG
CTGGTCCATGTTGAGGGAACTCGAGCTATTTCCTGTCGAACTCCTGTGACCCGACTGGGTGCTTCCGTTATCGAC
ATGGCTCTCGCTGCCGGAGCTCCCATCGTTCCTGTCCGATTCGCTCGAGGACTGCCTGAATCTGACTCTCCCGAA
CGACTCGACTTCCCCCTGGGTTACGGCCGACAAGACATTTACTTCGGTGCCCCTATTGAACCCGCTGAACTGGCC
CGACTGCCCCTGAAGGACCGAAAGGATGCTCTGCTCACTGCCCTGAATACCCTCGGTCCCGGAGCCTCCGATACC
CCTTCTGACCCCGATCCTTCCTTTGCCGCCCAGGTCGAGGCTTGGCGAGCTCGAACTGGTTGTGCTATCGAGGAC
GCCGTTTTCTACGCTACTCTCGCTGGCGCCTCTGCTCCCGAATCTGAAGGCGTGCAGCGACTGCTCGAGGGAGCT
CGAACTGGCAAACTCGTGATCGGCTCCGGCGAAAAGGATCGATGGCTGGGAGAATTCGCCCGATCCCTCTTCGGT
TCTGCTGACGCCACCCTGCTCGTCGAGGGAGGTTAAGCTATTTATCACTCTTTACAACTTCTACCTCAACTATCT
ACTTTAATAAATGAATATCGTTTATTCTCTATGATTACTGTATATGCGTTCCTCTAAGACAAATCGAAACCGGCA
CCTGTCCTAGG 
 
 
>building block 4 
CCTAGGAGTTGCATGATAAAGAAGACAGTCATAAGTGCGGCGACGATAGTCATGCCCCGCGCCCACCGGAAGGAG
CTGACTGGGTTGAAGGCTCTCAAGGGCATCGGTCCACGCTCTCCCTTATGCGACTCCTGCATTAGGAAGCAGCCC
AGTAGTAGGTTGAGGCCGTTGAGCACCGCCGCCGCAAGGAACATGCTGAGGTGTCTCACAAGTGCCGTGCAGTCC
CGCCCCCACTTGCTTCTCTTTGTGTGTAGTGTACGTACATTATCGAGACCGTTGTTCCCGCCCACCTCGATCCGG
CATGCTGAGGTGTCTCACAAGTGCCGTGCAGTCCCGCCCCCACTTGCTTCTCTTTGTGTGTAGTGTACGTACATT
ATCGAGACCGTTGTTCCCGCCCACCTCGATCCGGCATGCTGAGGTGTCTCACAAGTGCCGTGCAGTCCCGCCCCC
ACTTGCTTCTCTTTGTGTGTAGTGTACGTACATTATCGAGACCGTTGTTCCCGCCCACCTCGATCCGGCATGCTG
AGGTGTCTCACAAGTGCCGTGCAGTCCCGCCCCCACTTGCTTCTCTTTGTGTGTAGTGTACGTACATTATCGAGA
CCGTTGTTCCCGCCCACCTCGATCCGGCATGCACTGATCACGGGCAAAAGTGCGTATATATACAAGAGCGTTTGC
CAGCCACAGATTTTCACTCCACACACCACATCACACATACAACCACACACATCCACAATGGCCCTGCTGGACCTG
CCCCGAGGAGAAGCTCACCTGTACTATGCTCTCGAGGACCAGATCCGAGAGCCCGCTCTGCTCGCTGCCTACGAG
GCCCTCCTGACCCCTGAGGAGCGAGCCCGAAAGCAGCGATACTATTTTGAGAAGAACCGACATGAATACCTGATT
ACTCGAGCCCTGGTCCGATCCGTGCTGTCTCGATACGCCCGAGTCGTGCCCGCTGCTTGGGCTTTCTCTGCTAAT
CAATGGGGATGCCCCGCCATTGCCTCTCCCGAGGGAACCGGTCTCCGATTTAACCTGTCCAACACCCGAGGTCTC
GTTTGCTGTCTCGTCGCTCGAGACCGAGATGTCGGCGTTGACGTGGAAGACGTGGAGCGAGATGGCGAGACCGTG
GCCATTGCCGATCGATTTTTCTCTCCCACTGAGGTTGAGGAACTCCGAGCTCAGCCTGAGCCCCGACGACGACCT
CGATTTTTCGACTACTGGACTCTGAAGGAAGCCTACATTAAAGCCCGAGGAATGGGTCTCGCCATCCCCCTCGAC
CAATTCTCTTTCCAGCTCTCTCCCGGCCGACCTATTGGCATCGCCTTTGATCCCGTTCTGGAGGATGACCCTGCC
TCCTGGCAATTCGAACAGCTGCGACCTACCCCTTCCCACCTGGTCTCCCTCGCTATCCGACGACGAGACGAAGCT
GATGTTCGAGTCCTGGCCCGACGAGTCACCCCTCTCCTCCCTGCCGCTGATGTCGTGATCGACCTGCCCGCCACT
CTCGCCGTGTAAGCTATTTATCACTCTTTACAACTTCTACCTCAACTATCTACTTTAATAAATGAATATCGTTTA
TTCTCTATGATTACTGTATATGCGTTCCTCTAAGACAAATCGAAACCTTAATTAA 
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myxobacterial PUFA synthases 
  
CHAPTER 6: ELUCIDATION OF BIOSYNTHETIC MECHANISMS OF PUFA SYNTHASES 
169 
 
INTRODUCTION 
Various microorganisms from the marine ecosystem [1-3] but also some genera of terrestrial 
myxobacteria [4] have been found to produce long-chain polyunsaturated fatty acids (LC-
PUFAs) de novo from acyl-CoA precursors by iteratively acting polyketide synthase (PKS)-
like PUFA synthases. These multienzyme complexes are encoded by PUFA (pfa) biosynthetic 
gene clusters, which were described for the first time from marine microbes, including 
Shewanella pneumatophori SCRC-2738 and Photobacterium profundum SS9 [5;6], and 
Moritella marina MP-1 [7] (Figure 1). Some of these γ-Proteobacteria produce mainly 
eicosapentaenoic acid (EPA, 20:5, n-3) (Shewanella and Photobacterium), whereas others 
synthesize mainly docosahexaenoic acid (DHA, 22:6, n-3) (Moritella). The correlation of the 
distinct biosynthetic pathways with their products was supported by heterologous expression 
of these pfa gene clusters in suitable host strains, resulting in the same LC-PUFA production 
profiles as in the corresponding native producer [8-10]. Similarly, the three different types of 
myxobacterial pfa gene clusters, that have been recently discovered, contribute to individual 
LC-PUFA production profiles, as confirmed by heterologous expression described previously 
([4]; Chapter 2). Consequently, it can be concluded that the LC-PUFA products primarily 
synthesized by a specific PUFA synthase is determined by one or more of the pfa gene 
products. Deeper understanding of the working principles of PUFA synthases is crucial to 
fully exploit their potential for directed biotechnological production of selected LC-PUFAs. 
Up to now, several genetic and biochemical experiments have been performed with marine 
pfa gene clusters. Unfortunately, neither the exact biosynthetic function and underlying 
biochemistry of every catalytic domain from the PUFA synthase complex has been 
elucidated, nor the relevant factor(s) that determine the nature of the final LC-PUFA product 
have been identified.  
The function of the enoyl reductase (ER) domain encoded by pfaD from Shewanella 
oneidensis MR-1 has been demonstrated in vitro by trans-enoyl reduction of crotonic acid 
tethered to the acyl carrier protein (ACP) domains of PfaA in the presence of NADPH [11]. 
The consecutive ACP domains are encoded in a variable number by each pfa gene cluster 
(Figure 1+2), and all of these so called tandem ACP domains of a particular PUFA synthase 
share a striking degree of sequence similarity (> 95% identical). Site-directed mutagenesis of 
the six ACPs encoded by pfaA from Shewanella japonica to abolish the substrate binding 
capability of the respective ACP revealed that LC-PUFA biosynthesis is an ACP-dependent 
process. Moreover, it could be shown that each of the tandem ACPs is functionally equivalent 
for LC-PUFA biosynthesis regardless of its physical location within the PfaA subunit and that 
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the overall LC-PUFA titre directly depends on total number of active ACPs [12]. On the basis 
of a hybrid PUFA synthase in which pfaA from S. japonica was replaced by its homologue 
from M. marina, it could be concluded that the LC-PUFA product distribution is regulated 
independent of the ACPs and the other domains of PfaA, as the product spectrum was not 
significantly altered [12]. However, there are several hypotheses with respect to the role of the 
multiple tandem ACP domains. As they may provide a scaffold for parallel LC-PUFA 
biosynthesis, the overall pathway flow could be increased (additive effect). Furthermore, the 
extra ACP domains could make the extension step (catalysed by the ketosynthase (KS) 
domain) a biosynthetic bottleneck, thus controlling the complete processing of PUFA 
intermediates.  
 
 
Figure 1. PUFA biosynthetic gene clusters of marine γ-Proteobacteria.  
(A) Shewanella pneumatophori SCRC-2738 (EPA producer), (B) Photobacterium profundum SS9 (EPA 
producer), (C) Moritella marina MP-1 (DHA producer). 
 
 
In order to obtain deeper insights into the product specificity of different PUFA synthases 
and to identify relevant factors directing the biosynthesis toward specific LC-PUFA products, 
pfa genes from different pathways were coexpressed followed by analysis of PUFA 
production profiles. These combinatorial studies were based on the advantage that PUFA 
synthase subunits from different origins seem to be compatible to each other allowing for 
functional interaction. Coexpression of the genes pfaBCD from S. pneumatophori  
SCRC-2738 (EPA producer) plus the complete pfa gene cluster from M. marina MP-1 (DHA 
producer) in E. coli yielded the production of both EPA and DHA [13]. Similarly, 
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coexpression of pfaB from S. pneumatophori SCRC-2738 plus the complete pfa gene cluster 
from M. marina MP-1 or coexpression of pfaACD from S. pneumatophori SCRC-2738 plus 
pfaB from M. marina MP-1 in E. coli also resulted in the production of both EPA and DHA 
[14]. These results suggest that pfaB from marine γ-Proteobacteria may play a role in 
determining the final LC-PUFA product. In addition to the acyltransferase (AT) domain, pfaB 
from M. marina MP-1 encodes an extra KS domain (Figure 1), which was found to lack the 
active site cysteine [15]. The question whether the KS or the AT domain (or both) determine 
the final LC-PUFA product in these studies could not yet be resolved. Interestingly, the three 
types of myxobacterial PUFA synthases, catalysing the biosynthesis of linoleic acid, EPA, or 
DHA as main product, do not contain any domain homologues to the inactive KS domain of 
PfaB. It is even more astonishing that the pfa gene cluster responsible for the production of 
oleic acid (OA, 18:1, n-9)/linoleic acid (LA, 18:2, n-6) from Sorangium cellulosum lacks the 
AT domain homologous to the AT domain encoded by pfaB, whereas this domain is present 
in the pfa gene cluster responsible for the production of EPA or DHA from S. cellulosum or 
Aetherobacter spp. (Chapter 2).  
The discovery of three different types of myxobacterial PUFA pathways with different 
production profiles and the availability of heterologous production platforms established in 
previous studies ([4]; Chapter 2, 3, and 5) provided a convenient basis for experimental 
functional studies. The impact of selected catalytic domains and their relevance for chain 
length control was investigated by heterologous expression of mutated or chimeric versions of 
myxobacterial pfa gene clusters in E. coli, P. putida, and Y. lipolytica. In addition, efforts 
were undertaken to prove the function of the unique 1-acylglycerol-3-phosphate  
O-acyltransferase (AGPAT) domain from myxobacterial PUFA synthases in vitro.  
 
 
 
EXPERIMENTAL PROCEDURES 
 
Culture conditions 
Escherichia coli DH10B [16] was used for cloning experiments. E. coli BL21(DE3) [17] and 
Rosetta 2(DE3)pLysS (Novagen) were used for heterologous expression experiments. E. coli 
HS996/pSC101-BAD-gbaA (tet
R
) [18] was used for modification of a plasmid using Red/ET 
recombination. E. coli HB101/pRK2013 [19] was used as helper strain for conjugation 
experiments. The cells were grown in LB-medium or on LB-agar (1% tryptone, 0.5% yeast 
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extract, 0.5% NaCl, (1.5% agar)) at 37 °C (and 200 rpm) overnight. Antibiotics were used at 
the following concentrations: 100 µg/ml ampicillin, 50 µg/ml kanamycin, 20 µg/ml zeocin, 
and 6 µg/ml tetracycline. 
Pseudomonas putida KT2440 [20] was cultivated in liquid LB-medium at 30 °C and 
200 rpm overnight. Conjugation was carried out onto PMM-agar plates containing 0.61% 
K2HPO4, 0.5% KH2PO4, 0.1% (NH4)2SO4, 0.66% disodium succinate, and 1.5% agar. The 
medium was adjusted to pH 7.0 and supplemented with 0.12% MgSO4 after autoclaving. 
Antibiotics were used at the following concentrations: 60 µg/ml kanamycin and 30 µg/ml 
tetracycline. 
Auxotrophic Yarrowia lipolytica Po1h (CLIB 882) [21] was obtained from Centre 
International de Ressources Microbiennes (CIRM)-Levures, Institut National de la Recherche 
Agronomique (INRA), AgroParisTech, Thiverval-Grignon, France. It was grown in YPD-
medium or on YPD-agar containing 1% yeast extract, 2% peptone, and 2% dextrose. 
Prototrophic transformants were grown in minimal medium YNB containing 0.67% yeast 
nitrogen base (with 75% (NH4)2SO4 and without amino acids), and 50 mM KPO4 buffer  
pH 6.8. Different carbon sources were used: YNB-N5000 contains 1% glucose and YNBD 
contains 2% glucose. The cultures were incubated for 1-7 days at 20-30 °C (and 200 rpm). 
 
 
General molecular biology techniques  
Routine handling of nucleic acids, such as isolation of genomic and plasmid DNA, restriction 
endonuclease digestions, DNA ligations, and other DNA manipulations, were performed 
according to standard protocols [22]. All the enzymes were purchased from Thermo Scientific 
or New England Biolabs. 
 
 
Cloning of expression constructs containing the pfa gene cluster of A. fasciculatus 
(SBSr002) with active site mutations in the target domains of pfa3 for heterologous  
LC-PUFA production in P. putida 
Five protein domains encoded by gene pfa3 of the directly cloned pfa gene cluster from 
A. fasciculatus (SBSr002) were targeted for inactivation. Therefore, the wild type sequences 
were exchanged for mutated sequences either by conventional cloning or by linear plus 
circular homologous Red/ET recombineering. In the latter case, a fragment of pfa3 with active 
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site mutation in the target domain as well as a zeocin resistance gene flanked by unique 
restriction sites were amplified by PCR. Both fragments were then fused by overlap extension 
PCR. The zeocin resistance gene allowed for selection after the Red/ET recombineering step 
and could subsequently be removed via the flanking restriction sites. In the case of C194S, a 
zeocin resistance gene with FseI restriction sites as well as the appropriate homology arm and 
overlap, as the first fragment (0.6 kb), was amplified from plasmid pMyx-zeo (S. C. Wenzel, 
unpublished) using primers zeo
R
+HA_FseI_fwd and zeo
R
+overlap_FseI_rev (Table 1). The 
second fragment (0.6 kb) contained the overlapping sequence with the FseI restriction site 
plus the introduced T to A point mutation, which was amplified from plasmid pJB*PfaAf1** 
(Chapter 3) using primers C194S+overlap_FseI_fwd and C194S_T to A_rev (Table 1). In the 
case of S953A, a zeocin resistance gene with ScaI restriction sites (introduced by silent 
mutation) as well as the appropriate homology arm and overlap, as the first fragment (0.6 kb), 
was amplified from plasmid pMyx-zeo using primers zeo
R
+HA_ScaI_fwd and 
zeo
R
+overlap_ScaI_rev (Table 1). The second fragment (0.2 kb) contained the overlapping 
sequence with the ScaI restriction site (introduced by silent mutation) plus the introduced T to 
G point mutation, which was amplified from plasmid pJB*PfaAf1** using primers 
S953A+overlap_ScaI_fwd and S953A_T to G_rev (Table 1). In the case of H1755Q, a zeocin 
resistance gene with SpeI restriction sites (introduced by silent mutation) as well as the 
appropriate homology arm and overlap, as the first fragment (0.6 kb), was amplified from 
plasmid pMyx-zeo using primers zeo
R
+overlap_SpeI_fwd and zeo
R
+HA_SpeI_rev (Table 1). 
The second fragment (0.2 kb) contained the overlapping sequence with the SpeI restriction 
site (introduced by silent mutation) plus the introduced C to G point mutation, which was 
amplified from plasmid pJB*PfaAf1** using primers H1755Q_C to G_fwd and 
H1755Q+overlap_SpeI_rev (Table 1). In the case of H2166Q, a zeocin resistance gene with 
HindIII restriction sites as well as the appropriate homology arm and overlap, as the first 
fragment (0.6 kb), was amplified from plasmid pMyx-zeo using primers 
zeo
R
+overlap_HindIII_fwd and zeo
R
+HA_HindIII_rev (Table 1). The second fragment 
(0.5 kb) contained the overlapping sequence with the HindIII restriction site plus the 
introduced C to G point mutation, which was amplified from plasmid pJB*PfaAf1** using 
primers H2166Q_C to G_fwd and H2166Q+overlap_HindIII_rev (Table 1). In the case of 
E2455R, a 0.4 kb and a 0.8 kb fragment were amplified from plasmid pJB*PfaAf1** using 
primers E2455R_HindIII_fwd / E2455R_GA to CG_rev and E2455R_GA to CG_fwd / 
E2455R_PacI_rev (Table 1). Thereby, the GA to CG mutations as well as HindIII and PacI 
restriction sites were introduced. PCR amplification of the two fragments to be spliced was 
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performed with Phusion DNA polymerase (Thermo Scientific) and standard conditions 
according to the manufacturer’s protocol. The reactions contained 5% DMSO and were 
carried out in an Eppendorf Mastercycler under the following conditions: initial denaturation 
for 2 min at 98 °C; 30 cycles consisting of denaturation for 15 s at 98 °C, annealing for 20 s at 
66 °C, and extension for 10 s/kb at 72 °C; and a final extension for 10 min at 72 °C. For the 
subsequent overlap extension PCR, the two outer primers without overlap and the two 
amplified fragments as templates were used in each case. PCR was performed as described for 
the amplification of the two fragments to be spliced.  
In the case of C194S, S953A, and H1755Q, linear plus circular homologous Red/ET 
recombineering was performed as described previously [4] on the basis of plasmid 
pJB*PfaAf1** using 1.5 µl of the PCR product, resulting in plasmid  
pJB*PfaAf1**-C194S-zeo
R
, pJB*PfaAf1**-S953A-zeo
R
, and pJB*PfaAf1**-H1755Q-zeo
R
 
(Table 2). In the case of H2166Q, linear plus circular homologous Red/ET recombineering 
was performed on the basis of plasmid pPfaAf7.1** (Chapter 3) using 1.5 µl of the PCR 
product, yielding plasmid pPfaAf7.1**-H2166Q-zeo
R
 (Table 1). The zeocin resistance gene 
was subsequently removed via FseI restriction sites (in the case of C194S), the introduced 
ScaI restriction sites (in the case of S953A), the introduced SpeI restriction sites (in the case 
of H1755Q), or HindIII restriction sites (in the case of H2166Q), generating plasmids 
pJB*PfaAf1**-C194S, pJB*PfaAf1**-S953A, pJB*PfaAf1**-H1755Q, or  
pPfaAf7.1**-H2166Q (Table 2). In the case of E2455R, 1170 bp of the wild type version of 
pfa3 in plasmid pPfaAf7.1** were exchanged for the PCR amplicon with the point mutations 
via HindIII and PacI restriction sites, resulting in plasmid pPfaAf7.1**-E2455R (Table 2). 
Additionally, the backbones of plasmids pPfaAf7.1**-H2166Q and pPfaAf7.1**-E2455R 
were exchanged for the backbone of plasmid pJB861-SwaI-cm
R
-PacI-cop271C (Chapter 3) 
via SwaI and PacI restriction sites, yielding plasmids pJB*PfaAf1**-H2166Q and 
pJB*PfaAf1**-E2455R (Table 2). 
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Table 1. Primers used for cloning of expression plasmids or for active site mutagenesis in this study. 
The homology arms are shown in italics, the introduced restriction sites are underlined, and the introduced 
nucleotide exchanges are shown in bold. 
 
Primer Sequence (5'3') 
zeo
R
+HA_FseI_fwd 
CGGCCCGCCGAGGTCCGCGCGCCGCACCTCGTGGAGACAGGGCCGGCCT
CAGTCCTGCTCCTCGGCCAC 
zeo
R
+overlap_FseI_rev CGAAGGTCACGAGGCCGGCCGAATTCTGGACAGCAAGCGAACCG 
C194S+overlap_FseI_fwd CGGTTCGCTTGCTGTCCAGAATTCGGCCGGCCTCGTGACCTTCG 
C194S_T to A_rev ACGAGGCGCTGGCGGCGTCG 
zeo
R
+HA_ScaI_fwd 
CGCGCTCCCCGACGTGATGGCGCGCCTCGGCAACCGGCTCAGTACTCAG
TCCTGCTCCTCGGCCAC 
zeo
R
+overlap_ScaI_rev GTCGATCACCGCGGGCAGAGTACTGAATTCTGGACAGCAAGCGAACCG 
S953A+overlap_ScaI_fwd CGGTTCGCTTGCTGTCCAGAATTCAGTACTCTGCCCGCGGTGATCGAC 
S953A_T to G_rev CGGAGGCGTAGCCGATGGTCG 
zeo
R
+overlap_SpeI_fwd CGGCCAGGCCAGCGTGACTAGTGAATTCTGGACAGCAAGCGAACCG 
zeo
R
+HA_SpeI_rev 
TCGTGACCTCGTGGACGAAGATCTCGTAGACGATCTCCCGACTAGTCAG
TCCTGCTCCTCGGCCAC 
H1755Q_C to G_fwd GCGAGGGCAGTTCAAGAACGATCC 
H1755Q+overlap_SpeI_rev CGGTTCGCTTGCTGTCCAGAATTCACTAGTCACGCTGGCCTGGCCG 
zeo
R
+overlap_HindIII_fwd CGATCTCGCCTCGTTTCGAAGCTTGAATTCTGGACAGCAAGCGAACCG 
zeo
R
+HA_HindIII_rev 
CTCGATCGGCCAGGGCCCGACCCCGATCGAGGCGCGCCAGAAGCTTCAG
TCCTGCTCCTCGGCCAC 
H2166Q_C to G_fwd AAGCCCAGTTCTTCCAGGATCCCG 
H2166Q+overlap_HindIII_rev CGGTTCGCTTGCTGTCCAGAATTCAAGCTTCGAAACGAGGCGAGATCG 
E2455R_HindIII_fwd AAGCTTCTGGCGCGCCTCGATCGGG 
E2455R_GA to CG_rev GGCGCGCGTGCCCCGGACGTGGACGAGC 
E2455R_GA to CG_fwd GCTCGTCCACGTCCGGGGCACGCGCGCC 
E2455R_PacI_rev TTAATTAAAGACGGTGAAATCGTTCGACGTGTGCCTC 
AT_So026_2_ApaLI_fwd GGGCGTGCACTCGCGCTGGCGCTG 
AT_So026_2_FspI_rev GCGGATGCGCAGGGATCTTCAGCGTGG 
AfAGPAT_BamHI_fwd_2 GCGTCGGATCCGTCGCCGGCCCCGAGC 
AfAGPAT_NotI_rev_2 CACGCTGCGGCCGCTCAGCCGCCCTCCACC 
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Table 2. Plasmids constructed in this study.  
oriV = origin of replication, trfA = gene encoding replication initiation protein in RK2 replicons, oriT = origin of 
transfer, aph(3')-Ia = kanamycin resistance gene, ble = zeocin resistance gene, bla = ampicillin resistance gene, 
PTn5 = Tn5 promoter. 
 
Plasmid Characteristics 
pJB*PfaAf1**-C194S-zeo
R
 
Derivative of pJB*PfaAf1** (Chapter 3) in which PTn5-ble plus a 
C194S mutation were introduced into pfa3 by Red/ET recombineering. 
RK2 oriT, RK2 oriV, trfA*, aph(3')-Ia 
pJB*PfaAf1**-C194S 
Derivative of pJB*PfaAf1**-C194S-zeo
R
 in which PTn5-ble was 
removed via FseI 
pJB*PfaAf1**-S953A-zeo
R
 
Derivative of pJB*PfaAf1** in which PTn5-ble plus a S953A mutation 
flanked by ScaI restriction sites were introduced into pfa3 by Red/ET 
recombineering 
pJB*PfaAf1**-S953A 
Derivative of pJB*PfaAf1**-S953A-zeo
R
 in which PTn5-ble was 
removed via ScaI 
pJB*PfaAf1**-H1755Q-zeo
R
 
Derivative of pJB*PfaAf1** in which PTn5-ble plus an H1755Q 
mutation flanked by SpeI restriction sites were introduced into pfa3 by 
Red/ET recombineering 
pJB*PfaAf1**-H1755Q 
Derivative of pJB*PfaAf1**-H1755Q-zeo
R
 in which PTn5-ble was 
removed via SpeI 
pPfaAf7.1**-H2166Q-zeo
R
 
Derivative of pPfaAf7.1** (Chapter 3) in which PTn5-ble plus an 
H2166Q mutation were introduced into pfa3 by Red/ET recombineering. 
p15A oriV, bla, ble 
pPfaAf7.1**-H2166Q 
Derivative of pPfaAf7.1**-H2166Q-zeo
R
 in which PTn5-ble was 
removed via HindIII 
pJB*PfaAf1**-H2166Q 
Derivative of pPfaAf7.1**-H2166Q in which the vector backbone was 
exchanged for the vector backbone of pJB861-SwaI-cm
R
-PacI-cop271C 
(Chapter 3) via SwaI and PacI 
pPfaAf7.1**-E2455R 
Derivative of pPfaAf7.1** in which 1170 bp of pfa3 were replaced with 
the same 1170 bp of gene pfa3 except for an E2455R mutation via 
HindIII and PacI 
pJB*PfaAf1**-E2455R 
Derivative of pPfaAf7.1**-E2455R in which the vector backbone was 
exchanged for the vector backbone of pJB861-SwaI-cm
R
-PacI-cop271C 
(Chapter 3) via SwaI and PacI 
pSynHybPfa1 
Derivative of pPm**SynPfaAf2 (Chapter 4) in which the KS2 plus the 
CLF domain of gene pfa3 originating from A. fasciculatus (SBSr002) 
were replaced by KS/CLF_So026_2 via FseI and ApaLI. RK2 oriT, RK2 
oriV, trfA*, aph(3')-Ia 
pSynHybPfa2 
Derivative of pPm**SynPfaAf2 in which the AT2 domain of gene pfa3 
originating from A. fasciculatus (SBSr002) was replaced by the AT2 
domain of gene pfa3 from S. cellulosum SBSo026 via ApaLI and FspI 
pSynHybPfa3 
Derivative of pSynHybPfa2 in which the KS2 plus the CLF domain of 
gene pfa3 originating from A. fasciculatus (SBSr002) were replaced by 
KS/CLF_So026_2 via FseI and ApaLI 
pSynPfaPptAf2-hybpfa3 
Derivative of pSynPfaPptAf2 (Chapter 5) in which hp4d, the KS2, the 
CLF, plus the AT2 domain of gene pfa3 originating from A. fasciculatus 
(SBSr002) was replaced by building block 5 via AclI and KpnI 
pSynPfaPptAf2mc- hybpfa3 
Derivative of pSynPfaPptAf2-hybpfa3 in which hp4d-mcherry-LIP2t was 
inserted via AclI 
pGEX-6P-1-AfAGPAT+linker 
Derivative of pGEX-6P-1 (GE Healthcare) in which AfAGPAT flanked 
by 129 bp and 135 bp linker sequences was inserted via BamHI and NotI 
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Sequence analysis and design of the synthetic gene clusters 
The KS2 and chain length factor (CLF) domains of gene pfa3 from the arachidonic acid (AA, 
20:4, n-6)/EPA-type pfa gene cluster of S. cellulosum SBSo026 were analysed and compared 
to the genome sequence of P. putida KT2440 [23] retrieved from NCBI Genome RefSeq 
NC_002947 in collaboration with ATG:biosynthetics. Based on this, relevant parameters for 
constructional and functional sequence design were defined to generate an artificial DNA 
sequence comprising the KS2/CLF domains analogous to the artificial docosapentaenoic acid 
(DPA, 22:5)/DHA-type pfa gene cluster version 2a (Chapter 4) using the proprietary 
evoMAG-GeneDesign software [24].  
The KS2, CLF, and AT2 domains of gene pfa3 from the AA/EPA-type pfa gene cluster of 
S. cellulosum SBSo026 were analysed and compared to the genome sequence of Y. lipolytica 
CLIB 122 [25] retrieved from NCBI Genome RefSeq NC_006067, NC_006068, NC_006069, 
NC_006070, NC_006071, and NC_006072. Based on this, relevant parameters for 
constructional and functional sequence design were defined to generate an artificial DNA 
sequence comprising the KS2/CLF/AT2 domains analogous to the artificial DPA/DHA-type 
pfa gene cluster (Chapter 5) using the proprietary evoMAG-GeneDesign software [24].  
 
 
Cloning of expression constructs containing hybrid pfa gene clusters for heterologous 
LC-PUFA production in P. putida, E. coli, or Y. lipolytica 
For the heterologous expression of artificial and hybrid PUFA biosynthetic pathways in 
P. putida KT2440, building block KS/CLF_So026_2, comprising the KS2 plus CLF domain 
of gene pfa3 originating from the AA/EPA-type pfa gene cluster of S. cellulosum SBSo026 
and adapted to P. putida KT2440, was designed and supplied by gene synthesis companies. 
The building block contains a 40 bp intergenic region comprising a Shine-Dalgarno sequence 
at the 5' end and is flanked by the unique FseI and ApaLI restriction sites for cloning 
purposes, which were excluded from any other unwanted position within the sequence (see 
appendix for sequence). Plasmid pSynHybPfa1 (Table 2) was constructed by exchange of the 
KS2 plus CLF domain of gene pfa3 of the artificial pfa gene cluster originating from 
A. fasciculatus (SBSr002) located on plasmid pPm**SynPfaAf2 (Chapter 4) for the building 
block KS/CLF_So026_2 via FseI and ApaLI restriction sites.  
The AT2 domain of gene pfa3 from the AA/EPA-type pfa gene cluster of S. cellulosum 
SBSo026 (1 kb) was amplified from plasmid pHybPfa1-mx9.2 (Chapter 2) using primers 
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AT_So026_2_ApaLI_fwd and AT_So026_2_FspI_rev (Table 1). PCR was performed with 
Phusion DNA polymerase (Thermo Scientific) and standard conditions according to the 
manufacturer’s protocol. The reactions contained 5% DMSO and were carried out in an 
Eppendorf Mastercycler under the following conditions: initial denaturation for 2 min at 
98 °C; 30 cycles consisting of denaturation for 15 s at 98 °C, annealing for 20 s at 72 °C, and 
extension for 10 s/kb at 72 °C; and a final extension for 10 min at 72 °C. The PCR amplicon 
served for replacement of the AT2 domain of gene pfa3 from the pfa gene cluster of 
A. fasciculatus (SBSr002) located on plasmid pPm**SynPfaAf2 (Chapter 4) via ApaLI and 
FspI restriction sites, yielding plasmid pSynHybPfa2 (Table 2). Plasmid pSynHybPfa3 (Table 
2) was constructed by exchange of the KS2 plus the CLF domain of gene pfa3 from the 
artificial pfa gene cluster originating from A. fasciculatus (SBSr002) located on plasmid 
pSynHybPfa2 for the building block KS/CLF_So026_2 via FseI and ApaLI restriction sites. 
For the heterologous expression of an artificial and hybrid PUFA biosynthetic pathway in 
Y. lipolytica Po1h, building block 5, comprising the KS2, the CLF, plus the AT2 domain of 
gene pfa3 originating from the AA/EPA-type pfa gene cluster of S. cellulosum SBSo026, was 
designed and supplied by gene synthesis companies. The building block additionally contains 
a 134 bp non-coding intergenic linker at the 5' end, the strong hybrid hp4d promoter [26] for 
Y. lipolytica and is flanked by the unique AclI and KpnI restriction sites for cloning purposes, 
which were excluded from any other unwanted position within the sequence (see appendix for 
sequence). Plasmid pSynPfaPptAf2-hybpfa3 (Table 2) was constructed by exchange of hp4d, 
domains KS2, CLF, plus AT2 of gene pfa3 of the artificial pfa gene cluster originating from 
A. fasciculatus (SBSr002) located on plasmid pSynPfaPptAf2 (Chapter 5) for the building 
block 5 via AclI and KpnI restriction sites. Plasmid pSynPfaPptAf2mc-hybpfa3 (Table 2) was 
constructed by insertion of hp4d-mcherry-LIP2t from plasmid pSynPfaPptAf2mc (Chapter 5) 
into plasmid pSynPfaPptAf2-hybpfa3 via AclI restriction sites. 
 
 
Transformation of P. putida by triparental conjugation and heterologous expression 
Expression plasmids were transferred into P. putida KT2440 by triparental conjugation. 1 ml 
of an overnight culture of the acceptor strain P. putida KT2440::pPptAf1, the donor strain 
E. coli DH10B containing the final expression construct, and the helper strain E. coli 
HB101/pRK2013 were harvested at 13,000 rpm for 1 min. After discarding the supernatant, the 
cells were resuspended in 1 ml LB-medium in each case. The cells were spun down at  
13,000 rpm for 1 min, and the supernatant was discarded. This wash step was repeated once. 
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The cells were resuspended in 300 µl LB-medium in each case. The triparental mating was 
performed by combining 50 μl of each 300 µl suspension on a small area of a LB-agar plate 
[27]. After incubation at 37 °C for 4 h, the plate was transferred to 30 °C and incubated 
overnight. The cells were scraped from the plate and resuspended in 1 ml sterile ddH2O. 10-
100 µl of this suspension was then plated out on PMM-agar containing 60 µg/ml kanamycin 
and 30 μg/ml tetracycline. The E. coli strains were additionally counterselected by 150 μg/ml 
ampicillin, which P. putida is resistant to. The plates were incubated at 30 °C for 1-2 days. 
Transconjugants were verified by plasmid isolation and restriction analysis of the replicative 
plasmids. The constructed strains are listed in Table 3. 
 
 
Transformation of Y. lipolytica by lithium acetate-mediated heat shock transformation and 
heterologous expression 
Transformation of Y. lipolytica was carried out using a protocol developed by M.-T. Le Dall, 
modified by C. Madzak (Laboratoire de Microbiologie de l'Alimentation au Service de la 
Santé (MICALIS), AgroParisTech, Thiverval-Grignon, France; personal communication). 
One loopful of Y. lipolytica cells from a YPD-agar plate grown at 30 °C overnight were 
resuspended in 1 ml TE buffer in a sterile tube. The cells were centrifuged at 10,000 rpm for 
1 min, and the supernatant was discarded. After resuspension in 600 l 0.1 M lithium acetate 
pH 6.0, the cells were incubated at 28 °C for 1 h in a water bath. The samples were 
centrifuged at 3,000 rpm for 2 min, the supernatant was discarded, and the cells were softly 
resuspended in 80 l 0.1 M lithium acetate pH 6.0. 40 µl of competent cells were mixed with 
2 µl herring testes carrier DNA (10 mg/ml in TE buffer, denatured) and 3 µl linearized 
plasmid DNA to be transformed. The samples were incubated at 28 °C for 15 min in a water 
bath, and 350 μl 40% PEG 4000 in 0.1 M lithium acetate pH 6.0 plus 16 µl 1 M dithiothreitol 
(DTT) were added. After incubation of the cells at 28 °C for 1 h in a water bath, 40 µl DMSO 
were added. Subsequently, heat shock was carried out at 39 °C for 10 min in a heating block. 
600 l 0.1 M lithium acetate pH 6.0 were then added, and the cells were plated onto YNB-
N5000-agar. The plates were incubated at 30 °C for 3 days. Thereafter, selected colonies were 
transferred onto new YNB-N5000-agar plates. The constructed strains are listed in Table 3. 
Expression was carried out in 50 ml YNBD-medium inoculated with an overnight culture 
starting from OD600 = 0.1. The cells were cultivated at 28 °C and 200 rpm for 76-168 h and 
then harvested at 4,000 rpm for 5 min. 
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Heterologous LC-PUFA production in E. coli and P. putida 
E. coli BL21(DE3) was cotransformed with the expression constructs pSynHybPfa1 plus 
pPptAfA (Chapter 3), pSynHybPfa2 plus pPptAfA, or pSynHybPfa3 plus pPptAfA. The 
constructed strains are listed in Table 3. For heterologous LC-PUFA production, cultivation 
of the strains was carried out in 50 ml LB-medium containing 50 µg/ml kanamycin and 
100 µg/ml ampicillin. The medium was inoculated with an overnight culture (1:100) and 
incubated at 37 °C. Expression of the Pfa proteins and AfPpt was induced at OD600 of 0.4-0.8 
by addition of m-toluic acid to a final concentration of 2 mM. After induction, the cells were 
cultivated at 16 °C and 200 rpm for 24 h and then harvested at 8,000 rpm for 5 min. 
For heterologous LC-PUFA production in P. putida, cultivation was carried out in 50 ml 
LB-medium containing 60 µg/ml kanamycin and 30 μg/ml tetracycline. The medium was 
inoculated with an overnight culture (1:100) and incubated at 30 °C for 4 h. Expression of the 
Pfa proteins and AfPpt was induced by addition of m-toluic acid to a final concentration of 
2 mM. After induction, the cells were cultivated at 16 °C and 200 rpm for 24 h and then 
harvested at 8,000 rpm for 5 min. 
 
 
Cloning of an expression construct containing the AGPAT domain encoded by the pfa 
gene cluster of A. fasciculatus (SBSr002), heterologous expression in E. coli, and protein 
purification 
The AGPAT domain flanked by 129 bp and 135 bp linker sequences of gene pfa3 from the 
pfa gene cluster of A. fasciculatus (SBSr002) (1.1 kb) was amplified from plasmid 
pPfaAf7.1* (Chapter 3) using primers AfAGPAT_BamHI_fwd_2 and AfAGPAT_NotI_rev_2 
(Table 1). PCR was performed with Phusion DNA polymerase (Thermo Scientific) and 
standard conditions according to the manufacturer’s protocol. The reactions contained 5% 
DMSO and were carried out in an Eppendorf Mastercycler under the following conditions: 
initial denaturation for 2 min at 98 °C; 30 cycles consisting of denaturation for 15 s at 98 °C, 
annealing for 20 s at 72 °C, and extension for 10 s/kb at 72 °C; and a final extension for 
10 min at 72 °C. The PCR amplicon was inserted into plasmid pGEX-6P-1 (GE Healthcare) 
via BamHI and NotI restriction sites, yielding plasmid pGEX-6P-1-AfAGPAT+linker (Table 
2). 
E. coli Rosetta 2(DE3)pLysS was transformed with the expression construct  
pGEX-6P-1-AfAGPAT+linker. The constructed strain is listed in Table 3. For heterologous 
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protein production, cultivation of the strain was carried out in 50 ml LB-medium containing 
34 µg/ml chloramphenicol and 100 µg/ml ampicillin. The medium was inoculated with an 
overnight culture (1:100) and incubated at 37 °C. Expression of the GST-tagged protein 
AfAGPAT flanked by 43 aa and 45 aa linker sequences was induced at OD600 of 1.0 by 
addition of isopropyl β-D-1-thiogalactopyranoside (IPTG) to a final concentration of 1 mM. 
After induction, the cells were cultivated at 16 °C and 200 rpm for 19 h and then harvested at 
8,000 rpm for 5 min.  
Purification of GST-AfAGPAT+linker was carried out at 4 °C using the GST SpinTrap 
Purification Module (GE Healthcare). The cell pellet was resuspended in 1.5 ml PBS 
(140 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, 1.8 mM KH2PO4, 1 mM DTT; pH 7.3), and 
the cells were broken by three passes through a French Press (700 psi). The insoluble material 
was removed from the lysate by centrifugation at 14,000 rpm for 45 min at 4 °C. After 
loading 600 µl lysate onto a SpinTrap column (GE Healthcare) equilibrated with PBS, the 
sample was agitated on a tube rotator at 15 rpm for 1 h at 4 °C. The column was centrifuged 
at 3,500 rpm for 1 min, the flow-through was discarded, and the loading step was repeated. 
Afterwards, the column was washed by adding 600 µl PBS, centrifuging at 3,500 rpm for 
1 min, and discarding the flow-through. The wash step was repeated twice. Removal of the 
GST-tag was performed by on-column enzymatic cleavage with 20 U PreScission Protease 
(GE Healthcare) in 150 ml cleavage buffer (50 mM Tris-Cl pH 7.5, 150 mM NaCl, 1 mM 
EDTA, 1 mM DTT) at 4 °C overnight. The eluate was collected by centrifugation at  
3,500 rpm for 1 min and analysed by sodium dodecyl sulphate polyacrylamide gel 
electrophoresis (SDS-PAGE). Purified protein AfAGPAT+linker was then mixed with 
glycerol to a final concentration of 10% (v/v), flash frozen in liquid nitrogen, and stored at  
-80 °C. Determination of the protein concentration using the Bradford assay (Bio-Rad) 
revealed that 180 mg of purified protein AfAGPAT+linker were obtained from 50 ml cell 
culture. The protein identity was confirmed by ESI-qToF-MS analysis.  
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Table 3. Expression strains constructed in this study.  
 
Strain Characteristics 
P. putida KT2440::pPptAf1 + 
pJB*PfaAf1**-C194S 
P. putida KT2440::pPptAf1 (Chapter 3) with replicative plasmid 
pJB*PfaAf1**-C194S 
P. putida KT2440::pPptAf1 + 
pJB*PfaAf1**-S953A 
P. putida KT2440::pPptAf1 with replicative plasmid pJB*PfaAf1**-
S953A 
P. putida KT2440::pPptAf1 + 
pJB*PfaAf1**-H1755Q 
P. putida KT2440::pPptAf1 with replicative plasmid pJB*PfaAf1**-
H1755Q 
P. putida KT2440::pPptAf1 + 
pJB*PfaAf1**-H2166Q 
P. putida KT2440::pPptAf1 with replicative plasmid pJB*PfaAf1**-
H2166Q 
P. putida KT2440::pPptAf1 + 
pJB*PfaAf1**-E2455R 
P. putida KT2440::pPptAf1 with replicative plasmid pJB*PfaAf1**-
E2455R 
E. coli BL21(DE3)/ 
pSynHybPfa1/pPptAfA 
Escherichia coli BL21(DE3) with replicative plasmids pSynHybPfa1 and 
pPptAfA (Chapter 3) 
E. coli BL21(DE3)/ 
pSynHybPfa2/pPptAfA 
E. coli BL21(DE3) with replicative plasmids pSynHybPfa2 and pPptAfA  
E. coli BL21(DE3)/ 
pSynHybPfa3/pPptAfA 
E. coli BL21(DE3) with replicative plasmids pSynHybPfa3 and pPptAfA  
E. coli Rosetta 2(DE3)pLysS/ 
pGEX-6P-1-AfAGPAT+linker 
E. coli Rosetta 2(DE3)pLysS with replicative plasmid pGEX-6P-1-
AfAGPAT+linker 
Y. lipolytica 
Po1h::pSynPfaPptAf2mc-
hybpfa3 clones 
Y. lipolytica Po1h with pSynPfaPptAf2mc-hybpfa3 randomly integrated 
in the genome 
 
 
Extraction of cellular fatty acids 
The cellular fatty acids were extracted using the FAME method [28]. For this purpose, 50 ml 
of a culture were harvested at 8,000 rpm for 10 min at room temperature. The cell pellet was 
transferred to a glass vial and dried in a vacuum concentrator. Subsequently, the cell dry 
weight was determined. 50 µg of n-6 DPA or n-3 DPA (Sigma-Aldrich) and 500 µl of a 
mixture of methanol, toluene, and sulphuric acid (50:50:2, v/v/v) were added. The vial was 
capped with a teflon-lined screw cap and incubated at 80 °C for 24-48 h. After the mixture 
was cooled to room temperature, 400 µl of an aqueous solution consisting of 0.5 M NH4HCO3 
and 2 M KCl were added, and the sample was vortexed for 30 s. Phase separation was 
achieved by centrifugation at 4,000 rpm for 5 min at room temperature. 100 µl of the upper 
phase were used for GC-MS analysis. 
 
 
Analysis of fatty acid methyl esters by GC-MS 
GC-MS was carried out on an Agilent 6890N gas chromatograph (Agilent Technologies) 
equipped with a 7683B split/splitless injector with autosampler (Agilent Technologies) and 
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coupled to a 5973 electron impact mass selective detector (Agilent Technologies). Helium 
was used as the carrier gas at a flow rate of 1 ml/min. 1 µl of the sample was injected in split 
mode (split ratio, 10:1). The analytical column was a (5% phenyl)-methylpolysiloxane 
capillary column (Agilent J&W DB-5ht; 30 m x 0.25 mm i.d. x 0.1 µm film thickness, 
maximum temperature 400 °C; Agilent Technologies). The column temperature was kept at 
130 °C for 2.5 min, increased to 240 °C at a rate of 5 °C/min, then ramped to 300 °C at 
30 °C/min, and held at 300 °C for 5 min. Other temperatures were as follows: inlet, 275 °C; 
GC-MS transfer line, 280 °C; ion source, 230 °C; and quadrupole, 150 °C. The mass selective 
detector was operated in scan mode, scanning the mass range from m/z 40 to 700. Scan 
control, data acquisition, and processing were performed by MSD ChemStation and AMDIS 
software, version 2.68, based on the fragmentation patterns and retention times, in comparison 
with Supelco 37 Component FAME Mix and LC-PUFAs (all Sigma-Aldrich) as reference 
standards, and NIST 08 library. Absolute amounts of PUFAs were quantified by integration 
of the peaks using MSD ChemStation and by subsequent calculation in relation to the integral 
of DPA and to cell dry weight. 
 
 
Fluorescence measurements 
The fluorescence of mCherry produced by yeast cells grown on YNB-N5000-agar plates was 
determined using a Molecular Dynamics Typhoon 9410 Variable Mode Imager (Amersham 
Biosciences/GE Healthcare). An excitation wavelength of 532 nm ± 8 nm and an emission 
wavelength of 580 nm ± 15 nm were used. 
 
 
Synthesis of a docosahexaenoic acid N-acetylcysteamine thioester (DHA-NAC thioester) 
DHA methyl ester (1 mg, 0.003 mmol, 1 equiv.) dissolved in 100 µl heptane was mixed with 
LiOH (3.6 mg, 0.15 mmol, 50 equiv.) dissolved in 300 µl of a mixture of methanol and 
ddH2O (50:50, v/v) and stirred at room temperature for 4 days. Thereafter, 300 µl 3 M 
potassium acetate pH 5.5 were added, and the reaction mixture was extracted with 100 µl 
ethyl acetate for three times. The organic phase was evaporated by using a rotary evaporator, 
followed by a gentle stream of nitrogen, and concentrated to dryness in vacuo. The residue 
was dissolved in 1 ml dichloromethane. Dimethylaminopyridine (1 crystal, cat.),  
N,N'-diisopropylcarbodiimide (1.6 mg, 0.012 mmol, 4 equiv.), and N-acetylcysteamine (NAC; 
2.2 mg, 0.018 mmol, 6 equiv.) were added, and the reaction mixture was stirred, protected 
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from light, under a gentle stream of nitrogen for 3 h. Afterwards, 2 ml ethyl acetate and 2 ml 
10% HCl were added. The organic phase was mixed with 2 ml of a saturated solution of 
NaHCO3. After phase separation, the organic phase was evaporated to dryness under a gentle 
stream of nitrogen, and the residue was dissolved in 60 µl methanol. The crude product was 
purified by semi-preparative HPLC. Purified all-cis DHA-NAC thioester (0.14 mg, 
0.0003 mmol, 10% yield) was dissolved in methanol and stored at -20 °C.  
 
 
In vitro enzyme assay for the AGPAT domain encoded by the pfa gene cluster of 
A. fasciculatus (SBSr002) 
In order to assay for transfer of DHA bound onto an ACP (mimicked by NAC thioester) to the 
2-position of 1-acyl-sn-glycerol-3-phosphate catalysed by AGPAT, reactions (50 µl) 
contained 50 mM Tris-Cl or HEPES pH 7.0, 7.4, or 8.0, (5 mM MgCl2), 1 mg/ml bovine 
serum albumin (BSA; essentially fatty acid free), 20-100 µM oleoyl-L-α-lysophosphatidic 
acid, 20 µM DHA-NAC thioester, and 2 µM purified protein AfAGPAT+linker. The reactions 
were incubated at 30 °C for 30-120 min or overnight, quenched by the addition of 50 μl 
methanol, and then analysed by high resolution nano-ESI-FT-Orbitrap-MS analysis. 
Measurements were performed on a Dionex Ultimate 3000 RSLC system (Thermo Scientific) 
coupled to a Thermo Fisher Orbitrap (Thermo Scientific) supported by an Advion Triversa 
Nanomate nano-ESI system (Advion). 1 µl of the sample was injected. The analytical column 
was a BEH RP-C18 column (50 x 2.1 mm, 1.7 µm particle size; Waters). Separation was 
achieved by a linear gradient with (A) ddH2O containing 0.1% formic acid to (B) acetonitrile 
containing 0.1% formic acid at a flow rate of 600 µl/min and 45 °C. The gradient was 
initiated by a 0.33 min isocratic step at 5% B, followed by an increase to 95% B in 9 min to 
end up with a 4 min flush step at 95% B before reequilibration with initial conditions. UV and 
MS detection were performed simultaneously. Mass spectra were acquired in centroid mode 
ranging from m/z 200 to 2000 at a resolution of R = 30000. 
 
 
 
RESULTS AND DISCUSSION 
PUFA synthases are multienzyme complexes for de novo production of LC-PUFAs. They 
consist of several catalytic domains, many of which have not yet been investigated in detail in 
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terms of their exact function and biochemistry during PUFA assembly. Thus, selected 
myxobacterial protein domains were subjected to further analyses (Figure 2-4).  
A powerful traditional approach for studying essentiality and redundancy of catalytic 
protein domains represents their targeted inactivation by site-specific mutagenesis of the 
active site residues [29]. Hence, an active site amino acid of the KS2 domain, the AT2 
domain, the dehydratase (DH) domains DH2 and DH3, or the AGPAT domain was 
substituted by a catalytically inactive amino acid via introduction of point mutations by 
overlap extension PCR and subsequent Red/ET recombineering. In case of the KS2 domain, 
the active site cysteine was replaced by a serine (C194S) [30]; for the AT2 domain, the active 
site serine was replaced by an alanine (S953A) [31]; for the FabA-like DH domains, the 
active site histidine was replaced by a glutamine (H1755Q, H2166Q) [32]; and for the 
AGPAT domain, the active site glutamate was replaced by an arginine (E2455R) [33] (Figure 
2). P. putida KT2440 is known as a fast-growing, reliable, and robust host organism for 
recombinant LC-PUFA production (Chapter 3) and was therefore chosen as chassis for 
expression of the pfa genes encoding the mutated versions of PUFA synthases. 
 
 
Figure 2. Active site mutations introduced into selected domains encoded by the pfa gene cluster of 
Aetherobacter fasciculatus (SBSr002) and their impact on heterologous LC-PUFA production in 
Pseudomonas putida KT2440.  
ER = Enoyl reductase, KS = Ketosynthase, AT = Acyltransferase, ACP = Acyl carrier protein,  
KR = Ketoreductase, DH = Dehydratase, CLF = Chain length factor, AGPAT = 1-Acylglycerol-3-phosphate  
O-acyltransferase.  
 
 
Due to restriction site requirements during cloning procedures, site-directed mutagenesis of 
pfa3 was performed on two different plasmids constructed previously (Chapter 3), which both 
contain the native DPA (22:5, n-6 or n-3)/DHA (22:6, n-3)-type pfa gene cluster from 
A. fasciculatus (SBSr002) but differ in their vector backbone. Plasmid pJB*PfaAf1** was 
Figure x. Active site mutations introduced into selected domains encoded by the pfa gene cluster from
Aetherobacter fasciculatus (SBSr002).
ER = Enoyl reductase, KS = Ketosynthase, AT = Acyltransferase, ACP = Acyl carrier protein, KR =
Ketoreductase, DH = Dehydratase, CLF = Chain length factor, AGPAT = 1-Acylglycerol-3-phosphate O-
acyltransferase.
KS1 AT1 3x ACP KR DH1 KS2 CLF DH2 DH3 AGPATAT2ER
C194S
S953A
H1755Q
H2166Q
E2455R
pfa1 pfa2 pfa3
completely abolished
LC-PUFA production
< 10% of the production 
rate of non-mutated 
PUFA synthase
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used in case of C194S, S953A, as well as H1755Q and plasmid pPfaAf7.1** in case of 
H2166Q and E2455R, which contain the directly cloned DPA (22:5, n-6 or n-3)/DHA (22:6, 
n-3)-type pfa gene cluster of A. fasciculatus (SBSr002). The plasmids were modified by linear 
plus circular homologous Red/ET recombination [34] to exchange base pairs in the catalytic 
core regions of pfa3 and to introduce a zeocin resistance gene, resulting in plasmids 
pJB*PfaAf1**-C194S-zeo
R
, pJB*PfaAf1**-S953A-zeo
R
, pJB*PfaAf1**-H1755Q-zeo
R
, or 
pPfaAf7.1**-H2166Q-zeo
R
. The zeocin resistance cassette was deleted via restriction digest 
and religation to generate the derivatives pJB*PfaAf1**-C194S, pJB*PfaAf1**-S953A, 
pJB*PfaAf1**-H1755Q, and pPfaAf7.1**-H2166Q. By applying conventional cloning 
techniques, base pairs were exchanged in the active site of the AGPAT domain of pfa3, 
yielding plasmid pPfaAf7.1**-E2455R. In a final engineering step, the backbones of the 
obtained plasmids pPfaAf7.1**-H2166Q and pPfaAf7.1**-E2455R were replaced by the 
vector backbone of pJB*PfaAf1**. It is derived from the broad-host-range expression vector 
pJB861 with a copy-up point mutation [35]. Heterologous expression of the pfa genes is 
driven by the xylS-Pm promoter system with mutations in the 5'-untranslated region [36] plus 
the core region [37] of Pm promoter. The resulting plasmids pJB*PfaAf1**-C194S, 
pJB*PfaAf1**-S953A, pJB*PfaAf1**-H1755Q, pJB*PfaAf1**-H2166Q, or pJB*PfaAf1**-
E2455R were transferred into P. putida KT2440::pPptAf1 by triparental conjugation. This 
strain overexpresses the 4'-phosphopantetheinyl transferase (PPTase) AfPpt from 
A. fasciculatus (SBSr002) to increase the phosphopantetheinylation of PUFA synthases 
(Chapter 3). The transgenic clones were cultivated in 50 ml LB-medium at 30 °C for 4 h. 
Expression of the Pfa proteins plus AfPpt was induced by addition of m-toluic acid to a final 
concentration of 2 mM. After induction, the cells were cultivated at 16 °C for 24 h. The 
cellular fatty acids were extracted via acidic methanolysis using the FAME method [28] and 
analysed by GC-MS. Strain P. putida KT2440::pPptAf1 + pJB*PfaAf1** (Chapter 3) 
harbours the non-mutated DPA/DHA-type pfa gene cluster from A. fasciculatus (SBSr002), 
produces 0.1 mg n-6 DPA/g cell dry weight (CDW) plus 0.6 mg DHA/g CDW, and was used 
as a reference. Recombinant LC-PUFA production is completely abrogated for the strains 
P. putida KT2440::pPptAf1 + pJB*PfaAf1**-C194S, P. putida KT2440::pPptAf1 + 
pJB*PfaAf1**-H1755Q, and P. putida KT2440::pPptAf1 + pJB*PfaAf1**-H2166Q, and, in 
addition, no short-chain biosynthetic intermediate can be detected via GC-MS (Figure 2). In 
the other two expression strains, PUFA production can still be observed but is significantly 
reduced compared to the experiment with the non-mutated PUFA synthase (Figure 2). Strain 
P. putida KT2440::pPptAf1 + pJB*PfaAf1**-S953A produces 0.007 mg n-6 DPA/g CDW 
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plus 0.05 mg DHA/g CDW, and strain P. putida KT2440::pPptAf1 + pJB*PfaAf1**-E2455R 
produces 0.008 mg n-6 DPA/g CDW plus 0.04 mg DHA/g CDW. The profile of the intrinsic 
fatty acids does not alter among the recombinant P. putida strains with different mutated 
expression constructs. In conclusion, the KS2 domain and the FabA-like DH domains DH2 
and DH3 within Pfa3 appear to be essential and not substitutable by the homologous domains 
of Pfa2. Moreover, domains DH2 and DH3 of Pfa3 are obviously not able to substitute each 
other. After inactivation of the AT2 domain or the AGPAT domain, there is still some very 
low LC-PUFA production (< 10% of the production rate of non-mutated PUFA synthase). 
This could result from either some residual activity of the mutated domains or from 
complementation of their function by other enzymes. In case of the mutated APGAT domain, 
it is also conceivable that the fully processed LC-PUFA chains are released from the assembly 
line by a less efficient, spontaneous hydrolysis.  
The factor determining the chain length of the LC-PUFAs within the PUFA synthase has 
not yet been elucidated. A useful approach for dissecting the molecular basis of the specificity 
of PKS-catalysed reactions as well as for generation of new promising polyketide derivatives 
represents the expression of hybrid PKS. Generation of chimeric genes by swapping of 
homologous or heterologous domains has been applied to both modular polyketide synthase 
[38-40] and iterative polyketide synthases [41;42]. By taking a closer look at the catalytic 
domains of myxobacterial PUFA synthases (Figure 3), the KS2/CLF pair of Pfa3 proved to be 
a good candidate for the determinant of the final LC-PUFA molecular species, especially 
because it is well known that the CLF of type II PKS systems is the primary determinant of 
carbon chain length of the type II PKS products [43-45]. Besides, a recent study suggests that 
the AT domain encoded by pfaB from marine γ-Proteobacteria, which is homologous to 
domain AT2 of myxobacterial PUFA synthases, may play a role in determining the length of 
the final PUFA product [14]. In order to study the impact of KS2/CLF and AT2 domains on 
the PUFA production profile, chimeric Pfa3 versions were constructed by combining domains 
from two different myxobacterial PUFA synthases. Thus, the KS2/CLF domains, the AT2 
domain, or the KS2/CLF domains plus the AT2 domain of the DPA/DHA-type PUFA 
synthase from A. fasciculatus (SBSr002) were replaced for the homologous domains of the 
AA (20:4, n-6)/EPA (20:5, n-3)-type PUFA synthase from S. cellulosum SBSo026 (Figure 3). 
The resulting constructs were then transferred and expressed into P. putida, E. coli, and 
Y. lipolytica. 
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Figure 3. Construction of three hybrid PUFA synthases by exchange of the domains KS2-CLF, AT2, or 
KS2-CLF-AT2 of the DPA/DHA-type pfa gene cluster from Aetherobacter fasciculatus (SBSr002) (grey) 
for the corresponding domains of the AA/EPA-type pfa gene cluster from Sorangium cellulosum SBSo026 
(black).  
ER = Enoyl reductase, KS = Ketosynthase, AT = Acyltransferase, ACP = Acyl carrier protein, KR = 
Ketoreductase, DH = Dehydratase, CLF = Chain length factor, AGPAT = 1-Acylglycerol-3-phosphate  
O-acyltransferase.  
 
 
The cloning procedure for the heterologous expression of hybrid pfa gene clusters in 
P. putida and E. coli started from plasmid pPm**SynPfaAf2, constructed previously (Chapter 
4), which contains an artificial DPA/DHA-type pfa gene cluster originating from 
A. fasciculatus (SBSr002) with adapted DNA sequences for P. putida. The vector backbone is 
derived from the broad-host-range expression vector pJB861 with a copy-up point mutation 
[35]. Heterologous expression of the pfa genes is driven by the xylS-Pm promoter system with 
mutations in the 5'-untranslated region [36] plus the core region [37] of Pm promoter. During 
the cloning procedure, it was taken advantage of unique restriction sites introduced for 
exchangeability of genes/domains (Chapter 4). The KS2/CLF domains were exchanged for 
the corresponding region of the AA/EPA-type pfa gene cluster of S. cellulosum SBSo026, 
which was adapted for P. putida and equipped with a 40 bp intergenic region between pfa2 
and pfa3 comprising a Shine-Dalgarno sequence, yielding plasmid pSynHybPfa1. Plasmid 
pSynHybPfa2 was constructed by replacement of the AT2 domain by the native AT2 domain 
from the AA/EPA-type pfa gene cluster of S. cellulosum SBSo026. Exchange of the KS2/CLF 
domains plus the AT2 domain resulted in plasmid pSynHybPfa3. The plasmids were 
transferred into P. putida KT2440::pPptAf1 by triparental conjugation (details not shown). 
Heterologous expression of the Pfa proteins plus AfPpt and extraction as well as GC-MS 
analysis of the fatty acids were performed as described previously. Unfortunately, this 
procedure did not lead to any detectable LC-PUFA production in P. putida. Besides P. putida, 
Figure x. Construction of three hybrid PUFA synthases by exchange of the domains KS2-CLF, AT2, or
KS2-CLF-AT2 from the pfa gene cluster from Aetherobacter fasciculatus (SBSr002) for the corresponding
domains of the pfa gene cluster from Sorangium cellulosum SBSo026.
ER = Enoyl reductase, KS = Ketosynthase, AT = Acyltransferase, ACP = Acyl carrier protein, KR =
Ketoreductase, DH = Dehydratase, CLF = Chain length factor, AGPAT = 1-Acylglycerol-3-phosphate O-
acyltransferase.
KS1 AT1 3x ACP KR DH1 DH2 DH3 AGPATER
KS2 CLF AT2 KS2 CLF AT2 KS2 CLF AT2
or or
KS1 AT1 3x ACP KR DH1 KS2 CLF DH2 DH3 AGPATAT2ER
pfa1 pfa2 pfa3
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E. coli was tested as host for heterologous expression of the chimeric Pfa proteins in presence 
of the appropriate PPTase AfPpt from A. fasciculatus (SBSr002). Thereby, the expression 
constructs pSynHybPfa1, pSynHybPfa2, or pSynHynPfa3 were cotransformed with the 
compatible plasmid pPptAfA, which contains the gene encoding the PPTase AfPpt from 
A. fasciculatus (SBSr002) (Chapter 3), into E. coli BL21(DE3) by electroporation. The 
transgenic clones were cultivated in 50 ml LB-medium at 37 °C. Expression of the Pfa 
proteins and AfPpt was induced at OD600 of 0.4-0.8 by addition of m-toluic acid to a final 
concentration of 2 mM. After induction, the cells were cultivated at 16 °C for 24 h. The 
cellular fatty acids were extracted via acidic methanolysis using the FAME method [28] and 
analysed by GC-MS. In contrast to P. putida, the recombinant E. coli strains produce various 
LC-PUFAs: AA, EPA, dihomo-γ-linolenic acid (DHGLA, 20:3, n-6), docosatetraenoic acid 
(DTA, 22:4, n-6), and n-3 DPA are produced by all the three strains E. coli 
BL21(DE3)/pSynHybPfa1/pPptAfA, E. coli BL21(DE3)/pSynHybPfa2/pPptAfA, and E. coli 
BL21(DE3)/pSynHybPfa3/pPptAfA. DHA production can only be observed for strains E. coli 
BL21(DE3)/pSynHybPfa1/pPptAfA and E. coli BL21(DE3)/pSynHybPfa2/pPptAfA. Hence, 
compared to P. putida, E. coli seems to be less fastidious regarding the non-optimal 
arrangement of the protein domains and their poor ability to cooperate. However, only trace 
amounts of these LC-PUFAs were produced in the three recombinant E. coli strains, which 
cannot be exactly and reliably quantified. Merely the approximate ratios of the LC-PUFA 
species produced by two or three biological samples of each strain could be calculated. 
Thereby, it turned out that the exchange of both the KS2/CLF domains and the AT2 domain 
in the artificial DPA/DHA-type pfa gene cluster for the corresponding domains of the 
AA/EPA-type pfa gene cluster on plasmid pSynHybPfa3 led to the highest LC-PUFA 
production and to the lowest ratio of C22 PUFAs/C20 PUFAs. 
In order to obtain more informative results, a more productive system for the heterologous 
expression of the DPA/DHA-type pfa gene cluster with exchange of both the KS2/CLF 
domains and the AT2 domain for the corresponding domains of the AA/EPA-type pfa gene 
cluster was required. Consequently, a synthetic chimeric pfa gene cluster was generated for 
Y. lipolytica, which has proven to be the best heterologous LC-PUFA producer employing 
myxobacterial PUFA synthases (Chapter 5). The cloning procedure started from the 
monocopy auto-cloning vector pSynPfaPptAf2, constructed previously (Chapter 5), which is 
able to promote random integration into the genome of Po1h strain. It contains four single 
transcription units with the coding sequences of the DPA/DHA-type pfa gene cluster plus the 
PPTase AfPpt originating from A. fasciculatus (SBSr002) and adapted for Y. lipolytica, 
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flanked by the strong hybrid hp4d promoter [26] plus LIP2 terminator. During the cloning 
procedure, it was taken advantage of unique restriction sites introduced for exchangeability of 
genes/domains (Chapter 5). The KS2/CLF domains plus the AT2 domain of gene pfa3 were 
exchanged for the corresponding region of the AA/EPA-type pfa gene cluster of S. cellulosum 
SBSo026, which was adapted for Y. lipolytica and equipped with a 134 bp non-coding 
intergenic linker plus the strong hybrid hp4d promoter [26] located at the 5' end, yielding 
plasmid pSynPfaPptAf2-hybpfa3. A reporter gene expression cassette consisting of mcherry 
flanked by the strong hybrid hp4d promoter [26] plus LIP2 terminator (Chapter 5) was 
inserted into the linker region between genes pfa2 and pfa3 of plasmid pSynPfaPptAf2-
hybpfa3 by conventional cloning for facilitated and rapid identification of good recombinant 
LC-PUFA producers. The “yeast cassette” of the resulting plasmid pSynPfaPptAf2mc-
hybpfa3 was generated via hydrolysis with NotI and transferred into Y. lipolytica Po1h [21] 
by lithium acetate-mediated heat shock transformation. Ten transformants of Y. lipolytica 
Po1h::pSynPfaPptAf2mc-hybpfa3, which exhibited intensive mCherry fluorescence on agar 
plate, were cultivated in 1 ml YNBD-medium at 28 °C for 76 h. The cellular fatty acids were 
extracted via acidic methanolysis using the FAME method [28] plus analysed by GC-MS, and 
the best producing strain, Y. lipolytica Po1h::pSynPfaPptAf2mc-hybpfa3 clone E, was 
cultivated in 50 ml YNBD-medium at 28 °C for 168 h, analogous to the reference strain 
Y. lipolytica Po1h::pSynPfaPptAf2 clone C, which expresses the unmodified DPA/DHA-type 
PUFA synthase and the PPTase AfPpt from A. fasciculatus (SBSr002) (Chapter5). 
Interestingly, an evident deviation from the production profile of the native DPA/DHA-type 
PUFA synthase can be observed for the hybrid PUFA synthase (Table 4). Exchange of the 
KS2/CLF domains plus the AT2 domain of gene pfa3 in the artificial DPA/DHA-type pfa 
gene cluster originating from A. fasciculatus (SBSr002) for the corresponding domains 
derived from the AA/EPA-type pfa gene cluster from S. cellulosum SBSo026 leads to the 
production of EPA and n-3 DPA as major LC-PUFA species. In contrast, DHA is the main 
product of the DPA/DHA-type PUFA synthase. On top of that, the high ratio of C22 
PUFAs/C20 PUFAs observed for the native PUFA synthase is significantly decreased in the 
case of the chimeric PUFA synthase. Indeed, this indicates a change in the product specificity 
of the PUFA synthases and the identification of the KS2/CLF pair plus domain AT2 as factors 
determining the chain length of the produced LC-PUFAs. The low yields achieved with 
chimeric PUFA synthases (approx. 50-fold reduction of heterologous LC-PUFA production 
obtained with Y. lipolytica Po1h::pSynPfaPptAf2mc-hybpfa3 compared to Y. lipolytica 
Po1h::pSynPfaPptAf2 clone C) might result from perturbations in the overall structure of the 
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multienzyme complex that translate into reduced catalytic efficiency, as the heterologous 
domains of the hybrid PUFA synthases have not been evolutionary optimized for cooperative 
work with the native domains of the Pfa enzymes.  
 
Table 4. Recombinant LC-PUFA production by Yarrowia lipolytica Po1h::pSynPfaPptAf2 clone C and 
Y. lipolytica Po1h::pSynPfaPptAf2mc-hybpfa3 clone E.  
Cultivation was carried out in 50 ml YNBD-medium + 50 mM potassium phosphate buffer pH 6.8 at 28 °C and 
200 rpm for 168 h. The indicated values are means of three or four biological samples.  
 
PUFA 
Yield [mg/l] 
Y. lipolytica  
Po1h::pSynPfaPptAf2 clone C 
Y. lipolytica Po1h:: 
pSynPfaPptAf2mc-hybpfa3 clone E 
eicosatrienoic acid  
(ETrA, 20:3, n-6 or n-9) 
− < 0.10 
arachidonic acid  
(AA, 20:4, n-6) 
0.48 < 0.10 
eicosatetraenoic acid  
(ETA, 20:4, n-3) 
< 0.10 < 0.10 
eicosapentaenoic acid  
(EPA, 20:5, n-3) 
1.03 0.70 
docosapentaenoic acid 
(DPA, 22:5, n-6) 
1.56 − 
docosapentaenoic acid 
(DPA, 22:5, n-3) 
0.70 0.61 
docosahexaenoic acid 
(DHA, 22:6, n-3) 
 70.41 0.35 
Ratio C22/C20  45.72 1.19 
 
 
The probably most significant deviation of the PUFA synthases of terrestrial myxobacteria 
from the marine PUFA synthases described previously can be observed at the carboxyl-
terminus of Pfa3. In silico analyses revealed that it most likely contains a 1-acylglycerol-3-
phosphate O-acyltransferase (AGPAT) (EC 2.3.1.51) domain, which represents a unique and 
common characteristic of terrestrial myxobacterial PUFA synthases. The known function of 
such enzyme is the acylation of the 2-position of 1-acyl-sn-glycerol-3-phosphate during 
glycerophospholipid biosynthesis, utilising either acyl-ACP or acyl-CoA thioesters as 
substrate [46] (Figure 4A), which was to be proven via an in vitro enzyme assay. The AGPAT 
domain of gene pfa3 from the pfa gene cluster of A. fasciculatus (SBSr002), flanked by  
129 bp and 135 bp linker sequences to increase the protein solubility, was cloned into 
expression plasmid pGEX-6P-1. The resulting plasmid pGEX-6P-1-AfAGPAT+linker was 
transformed into E. coli Rosetta 2(DE3)pLysS by electroporation, and the strain was 
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cultivated in 50 ml LB-medium at 37 °C. Expression of the GST-tagged protein domain 
AfAGPAT flanked by 43 aa and 45 aa linker sequences was induced at OD600 of 1.0 by 
addition of IPTG to a final concentration of 1 mM. After induction, the cells were cultivated 
at 16 °C and 200 rpm for 19 h. Purification of GST-AfAGPAT+linker was carried out at 4 °C 
using a GST SpinTrap column. Removal of the GST-tag was performed by on-column 
enzymatic cleavage with a suitable protease, and the purified 39.1 kDa protein domain 
AfAGPAT+linker could be eluted from the column, as analysed by SDS-PAGE (Figure 4B). 
The protein identity was confirmed by ESI-qToF-MS analysis. In order to assay for transfer 
of DHA bound onto an ACP to the 2-position of 1-acyl-sn-glycerol-3-phosphate catalysed by 
AGPAT in vitro, a DHA N-acetylcysteamine (NAC) thioester was synthesized. NAC is 
identical to the end of the 4'-phosphopantetheine prosthetic group of carrier proteins. 
Therefore, DHA-NAC is supposed to mimic the ACP bound DHA. The 1-acyl-sn-glycerol-3-
phosphate species 1-oleoyl-sn-glycerol-3-phosphate was used as second substrate. The assay 
conditions were varied in terms of the utilized buffer in the reaction, pH value, presence of 
MgCl2, substrate concentration, as well as incubation time. Unfortunately, the expected 
product 1-oleoyl-2-docosahexaenoyl-sn-glycerol-3-phosphate could never be detected by high 
resolution nano-ESI-FT-Orbitrap-MS analysis. Possible explanations for the lack of the 
conversion of the substrates into the product are non-optimal assay conditions, lacking 
acceptance of the DHA-NAC thioester as substrate instead of ACP bound DHA, lacking 
acceptance of 1-oleoyl-sn-glycerol-3-phosphate as the second substrate, or expression and 
purification of AGPAT in an inactive form. Conceivably, enzyme activity of the isolated 
protein domain is not observed in case the active site is situated at an interface of Pfa domains 
or subunits, and electrostatic plus hydrophobic interactions between the subunits might be 
required for the functionality of AGPAT. 
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Figure 4. In vitro enzyme assay to prove the function of the 1-acylglycerol-3-phosphate O-acyltransferase 
(AGPAT) domain in LC-PUFA biosynthesis. 
(A) Reaction scheme for the acylation of the 2-position of 1-acyl-sn-glycerol-3-phosphate catalysed by AGPAT 
using acyl-ACP as substrate during glycerophospholipid biosynthesis, (B) SDS-PAGE of heterologously 
produced and purified AGPAT domain flanked by 87 aa linker sequences from Aetherobacter fasciculatus 
(SBSr002).  
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APPENDIX 
 
DNA sequence of the synthetic building block 
 
>KS/CLF_So026_2 
GGCCGGCCGAAGTCCGGGCTCCGCATCTGGTTGAGACCGGGCCCGCGAGCTGAAACTAAATACAACAACACAACA
AAATAAGGAGGATACATCATGACGTTCGAACCCATTGCAATCGTAGGCCAAGGCTGCGTGCTGCCAGGTGCATTG
AGCCCGCGCGCCCTGAACGAAGCAGTGCGCGCACGTCGCTGCGCAGTAACCGGCGCACCCGAAGGTCGTCTGCGC
TTGAGCGCCGCCCATGCCATGGGTCCAGCTGACCAGGCTGGCGACCGGATGTGGTCCGATGCGGGTGGCTACGTC
GAAGGGTTCGAGCCCGCGTTCGATGCGGCCGGGTTCCAGCTCGATGAAGGCGTCGTCCGCGCACTCGATCCGTCC
CTGAAATGGGTGCTGCATGCCGGTCGCGAAGCGTTGCGCCCGTTGGGCCATGACCGTGCAAGCGCACGCGCTGGC
TTGGCCTTGGGCAACCTGAGCTTTCCCACCCCCGCCATGGCTCGCTACGCTGAAGGCGTCTGGCTCGACGCCCAA
GGTGCCGCCTTCCTCGATGGTGCAGCCCGCGGTTTCGCAGCCTCGGAACGCCCTGATCCGCGCTCGCGGTTCATG
AGCGGTCTGCCTGCCTCGCTGGCTGCAGAAGCCCTGGGTTTGGGTGGCGGCGGCTTTGCCTTGGACGCAGCGTGC
GCGAGCTCGCTGTACGCGATTAAGCTGGCGTGCGACCGGCTCCACGATCGGACCGCTGACCTGATGCTCGCCGGT
GCGGTGAATGCCGCGGATCCGCTGTTCCTCCACATGGGCTTCTGTGCGTTGGCGGCGATGAGCCGCAGCGGTGCA
TCGCGGCCTTTCCATCGCGACGCTGACGGCCTGGTGCCAGCTGAAGGTGCCGCCCTGGTCGCCCTGAAACGGTTG
GCAGATGCCCGCGCAGCTGGCGATCGTGTGCTGGGCGTGATCCGCGGGATTGGCCTGAGCAATGACGGTCGTGGT
CGTGGGCTGCTGTCGCCGTCCGAAGAAGGGCAGATCCGGGCCATGCGCCTGGCATACGCTGCGGCTGGGCTGACC
CCAGCTGACGTGTCCATGATCGAGTGCCACGCGACCGGGACCTTGGTCGGTGACGCGACCGAAGTCCGGTCCACC
GCTGCGGTCTTCGAAGGGCAGCGTGACGTGCCGATCGGGTCCCTGAAGTCGAACCTCGGGCACCTGATCACCGCG
GCTGGTGCCGCAGGGCTGATGAAGGTCCTGGGCGCTCTGGAAGCGGGTGTACGCCCGGCTACCCTGCACGCTGAA
GCGCCCATCGAAGCGCTGCGTGGGTCCCCGTTTCGGCTGCTGGCCGAAGAAGAGCCCTGGCCTAGCGATCGTCCG
CGCGTAGCTGCGGTGAGCGCTTTCGGGTTTGGCGGCAACAACGCGCACCTCCTGGTCTCGCAAGACGACGCGCAC
GATGACCTGGGCACGGCTCCGGCTAGCTTCGTGCCTGCACGCCCACGTCCAGCCGTAGCCATCATCGGGATCGGC
GCGATGCTGGGCGATACCACCGGTGCCCCTGAGGCAGCTCGTGCAGTGCTGGGCGGTGAACCATGGACCCCTCGC
CGTGCAGAAGTGGCCGTAGCCCAAGAAGGCTTGCGCTTCCCGCCCCGGGATCTCGAGCAGACGCTGCCCCAGCAG
CTGCTCGTCTTCGAAGCGGCGCGTGAAGCGATCGCGGGTATCTCCGTCCCCCGTGAGCGCACGGGTGTGTTGGTC
GGCATGGGCTGCGACCCGGAAGTAGCGCGGTACGGGCTGCGTTGGCGTCTCGCGGACCTGGCCGACGCTTGGTCG
TCGTCGTCGCCTGCCCGTGGTGACCACAAGGCTCCGCCCGATTGGCTGGGTCAGGCTCGCGACGCGGTCTTGCCC
AAGCTGACCGCTGTCGGCGTGCTCGGCACGATGCCCAACATCCCCGCGAACCGGATTAGCTCGCAGTTGGACCTG
GGCGGTCCCGGGTATACGGTGAGCGCTGAACAGGCGAGCGGCGTCGTGGCGCTGGAAATTGCAGCGCGGGCCTTG
CGCGAAGGCGAACTGGATGCGGCTGTGGTCGCGGCTGTCGACCTGAGCGATGAGCCAGTGCATCGCGCGGCGTTG
TCGGCGTTGGGCATCGAGACCCCGACCGGTGACGCAGCCGTAGCTCTGGTGCTCAAGCGCCTCGATGACGCGCGT
CGTGACGGCGACCACGTCTTGGCCGAGCTCGACGAAGAAGGCGCCCCAGCACTCCGTGTGGGTGACGGCGACGGT
GCAGTGGACCCGTTGGCCCGTGGTGCTGCACATGCAGCCGCAGGCCTGCTGCACGTAGCCGCAGCCGCATGGTCG
GTCCACCATGGTGCCCGTCCGGCACGTAGCGCCGTAGGTAGCGGCGCACGTGGTGCAGCCCCATGGTTCGGTGCT
CGTACCGCCGAGACCCGCACCCGTGTGTTGGGCGGTGCAGACGCAAGCGTGCGTCTGAGCGCCCGTGGTCCAGCA
GCCCCATTGGGCTTTGAGCCGCCGCCGCGGTTGTTCGTGTACGGCGGCGCAGATCGCGCGAGCGTGTTGCGCGCG
TTGGCAGAAGGTCGCCCTAGCGATGCCGGCCCAGCACGTCTGGTGCTGGTAGCCGCCAGCGAAGAGCAACGTGCT
GCCCGTGCCGCACAGGCACGTCTGCACCTGGAAAAAGGCGGCCCGGCACCTGAAGGTGTGGCATATCGCGATGCC
CCAGCCGGCGGCCAGCTGGCCTTTGTCTTCGCGGGCGCAGCCGCCGCATACCCGAGCATGGGCCGTGCAC 
 
 
>building block 5 
AACGTTTGGTGGCGGGACCAGTGACGAAGGCTTGAGCGAGGGCGTGCAAGATTCCGAATACCGCAAGCGACAGGC
CGATCATCGTCGCGCTCCAGCGAAAGCGGTCCTCGCCGAAAATGACCCAGAGCGCTGCCCATGCTGAGGTGTCTC
ACAAGTGCCGTGCAGTCCCGCCCCCACTTGCTTCTCTTTGTGTGTAGTGTACGTACATTATCGAGACCGTTGTTC
CCGCCCACCTCGATCCGGCATGCTGAGGTGTCTCACAAGTGCCGTGCAGTCCCGCCCCCACTTGCTTCTCTTTGT
GTGTAGTGTACGTACATTATCGAGACCGTTGTTCCCGCCCACCTCGATCCGGCATGCTGAGGTGTCTCACAAGTG
CCGTGCAGTCCCGCCCCCACTTGCTTCTCTTTGTGTGTAGTGTACGTACATTATCGAGACCGTTGTTCCCGCCCA
CCTCGATCCGGCATGCTGAGGTGTCTCACAAGTGCCGTGCAGTCCCGCCCCCACTTGCTTCTCTTTGTGTGTAGT
GTACGTACATTATCGAGACCGTTGTTCCCGCCCACCTCGATCCGGCATGCACTGATCACGGGCAAAAGTGCGTAT
ATATACAAGAGCGTTTGCCAGCCACAGATTTTCACTCCACACACCACATCACACATACAACCACACACATCCACA
ATGCGATTCGAACCCATTGCTATCGTTGGTCAAGGCTGCGTGCTGCCTGGAGCCCTGTCCCCTCGAGCCCTGAAC
GAGGCTGTTCGAGCTCGACGATGTGCTGTGACTGGCGCCCCTGAGGGTCGACTCCGACTGTCTGCTGCCCATGCT
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ATGGGTCCTGCCGACCAGGCTGGAGACCGAATGTGGTCTGACGCCGGCGGCTATGTGGAGGGATTTGAGCCTGCT
TTTGACGCCGCTGGCTTCCAGCTGGACGAAGGCGTTGTCCGAGCCCTGGACCCCTCTCTGAAATGGGTGCTGCAC
GCCGGACGAGAGGCTCTCCGACCCCTGGGTCACGATCGAGCTTCCGCTCGAGCCGGACTCGCCCTGGGAAACCTG
TCCTTCCCTACCCCCGCCATGGCCCGATATGCTGAGGGCGTCTGGCTCGATGCCCAGGGTGCCGCCTTTCTCGAC
GGCGCTGCTCGAGGATTTGCTGCTTCTGAGCGACCCGACCCCCGATCCCGATTTATGTCTGGACTCCCCGCCTCT
CTCGCTGCCGAAGCCCTGGGACTGGGAGGAGGCGGCTTCGCTCTGGACGCCGCTTGCGCCTCTTCTCTCTATGCC
ATTAAACTGGCCTGCGACCGACTGCATGACCGAACTGCTGACCTGATGCTCGCCGGCGCCGTTAACGCTGCTGAC
CCTCTGTTCCTGCACATGGGCTTCTGTGCTCTCGCTGCTATGTCCCGATCTGGCGCTTCCCGACCCTTTCATCGA
GACGCCGACGGTCTCGTCCCTGCTGAGGGAGCCGCCCTGGTTGCCCTGAAACGACTGGCTGACGCCCGAGCTGCT
GGCGATCGAGTCCTGGGCGTGATTCGAGGCATCGGTCTCTCTAACGATGGCCGAGGTCGAGGACTGCTGTCCCCT
TCCGAAGAGGGACAGATCCGAGCCATGCGACTCGCCTACGCTGCTGCTGGCCTGACCCCTGCCGATGTCTCTATG
ATTGAATGTCATGCTACCGGAACCCTCGTTGGCGACGCCACCGAGGTCCGATCCACCGCTGCTGTCTTCGAGGGA
CAGCGAGATGTCCCCATCGGATCTCTGAAATCTAACCTCGGACACCTGATTACCGCTGCTGGAGCTGCCGGACTG
ATGAAGGTCCTGGGTGCTCTCGAGGCTGGCGTTCGACCCGCTACCCTGCACGCTGAAGCCCCCATTGAAGCTCTG
CGAGGCTCCCCCTTCCGACTGCTCGCTGAGGAGGAGCCCTGGCCTTCTGATCGACCTCGAGTCGCCGCTGTGTCT
GCCTTCGGTTTCGGTGGCAACAATGCCCACCTGCTCGTGTCTCAGGATGACGCCCACGATGACCTCGGAACCGCC
CCTGCTTCTTTTGTGCCCGCTCGACCTCGACCTGCTGTGGCTATCATTGGCATTGGTGCTATGCTGGGAGACACT
ACTGGCGCTCCTGAGGCCGCTCGAGCTGTGCTGGGTGGAGAGCCTTGGACTCCCCGACGAGCTGAGGTTGCCGTC
GCTCAGGAGGGCCTGCGATTTCCTCCCCGAGATCTGGAACAGACCCTGCCCCAGCAACTGCTGGTCTTCGAGGCC
GCTCGAGAGGCTATCGCTGGCATCTCTGTCCCTCGAGAACGAACCGGCGTGCTCGTGGGAATGGGCTGTGATCCT
GAGGTTGCCCGATACGGTCTCCGATGGCGACTGGCTGATCTCGCTGACGCCTGGTCCTCCTCCTCCCCTGCTCGA
GGAGACCATAAGGCTCCTCCTGACTGGCTCGGCCAGGCTCGAGACGCTGTTCTGCCCAAGCTGACTGCCGTTGGC
GTTCTCGGCACCATGCCCAACATTCCCGCTAACCGAATTTCCTCCCAACTGGACCTGGGTGGTCCCGGCTACACC
GTTTCCGCTGAACAGGCTTCCGGCGTGGTGGCCCTCGAGATTGCTGCTCGAGCTCTGCGAGAGGGAGAGCTGGAT
GCCGCCGTCGTTGCCGCTGTCGACCTCTCTGATGAGCCCGTCCATCGAGCCGCCCTCTCTGCCCTGGGAATTGAG
ACTCCCACTGGCGATGCCGCCGTTGCCCTCGTGCTGAAGCGACTCGACGATGCTCGACGAGATGGAGACCACGTG
CTCGCTGAGCTGGACGAGGAGGGTGCTCCCGCTCTGCGAGTCGGAGACGGCGATGGTGCCGTTGATCCCCTGGCT
CGAGGAGCTGCCCATGCTGCTGCCGGACTCCTCCACGTGGCCGCTGCTGCTTGGTCTGTCCACCATGGAGCTCGA
CCCGCTCGATCCGCTGTTGGTTCCGGAGCCCGAGGCGCTGCTCCTTGGTTTGGCGCCCGAACCGCCGAAACCCGA
ACTCGAGTCCTGGGCGGAGCTGACGCTTCCGTTCGACTCTCCGCCCGAGGACCTGCTGCTCCTCTGGGTTTTGAG
CCCCCTCCCCGACTCTTTGTTTACGGTGGTGCCGACCGAGCTTCTGTGCTGCGAGCCCTCGCCGAAGGACGACCC
TCTGACGCTGGACCCGCTCGACTCGTTCTGGTGGCCGCCTCTGAAGAGCAGCGAGCTGCCCGAGCTGCCCAAGCT
CGACTGCACCTGGAGAAGGGAGGTCCCGCTCCCGAAGGCGTTGCCTACCGAGACGCCCCTGCTGGTGGCCAACTG
GCCTTCGTGTTCACTGGAGCCGCCGCCTCCTACGCTGGCATGGGTCGAGAACTGGCCCTGGCCCTCCCTGATGTG
ACCGCTCGACTCGGAGAGCGATTCGCCTCCATGGACCAAGCCGCCCGATGGATCTTTGATCCTCCTGAGGCTCCC
TCCCACCCTCTCGACCAGCTCTGGGCCTCCGCTTTTCTCTGTCAGCTGCATGCTGAGGTCTCCCGACGAGTCCTG
GGACTGACTCCTGACGCTACTGTCGGATACTCCTCCGGAGAATCCAACGCCCTCTTTGCCACCGGCGCTTGGCGA
GACCTGGATGCCATGATCCGAGATTGCTCTGAATCCCCCGTGTTCACCACTGAACTCGTGGGCGAATTCGCCGCC
GCTCGACGAGCCTGGCGAAAGCTCGGTGGTGGAGCCCTCGAGGCTTGGAAGGCTTGGTCTGTCGCTGCCCCCGTG
GAATCTGTGCGAGAAGCCCTGCGAGGCGAGCCCCTCGCTCATCTCACCATCGTGAACACCCCTGAGGATTGCGTG
CTGGGTGGCGAAGCCTCCGCTTGCGAACGAGTGATCGAGCGACTCGGTCGAGGTCGAGCTATGCCTCTCGGTTAC
GAGATGGCCGCCCACTGTCCTGAAATCGAAGAGATTCGAGGAGCTTGGTACGACCTCCACCACCGAGCTACTTGG
GAGGTCCCCGGCGTTCGACATTACTCTGCTGGTCGAGCCACCGCCTTCCAAGCCACTTCTGAGGCCGCCGCTGAG
GCTATCACTGCCCAAGCCCTGGGCACTCTGGACTTCCCTCGAATGATCGAACGAGCCTGGGCTGATGGCGTCCGA
GTCTTCCTCGAACACGGACCCCGAGGCCTCTGCTCCGGATGGATTCGACGAATTCTCGGAGACCGAGAGCACGTT
GCCGTTCCTCTCGACGTGGCTGGTCGATCTGGCGTGCAACAGCTGGCCAATGCCGCTGCTTGGCTGATTGCCGCT
GGCGTCCCCGTTGACCGAGGAGCCCTCGAACGATCCCTGGGTGCTATTGGCGTGCCCGCTGCTCCTCCTCGAGCT
ACCCTGAAGATCCCTGCCCATCCTCCCGCCATCCGACTGCCCCCTCTCGAGCAATGGATGGCCCCCGCTCCTCGA
CTGGTTCCCGTTCTGGACGATGCTACCGCTGCTCCTGTGAAGGCTCCCGCCCCTTCTCCCGTCCATTTCGCCGCT
CCTGCTCAAGCTCGAGCCGCCGTGCCCTCTCTGGTCCACGCTGCTCCCCCTTCCCTCGTGCATGCTGCTCCCCCC
TCCCTCGCTCACGCCGCTCCTCCCTCTCTGGTGCATGCCGCCCCTCCTTCTCTGGCCCAAGCTGCTCCTCCTGCT
CCCGCCCGACCTTCCACTCGATCTCCTGCCATCTCTATCGGTTCTCCCGCTGGTGAAATCGTGGCCCGAGCCACC
GAACAACAGGCCCGACTGGGCGCCCTGCATCGAGAATTCCTGGCTTCTCAGGCCACCGCCCACGCCCAATTCCTG
GCCCTCCAGCAGGGACTGCTCGGTCGATTTCTCCGAGCCTACGAACACCAGGCTTCTCCCCCTCCTCCCCCTCCT
CTGCCCTCTCTGCCCCCTGTTGCTCCTCCTCTCCCCTCTCTCCCCCGAGCTGGTGAAGACGCCGGACTGCCTGCT
CCTGCTCCCGTCTCCCCCGAGGCTTCTACCGACGCTTCCTCCGTCGATGCCCCCGTCGGAGGTCGACCCCTGCTC
CCCGGTCCTAAATTCTCCCGAGCCGATCTGGAGGTTCTGGCCTCTGGTTCCATCTCCTCCATCTTCGGCCCCCAA
TTCGCCGGACAAGACGGCTACGCCAAGCAATGTCGAATGCCCGAGCCCCCTCTGCTCCTGGCTGACCGAGTGACT
GGAATCGACGCCGTCCCCGGTTCTATGGATACTGGAACCATCTGGACTGAGACTGACGTCAAGCATGACTCTTGG
TACC
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Myxobacteria have been proven to be proficient producers of not only secondary metabolites 
with impressive structural diversity, bioactivity, and diversity of mode-of-action [109] but 
additionally of LC-PUFAs, such as AA, EPA, or DHA [127-129]. In the present work, for the 
first time, iteratively acting type I fatty acid synthase (FAS)/polyketide synthase (PKS)-like 
enzymes, termed PUFA synthases, responsible for the production of LC-PUFAs have been 
identified and characterized in detail from both terrestrial origin and myxobacteria.  
 
 
Discovery and detailed comparisons of characteristic features of myxobacterial pfa gene 
clusters at the molecular level 
Extensive shotgun sequencing of myxobacterial genomes by next generation sequencing 
(NGS) technologies has tremendously simplified the detection of biosynthetic pathways. In 
the present studies, five types of PUFA biosynthetic pathways employing PUFA synthases 
could be identified in a variety of PUFA-producing myxobacteria, belonging to the suborders 
Sorangiineae and Nannocystineae, whose genomes have been sequenced (Table 1). Among 
all the catalytic domains of PUFA synthases, the tandem acyl carrier protein (ACP) domains 
are obviously most remarkable. Five to nine consecutive domains are present in these 
multienzyme complexes from the marine γ-Proteobacteria Shewanella pneumatophori SCRC-
2738, Photobacterium profundum SS9, and Moritella marina MP-1, as well as from the 
marine microalgae Schizochytrium sp. ATCC 20888 [77-79]. The DNA sequence of the 
region encoding the tandem ACP domains of myxobacterial PUFA synthases was determined 
in case of the OA/LA-type pfa gene clusters from S. cellulosum So ce56, So ce377, and 
SBSo026, in case of the arachidonic acid (AA, 20:4, n-6)/EPA-type pfa gene clusters from 
S. cellulosum SBSo026 and So ce1128, and in case of the docosapentaenoic acid (DPA, 
22:5)/DHA-type pfa gene clusters from the Aetherobacter species Aetherobacter sp. 
(SBSr001) nov. ined., Aetherobacter fasciculatus sp. nov. ined. (SBSr002), Aetherobacter 
rufus sp. nov. ined. (SBSr003), and Aetherobacter sp. nov. ined. (SBSr008). The striking 
degree of sequence similarity (> 90% pairwise identity at DNA level) between the ACP 
domains encoded by a particular pfa gene cluster considerably impeded proper assembly of 
the short sequencing reads from NGS to completely cover this highly repetitive region. 
Therefore, it is hardly surprising that for most of the myxobacterial pfa gene clusters 
mentioned previously, the exact DNA sequence of this section had to be ascertained by PCR 
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amplification or subcloning from a chromosomal gene library prior to Sanger sequencing 
(details not shown). The number of tandem ACP domains detected in the PUFA synthases 
from myxobacteria of the suborder Sorangiineae ranges from three to five (Figure 10). It had 
been demonstrated that all tandem ACPs encoded by pfaA from Shewanella japonica are 
functionally equivalent for LC-PUFA biosynthesis and that an increase in the number of 
ACPs increases the throughput of LC-PUFA biosynthesis [154]. In order to make a valid 
statement about the impact of the quantity of ACPs on the production rate of myxobacterial 
PUFA synthases, the amounts of octadecenoic acid, LA, and eicosadienoic acid (EDA, 20:2, 
n-6) synthesized by S. cellulosum So ce56, harbouring an OA/LA-type PUFA synthase with 
five tandem ACPs, and by S. cellulosum SBSo026, comprising an OA/LA-type PUFA 
synthase with only four tandem ACPs, were directly compared. Actually, no correlation can 
be deduced, as both strains produce comparable amounts of these fatty acids ([155]; Chapter 
2). Thus, it remains unresolved whether additional copies of ACP domains within the 
(myxobacterial) PUFA synthases would lead to enhanced LC-PUFA production. 
So far, an OA/LA-type pfa gene cluster could be detected in virtually all of the 
S. cellulosum strains whose genome sequence is available (Table 1). From this data, it can be 
concluded that this gene cluster is most likely almost ubiquitous in S. cellulosum. Intriguingly, 
among the S. cellulosum strains mentioned previously, the five strains SBSo026, So ce1128, 
So ce340, So ce427, and So ce690 additionally contain an AA/EPA-type pfa gene cluster 
embedded in 18 putative maracin/maracen biosynthetic genes, exclusively present in the 
genomes of these five So ce strains. The OA/LA-type PUFA synthase and the AA/EPA-type 
PUFA synthase from S. cellulosum SBSo026 only show a pairwise sequence identity of  
≤ 64% at DNA level and of ≤ 53% at protein level. These observations indicate that the 
genomic island comprising the AA/EPA-type pfa gene cluster rather originates from 
horizontal gene transfer into a S. cellulosum ancestor already harbouring the OA/LA-type pfa 
gene cluster than from duplication of this gene cluster. Remarkably, the AA/EPA-type pfa 
gene clusters miss gene pfa1 (Figure 10), but the point in time of its loss is uncertain. A 
common characteristic of both types of PUFA synthases from Sorangium represents the long 
linker sequence between the final FabA-like dehydratase (DH) domain and the  
1-acylglycerol-3-phosphate O-acyltransferase (AGPAT) domain (Figure 10). It exhibits a 
length of more than 400 aa in case of the OA/LA-type PUFA synthase as well as in the 
AA/EPA-type PUFA synthase. The corresponding linker sequences in the DPA/DHA-type 
PUFA synthases from Aetherobacter spp. only have an average length of 40 aa. All these 
non-catalytic regions are rich in alanine, proline, and charged amino acids. They are 
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principally flexible, but the presence of alanine-proline peptide bonds introduces a degree of 
rigidity if they exist in the trans form [156]. These features ensure that tethered domains are 
kept apart while allowing them to make essential interactions with other catalytic entities. 
Thus, the different length of these linkers might affect the performance of adjacent domains to 
a varying extent. However, this is purely speculative and an experimental proof is pending. 
Apart from the described pfa gene clusters from Sorangium and Aetherobacter, gene 
clusters encoding PUFA synthases have also been identified in other myxobacterial species in 
the course of the present studies (Table 1). Minicystis rosea (SBNa008) nov. ined. (R. O. 
Garcia et al., submitted), which belongs to the suborder Sorangiineae, produces AA as major 
PUFA (> 20% of TFAs) and minor amounts of EPA, γ-linolenic acid (GLA, 18:3, n-6),  
dihomo-γ-linolenic acid (DHGLA, 20:3, n-6), and docosatetraenoic acid (DTA, 22:4, n-6). 
Sequencing of the genome of this strain by NGS and in silico analysis of the genome data 
revealed the presence of an incompletely sequenced pfa gene cluster. It comprises the genes 
pfa1, pfa2, and pfa3. Missing sequences within the gene cluster were amplified by PCR prior 
to Sanger sequencing in order to complete the cluster sequence. Catalytic domain 
arrangements and sequences of the proteins Pfa2 and Pfa3 resemble the homologous proteins 
of the AA/EPA-type PUFA synthase from S. cellulosum the most (> 73% pairwise identity). 
Parts of a pfa gene cluster could also be identified in the unpublished genome sequence of the 
terrestrial AA-producing myxobacterium Sandaracinus amylolyticus NOSO-4, also belonging 
to the suborder Sorangiineae [128]. A fragment of gene pfa2 encoding a ketoreductase (KR) 
domain and a PKS-like DH domain and fragments of gene pfa3 encoding a ketosynthase (KS) 
domain, parts of a chain length factor (CLF) domain, two FabA-like DH domains separated 
by a DH' pseudo-domain, an additional PKS-like DH domain, and an AGPAT domain could 
be detected on two small scaffolds. Even the marine AA-producing myxobacterium 
Plesiocystis pacifica SIR-1, belonging to the suborder Nannocystineae [124], possess a pfa 
gene cluster (the genome was sequenced by the J. Craig Venter Institute in the context of the 
Gordon and Betty Moore Foundation Marine Microbial Genome Sequencing Project and 
deposited into the public domain). This finding obviously shows that the existence of PUFA 
synthases in myxobacteria is not only restricted to the suborder Sorangiineae. The PUFA 
synthase from P. pacifica SIR-1 contains FAS/PKS domains in the same number and order as 
the homologous enzymes from Aetherobacter spp. except that only two tandem ACP domains 
could be found. However, as there seems to be a misassembly of the sequencing reads in this 
genomic region, a larger number of ACPs might be available. Completely unexpected, an 
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AGPAT domain neither was encoded by the pfa gene cluster nor could be identified at any 
other locus within the genome.  
Analyses of the PUFA synthases with focus on the AGPAT domains encoded by the 
OA/LA-type pfa gene cluster from S. cellulosum So ce56, the AA/EPA-type pfa gene cluster 
from S. cellulosum SBSo026, and the DPA/DHA-type pfa gene cluster from A. fasciculatus 
(SBSr002) using BlastP [157] and Pfam [158] searches revealed occurrence of PUFA 
synthase homologues including an AGPAT domain. They were found to be encoded by the 
genomes of Azospirillum lipoferum 4B, a bacterium associated with roots of terrestrial plants 
[159], of the soil bacterium Paenibacillus curdlanolyticus YK9 (the genome was sequenced 
by the DOE Joint Genome Institute and deposited into the public domain), and of the 
actinobacterium Nakamurella multipartita Y-104, isolated from activated sludge [160]. The 
biosynthetic products of all these PUFA synthase-like proteins, however, have not yet been 
determined. Nevertheless, this clearly indicates that the presence of an AGPAT domain, 
which is assumed to allow for direct transfer of the produced PUFAs into lipids, is a 
characteristic of PUFA synthases from non-marine origin. Interestingly, exceptions to the rule 
constitute the homologous, uncharacterized Pfa proteins from terrestrial streptomycetes, such 
as Streptomyces coelicolor A3(2) [161] and Streptomyces lividans 1326 [162], which are 
lacking an AGPAT domain, and the putative PUFA synthase form the marine  
γ-Proteobacterium Saccharophagus degradans 2-40 [163], which contains an AGPAT 
domain. 
Myxobacterial pfa gene clusters have been shown to differ from the well-known PUFA 
biosynthetic pathways of marine γ-Proteobacteria and microalgae. They only consist of three 
genes (pfa1, pfa2, and pfa3) arranged in a different order and encoding multifunctional PUFA 
synthases that also differ in their catalytic domain composition [155]. Although the 
organization of the pfa gene clusters is very similar among different myxobacterial species, 
the profiles of the produced fatty acids vary significantly (Table 1 and Figure 10). The 
presence of different types of PUFA biosynthetic pathways with such product diversity within 
the same bacterial suborder (Sorangiineae) is an outstanding aspect in the field of research on 
PUFA biosynthesis and serves as unique selling point with the potential to arouse economic 
interests. 
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Table 1. Overview of the myxobacterial strains with identified and characterized pfa gene clusters and 
correlating MUFA/PUFA production profiles, as determined in the present work.  
OA = oleic acid (18:1, n-9), LA = linoleic acid (18:2, n-6), GLA = γ-linolenic acid (18:3, n-6),  
SDA = stearidonic acid (18:4, n-3), EDA = eicosadienoic acid (20:2, n-6), DHGLA = dihomo-γ-linolenic acid 
(20:3, n-6), AA = arachidonic acid (20:4, n-6), ETA = eicosatetraenoic acid (20:4, n-3), EPA = eicosapentaenoic 
acid (20:5, n-3), DTA = docosatetraenoic acid (22:4, n-6), DPA = docosapentaenoic acid (22:5, n-6 or n-3), and 
DHA = docosahexaenoic acid (22:6, n-3). 
 
Suborder Genus Species Strain 
Type of pfa 
gene cluster 
MUFA/PUFA 
production profile 
Sorangiineae Sorangium cellulosum So ce56 
OA/LA-type pfa 
gene cluster 
OA, isomers of 
octadecenoic acid, LA, 
EDA 
Sorangiineae Sorangium cellulosum So0157-2 
OA/LA-type pfa 
gene cluster 
n.d. 
Sorangiineae Sorangium cellulosum So ce10 
OA/LA-type pfa 
gene cluster 
OA, isomers of 
octadecenoic acid, LA, 
EDA 
Sorangiineae Sorangium cellulosum So ce1525 
OA/LA-type pfa 
gene cluster 
OA, isomers of 
octadecenoic acid, LA, 
EDA 
Sorangiineae Sorangium cellulosum So ce307 
OA/LA-type pfa 
gene cluster 
OA, isomers of 
octadecenoic acid, LA, 
EDA 
Sorangiineae Sorangium cellulosum So ce377 
OA/LA-type pfa 
gene cluster 
OA, isomers of 
octadecenoic acid, LA, 
EDA 
Sorangiineae Sorangium cellulosum So ce38 
OA/LA-type pfa 
gene cluster 
OA, isomers of 
octadecenoic acid, LA, 
EDA 
Sorangiineae Sorangium cellulosum So ce487 
OA/LA-type pfa 
gene cluster 
OA, isomers of 
octadecenoic acid, LA, 
EDA 
Sorangiineae Sorangium cellulosum So ce836 
OA/LA-type pfa 
gene cluster 
OA, isomers of 
octadecenoic acid, LA, 
EDA 
Sorangiineae Sorangium cellulosum So ceGT47 
OA/LA-type pfa 
gene cluster 
OA, isomers of 
octadecenoic acid, LA, 
EDA 
Sorangiineae Sorangium cellulosum So ce969 
OA/LA-type pfa 
gene cluster 
OA, isomers of 
octadecenoic acid, LA, 
EDA 
Sorangiineae Sorangium cellulosum SBSo026 
OA/LA-type pfa 
gene cluster + 
AA/EPA-type 
pfa gene cluster 
OA, isomers of 
octadecenoic acid, LA, 
EDA, GLA, SDA, 
DHGLA, AA, ETA, 
EPA, n-3 DPA 
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Continuation of Table 1. 
 
Suborder Genus Species Strain 
Type of pfa 
gene cluster 
MUFA/PUFA 
production profile 
Sorangiineae Sorangium cellulosum So ce1128 
OA/LA-type pfa 
gene cluster + 
AA/EPA-type 
pfa gene cluster 
OA, isomers of 
octadecenoic acid, LA, 
EDA, GLA, SDA, 
DHGLA, AA, ETA, 
EPA, n-3 DPA 
Sorangiineae Sorangium cellulosum So ce340 
OA/LA-type pfa 
gene cluster + 
AA/EPA-type 
pfa gene cluster 
OA, isomers of 
octadecenoic acid, LA, 
EDA, GLA, SDA, 
DHGLA, AA, ETA, 
EPA, n-3 DPA 
Sorangiineae Sorangium cellulosum So ce427 
OA/LA-type pfa 
gene cluster + 
AA/EPA-type 
pfa gene cluster 
OA, isomers of 
octadecenoic acid, LA, 
EDA, GLA, SDA, 
DHGLA, AA, ETA, 
EPA, n-3 DPA 
Sorangiineae Sorangium cellulosum So ce690 
OA/LA-type pfa 
gene cluster + 
AA/EPA-type 
pfa gene cluster 
n.d. 
Sorangiineae Sorangium cellulosum So ce26 
AA-type pfa 
gene cluster 
AA, DHGLA, DTA, EPA 
Sorangiineae Aetherobacter sp. SBSr001 
DPA/DHA-type 
pfa gene cluster 
AA, EPA, n-6 DPA, n-3 
DPA, and DHA 
Sorangiineae Aetherobacter fasciculatus SBSr002 
DPA/DHA-type 
pfa gene cluster 
AA, EPA, n-6 DPA, n-3 
DPA, and DHA 
Sorangiineae Aetherobacter rufus SBSr003 
DPA/DHA-type 
pfa gene cluster 
AA, EPA, n-6 DPA, n-3 
DPA, and DHA 
Sorangiineae Aetherobacter sp. SBSr008 
DPA/DHA-type 
pfa gene cluster 
AA, EPA, n-6 DPA, n-3 
DPA, and DHA 
Sorangiineae Minicystis rosea SBNa008 
EPA/AA-type 
pfa gene cluster 
AA, EPA, GLA, 
DHGLA, DTA 
Sorangiineae Sandaracinus  amylolyticus NOSO-4 
AA-type pfa 
gene cluster 
AA [128] 
Nannocystineae Plesiocystis  pacifica SIR-1 
AA-type pfa 
gene cluster 
AA [124] 
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Physiological roles of PUFAs in microbes 
The exact function of PUFA biosynthesis by microorganisms remains obscure. However, it is 
known that a dynamic structure of biological membranes, in which the individual components 
are free to spin, wobble, and diffuse laterally within the membrane leaflet, are essential 
requirements for the cells of all organisms. Hence, this lamellar, liquid crystalline phase of the 
membrane is essential for proper functioning and must be preserved in the face of altered 
environmental conditions [164]. Adjustments in various aspects of acyl chain composition are 
among the most thoroughly documented of membrane adaptations to temperature change 
[165]. A nearly ubiquitous response to low temperatures or high hydrostatic pressures is a 
reduction in the proportion of saturated fatty acids (SFAs) and a corresponding increase in the 
proportion of unsaturated fatty acids (UFAs). The introduction of a cis double bond generates 
a bend in the acyl chain and can therefore have a pronounced effect on both the molecular 
shape and physical properties of a phospholipid. Consequently, UFAs decrease the molecular 
order of the acyl chains, promote less compact packing of phospholipids, and possess lower 
melting points than their saturated homologues [165]. Numerous psychrotolerant piezophilic 
deep-sea bacterial isolates were found to contain substantial quantities of n-3 long-chain 
polyunsaturated fatty acids (LC-PUFAs), namely eicosapentaenoic acid (EPA, 20:5, n-3) and 
docosahexaenoic acid (DHA, 22:6, n-3), whereas mesophilic and pressure-sensitive bacteria 
only produce scant amounts thereof. This preponderance of PUFA producers in the deep-sea 
environment led to the speculation that such polyenoic fatty acids are specifically involved in 
the adaptation of bacteria to the high-pressure, low-temperature conditions [166-168]. 
Moreover, it could be demonstrated for Shewanella oneidensis MR-1 that pfa gene products 
serve as precursors for the production of olefinic hydrocarbons, which are proposed to aid in 
adapting cells to a rapid drop in temperature [169]. However, oleic acid (OA, 18:1, n-9) or 
linoleic acid (LA, 18:2, n-6) located at position sn-2 of phosphatidylcholine lower the gel-to-
liquid-crystalline phase transition temperature considerably more effectively than DHA [170]. 
In line with this, it has been shown that OA rather than EPA is required for growth of the 
psychrotolerant piezophilic deep-sea bacterium Photobacterium profundum SS9 at high 
pressure and low temperature [171].  
In general, PUFAs are among the molecules most susceptible to oxygen and reactive 
oxygen species (ROS), because they have many bis-allylic carbon atoms [172]. However, in 
the aqueous system, n-3 LC-PUFAs are rather stable against oxidative stresses caused by 
ROS [173]. An antioxidative function of EPA could be demonstrated in vivo using EPA-
producing Escherichia coli strains that had been transformed with the pfa gene cluster from 
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the marine γ-Proteobacterium Shewanella pneumatophori SCRC-2738. In the recombinant 
E. coli strains grown in the presence of H2O2, cellular EPA seemed to be stable and protected 
cells against harmful effects of H2O2, namely, growth inhibition, carbonylation of cellular 
proteins, and breakage of the cell structure [174;175]. Analogous results have been obtained 
using the marine EPA-producer Shewanella marinintestina IK-1 and its EPA-deficient mutant 
IK-1Δ8 [176]. In bacteria, and probably in microalgae, membrane phospholipids with EPA 
and/or DHA are supposed to function as shield molecules against exogenous and endogenous 
ROS. The molecular mechanism of the membrane-shielding effects of LC-PUFAs has not yet 
been elucidated. Possibly, lipid membranes consisting of phospholipids with saturated fatty 
acids plus LC-PUFAs may form more hydrophobic interfaces between the phospholipid 
bilayers, which could prevent the entry of hydrophilic ROS molecules [177]. Another 
explanation for the protection against oxidative stress might be in terms of a hydroxyl radical 
scavenging capacity of the double bonds of PUFAs [178]. 
Certain members of mesophilic terrestrial myxobacteria, especially of the genus 
Aetherobacter, are capable of synthesizing up to 20% LC-PUFAs of total fatty acids (TFAs). 
This implies important physiological roles of LC-PUFAs in these myxobacteria, which have 
not yet been investigated. Nonetheless, an antioxidative function of LC-PUFAs to protect the 
cells against ROS induced by ultraviolet radiation appears likelier than an adaptation 
mechanism regarding modulation of membrane fluidity. Additionally, it is hypothesized that 
there is a connection between LC-PUFA biosynthesis and secondary metabolism in 
myxobacteria. EPA produced by the Sorangium cellulosum strains SBSo026, So ce1128, 
So ce340, So ce427, and So ce690 may serve as biosynthetic precursor for the secondary 
metabolites maracin/maracen (Chapter 2). Also in case of the antibiotic zeamine produced by 
Serratia plymuthica RVH1, pfa-like genes have been identified in the corresponding 
biosynthetic gene cluster. It is postulated that the Pfa-like proteins and hybrid non-ribosomal 
polypeptide synthetases (NRPSs)/PKSs each synthesize parts of the backbone, which are 
linked together post-assembly [179].  
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Figure 10. PUFA biosynthetic gene clusters from terrestrial myxobacteria of the Polyangiaceae family and 
their corresponding fatty acid products.  
(A) OA/LA-type pfa gene cluster from Sorangium cellulosum (the number of ACP domains is ranging from four 
to five), production of LA > OA > EDA, (B) AA/EPA-type pfa gene cluster from Sorangium cellulosum, 
production of EPA > AA > n-3 DPA > ETA > DHGLA, (C) DPA/DHA-type pfa gene cluster from 
Aetherobacter sp., production of DHA > n-6 DPA > n-3 DPA.  
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Profound analyses of the product spectra of myxobacterial PUFA synthases 
In the present work, selected myxobacterial PUFA biosynthetic pathways have been cloned, 
engineered, and transferred as well as expressed in the heterologous hosts Myxococcus 
xanthus DK1622, E. coli BL21 (DE3), Pseudomonas putida KT2440, and Yarrowia lipolytica 
Po1h. This approach enabled the characterisation of the products of a certain PUFA synthase 
by comparison of the fatty acid production profiles of the myxobacterial producers with those 
of corresponding transgenic host strains. However, recombinant LC-PUFA production 
revealed remarkable differences in the production profile between the native producers and 
the heterologous hosts as well as among the host strains themselves, which might be due to 
the activity of strain-specific housekeeping genes. Nonetheless, rational considerations enable 
the correlation between the different types of myxobacterial pfa gene clusters and the 
synthesized PUFA species (Figure 10).  
In accordance with the results from feeding experiments [155], it can be deduced from 
heterologous expression in M. xanthus DK1622 ([155]; Chapter 2) that the OA/LA-type 
PUFA synthase from S. cellulosum is most likely responsible for the production of isomers of 
octadecenoic acid, EDA, and either of both OA plus LA or of simply OA, which can be 
converted into LA by an oleoyl-coenzyme A (oleoyl-CoA)-Δ12 desaturase (EC 1.14.19.6). 
Candidates for this desaturase could be identified by in silico analysis of the genome of 
M. xanthus DK1622 [130], which comprises 16 genes encoding mostly uncharacterized fatty 
acid desaturases. The genome sequence of S. cellulosum So ce56 encodes at least five 
uncharacterized fatty acid desaturases [131]. In contrast to S. cellulosum, M. xanthus DK1622 
converts LA into GLA, probably catalysed by a linoleoyl-CoA desaturase (EC 1.14.19.3), and 
EDA into DHGLA, possibly via a Δ8 desaturase (EC 1.14.19.4). 
Besides LA and EDA, the LC-PUFAs GLA, stearidonic acid (SDA, 18:4, n-3), DHGLA, 
AA, eicosatetraenoic acid (ETA, 20:4, n-3), EPA, and n-3 DPA are produced by S. cellulosum 
SBSo026 as well as by the transgenic host strain M. xanthus DK1622::pHybPfa1-mx9.2, 
harbouring a hybrid pfa gene cluster comprising gene pfa1 from the OA/LA-type pfa gene 
cluster plus genes pfa2 and pfa3 from the AA/EPA-type pfa gene cluster of S. cellulosum 
SBSo026, in a similar ratio (Table 2). According to this, the proteins Pfa2 and Pfa3 from the 
AA/EPA-type PUFA synthase from S. cellulosum in collaboration with Pfa1 from the 
OA/LA-type PUFA synthase catalyse the synthesis of EPA as major product and of minor 
amounts of other C20 PUFAs with fewer double bonds (AA, ETA, and DHGLA). The 
biosynthesis of n-3 DPA can be accomplished via the elongation of EPA with malonyl-CoA 
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catalysed either by the hybrid PUFA synthase or, less likely, by a separate fatty acid elongase. 
Additional shunt products of the AA/EPA-type PUFA synthase may be GLA and SDA. 
However, these C18 PUFAs could also easily result from degradation of the C20 PUFAs ETA 
and DHGLA via β-oxidation.  
 
Table 2. Ratios of LC-PUFAs synthesized by the native producer S. cellulosum SBSo026 or the 
heterologous host M. xanthus DK1622::pHybPfa1-mx9.2, comprising gene pfa1 from the OA/LA-type pfa 
gene cluster plus genes pfa2 and pfa3 from the AA/EPA-type pfa gene cluster of S. cellulosum SBSo026.  
In each case, the least produced LC-PUFA is given as 1.0.  
 
PUFA 
Ratio of produced LC-PUFAs 
S. cellulosum SBSo026 
M. xanthus DK1622::pHybPfa1-
mx9.2 
γ-linolenic acid  
(GLA, 18:3, n-6) 
1.0 7.0 
stearidonic acid 
(SDA, 18:4, n-3) 
4.5 1.0 
dihomo-γ-linolenic acid  
(DHGLA, 20:3, n-6) 
1.2 2.5 
arachidonic acid  
(AA, 20:4, n-6) 
6.5 43.5 
eicosatetraenoic acid  
(ETA, 20:4, n-3) 
2.0 7.0 
eicosapentaenoic acid  
(EPA, 20:5, n-3) 
  105.5  295.0 
docosapentaenoic acid 
(DPA, 22:5, n-3) 
3.5 2.5 
 
 
Aetherobacter spp. have proven to be prolific produces of a broad range of LC-PUFAs 
because these strains synthesize AA, EPA, n-6 DPA, n-3 DPA, and DHA. The DPA/DHA-
type PUFA synthase encoded by the pfa gene cluster of A. fasciculatus (SBSr002) was 
expressed in various heterologous hosts including M. xanthus DK1622, P. putida KT2440, 
and Y. lipolytica Po1h. The transgenic host strain M. xanthus DK1622::pPfaAf-Ptet-mx9.2 
produces the same LC-PUFAs in a similar ratio like A. fasciculatus (SBSr002) (Table 3). As 
with the native producer, both EPA and DHA are the predominant LC-PUFAs. Surprisingly, 
the transgenic hosts strains of P. putida KT2440 harbouring the native or a synthetic pfa gene 
cluster originating from A. fasciculatus (SBSr002) produce only n-6 DPA and DHA (Table 
3). Trace amounts of AA, EPA, and n-3 DPA can be detected merely in potent overproducing 
strains of P. putida KT2440, but synthesis of the latter LC-PUFAs is not stably reproducible. 
The recombinant strain Y. lipolytica Po1h::pSynPfaPptAf2 clone C, which contains an 
artificial pfa gene cluster originating from A. fasciculatus (SBSr002), heterologously produces 
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AA, ETA, EPA, n-6 DPA, n-3 DPA, and DHA, with a clear preference for DHA (Table 3). 
From this data, in keeping with the results from feeding experiments ([155]; Chapter 3) and 
studies on production kinetics [129], it can be inferred that the PUFA synthase from 
Aetherobacter spp. may only produce DHA and minor amounts of the other C22 PUFAs n-6 
DPA and n-3 DPA. The C20 PUFA EPA is likely a degradation product resulting from the β-
oxidation of n-3 DPA and/or is derived from DHA via β-oxidation plus 2,4-dienoyl-CoA 
reductase (EC 1.3.1.34) and Δ3-Δ2-enoyl-CoA isomerase (EC 5.3.3.8), needed for the 
oxidation of unsaturated fatty acids. In the same degradation pathway, n-6 DPA could be 
converted into AA. Furthermore, there are strain-dependent differences in the synthesis ratios 
of n-6 DPA, n-3 DPA, and DHA, ranging from 2 (n-6 DPA) : 1 (n-3 DPA) : 97 (DHA) in the 
case of Y. lipolytica Po1h::pSynPfaPptAf2 clone C to 1 (n-6 DPA) : 0 (n-3 DPA) : 5.5 (DHA) 
in the case of transgenic host strains of P. putida KT2440. Conceivably, the host-related 
intracellular milieu may have an influence on the functioning and consequently on the product 
spectrum of the PUFA synthase. 
 
Table 3. Ratios of LC-PUFAs synthesized by the native producer A. fasciculatus (SBSr002) or the 
heterologous hosts M. xanthus DK1622::pPfaAf-Ptet-mx9.2, P. putida KT2440 strains harbouring native or 
synthetic pfa gene clusters, and Y. lipolytica Po1h::pSynPfaPptAf2 clone C, comprising the DPA/DHA-
type pfa gene cluster derived from A. fasciculatus (SBSr002).  
In each case, the least produced LC-PUFA is given as 1.0.  
 
PUFA 
Ratio of produced LC-PUFAs 
A. fasciculatus 
(SBSr002) 
M. xanthus 
DK1622::pPfaA
f-Ptet-mx9.2 
P. putida 
KT2440 strains 
harbouring 
native or 
synthetic pfa 
gene clusters 
Y. lipolytica 
Po1h::pSynPfaP
ptAf2 clone C 
arachidonic acid  
(AA, 20:4, n-6) 
5.5 1.0 – 6.0 
eicosatetraenoic acid  
(ETA, 20:4, n-3) 
– – – 1.0 
eicosapentaenoic acid  
(EPA, 20:5, n-3) 
 42.5 2.5 – 13.0 
docosapentaenoic acid 
(DPA, 22:5, n-6) 
1.5 2.5 1.0 19.5 
docosapentaenoic acid 
(DPA, 22:5, n-3) 
1.0 1.1 – 9.0 
docosahexaenoic acid 
(DHA, 22:6, n-3) 
 52.0 32.5 5.5  851.5 
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In-depth analyses of the biosynthetic mechanisms of myxobacterial PUFA synthases and 
the contributing 4'-phosphopantetheinyl transferases (PPTases) 
Deeper understanding of the working principles of PUFA synthases is crucial to fully exploit 
their potential for directed biotechnological production of selected LC-PUFAs. Up to now, 
several genetic and biochemical experiments have been performed with marine pfa gene 
clusters [101;103;154;180]. Unfortunately, these results neither elucidated the exact 
biosynthetic function and underlying biochemistry of every catalytic domain from the PUFA 
synthase complex, nor identified the relevant factor(s) that determine the nature of the final 
LC-PUFA product.  
LC-PUFA biosynthesis catalysed by iteratively acting PUFA synthases is closely related to 
the biosynthesis of SFAs or monounsaturated fatty acids (MUFAs) catalysed by FAS. In both 
assembly lines, the apo-form of ACP must initially be activated to the holo-form by transfer 
of the 4'-phosphopanthetheine (4'-PP) moiety from CoA to an invariant serine residue, as the 
growing fatty acid chain is linked to the 4'-PP prosthetic group of ACP via a thioester bond 
during biosynthesis. This posttranslational modification of ACP is catalysed by  
4'-phosphopantetheinyl transferases (PPTases), which are divided into several types [50]. Sfp-
type PPTases have been shown to be involved in LC-PUFA biosynthesis of Shewanella 
pneumatophori SCRC-2738, Photobacterium profundum SS9, and Moritella marina MP-1 
[82;83]. A homologue of gene pfaE from S. pneumatophori SCRC-2738 and M. marina  
MP-1, encoding the PPTase involved in the 4'-phosphopantetheinylation of PUFA synthases, 
was found in the genome of S. cellulosum (sce5058) and Aetherobacter spp.. Indeed, it could 
be demonstrated via heterologous expression that the PPTase from A. fasciculatus (SBSr002) 
activates the tandem ACPs encoded by the pfa gene cluster of this strain in vivo (Chapter 3). 
Sfp-type PPTases involved in the biosynthesis of polyketides and non-ribosomal peptides 
incorporate the three highly conserved motifs P1, P2, and P3 [181]. Additively, the P0 motif 
could be identified at the amino-terminal region, and motif P1 can be separately recognized as 
P1a and P1b [82]. Conserved residues of P2 and P3 participate in Mg
2+
 binding, whereas 
conserved residues of P1 and P3 are involved in binding of the substrate CoA and in catalysis 
[182]. Consensus sequences of the motifs P0, P1b, P2, and P3 of the Sfp-type PPTases with 
broad substrate specificity Sfp from Bacillus subtilis [183] and MtaA from Stigmatella 
aurantiaca DW4/3-1 [184], of the PUFA synthase-specific Sfp-type PPTases PfaE from 
S. pneumatophori SCRC-2738 and M. marina MP-1, as well as of the PPTases from 
S. cellulosum and Aetherobacter spp. were defined by alignment of the proteins (Table 4). In 
terms of motif P1a, these PPTases can be divided into two groups. For Sfp, MtaA, and the 
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PPTases of S. cellulosum and Aetherobacter spp., the consensus sequence is Y/W/FGXP, 
while KXKP represents the consensus sequence of the PfaE proteins. A possible explanation 
for these deviations might be linked to the different substrates. The identified PPTases are the 
only Sfp-type PPTases encoded by the genomes of S. cellulosum and Aetherobacter spp., but 
these strains contain a number of NRP and PK biosynthetic pathways. Hence, like Sfp and 
MtaA, these PPTases may have the ability to posttranslationally activate a variety of carrier 
proteins. In contrast, the activity of PfaE proteins might be restricted to tandem ACPs of 
PUFA synthases.  
 
Table 4. Conserved motifs in Sfp-type 4’-phosphopantetheinyl transferases (PPTases) involved in the 
biosynthesis of non-ribosomal peptides, polyketides, and polyunsaturated fatty acids. 
 
PPTase      P0 
P1 
P2 P3 
   P1a       P1b 
Sfp  
(Bacillus subtilis) 
VRSVIS   YGKP FNISHS GIDIE WSMKESFIK 
MtaA 
(Stigmatella aurantiaca 
DW4/3-1) 
VRLTLS   YGRP FNLSHT GADVE WTLKEAYIK 
PfaE  
(Shewanella 
pneumatophori SCRC-
2738) 
LRALLS   KGKP FNVSHS GVDIE WALKESYIK 
PfaE  
(Moritella marina MP-1) 
VRDLLS   KDKP FNISHT GCDVE WTLKESYIK 
PPTase  
(Sorangium cellulosum) 
VRXV/TLS F/YGRP FNLSNT GVDVE WTLKESYIK 
PPTase  
(Aetherobacter spp.) 
VRSVLS   WGCP FNLSNT GVDVE WTLKEAYIK 
Consensus L/VRXXL/IS 
  XGXP 
  KXKP 
FNXSH/NT/S GXDV/IE WXL/MKES/AY/FIK 
 
 
In the biosynthesis of LC-PUFAs catalysed by PUFA synthases, acetyl-CoA serves as 
starter molecule, whereas malonyl-CoA, formed by carboxylation of acetyl-CoA using acetyl-
CoA carboxylase (EC 6.4.1.2) [48], is required for all elongation steps (Figure 12). The 
pathway proceeds in two stages, initiation and cyclic elongation. In the initiation phase, an 
acyltransferase (AT) domain transfers the malonyl group of malonyl-CoA to an ACP. The 
AA/EPA-type pfa gene cluster from S. cellulosum and the DPA/DHA-type pfa gene cluster 
from Aetherobacter spp. encode domain AT1 within gene pfa2 and domain AT2 in gene pfa3 
(Figure 10 and 11). Interestingly, the AT2 domain is missing in the OA/LA-type PUFA 
synthase from S. cellulosum (Figure 10). Thus, in conformity with the results obtained from 
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mutated or chimeric PUFA synthases (Chapter 6), it can be speculated that domain AT1 
prevails in the early cycles of the elongation, approximately until the fatty acid chain consists 
of 18 carbon atoms. In the later rounds of elongation, the activity of domain AT2 appears to 
be dominating over the AT1 domain and might contribute to the determination of the final 
chain length of the produced LC-PUFAs (Figure 12).  
At the onset of the elongation cycle, the decarboxylative Claisen condensation of malonyl-
ACP with the acetyl group or the growing acyl chain takes places at the active site cysteine of 
the KS domain. Again, redundancy of domains in PUFA synthases emerges, as all pfa gene 
clusters encode domain KS1 within gene pfa2 and domain KS2 in gene pfa3 (Figure 10). 
Functionality of domain KS2 is supposed to depend on direct interaction with the CLF 
domain, a KS domain that lacks the active site cysteine and is characteristic for type II PKS 
systems [94]. The results from mutated PUFA synthases (Chapter 6) are indicative that 
domain KS1 is only active, if at all, in the early cycles of elongation. In the later rounds of 
elongation, the KS2 domain is expected to catalyse the decarboxylative Claisen condensation 
and to determine the chain length of the produced LC-PUFAs in cooperation with the CLF 
domain (Figure 12), as deciphered by rational domain swaps (Chapter 6). Similar results, that 
indicate the proposed function of the KS/CLF pair, have been obtained for the common type 
II PKS systems from streptomycetes synthesizing the octaketide actinorhodin from 
S. coelicolor A3(2) [185], the decaketide tetracenomycin from S. glaucescens [186], the 
dodecaketide WhiE pigment from S. coelicolor A3(2) [187], or the pentadecaketide 
fredericamycin from S. griseus [188]. In vivo experiments with various PKS hybrids 
suggested that the CLF controls the number of Claisen condensations during polyketide 
assembly and thereby the chain length [94]. Moreover, chimeric KS and CLF genes designed 
from sequences of actinorhodin and tetracenomycin biosynthetic genes reinforced the 
importance of CLF in defining chain length and proposed that the regions of KS and CLF 
which are most important for activity and specificity are located at the interface of this dimer 
[189]. The model of a protein cavity which controls the size of the growing chain is strongly 
supported by the finding that specific residues in the CLF of the actinorhodin biosynthetic 
pathway serve as gatekeepers in the polyketide tunnel. Reducing the size of these residues by 
site-directed mutagenesis lengthened the channel and allowed for two more elongation cycles 
[95]. In the context of KS/CLF structural studies, the number of the residues forming a gate at 
the interface of the dimer was extended, and it was proposed that novel chain lengths could be 
engineered by opening or closing the gates [96]. Regrettably, in silico analyses of the protein 
sequences unveiled that the consensus of these CLFs from streptomycetes and the CLF 
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domains of myxobacterial PUFA synthases are insufficient to assign the gatekeeping residues 
in the latter protein species. However, detailed sequence comparisons of the DPA/DHA-type 
PUFA synthase from Aetherobacter spp., the OA/LA-type PUFA synthase and the AA/EPA-
type PUFA synthase from S. cellulosum strains revealed that the KS2/CLF domains of the 
particular types of PUFA synthases mainly differ from each other in several insertions at 
specific positions (Figure 11). These observations indicate that conversion of a chain length 
determinant specific for PUFAs with a longer chain length into a factor specific for a shorter 
chain length requires the sum of the differences in several regions within the KS2/CLF 
domains rather than simple single amino acid substitutions.  
After elongation of the fatty acyl chain by two carbons, the β-keto group of the 
biosynthetic intermediate is either fully reduced by sequential action of NADPH-dependent 
KR domain, PKS-like DH domain, and NADPH-dependent enoyl reductase (ER) domain or 
only reduced to the trans double bond by the KR domain and a FabA-like DH domain and 
isomerized to the cis double bond by the latter domain. Both FabA-like DH domains of the 
PUFA synthases, DH2 and DH3, turned out to be essential for LC-PUFA biosynthesis, as 
shown by inactivation studies (Chapter 6). Based on the biosynthetic logic, the trans-2 
biosynthetic intermediates have to be alternately isomerized to the cis-3 intermediate, similar 
to the reaction catalysed by the β-hydroxydecanoyl-ACP dehydratase FabA from α- and  
γ-Proteobacteria [52], or converted into the cis-2 intermediate (Figure 12). It seems plausible 
to assume that each of the domains DH2 and DH3 may catalyse only one of these different 
isomerization reactions. Unfortunately, as no short-chain biosynthetic intermediate could be 
detected for the heterologous host strains harbouring the corresponding mutated pfa gene 
cluster (Chapter 6), the two individual FabA-like DH domains cannot be assigned to a distinct 
isomerization. Likewise, in silico analyses of protein sequences are not able to clarify this 
issue, as the outcomes from sequence alignments of FabA from E. coli and either DH2 or 
DH3 are almost indistinguishable (29% versus 26% pairwise identity / 46% versus 44% 
pairwise similarity).  
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Figure 11. Sequence alignment of the KS2/CLF domains of the OA/LA-type PUFA synthase from 
Sorangium cellulosum So ce56, So ce377, So ce38, So ce1525, and So ceGT47, of the DPA/DHA-type PUFA 
synthase from Aetherobacter spp. Sr001, Sr002, Sr003, and Sr008, and of the AA/EPA-type PUFA 
synthase from S. cellulosum So026 and So ce1128. 
 
 
MIEASV FEP IA IVGRGCVLPGALHPAAL WD NVLAGRDLLSAAPDGR WRLSR ERALAQ EGPSARGARDVRDAKDRA WSDRGG YV TG FD EH FRRVLASDP FPRRG
G TP ESLLALDPL FQ WVLHAGR EALR EAGH EGRSDRAGAVLG NLS FPSSA MSA WV ES TWLGDL ------------AGVPRPDPR NR FMSGLPAHLLADVLGLGA
GA FALDAACASSL YA IALAC ERLQDR EADR MLAGAVCRSDDL FMH IG FCALSA MSR TGQSRP FSS EADGLVPA EGAA FVVL ERLSDA EAAGRP ILGV IRG IGL
S NDGRGRGLLAPSV EGQLRA MRAA YA MAGLDPR EVSLL ECHA TG TPLGDA TEIA TLK EV F-GSR EVPLGSLKS NLGHLV TTAGAAGLLKLLGA MAAGVRPP TL
HADPLS EAVASSP FRVLQRA EP WE--GRRLAGLSA FG FGG NNAHLLV EA YEPSSPR ---GRAARAAPQA -----------------AAAASRPVDAGRPAPAG
HLAVVA MGLCVG ELSGVRA FA EPLLSGRGADPRRAAVALPADRLR FPPRDLQQALAQQ TLLL EAA IEA TEGLALPRDR TAVL IG MGAD TEVCR YMTR WRLA ET
APARLGPS ----------VDVGALQDA IIPALQAAGVVG NMP NIPA NRL NSQLDVGGPS FTIAA EELSGP WALRVASRALRAGAVDAA IVGAVDLSC EPAHAA
AL EALGVRLPPGDAAVVLVL ERLDDAVR ERHPVLAVVVD E---------PADPGLVLSS TDLAPR FGHAHAASGLLHVAAAVLACRHGRKPDG ----------
AP WSD EIRVA EVRCAGLGGGSLSVR IGAGGPAAPL
MIEASV FEP IA IVGRGCVLPGALHPAAL WD NVLAGRDLLSAAPDGR WRLSR ERALA --GPSVRGARDVRDAQDRA WSDRGG YVAG FD EH FRRVLARDP FPRRG
GPP ESLLALDPL FQ WVLHAGR EALR EAGH EGRSDRAGAV FG NLS FPSSA MSA WV ES TWLGDL ------------AGVPRPDPR NR FMSGLPAHLLADVLGLGA
GA FALDAACASSL YA IALAC ERLHDR EADR MLAGAVCRSDDL FIH IG FCALSA MSR TGQSRP FSS EADGLVPA EGAA FVVL ERLSDA EAAGRP ILGV IRGVGL
S NDGRGRGLLAPAV EGQLRA MRAA YA TAGLDPR EVSLL ECHA TG TPLGDA TEIA TLK EV F-GSR EVPLGSLKS NLGHLV TTAGAAGLLKLLGA MAAG IRPP TL
HADPLS EAVASSP FRVLQRA EP WE--GRRLAGLSA FG FGG NNAHLLV EA YEPSSPR ---SRAAHAAPQV -----------------AAAASRPVDAARPAPAG
HLAVVA MGLCVG ELSGVRA FA EPLLSGRSADPRRAAVALPADRLR FPPRDLQQALAQQ TLLL EAA IEA TEGLALPRDR TAVL IG MGAD TEVCR YMTR WRLA ET
APARLGPS ----------ADVGALQDA IIPALQAAGVVG NMP NIPA NRL NSQLDVGGPS FTIAA EELSGP WALRVASRALRAGAVDAA IVGAVDLSC EPAHAA
AL EALGVHLPPGDAAVVLVL ERLDDAVR ERHPVLAVVVD E---------PGDPGLVLSS TDLAPR FGHAHAASGLLHVAAAVLACRHGRRLDG ----------
AP WSD EIRVA EVRCAGLGGGSLSVR IGAGGPAAPL
MIEETV FEP IA IVGRGCVLPGALHPAAL WD NVLAGRDLLS TAPDGR WRLSR ERALAH EPRGPRD TRDLRDVKDRA WSDRGG YV TG FD ER FRRVLAGDP FPRRG
GPP EALLALDPL FQ WVL YAGR EALR EAGH EGRSDRAGAVLG NLS FPSSA MSA WV ESA WLGDL ------------AGVPRPDPR NR FMSGLPAHLLADVLGLGA
GA FALDAACASSL YA ISLAC ERLQRR EVDR MLAGAVCRSDDL FIH IG FCALSA MSR TGRSRP FSS EADGLVPA EGAA FVVL ERLSDA EAAGRP ILGV IRGVGL
S NDGRGRGLLAPAV EGQLRA MRSA YA MAGLDPR EVSLL ECHA TG TPLGDA TEIA TL TEV F-GRR EVPLGSLKS NLGHLV TTAGAAGLLKLLGA MAAGVRPP TL
HADPLSDAVAASP FRVLQRA EP WE--GRRLAGLSA FG FGG NNAHLLV EA YEPAARP ---ARAAAAAAPR -----------------PGAS --DVAAA EPAPAG
HLAVVA MGLCVG ELGGVPA FA EALLSGGGADPRRA TVALPADQLR FPPRDLQQALAQQ TLLL EAA IEA TEGLALPRDR TAVL IG MGAD TEVCR YMAR WRLA ET
APARLGPS ----------VDVGALQDAV IPALQAAGV IG NMP NIPA NRL NSQLDVGGPS FTVAA EELSGP WALRVAGSALRAGAVDAA IVGAVDLSC EPAHVA
ALAALGVRLPPGDAAVVLVL ERLDDAVRQRHPVLAVVVD E---------PADPGLVLSA TDLAPR FGHAHAASGLLHVAAAVLACRHARKPDG ----------
TP WSD EVRVA EVRCAGLGGGSLSVC IGAGGPAAPL
MTGA TV FEP IA IVGRGCVLPGALHPAAL WD NVLAGRDLLSSAPAGR WRLSRDRALA ---------RGPGDAADRA WSDRGG YV TA FD EH FRRVLAGDP FPRRA
GPP EDLLALDPL FH WVL YAGR EALR EAGHDGRSDRAGAVLG NLS FPSSA MSA WA ES TWLG EL ------------AGVARPDPR NR FMSGLPARLLADVLGLGA
GA FALDAACASSL YA IALAC ERLQDR EADR MLAGAVCRSDDL FMHVG FCALSALSR TGQSRP FSSAADGLVPA EGAA FVVL ERLSDA EAAGRP IFGV IRGVGL
S NDGRGRGLLAPAV EGQLRA MRAA YA MAGVDPG EVSLL ECHA TG TPLGDA TEIA TLS EV F-GRR EVPLGSLKS NLGHLV TAAGAAGLLKLLGA MAAGVRPP TL
HADPLS EAVAASP FRVLRRP EP WE--GRRLAGLSA FG FGG NNAHLLV EAH EPAARPRGAARGAPAAPQAGVSGAAAPQAGVPGSVGARPAASPAAGSRPAASG
HLAVVA MGLCVG ELSGVRA FTEALLSGGGA EPRR EAVALPADRLR FPPRDLQQALAQQ TLLL EAA IEA TEGLALPR ER TAVLVG MGAD TEVCR YMAR WRLA EA
APARLDPS ----------VDVGALQDA IIPVLQAAGVVG NMP NVPA NRL NSQLDVAGPS FTVAA EELSGP WAL FLASRALRAGAADAA IVGAVDLSC EPAHVA
AL EALGVHLPPGDAAVVLVL ERLDDAVRQGHPVLAVVVD E---------PADPGLVL TA TDLAPR FGHAHAASGLLHVAAAVLACRHARKLDG ----------
AP WSD EVRVA EVRCAGL FGGSLS FR IGAGGPAAPL
MTEA TL FEP IA IVGRGCVLPGALDPAAL WD NV IAGRDLLAAAPAGR WRLSR ERALVGDGR EGRDGR EGRDVRDRA WSDRGG YV TG FD EH FRRVLARDP FSRGG
RP WGDVLALDPL FQ WVLHAGR EALR EAGH EGRSDRAGAVLG NLS FPSSA MSA WA ES TWLGAL ------------AGVPRPDPR NR FMSGLPAHLLADALGLGA
GA FALDAACASSL YA IALAC ERLHDR EVDR MLAGAVCRSDDL FIH IG FCALSALSR TGQSRP FSAAADGLVPA EGAA FVVL ERLSDA EAAGRR ILGV IRGVGL
S NDGRGRGLLAPAV EGQLRA MRAA YA MAGVDPG EVSLL ECHA TG TPLGDA TEIA TL TEV F-GRR EVPLGSLKS NLGHLV TAAGAAGLLKLLAA MDAGVRPP TL
HADPLSDAVAASP FRVLRRA EP WE--GRRLAGLSA FG FGG NNAHLLV EA YEPASPR ---GRA TRVAARG -------------------AAPV TAAASPPAPAG
HLAVVA MGLC IG ELSGVRA FA EPLLSGGGAAPRRADVSLPADRLR FPPRDLQQALAQQ TLLL EAA IEA TEGLALPR ER TAVL IG MGAD TEVCR YMAR WRLAD T
APARLGPS ----------VDVGALRDA IAPVLQAAGVVG NMP NIPA NRL NSQLDVAGPS FTVAA EELSGP WALRLACRALRAG TADAA IVGAVDLSC EPAHAA
AL EALGVHLPPGDAAVVLV IERLDDAVR ERHPVLAVLVD E---------PA EPGLVLSS TDLAPR FGHAHAASGLVHVAAAVLACRHGRKLDG ----------
SP WSD EVRVA EVRCAGLGGGSLSVC IGAGGPPAPL
MTFEP IA IVGQAC TLPGAL TP EAL WA NVLRG ESAV TSPP EGR WRLPA WHA MG ----------KPGAQ EERA WSDAGG YVRG FDSV FD -------PGGLR
VP EA ELRGLDPV FQ WTLH TARAALRSAG MEGPSARAGLVLG NLS FP TAS MSR YA ESV WL EALGK ELLGGRAAALAGVSHPDAH NR FMSGLPAHLAAQALGLGG
GA FALDAACASSL YA IKLACDRLQDRAADL MLAGAV NAADSL FLH IG FSALSA MSR TGQSRP FHR EADGLVPS EGAV FFALQRLDDARAAGRRVLG IIRGVGL
S NDGRGRGLLAPS EEGQ IRA MRLA YTAAGL TPSDVS FV ECHA TG TPVGDA TEIRSLSDV FAGCRDVP IGSLKS NLGHL ITAAGGAGL IKVLGS FTA ETIAP TI
HAGAS IP ELAGSPVRLV TQA EP WRAAGRR IAA ISA FG FGG NNAHL IV EQDDGR ------------------------------------A TAPRAAA TRSAPA
P IAVVSLGAR IG ETTGRD EAARALLSGAG WGSRR EAV TV EL EGLR FPPRDL EQ TLPQQLLVL EAGR EA IRGLSLPRDR TAVL IG MGADP EVAR YGAR WRLPA F
ADA WS TAG -----LPVSSA WTEAARDAVQ EQHGAAGVVGA MP NIPA NRLSSQLDLAGPS FTISS EELSGVVALQLAARALRSG EIDAALVGAVDLADQ IVHR E
ALG ELGL EPRAGDAAVALVLKRL TDVR -KS EKVLA ILD EG IVDASSDPARLRVGDGGADLDP FA TTGKPHAA TGLAHVAAAVLALHHGARPAP ------GRAS
MP WVGP -RHA EV TTQALGDQAA TIHLRGGGPAAPL
MTFEP IA IVGQAC TLPGAL TP EAL WA NVLRG ESAV TSPP EGR WRLPA WHA MG ----------KPGAQ EERA WSDAGG YVRG FDSV FD -------PGGLR
LP EA ELRGLDPV FQ WTLH TARAALRSAG MEGPSARAGLVLG NLS FP TAS MSR YA ESV WL EALGK ELLGGRAAAQAGV THPDAH NR FMSGLPAHLAAQALGLGG
GA FALDAACASSL YA IKLACDRLQDRAADL MLAGAV NAADSL FLH IG FSALSA MSR TGQSRP FHR EADGLVPS EGAV FFALQRLDDARAAGRRVLG IIRG IGL
S NDGRGRGLLAPS EEGQ IRA MRLA YAAAGL TPSDVS FV ECHA TG TPVGDA TEIRSLSDV FAGCRDVP IGSLKS NLGHL ITAAGGAGL IKVLGS FTA ETIAP TI
HAGAS IP ELAGSPVRLV TQA EP WRAAGRR IAA ISA FG FGG NNAHL IV EQDDGR ------------------------------------A TA TRA TA TRSAPA
P IAVVSLGAR IG ETTGRD EAARALLSGAG WGSRR EAV TV EL EGLR FPPRDL EQ TLPQQLLVL EAGR EA IRGLSLPRDR TAVL IG MGADP EVAR YGAR WRLPA F
ADA WA TAG -----LPVSSA WTEAARDAVQ EQHGAAGVVGA MP NIPA NRLSSQLDLAGPS FTISS EELSGVVALQLAARALRSG EIDAALVGAVDLADQ IVHRQ
ALG ELGL EPRAGDAAVALVLKRL TDVR -KS EKVLA ILD EG IVDASSDPARLRVGDGGADLDP FAA TGKPHAAAGLVHVAAAVLALHHGARPAP ------GRAS
MP WVGP -RHA EV TTQALGDQAA TIHLRGGGPAAPL
MTFEP IA IVGQAC TLPGAL TP EAL WA NVLRG ESAV TSPP EGR WRLPA WHA MG ----------KPGAQ EERA WSDAGG YVRG FESA FD -------PGGLR
LP EA ELRGLDPV FQ WTLH TARAALRSAG MEGPSARAGLVLG NLS FP TAS MSR YA ESV WL EALGK ELLGGRAAAQAGV THPDAH NR FMSGLPAHLAAQALGLGG
GA FALDAACASSL YA IKLACDRLQDRA TDL MLAGAV NAADSL FLH IG FSALSA MSR TGQSRP FHR EADGLVPS EGAV FFALQRLDDARAAGRRVLG IIRGVGL
S NDGRGRGLLAPS EEGQ IRA MRLA YAAAGL TPSDVS FV ECHA TG TPVGDA TEIRSLS EV FAGCRDVP IGSLKS NLGHL ITAAGGAGL IKVLGS FTA ETIAP TI
HAGAS IP ELAGSPVRLV TQA EP WRAAGRR IAA ISA FG FGG NNAHL IV EQDDGR ------------------------------------A TAPRAAAPRSAPA
P IAV ISLGAR IGD TTGRD EAARALLSGAG WGSRR EAV TV EL EGLR FPPRDL EQ TLPQQLLVL EAGR EA IRGLSLPRDR TAVL IG MGADP EVAR YGAR WRLPA F
ADA WAAAG -----LPVSSA WTEAARDAVQ EQHGAAGVVGA MP NIPA NRLSSQLDLAGPS FTISS EELSGVVALQLAARALRSG EIDAALVGAVDLADQ IVHRK
ALG ELGL EPRAGDAAVALVLKRL TDVR -KS EKVLA ILD EG IVDASSDPARLRVGDGGADLDP FA TTGKPHAAAGLVHVAAAVLALHHGARPAP ------GRAS
MP WVGP -RHA EV TTQALGDQAA TIHLRGGGLAAPL
MTFEP IA IVGQAC TLPSAL TP EAL WA NVLRG ESAV TSPP EGR WRLPA WHA MG ----------TPGAQ EERA WSDAGG YVRG FESV FD -------PSGLR
LP EA ELRRLDPV FQ WTLH TAR TALRSAG MEGPSARAGLVLG NLS FPSAS MSR YA ESV WFEALGQ EFLGGRAAAQAGV THPDAH NR FMSGLPAHL TAQALGLGG
GA FALDAACASSL YA IKLACDKLHDRAADL MLAGAV NAADSL FLH IG FSALSA MSR TGQSRP FHR EADGLVPS EGAV FFALQRLDDARASGRP ILG IIRG IGL
S NDGRGRGLLAPS EEGQ IRA MRLA YAAAGL TPSDVS FV ECHA TG TPVGDA TEIRSLADV FAGRRDVP IGSLKS NLGHL ITAAGGAGL IK ILGS FTA ETIAP TI
HAGAS IP ELAGSPVRLV TQA EP WRA TGRR IAA ISA FG FGG NNAHLLV EQDDG -------------------------------------AKAPRASAPRPAP T
P IA IVGLGAR IGD TTGRD EAARALLSGAG WGSRR EAV TV EL EGLR FPPRDL EQ TLPQQLLVL EAGR EA IRGLSLPRDR TAVL IG MGADP EVAR YGAR WRLPA F
ADA WSASG -----LPVSDA WIEASRDAVQAQHGAAGVVGA MP NIPA NRLSSQLDLAGPS FTISS EELSGVVALQLAARALRSG EIDAALVGAVDLADQ IVHRK
ALG ELGL EPRAGDAAVALVLKRLDDVR -DG EEVLALV EEG ---ASDDP TRLRVGDGA TDLDP FAK TGKPHAA TGLVHVAAAVLALHHGARPAP ------GRAS
MP WVGP -RSAAV TTQALGDQAA TIHLRSAGPAAPL
MR FEP IA IVGQGCVLPGALSPRAL NEAVRARRCAV TGAP EGRLRLSAAHA MG ----------PADQAGDR MWSDAGG YV EG FEPA FD -------AAG FQ
LD EGVVRALDPSLK WVLHAGR EALRPLGHDRASARAGLALG NLS FP TPA MAR YA EGV WLDAQGAA FLDGAARG FAAS ERPDPRSR FMSGLPASLAA EALGLGG
GG FALDAACASSL YA IKLACDRLHDR TADL MLAGAV NAADPL FLH MG FCALAA MSRSGASRP FHRDADGLVPA EGAALVALKRLADARAAGDRVLGV IRG IGL
S NDGRGRGLLSPS EEGQ IRA MRLA YAAAGL TPADVS MIECHA TG TLVGDA TEVRS TAAV FEGQRDVP IGSLKS NLGHL ITAAGAAGL MKVLGAL EAGVRPA TL
HA EAP IEALRGSP FRLLA EEEP WPSDRPRVAAVSA FG FGG NNAHLLVSQDDAHDDL ---------------------------------G TAPAS FVPARPRP
AVA IIG IGA MLGD TTGAP EAARAVLGG EP WTPRRA EVAVAQ EGLR FPPRDL EQ TLPQQLLV FEAAR EA IAG ISVPR ER TGVLVG MGCDP EVAR YGLR WRLADL
ADA WSSSSPARGDHKAPPD WLGQARDAVLPKL TAVGVLG TMP NIPA NR ISSQLDLGGPG YTVSA EQASGVVAL EIAARALR EG ELDAAVVAAVDLSD EPVHRA
ALSALG IETP TGDAAVALVLKRLDDARRDGDHVLA ELD EE------GAPALRVGDGDGAVDPLAR -GAAHAAAGLLHVAAAA WSVHHGARPARSAVGSGARGA
AP WFGA -R TA ETR TRVLGGADASVRLSARGPAAPL
MR FEP IA IVGQGCVLPGALSPRAL NEAVRARRSAV TGAP EGRLRLSAAHA MG ----------PADQAGDR MWSDAGG YV EG FEPA FD -------AAG FQ
LDADVVRALDPSLK WVLHAAR EALRPLGHDR TSARAGLVLG NLS FP TPA MAR YA ESV WLDAQGAA FLDGAARG FAAS ERPDPQSR FMSGLPAALAA EALGLGG
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Figure 12. Anaerobic biosynthesis of polyunsaturated fatty acids (PUFAs) by myxobacterial iterative type 
I fatty acid synthase (FAS)/polyketide synthase (PKS)-like PUFA synthases encoded by a pfa gene cluster.  
The primer molecule (in the form of acetyl-CoA) undergoes several rounds of decarboxylative Claisen 
condensation reactions, resulting in the elongation of the fatty acyl chain by two carbons (derived from malonyl-
CoA) per cycle. Following each round of elongation, the β-keto group is either fully reduced or only reduced to 
the trans double bond which is then isomerized with or without shifting the position (3). The intermediate then 
functions as a starter substrate for the next round of elongation with malonyl-ACP, and an acyl chain with 
methylene-interrupted cis double bonds is synthesized. The chain length is probably determined by the action of 
AT2 and/or CLF (1+2). The fatty acyl-ACP can then serve as substrate for the acylation of the 2-position of  
1-acyl-sn-glycerol-3-phosphate catalysed by AGPAT during glycerophospholipid biosynthesis (4). 
 
Figure x. Anaerobic biosynthesis of polyunsaturated fatty acids (PUFAs) by iterative type I fatty acid
synthase (FAS)/polyketide synthase (PKS)-like PUFA synthases encoded by a pfa gene cluster.
The primer molecule (in the form of acetyl-CoA) undergoes several rounds of decarboxylative Claisen
condensation reactions, resulting in the elongation of the fatty acyl chain by two carbons (derived from malonyl-
CoA) per cycle. Following each round of elongation the β-keto group is either fully reduced or only reduced to
the trans double bond which is then isomerized with or without shifting the position (3). Finally, an acyl chain
with methylene-interrupted cis double bonds is synthesized. The chain length is probably determined by the
action of AT2 and/or CLF (1+2). The fatty acyl-ACP can then serve as substrate for the acylation of the 2-
position of 1-acylglycerol-3-phosphate catalysed by AGPAT during glycerophospholipid biosynthesis (4).
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When the fatty acid chain with methylene-interrupted cis double bonds reaches its final 
length, the product is either released from ACP as free fatty acid by a discrete thioesterase, as 
presumed for Schizochytrium sp. ATCC 20888 [87] and P. profundum SS9 [88], or the acyl 
chain is directly transferred from ACP into glycerophospholipids. In the latter case, the 
acylation of the 2-position of 1-acyl-sn-glycerol-3-phosphate utilising either acyl-ACP or 
acyl-CoA thioesters as substrate can be performed by AGPAT [190] (Figure 12). An AGPAT 
domain was also discovered in silico at the carboxyl-terminus of Pfa3. Since its activity could 
not been verified via an in vitro enzyme assay, detailed sequence analyses may help to 
provide some information about its functionality. Four highly conserved motifs were found to 
be incorporated into AGPATs, such as PlsC from E. coli [191] and human AGPAT1 [192]. 
Unfortunately, basic information regarding topology of PlsC and the key residues involved in 
catalysis are lacking. However, for the human homologue, site-directed mutagenesis revealed 
the importance of all the motifs for AGPAT catalysis, and important catalytic amino acid 
residues were identified [192] (Table 5). These results suggest that conserved residues of 
motifs 2 and 3 are involved in binding of 1-acyl-sn-glycerol-3-phosphate and motifs 1 and 4 
are involved in acyl-CoA binding and catalysis [191;192]. Sequence alignments of PlsC, 
AGPAT1, and AGPAT domains of the PUFA synthases from S. cellulosum and 
Aetherobacter spp. were performed, disclosing the conserved motifs within the myxobacterial 
AGPAT domains (Table 5). Amino acid residues identical or at least similar to those of PlsC 
and AGPAT1 could be found at putative catalytic sites, which serve as indicator for a proper, 
proposed functioning of the AGPAT domains.  
  
DISCUSSION 
218 
 
Table 5. Conserved motifs in 1-acylglycerol-3-phosphate O-acyltransferases (AGPATs) involved in the 
glycerophospholipid biosynthesis.  
The most important catalytic amino acid residues determined for AGPAT1 [192] as well as the glutamic acid 
residue exchanged by site-directed mutagenesis of the AGPAT domain from Aetherobacter fasciculatus 
(SBSr002), leading to a very low LC-PUFA production (< 10% of the production rate of non-mutated PUFA 
synthase) (Chapter 6), are shown in italics. 
 
AGPAT Motif 1 Motif 2 Motif 3 Motif 4 
PlsC 
(Escherichia coli) 
NHQNNYD LIDR MFPEGTR     VPIIPV 
AGPAT1 
(Homo sapiens) 
NHQSSLD FIDR VFPEGTR     VPIVPI 
AGPAT domain of OA/LA-
type PUFA synthase  
(Sorangium cellulosum) 
NHQVG/AVE YFDR VHVEGTR   V/APVVPV 
AGPAT domain of AA/EPA-
type PUFA synthase  
(Sorangium cellulosum) 
NHQVAVE FFDR VHVEGTR     APIVPV 
AGPAT domain of DPA/DHA-
type PUFA synthase  
(Aetherobacter spp.) 
NHQVALE FFDR VHVEGTR A/TP/LIVPV 
consensus NHQXXXD/E XXDR V/MXXEGTR XP/LI/VV/IPV/I 
 
 
In conclusion, it can be stated that the identification of different types of myxobacterial 
PUFA synthases and the establishment of heterologous expression platforms, which allow 
genetic engineering of the myxobacterial PUFA biosynthetic pathways, provided the basis for 
studying the exact working principles of PUFA synthases and thus, for full exploitation of 
their potential for directed biotechnological production of selected LC-PUFAs. 
 
 
 
Exploring different host strains for efficient heterologous PUFA production employing 
myxobacterial PUFA synthases 
Myxobacteria have been characterized as producers of a wide range of different LC-PUFAs, 
such as AA, EPA, or DHA [127-129], employing unique biosynthetic gene clusters [155]. 
Regretfully, most myxobacteria are characterized by slow growth behaviour, and particularly 
for novel myxobacterial isolates, tools for the genetic modification are not readily available. 
Hence, Synthetic Biotechnology approaches for lateral transfer of the PUFA biosynthetic 
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pathways into a well-developed surrogate host and for further engineering of the host strain 
are an attractive alternative to overproduce the LC-PUFAs of interest. 
In the present work, the OA/LA-type pfa gene clusters from S. cellulosum So ce56 and 
SBSo026, the AA/EPA-type pfa gene cluster from S. cellulosum SBSo026, and the 
DPA/DHA-type pfa gene clusters from A. fasciculatus (SBSr002) and Aetherobacter sp. 
(SBSr008) have been transferred and expressed into the myxobacterial model strain  
M. xanthus DK1622 ([155]; Chapter 2). Therefore, the gene clusters were directly cloned 
from the genome of the producing strain into cloning vectors via linear plus linear 
homologous recombination in E. coli [143]. The obtained plasmids were further engineered 
by applying conventional cloning techniques or linear to circular homologous Red/ET 
recombination [144] in order to insert genetic elements adapted to the host organism, such as 
genes for the integration into the genome and heterologous promoters (Tn5 promoter plus 
tetracycline promoter). The yields of DHA produced by the native producer A. fasciculatus 
(SBSr002) and the heterologous host (1.6 mg/l versus 1.2 mg/l) are comparable. However, 
using M. xanthus DK1622::pPfaAf-Ptet-mx9.2, harbouring the DPA/DHA-type pfa gene 
cluster from A. fasciculatus (SBSr002) site-specifically integrated at Mx9 attB2 site of the 
genome, the fermentation time is 3.5-fold reduced (two versus seven days) (Figure 13). In 
general, M. xanthus is readily utilised for the heterologous expression of gene clusters from 
slower growing myxobacteria. Common compounds produced in this manner are epothilone, 
myxochromide S, and myxothiazol. While the yield of recombinant epothilone was 
disappointing (0.1 mg/l in M. xanthus DK1622 [193]), production could be doubled for 
myxothiazol (20 mg/l in M. xanthus DZF1 versus 10 mg/l in the native producer 
S. aurantiaca DW4/3-1 [194]) and enormously raised in case of myxochromide S (1 g/l in 
M. xanthus DK1622 versus 8 mg/l in the native producer S. aurantiaca DW4/3-1 [193]). 
According to this, M. xanthus has been proven to be a popular host for the heterologous 
expression of myxobacterial gene clusters, albeit the current unpredictability of the yield.  
Successful heterologous expression of a biosynthetic pathway in genetically distant 
microbes poses a major challenge, as codon usage bias and functionality of regulatory 
elements and promoter structures in both native producer and host are unlikely. The 
DPA/DHA-type pfa gene cluster from A. fasciculatus (SBSr002) was cloned into replicative 
plasmids under control of inducible promoter systems (xylS-Pm or araC-PBAD) suitable for the 
easy to handle host strains E. coli, the best studied bacterial model strain, as well as P. putida 
KT2440, a genetically amenable and metabolically versatile microbe [146], which is generally 
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recognized as safe (GRAS) (Chapter 3). Using initial expression constructs, P. putida 
KT2440 turned out to be a fast-growing and reliable host organism for heterologous LC-
PUFA production with a higher and more robust production rate of DHA compared to E. coli 
(0.3 mg/l after 28 h of cultivation for P. putida KT2440 + pJBPfaAf1 versus 0.2 mg/l after  
27 h of cultivation for E. coli BL21(DE3)/pJBPfaAf4/pPptAfD) (Figure 13). The low GC-
content of the genome sequence from E. coli and its codon usage make it apparently rather 
unsuitable for the expression of myxobacterial genes. Using the Graphical Codon Usage 
Analyser software tool [195], the fraction of usage of each codon in the sequences of the 
DPA/DHA-type pfa gene cluster from A. fasciculatus (SBSr002) was computed and plotted 
against the fraction of usage of the codon in the hosts. In fact, a mean difference of 17% was 
obtained for P. putida, whereas a value of 48% was acquired for E. coli. The assertion, that 
deviations in the codon usage of the native producer and E. coli are the most reasonable 
explanation for the low production rate, is supported by the outcome of an additional 
comparison: The mean difference of codon usage in the coding sequences from E. coli and in 
the EPA-type pfa gene cluster from the marine γ-Proteobacterium S. pneumatophori SCRC-
2738 is only 27%, and in fact, heterologous expression of this gene cluster located on a 
cosmid under control of its native promoters in E. coli yielded 3.3 mg/g cell dry weight 
(CDW) after 72 h of cultivation [196]. In contrast, E. coli BL21(DE3)/pJBPfaAf4/pPptAfD 
only synthesizes 0.1 mg DHA/g CDW after 27 h of cultivation (Chapter 3). The produced 
amounts of EPA plus DHA among the corresponding native producers, however, are 
comparable [76;155].  
In the follow-up work, P. putida was chosen as preferred chassis for expression of the pfa 
gene cluster, and efforts were undertaken to further improve the production yield. 
Modification of the expression constructs to increase the expression rate of the pfa genes, 
genetic and metabolic engineering of the strain (Chapter 3), and adaptation of the sequences 
of the pfa genes to the host (Chapter 4) gave rise to a ten-fold increase in DHA production 
rate (3 mg/l after 28 h of cultivation for P. putida KT2440::pfadH_KO/pME2 + 
pPm**SynPfaAf2a). This gain significantly surpasses the LC-PUFA production rate achieved 
with the native myxobacterial producer, even in a six-fold reduced fermentation time 
(Figure 13). Despite the obvious potential of pseudomonads in biotechnological processes, 
only a few examples for the heterologous expression of myxobacterial natural product 
biosynthetic pathways in these bacteria are described in literature. Prominent instances for this 
involve gene clusters from S. aurantiaca DW4/3-1: An enormous increase in the production 
rate was achieved in case of myxochromide S in the heterologous host P. putida KT2440 
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(production of up to 40 mg/l in two to three days) compared to the native producer 
(production of 8 mg/l in six days) [197]. However, a drastic reduction in the yield of 
myxothiazol (production of 10 mg/l in the native producer) could be observed using 
the heterologous host P. putida KT2440 (production of 0.6 mg/l in two to three days) [198].  
Techniques and methodologies of Synthetic Biology were exploited to implement redesign 
and subsequent synthesis of the DPA/DHA-type pfa gene cluster from A. fasciculatus 
(SBSr002) adapted to the hemiascomycetous, oleaginous yeast Y. lipolytica under control of 
the strong hybrid hp4d promoter [199] (Chapter 5). This yeast has emerged as a promising 
host for heterologous protein production [199-201], and several processes based on 
Y. lipolytica were classified as GRAS by the food and drug administration (FDA). The 
transgenic strain Y. lipolytica Po1h::pSynPfaAf2 clone C is by far the best heterologous LC-
PUFA producer utilizing the DPA/DHA-type myxobacterial PUFA synthase (70.4 mg/l after 
seven days of cultivation) and thus clearly beats the native producer with a 44-fold increase in 
DHA yield (Figure 13).  
Over the course of studies on the heterologous expression of myxobacterial pfa gene 
clusters, it became obvious that in case of integrative expression constructs the random 
integration into the genome of a host yielded highly productive clones. This has been 
demonstrated for transgenic strains of Y. lipolytica Po1h (Chapter 5) or M. xanthus DK1622 
[155] and can be illustrated well by an example: In regard to production yields of 
octadecenoic acid, LA, GLA plus EDA, integration of the OA/LA-type pfa gene cluster from 
S. cellulosum So ce56 into the genome of M. xanthus DK1622 via transposition and screening 
for a good producer resulted in a yield of 11.3 mg/l [155]. Hence, this strategy was superior to 
the site-specific integration of the homologous gene cluster from S. cellulosum SBSo026 at 
Mx9 attB2 site of M. xanthus DK1622, which generated 3.4 mg/l (Chapter 2). The produced 
amounts of these fatty acids among the corresponding native producers, however, are 
comparable ([155]; Chapter 2). 
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Figure 13. Yields of DHA produced by Aetherobacter fasciculatus (SBSr002) and different host strains 
with native or synthetic DPA/DHA-type pfa gene clusters after appropriate cultivation times in a shake 
flask. 
 
 
 
Comparison of different recombinant enzyme systems for LC-PUFA production in the 
oleaginous yeast Yarrowia lipolytica 
As already mentioned, the yeast Y. lipolytica has turned out to be especially suitable for 
heterologous LC-PUFA production not least because of the ability to accumulate large 
amounts of lipids (up to 50% of its cell dry weight, depending on the growth conditions) 
[202]. As a consequence, DuPont (USA) invested in the engineering of a Y. lipolytica strain 
capable of producing large amounts of EPA [203]. Contrary to Y. lipolytica 
Po1h::pSynPfaAf2 clone C, which employs a DPA/DHA-type myxobacterial PUFA synthase 
for heterologous LC-PUFA production, DuPont made use of alternatingly acting position-
specific desaturases and elongases (Figure 14). These aerobic enzyme systems allow for the 
introduction of double bonds into SFAs and MUFAs synthesized by FAS and their 
elongation. In order to ensure efficient expression of the heterologous genes in Y. lipolytica, 
integration vectors with codon-optimized coding sequences driven by strong Y. lipolytica 
promoters were constructed [203]. In total, a C16/18 elongase gene originating from 
Mortierella alpina, two copies of a Δ12 desaturase gene originating from Fusarium 
moniliforme, three copies of a Δ9 elongase gene and two copies of a mutant Δ8 desaturase 
gene originating from Euglena gracilis, three copies of Δ5 desaturase genes originating from 
E. gracilis and Peridinium sp., and three copies of a Δ17 desaturase gene originating from 
Figure x. Yields of DHA produced by Aetherobacter fasciculatus (SBSr002) and different host strains with
native or synthetic DPA/DHA type pfa gene clusters after appropriate cultivation times.
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Pythium aphanidermatum have been integrated into the genome and expressed. In addition to 
the fatty acids produced by the corresponding wild type, the resulting strain Y. lipolytica 
Y4086 synthesizes 6.9% α-linolenic acid (ALA, 18:3, n-3), 7.6% EDA, 1% DHGLA, 2% 
ETA, and 9.8% EPA of TFAs [204]. As opposed to this, simply four synthetic genes encoding 
the DPA/DHA-type myxobacterial PUFA synthase and the PPTase originating from 
A. fasciculatus (SBSr002) were integrated into the genome of Y. lipolytica Po1h::pSynPfaAf2 
clone C and expressed (Chapter 5). This strain produces 8.9% DHA of TFAs, thus amounts 
comparable to those of EPA produced by Y4086, but only 0.5% of TFAs of the unpreferred 
LC-PUFA shunt or degradation products. Substantial advantages of LC-PUFA biosynthesis 
via PUFA synthases as against exploitation of the aerobic pathways are the low consumption 
of NAD(P)H and the independence from endogenous fatty acids as biosynthetic precursors. 
For instance, de novo synthesis of EPA catalysed by PUFA synthases merely relies on ten 
molecules of acetyl-CoA/malonyl-CoA and 13 molecules of NADPH. However, using the 
aerobic route in which palmitic acid (synthesized by FAS using eight molecules of acetyl-
CoA/malonyl-CoA and 14 molecules of NADPH) is converted into EPA via diverse fatty acid 
desaturases and elongases, additionally two molecules malonyl-CoA plus nine molecules 
NAD(P)H are consumed.  
Beyond the integration of an aerobic EPA biosynthetic pathway, the transgenic strain 
Y4086 was further engineered by DuPont to improve the flow of fatty acids into EPA 
biosynthesis [203]. Accordingly, one additive copy of the Δ12 desaturase gene as well as of 
the Δ9 elongase gene plus two additional copies of mutant Δ8 desaturase genes have been 
integrated and expressed. Remarkably, the generated strain Y4128 produces 38% EPA of 
TFAs. Taking a closer look at the genome sequence of this strain disclosed that the integration 
cassette of the expression plasmid inadvertently interrupted the coding region of the 
peroxisomal biogenesis factor 10 (PEX10) gene. Pex10p is necessary for normal peroxisome 
morphology and functions in the peroxisomal protein import by interacting with other Pex 
proteins [205]. It can be deduced from further experiments that the loss-of-function mutation 
causes a defect in β-oxidation and therefore has a considerable impact on lipid accumulation 
[203]. Subsequent strain engineering involved the integration and expression of two additive 
copies of the Δ12 desaturase gene, three copies of Δ9 elongase genes originating from 
E. gracilis and Eutreptiella sp., three additional copies of mutant Δ8 desaturase genes, two 
extra copies of the Δ5 desaturase gene originating from E. gracilis, and two copies of the 
cholinephosphotransferase 1 gene from Y. lipolytica. Other open reading frames of interest 
which were accidentally disrupted by integration events are the lipase 1 gene LIP1 and gene 
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SCP2, encoding a sterol carrier protein. The final strain Y4305 contains 30 copies of nine 
different genes and produces EPA at 56.6% of TFAs (mainly incorporated into 
triacylglycerols) and less than 5% SFAs of TFAs. The resulting yeast based production 
process has already been translated into an industrial process as sustainable source of EPA, 
and two commercial products have been developed: NewHarvest EPA-rich oil (a human 
nutritional supplement) and Verlasso sustainably farmed salmon (where the yeast serves as 
aquaculture feed) [203].  
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Figure 14. Simplified scheme for the comparison of LC-PUFA production in recombinant strains of 
Yarrowia lipolytica engineered in the present work and by DuPont. 
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Figure x. Simplified scheme for the comparison of LC-PUFA production in recombinant strains of
Yarrowia lipolytica engineered in the present work or by DuPont.
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OUTLOOK 
In the present work, three different types of myxobacterial polyunsaturated fatty acid (PUFA) 
synthases with distinct product spectra have been identified and characterized from 
S. cellulosum and Aetherobacter spp.. These kinds of iteratively acting type I fatty acid 
synthase (FAS)/polyketide synthase (PKS)-like enzymes are specific for de novo biosynthesis 
of the major products linoleic acid (LA, 18:2, n-6), eicosapentaenoic acid (EPA, 20:5, n-3), or 
docosahexaenoic acid (DHA, 22:6, n-3). Moreover, some myxobacteria, such as Plesiocystis 
pacifica, Phaselicystis flava, and Minicystis rosea, have been found to produce considerable 
amounts of arachidonic acid (AA, 20:4, n-6) [124;127]. There is evidence that these 
myxobacteria synthesize this long-chain PUFA (LC-PUFA) by use of AA-type PUFA 
synthases. Characterization and analysis of the putative fourth type of myxobacterial PUFA 
synthase in comparison with the already described myxobacterial de novo PUFA biosynthetic 
pathways would contribute to the understanding of the mechanisms underlying determination 
of the main LC-PUFA product.  
Establishment of an efficient expression system for heterologous PUFA production 
employing myxobacterial PUFA synthases is a major challenge. Successful DHA production 
could be implemented in the host Pseudomonas putida KT2440 by use of the PUFA 
biosynthetic pathway from Aetherobacter fasciculatus (SBSr002). Expression of the 
biosynthetic genes was significantly improved using mutated versions of a heterologous 
promoter. Therefore, construction of a synthetic promoter library, identification of strong 
promoter variants prior to further tuning expression of the recombinant PUFA genes appears 
to be the obvious choice for future experiments. Nevertheless, the oleaginous yeast Yarrowia 
lipolytica expressing the PUFA synthase from A. fasciculatus (SBSr002) turned out to be by 
far the best of the generated DHA producers. Hence, most efforts should be directed towards 
further increase of the DHA production rate in the transgenic strain. Obviously, this will 
involve metabolic engineering in order to achieve accumulation of recombinantly produced 
LC-PUFAs (e.g. by preventing degradation of DHA via β-oxidation and/or by diverting 
allocation of incorporated DHA from the phospholipid fraction toward triacylglycerols) in 
combination with the establishment of tailored fermentation and downstream processes. 
Besides, exploitation of the diversity of myxobacterial PUFA biosynthetic pathways is 
targeted to create chimeric PUFA synthases for Y. lipolytica with deliberately directed product 
spectra.  
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